1	Journal	NNP	O	Journal	_	0	SENT_1	[p1l41t81r128b109],
2	of	IN	O	of	_	0	SENT_1	[p1l138t81r164b103],
3	the	DT	O	the	det	5	SENT_1	[p1l171t81r207b103],
4	American	NNP	ORGANIZATION	American	nn	5	SENT_1	[p1l217t81r333b103],
5	College	NNP	ORGANIZATION	College	prep_of	1	SENT_1	[p1l344t81r432b111],
6	of	IN	ORGANIZATION	of	_	0	SENT_1	[p1l443t81r470b103],
7	Cardiology	NNP	ORGANIZATION	Cardiology	nn	8	SENT_1	[p1l477t81r607b111],
8	Vol	NNP	ORGANIZATION	Vol	prep_of	1	SENT_1	[p1l1869t81r1916b103],
9	.	.	O	.	_	0	SENT_1	[p1l1869t81r1916b103],

1	47	CD	NUMBER	47	_	0	SENT_2	[p1l1928t82r1963b108],
2	,	,	O	,	_	0	SENT_2	[p1l1928t82r1963b108],
3	No.	NN	O	no.	appos	1	SENT_2	[p1l1974t81r2017b103],
4	3	CD	NUMBER	3	num	3	SENT_2	[p1l2030t82r2049b108],
5	,	,	O	,	_	0	SENT_2	[p1l2030t82r2049b108],
6	2006	CD	DATE	2006	num	7	SENT_2	[p1l2061t82r2118b104],
7	©	CD	DATE	©	appos	1	SENT_2	[p1l44t111r66b134],
8	2006	CD	DATE	2006	dep	29	SENT_2	[p1l77t113r134b134],
9	by	IN	O	by	_	0	SENT_2	[p1l145t112r173b141],
10	the	DT	O	the	det	12	SENT_2	[p1l183t112r219b134],
11	American	NNP	ORGANIZATION	American	nn	12	SENT_2	[p1l229t111r344b134],
12	College	NNP	ORGANIZATION	College	prep_by	8	SENT_2	[p1l356t111r444b141],
13	of	IN	ORGANIZATION	of	_	0	SENT_2	[p1l455t111r481b134],
14	Cardiology	NNP	ORGANIZATION	Cardiology	nn	16	SENT_2	[p1l489t111r619b141],
15	Foundation	NNP	ORGANIZATION	Foundation	nn	16	SENT_2	[p1l628t111r765b134],
16	ISSN	NNP	ORGANIZATION	ISSN	prep_of	12	SENT_2	[p1l1785t111r1850b134],
17	0735-1097/06	CD	DURATION	0735-1097/06	num	16	SENT_2	[p1l1861t111r2118b135],
18	/	:	O	/	punct	19	SENT_2	[p1l1861t111r2118b135],
19	$	$	MONEY	$	dep	12	SENT_2	[p1l1861t111r2118b135],
20	32.00	CD	MONEY	32.00	num	19	SENT_2	[p1l1861t111r2118b135],
21	Published	VBN	O	publish	partmod	19	SENT_2	[p1l44t142r159b164],
22	by	IN	O	by	_	0	SENT_2	[p1l169t142r197b171],
23	Elsevier	NNP	ORGANIZATION	Elsevier	nn	24	SENT_2	[p1l207t142r300b164],
24	Inc.	NNP	ORGANIZATION	Inc.	agent	21	SENT_2	[p1l309t142r353b164],
25	doi	FW	O	doi	dep	24	SENT_2	[p1l1758t142r2119b171],
26	:10.1016	CD	NUMBER	:10.1016	dep	25	SENT_2	[p1l1758t142r2119b171],
27	/	:	O	/	punct	19	SENT_2	[p1l1758t142r2119b171],
28	j.	NN	O	j.	nn	29	SENT_2	[p1l1758t142r2119b171],
29	jacc	NN	O	jacc	rcmod	7	SENT_2	[p1l1758t142r2119b171],
30	.2005.09.034	CD	NUMBER	.2005.09.034	dep	29	SENT_2	[p1l1758t142r2119b171],

1	Effect	NN	O	effect	_	0	SENT_3	[p1l47t224r232b283],
2	of	IN	O	of	_	0	SENT_3	[p1l260t224r331b283],
3	Platelet	NN	O	platelet	nn	5	SENT_3	[p1l350t224r589b283],
4	Antigen	NN	O	antigen	nn	5	SENT_3	[p1l614t223r875b304],
5	Polymorphism	NN	O	polymorphism	prep_of	1	SENT_3	[p1l905t224r1370b304],
6	on	IN	O	on	_	0	SENT_3	[p1l1401t248r1479b283],
7	Platelet	NN	O	platelet	nn	8	SENT_3	[p1l1508t224r1747b283],
8	Inhibition	NN	O	inhibition	prep_on	5	SENT_3	[p1l45t322r352b380],
9	by	IN	O	by	_	0	SENT_3	[p1l377t322r452b401],
10	Aspirin	NNP	MISC	Aspirin	nn	12	SENT_3	[p1l472t320r717b401],
11	,	,	O	,	_	0	SENT_3	[p1l472t320r717b401],
12	Clopidogrel	NNP	O	Clopidogrel	prep_by	8	SENT_3	[p1l748t322r1124b401],
13	,	,	O	,	_	0	SENT_3	[p1l748t322r1124b401],
14	or	CC	O	or	_	0	SENT_3	[p1l1153t344r1216b380],
15	Their	PRP$	O	they	poss	16	SENT_3	[p1l1238t320r1413b380],
16	Combination	NN	O	combination	prep_on	5	SENT_3	[p1l1433t322r1840b380],
17	Glen	NNP	PERSON	Glen	nn	19	SENT_3	[p1l45t425r136b459],
18	E.	NNP	PERSON	E.	nn	19	SENT_3	[p1l153t425r192b459],
19	Cooke	NNP	PERSON	Cooke	rcmod	16	SENT_3	[p1l212t425r342b467],
20	,	,	O	,	_	0	SENT_3	[p1l212t425r342b467],
21	MD	NNP	O	MD	appos	19	SENT_3	[p1l359t425r451b467],
22	,	,	O	,	_	0	SENT_3	[p1l359t425r451b467],
23	FACC	NNP	O	FACC	appos	19	SENT_3	[p1l469t424r624b466],
24	,	,	O	,	_	0	SENT_3	[p1l469t424r624b466],
25	*	CD	NUMBER	*	num	27	SENT_3	[p1l469t424r624b466],
26	Yiwen	NN	PERSON	yiwen	nn	27	SENT_3	[p1l639t425r758b459],
27	Liu-Stratton	NNP	PERSON	Liu-Stratton	appos	19	SENT_3	[p1l775t425r1019b466],
28	,	,	O	,	_	0	SENT_3	[p1l775t425r1019b466],
29	PHD	NNP	O	PHD	appos	19	SENT_3	[p1l1037t425r1156b466],
30	,	,	O	,	_	0	SENT_3	[p1l1037t425r1156b466],
31	*	NNP	O	*	nn	34	SENT_3	[p1l1037t425r1156b466],
32	Amy	NNP	PERSON	Amy	nn	34	SENT_3	[p1l1171t424r1264b471],
33	K.	NNP	PERSON	K.	nn	34	SENT_3	[p1l1280t425r1319b459],
34	Ferketich	NNP	PERSON	Ferketich	appos	19	SENT_3	[p1l1339t425r1522b467],
35	,	,	O	,	_	0	SENT_3	[p1l1339t425r1522b467],
36	PHD	NNP	O	PHD	appos	19	SENT_3	[p1l1541t425r1667b466],
37	,	,	O	,	_	0	SENT_3	[p1l1541t425r1667b466],
38	'	''	O	'	_	0	SENT_3	[p1l1541t425r1667b466],
39	{	NN	O	{	dep	19	SENT_3	[p1l1541t425r1667b466],
40	'	''	O	'	_	0	SENT_3	[p1l1541t425r1667b466],
41	Melvin	NNP	PERSON	Melvin	nn	43	SENT_3	[p1l43t475r175b509],
42	L.	NNP	PERSON	L.	nn	43	SENT_3	[p1l193t475r230b509],
43	Moeschberger	NNP	PERSON	Moeschberger	dep	19	SENT_3	[p1l249t475r521b521],
44	,	,	O	,	_	0	SENT_3	[p1l249t475r521b521],
45	PHDJ	NNP	O	PHDJ	nn	48	SENT_3	[p1l539t475r665b516],
46	”	CD	NUMBER	”	num	48	SENT_3	[p1l539t475r665b516],
47	David	NNP	PERSON	David	nn	48	SENT_3	[p1l683t475r833b518],
48	Frid	NNP	PERSON	Frid	appos	43	SENT_3	[p1l853t475r940b516],
49	,	,	O	,	_	0	SENT_3	[p1l853t475r940b516],
50	MD	NNP	O	MD	appos	43	SENT_3	[p1l958t475r1049b516],
51	,	,	O	,	_	0	SENT_3	[p1l958t475r1049b516],
52	FACC	NNP	O	FACC	appos	43	SENT_3	[p1l1068t474r1223b516],
53	,	,	O	,	_	0	SENT_3	[p1l1068t474r1223b516],
54	*	NNP	O	*	nn	57	SENT_3	[p1l1068t474r1223b516],
55	Raymond	NNP	PERSON	Raymond	nn	57	SENT_3	[p1l1241t475r1418b521],
56	D.	NNP	PERSON	D.	nn	57	SENT_3	[p1l1435t475r1480b509],
57	Magorien	NNP	PERSON	Magorien	appos	43	SENT_3	[p1l1498t475r1689b521],
58	,	,	O	,	_	0	SENT_3	[p1l1498t475r1689b521],
59	MD	NNP	O	MD	appos	43	SENT_3	[p1l1706t475r1798b517],
60	,	,	O	,	_	0	SENT_3	[p1l1706t475r1798b517],
61	FACC	NNP	O	FACC	appos	43	SENT_3	[p1l1816t474r1971b516],
62	,	,	O	,	_	0	SENT_3	[p1l1816t474r1971b516],
63	*	CD	NUMBER	*	num	66	SENT_3	[p1l1816t474r1971b516],
64	Paul	NNP	PERSON	Paul	nn	66	SENT_3	[p1l44t545r126b579],
65	F.	NNP	PERSON	F.	nn	66	SENT_3	[p1l142t545r177b579],
66	Bray	NNP	PERSON	Bray	appos	43	SENT_3	[p1l196t545r290b591],
67	,	,	O	,	_	0	SENT_3	[p1l196t545r290b591],
68	MD	NNP	O	MD	appos	43	SENT_3	[p1l308t545r423b587],
69	,	,	O	,	_	0	SENT_3	[p1l308t545r423b587],
70	:	:	O	:	_	0	SENT_3	[p1l308t545r423b587],
71	l	NN	O	l	tmod	5	SENT_3	[p1l308t545r423b587],
72	:	:	O	:	_	0	SENT_3	[p1l308t545r423b587],
73	Philip	NNP	PERSON	Philip	nn	75	SENT_3	[p1l441t545r550b591],
74	F.	NNP	PERSON	F.	nn	75	SENT_3	[p1l568t545r603b579],
75	Binkley	NNP	PERSON	Binkley	dep	1	SENT_3	[p1l623t545r772b591],
76	,	,	O	,	_	0	SENT_3	[p1l623t545r772b591],
77	MD	NNP	O	MD	nn	85	SENT_3	[p1l789t545r881b586],
78	,	,	O	,	_	0	SENT_3	[p1l789t545r881b586],
79	MPH	NNP	O	MPH	appos	85	SENT_3	[p1l898t545r1020b586],
80	,	,	O	,	_	0	SENT_3	[p1l898t545r1020b586],
81	FACC	NNP	O	FACC	appos	85	SENT_3	[p1l1038t544r1193b586],
82	,	,	O	,	_	0	SENT_3	[p1l1038t544r1193b586],
83	*	NNP	O	*	appos	85	SENT_3	[p1l1038t544r1193b586],
84	Pascal	NNP	PERSON	Pascal	nn	85	SENT_3	[p1l1210t545r1362b588],
85	Goldschmidt	NNP	PERSON	Goldschmidt	appos	75	SENT_3	[p1l1382t545r1832b587],
86	.	.	O	.	_	0	SENT_3	[p1l1382t545r1832b587],

1	—	NN	O	—	_	0	SENT_4	[p1l1382t545r1832b587],
2	.	.	O	.	_	0	SENT_4	[p1l1382t545r1832b587],

1	Clermont	NNP	LOCATION	Clermont	nn	7	SENT_5	[p1l1382t545r1832b587],
2	,	,	O	,	_	0	SENT_5	[p1l1382t545r1832b587],
3	MD	NNP	O	MD	appos	7	SENT_5	[p1l1849t545r1941b587],
4	,	,	O	,	_	0	SENT_5	[p1l1849t545r1941b587],
5	FACC	NNP	O	FACC	appos	7	SENT_5	[p1l1959t544r2110b585],
6	§	CD	NUMBER	§	num	7	SENT_5	[p1l1959t544r2110b585],
7	Columhus	NNP	O	Columhus	_	0	SENT_5	[p1l48t593r223b631],
8	,	,	O	,	_	0	SENT_5	[p1l48t593r223b631],
9	Ohio	NNP	LOCATION	Ohio	appos	7	SENT_5	[p1l247t593r338b631],
10	;	:	O	;	_	0	SENT_5	[p1l247t593r338b631],
11	Houston	NNP	LOCATION	Houston	dep	7	SENT_5	[p1l354t594r508b631],
12	,	,	O	,	_	0	SENT_5	[p1l354t594r508b631],
13	Texas	NNP	LOCATION	Texas	dep	7	SENT_5	[p1l532t593r640b631],
14	;	:	O	;	_	0	SENT_5	[p1l532t593r640b631],
15	and	CC	O	and	_	0	SENT_5	[p1l657t594r727b626],
16	Durham	NNP	LOCATION	Durham	nn	19	SENT_5	[p1l738t594r895b631],
17	,	,	O	,	_	0	SENT_5	[p1l738t594r895b631],
18	North	NNP	LOCATION	North	appos	19	SENT_5	[p1l913t594r1019b627],
19	Carolina	NNP	LOCATION	Carolina	dep	7	SENT_5	[p1l1039t593r1190b626],

1	OBJECTIVES	NNS	O	objective	nsubj	3	SENT_6	[p1l243t693r424b721],
2	We	PRP	O	we	nsubj	3	SENT_6	[p1l492t693r548b721],
3	studied	VBD	O	study	_	0	SENT_6	[p1l560t693r667b721],
4	the	DT	O	the	det	6	SENT_6	[p1l678t693r725b721],
5	modiﬁer	NN	O	modiﬁer	nn	6	SENT_6	[p1l736t693r863b721],
6	effect	NN	O	effect	dobj	3	SENT_6	[p1l874t693r952b721],
7	of	IN	O	of	_	0	SENT_6	[p1l963t693r997b721],
8	platelet	NN	O	platelet	nn	13	SENT_6	[p1l1002t693r1113b731],
9	antigen	NN	O	antigen	nn	13	SENT_6	[p1l1124t694r1234b731],
10	polymorphism	NN	O	polymorphism	nn	13	SENT_6	[p1l1244t693r1462b731],
11	(	CD	NUMBER	(	num	13	SENT_6	[p1l1474t688r1564b727],
12	PIAZ	NN	O	piaz	nn	13	SENT_6	[p1l1474t688r1564b727],
13	)	NN	O	)	prep_of	6	SENT_6	[p1l1474t688r1564b727],
14	on	IN	O	on	_	0	SENT_6	[p1l1577t704r1614b721],
15	platelet	NN	O	platelet	nn	16	SENT_6	[p1l1624t693r1735b731],
16	inhibition	NN	O	inhibition	prep_on	13	SENT_6	[p1l1745t693r1893b721],
17	by	IN	O	by	_	0	SENT_6	[p1l493t734r530b772],
18	acetylsalicylic	JJ	O	acetylsalicylic	amod	21	SENT_6	[p1l542t734r741b772],
19	acid	NN	O	acid	nn	21	SENT_6	[p1l755t734r814b762],
20	(	NN	O	(	nn	21	SENT_6	[p1l828t733r922b768],
21	ASA	NN	O	asa	prep_by	3	SENT_6	[p1l828t733r922b768],
22	,	,	O	,	_	0	SENT_6	[p1l828t733r922b768],
23	i.e.	FW	O	i.e.	conj_or	21	SENT_6	[p1l937t735r989b768],
24	,	,	O	,	_	0	SENT_6	[p1l937t735r989b768],
25	aspirin	NN	O	aspirin	nn	26	SENT_6	[p1l1004t733r1124b772],
26	)	NN	O	)	conj_or	21	SENT_6	[p1l1004t733r1124b772],
27	,	,	O	,	_	0	SENT_6	[p1l1004t733r1124b772],
28	clopidogrel	NN	O	clopidogrel	conj_or	21	SENT_6	[p1l1139t734r1313b772],
29	,	,	O	,	_	0	SENT_6	[p1l1139t734r1313b772],
30	or	CC	O	or	_	0	SENT_6	[p1l1328t745r1358b762],
31	their	PRP$	O	they	poss	32	SENT_6	[p1l1371t734r1441b762],
32	combination	NN	O	combination	conj_or	21	SENT_6	[p1l1454t734r1642b762],
33	in	IN	O	in	_	0	SENT_6	[p1l1655t735r1684b762],
34	patients	NNS	O	patient	prep_in	3	SENT_6	[p1l1696t735r1813b772],
35	with	IN	O	with	_	0	SENT_6	[p1l1825t734r1893b762],
36	coronary	JJ	O	coronary	amod	38	SENT_6	[p1l494t786r625b813],
37	heart	NN	O	heart	nn	38	SENT_6	[p1l637t775r714b803],
38	disease	NN	O	disease	prep_with	34	SENT_6	[p1l727t775r837b803],
39	.	.	O	.	_	0	SENT_6	[p1l727t775r837b803],

1	BACKGROUND	NN	O	background	nn	2	SENT_7	[p1l245t816r456b845],
2	Clopidogrel	NN	O	clopidogrel	nsubjpass	10	SENT_7	[p1l495t817r681b855],
3	,	,	O	,	_	0	SENT_7	[p1l495t817r681b855],
4	when	WRB	O	when	advmod	5	SENT_7	[p1l693t817r775b845],
5	administered	VBN	O	administer	dep	2	SENT_7	[p1l787t817r981b845],
6	with	IN	O	with	_	0	SENT_7	[p1l991t817r1059b845],
7	ASA	NN	O	asa	prep_with	5	SENT_7	[p1l1069t816r1154b851],
8	,	,	O	,	_	0	SENT_7	[p1l1069t816r1154b851],
9	was	VBD	O	be	auxpass	10	SENT_7	[p1l1165t828r1220b845],
10	shown	VBN	O	show	_	0	SENT_7	[p1l1233t817r1329b845],
11	to	TO	O	to	aux	13	SENT_7	[p1l1340t824r1369b845],
12	signiﬁcantly	RB	O	signiﬁcantly	advmod	13	SENT_7	[p1l1382t817r1563b855],
13	improve	VB	O	improve	xcomp	10	SENT_7	[p1l1573t818r1694b855],
14	the	DT	O	the	det	15	SENT_7	[p1l1706t817r1753b845],
15	outcome	NN	O	outcome	dobj	13	SENT_7	[p1l1765t824r1893b845],
16	of	IN	O	of	_	0	SENT_7	[p1l494t857r528b885],
17	patients	NNS	O	patient	prep_of	15	SENT_7	[p1l536t859r653b895],
18	with	IN	O	with	_	0	SENT_7	[p1l665t857r733b885],
19	acute	JJ	O	acute	amod	21	SENT_7	[p1l746t865r823b885],
20	coronary	JJ	O	coronary	amod	21	SENT_7	[p1l836t868r967b895],
21	syndromes	NNS	O	syndrome	prep_with	13	SENT_7	[p1l979t857r1136b895],
22	compared	VBN	O	compare	_	0	SENT_7	[p1l1151t857r1297b895],
23	with	IN	O	with	prepc_compared_with	13	SENT_7	[p1l1308t857r1376b885],
24	patients	NNS	O	patient	pobj	13	SENT_7	[p1l1389t859r1506b895],
25	receiving	VBG	O	receive	partmod	24	SENT_7	[p1l1519t859r1654b895],
26	only	RB	O	only	advmod	27	SENT_7	[p1l1666t857r1731b895],
27	ASA	NN	O	asa	dobj	25	SENT_7	[p1l1741t857r1825b885],
28	.	.	O	.	_	0	SENT_7	[p1l1741t857r1825b885],

1	We	PRP	O	we	nsubj	3	SENT_8	[p1l1838t858r1893b885],
2	have	VBP	O	have	aux	3	SENT_8	[p1l494t898r561b926],
3	shown	VBN	O	show	_	0	SENT_8	[p1l573t898r668b926],
4	previously	RB	DATE	previously	advmod	3	SENT_8	[p1l679t898r831b936],
5	that	IN	O	that	complm	13	SENT_8	[p1l840t899r900b926],
6	the	DT	O	the	det	7	SENT_8	[p1l909t898r956b926],
7	effect	NN	O	effect	nsubjpass	13	SENT_8	[p1l967t898r1046b926],
8	of	IN	O	of	_	0	SENT_8	[p1l1056t898r1090b926],
9	ASA	NN	O	asa	prep_of	7	SENT_8	[p1l1094t898r1171b926],
10	on	IN	O	on	_	0	SENT_8	[p1l1181t909r1218b926],
11	platelets	NNS	O	platelet	prep_on	9	SENT_8	[p1l1228t898r1351b936],
12	is	VBZ	O	be	auxpass	13	SENT_8	[p1l1362t900r1383b926],
13	modiﬁed	VBN	O	modiﬁed	ccomp	3	SENT_8	[p1l1395t898r1528b926],
14	by	IN	O	by	_	0	SENT_8	[p1l1538t899r1574b936],
15	the	DT	O	the	det	17	SENT_8	[p1l1583t898r1630b926],
16	glycoprotein	NN	O	glycoprotein	nn	17	SENT_8	[p1l1640t899r1826b936],
17	IIIa	NN	O	iium	agent	13	SENT_8	[p1l1837t899r1894b926],
18	single	JJ	O	single	amod	21	SENT_8	[p1l495t940r580b978],
19	nucleotide	NN	O	nucleotide	nn	21	SENT_8	[p1l604t940r758b968],
20	polymorphism	NN	O	polymorphism	nn	21	SENT_8	[p1l782t940r1000b978],
21	PIAZ	NN	O	piaz	dep	17	SENT_8	[p1l1024t935r1099b968],
22	.	.	O	.	_	0	SENT_8	[p1l1024t935r1099b968],

1	Hence	RB	O	hence	advmod	7	SENT_9	[p1l1125t941r1231b974],
2	,	,	O	,	_	0	SENT_9	[p1l1125t941r1231b974],
3	an	DT	O	a	det	6	SENT_9	[p1l1257t951r1291b968],
4	important	JJ	O	important	amod	6	SENT_9	[p1l1314t941r1465b978],
5	pharmacogenetic	JJ	O	pharmacogenetic	amod	6	SENT_9	[p1l1488t940r1743b978],
6	question	NN	O	question	nsubj	7	SENT_9	[p1l1767t941r1893b978],
7	remains	VBZ	O	remain	_	0	SENT_9	[p1l494t982r610b1009],
8	whether	IN	O	whether	complm	15	SENT_9	[p1l628t981r752b1009],
9	the	DT	O	the	det	11	SENT_9	[p1l770t981r817b1009],
10	antiplatelet	JJ	O	antiplatelet	amod	11	SENT_9	[p1l837t981r1004b1019],
11	effect	NN	O	effect	nsubj	15	SENT_9	[p1l1022t981r1101b1009],
12	of	IN	O	of	_	0	SENT_9	[p1l1119t981r1153b1009],
13	clopidogrel	NN	O	clopidogrel	prep_of	11	SENT_9	[p1l1167t981r1333b1019],
14	is	VBZ	O	be	cop	15	SENT_9	[p1l1352t982r1373b1009],
15	uniform	JJ	O	uniform	ccomp	7	SENT_9	[p1l1392t981r1513b1009],
16	for	IN	O	for	_	0	SENT_9	[p1l1533t981r1575b1009],
17	all	DT	O	all	det	18	SENT_9	[p1l1594t981r1628b1009],
18	patients	NNS	O	patient	prep_for	15	SENT_9	[p1l1645t982r1762b1019],
19	or	CC	O	or	_	0	SENT_9	[p1l1782t992r1821b1015],
20	,	,	O	,	_	0	SENT_9	[p1l1782t992r1821b1015],
21	like	IN	O	like	conj_or	18	SENT_9	[p1l1840t981r1893b1009],
22	acetylsalicyli/cA	NN	O	acetylsalicyli/ca	pobj	21	SENT_9	[p1l495t1022r776b1076],
23	:	:	O	:	_	0	SENT_9	[p1l495t1022r776b1076],
24	;	:	O	;	_	0	SENT_9	[p1l495t1022r776b1076],
25	cid	NN	O	cid	dep	15	SENT_9	[p1l495t1022r776b1076],
26	,	,	O	,	_	0	SENT_9	[p1l495t1022r776b1076],
27	more	JJR	O	more	dep	28	SENT_9	[p1l791t1033r867b1050],
28	selective	JJ	O	selective	amod	15	SENT_9	[p1l881t1022r1012b1050],
29	.	.	O	.	_	0	SENT_9	[p1l881t1022r1012b1050],

1	METHODS	NNS	O	method	nsubjpass	10	SENT_10	[p1l245t1064r393b1092],
2	Thirty	CD	NUMBER	thirty	num	4	SENT_10	[p1l493t1063r592b1102],
3	P1	NN	O	p1	nn	4	SENT_10	[p1l611t1058r677b1092],
4	“	NN	O	“	dep	1	SENT_10	[p1l611t1058r677b1092],
5	and	CC	O	and	_	0	SENT_10	[p1l747t1064r800b1092],
6	30	CD	NUMBER	30	num	8	SENT_10	[p1l821t1065r857b1092],
7	PIA1/A2	NN	O	pia1/a2	nn	8	SENT_10	[p1l878t1058r992b1092],
8	patients	NNS	O	patient	conj_and	4	SENT_10	[p1l1012t1065r1129b1102],
9	were	VBD	O	be	auxpass	10	SENT_10	[p1l1149t1075r1220b1092],
10	assigned	VBN	O	assign	_	0	SENT_10	[p1l1242t1064r1366b1102],
11	randomly	RB	O	randomly	advmod	10	SENT_10	[p1l1387t1064r1530b1102],
12	to	TO	O	to	_	0	SENT_10	[p1l1550t1071r1578b1092],
13	ASA	NN	O	asa	nn	15	SENT_10	[p1l1599t1063r1676b1092],
14	325	CD	NUMBER	325	num	15	SENT_10	[p1l1696t1064r1749b1092],
15	mg/day	NN	O	mg/day	prep_to	10	SENT_10	[p1l1772t1064r1892b1102],
16	,	,	O	,	_	0	SENT_10	[p1l1772t1064r1892b1102],

1	clopidogrel	NN	O	clopidogrel	_	0	SENT_11	[p1l494t1105r661b1143],
2	75	CD	NUMBER	75	num	3	SENT_11	[p1l675t1105r709b1133],
3	mg/day	NN	O	mg/day	dep	1	SENT_11	[p1l725t1105r845b1143],
4	,	,	O	,	_	0	SENT_11	[p1l725t1105r845b1143],
5	or	CC	O	or	_	0	SENT_11	[p1l860t1116r891b1133],
6	both	DT	O	both	dep	1	SENT_11	[p1l903t1105r980b1133],
7	.	.	O	.	_	0	SENT_11	[p1l903t1105r980b1133],

1	After	IN	O	after	_	0	SENT_12	[p1l994t1104r1075b1133],
2	10	CD	DURATION	10	num	3	SENT_12	[p1l1090t1106r1124b1133],
3	days	NNS	NUMBER	day	prep_after	8	SENT_12	[p1l1139t1105r1210b1143],
4	,	,	O	,	_	0	SENT_12	[p1l1139t1105r1210b1143],
5	platelet	NN	O	platelet	nn	6	SENT_12	[p1l1225t1105r1335b1143],
6	function	NN	O	function	nsubjpass	8	SENT_12	[p1l1348t1105r1474b1133],
7	was	VBD	O	be	auxpass	8	SENT_12	[p1l1486t1116r1540b1133],
8	studied	VBN	O	study	_	0	SENT_12	[p1l1556t1105r1671b1133],
9	.	.	O	.	_	0	SENT_12	[p1l1556t1105r1671b1133],

1	RESULTS	NNS	O	result	nsubj	3	SENT_13	[p1l245t1146r379b1174],
2	Clopidogrel	NNP	O	Clopidogrel	dep	1	SENT_13	[p1l495t1146r674b1184],
3	provided	VBD	O	provide	dep	26	SENT_13	[p1l687t1146r818b1184],
4	stronger	JJR	O	stronger	amod	6	SENT_13	[p1l833t1154r955b1184],
5	platelet	NN	O	platelet	nn	6	SENT_13	[p1l968t1146r1079b1184],
6	inhibition	NN	O	inhibition	dobj	3	SENT_13	[p1l1092t1146r1241b1174],
7	than	IN	O	than	_	0	SENT_13	[p1l1255t1147r1322b1174],
8	ASA	NN	O	asa	prep_than	3	SENT_13	[p1l1335t1146r1411b1174],
9	with	IN	O	with	_	0	SENT_13	[p1l1423t1146r1492b1174],
10	adenosine	NN	O	adenosine	nn	11	SENT_13	[p1l1506t1146r1653b1174],
11	diphosphate	NN	O	diphosphate	prep_with	3	SENT_13	[p1l1668t1146r1851b1184],
12	as	IN	O	as	_	0	SENT_13	[p1l1866t1157r1893b1174],
13	the	DT	O	the	det	14	SENT_13	[p1l494t1187r541b1215],
14	agonist	NN	O	agonist	prep_as	11	SENT_13	[p1l553t1188r667b1225],
15	,	,	O	,	_	0	SENT_13	[p1l553t1188r667b1225],
16	and	CC	O	and	_	0	SENT_13	[p1l681t1187r734b1215],
17	combination	NN	O	combination	nn	18	SENT_13	[p1l746t1187r934b1215],
18	therapy	NN	O	therapy	nsubj	19	SENT_13	[p1l945t1187r1058b1225],
19	resulted	VBD	O	result	dep	26	SENT_13	[p1l1068t1187r1185b1215],
20	in	IN	O	in	_	0	SENT_13	[p1l1196t1188r1225b1215],
21	greater	JJR	O	greater	amod	22	SENT_13	[p1l1235t1194r1339b1225],
22	inhibition	NN	O	inhibition	prep_in	19	SENT_13	[p1l1350t1187r1498b1215],
23	than	IN	O	than	prep	19	SENT_13	[p1l1509t1187r1576b1215],
24	either	CC	O	either	dep	23	SENT_13	[p1l1588t1187r1674b1215],
25	inhibitor	NN	O	inhibitor	conj	23	SENT_13	[p1l1684t1187r1816b1215],
26	used	VBD	O	use	_	0	SENT_13	[p1l1826t1187r1894b1215],
27	alone	RB	O	alone	advmod	28	SENT_13	[p1l495t1228r573b1256],
28	(	RB	O	(	amod	29	SENT_13	[p1l585t1227r613b1266],
29	p	NN	O	p	nsubj	30	SENT_13	[p1l585t1227r613b1266],
30	<	JJR	O	<	xcomp	26	SENT_13	[p1l627t1232r652b1254],
31	0.0001	CD	NUMBER	0.0001	num	32	SENT_13	[p1l665t1227r787b1262],
32	)	NN	O	)	nsubj	26	SENT_13	[p1l665t1227r787b1262],
33	.	.	O	.	_	0	SENT_13	[p1l665t1227r787b1262],

1	The	DT	O	the	det	2	SENT_14	[p1l798t1227r860b1256],
2	use	NN	O	use	nsubj	5	SENT_14	[p1l871t1239r918b1256],
3	of	IN	O	of	_	0	SENT_14	[p1l929t1228r963b1256],
4	ASA	NN	O	asa	prep_of	2	SENT_14	[p1l967t1227r1044b1256],
5	resulted	VBD	O	result	_	0	SENT_14	[p1l1054t1228r1171b1256],
6	in	IN	O	in	_	0	SENT_14	[p1l1181t1229r1210b1256],
7	greater	JJR	O	greater	amod	8	SENT_14	[p1l1220t1235r1324b1266],
8	inhibition	NN	O	inhibition	prep_in	5	SENT_14	[p1l1334t1228r1482b1256],
9	compared	VBN	O	compare	_	0	SENT_14	[p1l1493t1228r1639b1266],
10	with	IN	O	with	prepc_compared_with	8	SENT_14	[p1l1648t1228r1716b1256],
11	clopidogrel	NN	O	clopidogrel	dep	16	SENT_14	[p1l1727t1228r1894b1266],
12	with	IN	O	with	_	0	SENT_14	[p1l493t1269r561b1297],
13	epinephrine	NN	O	epinephrine	prep_with	11	SENT_14	[p1l574t1269r751b1307],
14	(	CD	NUMBER	(	num	15	SENT_14	[p1l766t1268r794b1307],
15	p	NN	O	p	dep	16	SENT_14	[p1l766t1268r794b1307],
16	<	JJR	O	<	dep	27	SENT_14	[p1l810t1273r836b1295],
17	0.0001	CD	NUMBER	0.0001	num	18	SENT_14	[p1l851t1268r964b1303],
18	)	NN	O	)	dep	16	SENT_14	[p1l851t1268r964b1303],
19	and	CC	O	and	_	0	SENT_14	[p1l979t1269r1033b1297],
20	collagen	NN	O	collagen	dep	27	SENT_14	[p1l1046t1269r1168b1307],
21	as	IN	O	as	_	0	SENT_14	[p1l1181t1280r1208b1297],
22	agonists	NNS	O	agonist	prep_as	20	SENT_14	[p1l1222t1270r1341b1307],
23	(	CD	NUMBER	(	num	24	SENT_14	[p1l1356t1268r1384b1307],
24	p	NN	O	p	npadvmod	25	SENT_14	[p1l1356t1268r1384b1307],
25	<	JJR	O	<	amod	22	SENT_14	[p1l1400t1273r1425b1295],
26	0.0001	CD	NUMBER	0.0001	num	27	SENT_14	[p1l1441t1268r1563b1303],
27	)	NN	O	)	dep	8	SENT_14	[p1l1441t1268r1563b1303],
28	.	.	O	.	_	0	SENT_14	[p1l1441t1268r1563b1303],

1	With	IN	O	with	_	0	SENT_15	[p1l1576t1269r1658b1297],
2	collagen	NN	O	collagen	prep_with	12	SENT_15	[p1l1671t1269r1793b1307],
3	as	IN	O	as	_	0	SENT_15	[p1l1806t1280r1833b1297],
4	the	DT	O	the	det	5	SENT_15	[p1l1847t1269r1893b1297],
5	agonist	NN	O	agonist	prep_as	2	SENT_15	[p1l495t1312r609b1349],
6	,	,	O	,	_	0	SENT_15	[p1l495t1312r609b1349],
7	platelets	NNS	O	platelet	nsubjpass	12	SENT_15	[p1l621t1311r744b1349],
8	from	IN	O	from	_	0	SENT_15	[p1l756t1311r827b1339],
9	PIAI/A2	NN	O	piai/a2	nn	10	SENT_15	[p1l839t1305r952b1339],
10	donors	NNS	O	donor	prep_from	7	SENT_15	[p1l965t1311r1065b1339],
11	were	VBD	O	be	auxpass	12	SENT_15	[p1l1076t1322r1146b1339],
12	markedly	RB	O	markedly	_	0	SENT_15	[p1l1158t1311r1297b1349],
13	and	CC	O	and	cc	12	SENT_15	[p1l1308t1311r1362b1339],
14	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_15	[p1l1373t1311r1554b1349],
15	less	RBR	O	less	advmod	16	SENT_15	[p1l1563t1311r1614b1339],
16	inhibited	VBN	O	inhibit	dep	12	SENT_15	[p1l1626t1311r1762b1339],
17	by	IN	O	by	_	0	SENT_15	[p1l1772t1311r1809b1349],
18	ASA	NN	O	asa	nn	20	SENT_15	[p1l1817t1310r1894b1339],
19	(	CD	NUMBER	(	num	20	SENT_15	[p1l495t1352r524b1391],
20	p	NN	O	p	prep_by	16	SENT_15	[p1l495t1352r524b1391],
21	=	JJ	O	=	amod	20	SENT_15	[p1l538t1364r561b1372],
22	0.005	CD	NUMBER	0.005	num	23	SENT_15	[p1l575t1352r678b1387],
23	)	NN	O	)	dep	21	SENT_15	[p1l575t1352r678b1387],
24	.	.	O	.	_	0	SENT_15	[p1l575t1352r678b1387],

1	In	IN	O	in	_	0	SENT_16	[p1l690t1353r723b1380],
2	contrast	NN	O	contrast	prep_in	12	SENT_16	[p1l733t1360r860b1387],
3	,	,	O	,	_	0	SENT_16	[p1l733t1360r860b1387],
4	with	IN	O	with	_	0	SENT_16	[p1l870t1353r938b1381],
5	clggidogrel	NN	O	clggidogrel	prep_with	12	SENT_16	[p1l948t1353r1123b1407],
6	,	,	O	,	_	0	SENT_16	[p1l948t1353r1123b1407],
7	no	DT	O	no	det	9	SENT_16	[p1l1134t1364r1171b1381],
8	signiﬁcant	NN	O	signiﬁcant	nn	9	SENT_16	[p1l1182t1353r1336b1390],
9	difference	NN	O	difference	nsubjpass	12	SENT_16	[p1l1346t1353r1490b1381],
10	could	MD	O	could	aux	12	SENT_16	[p1l1501t1353r1581b1381],
11	be	VB	O	be	auxpass	12	SENT_16	[p1l1590t1353r1625b1381],
12	detected	VBN	O	detect	_	0	SENT_16	[p1l1635t1353r1760b1381],
13	between	IN	O	between	_	0	SENT_16	[p1l1769t1353r1893b1381],
14	inhibition	NN	O	inhibition	prep_between	12	SENT_16	[p1l494t1394r642b1422],
15	of	IN	O	of	_	0	SENT_16	[p1l657t1394r690b1422],
16	PIA1/A1	NN	O	pia1/a1	prep_of	14	SENT_16	[p1l699t1389r811b1422],
17	and	CC	O	and	_	0	SENT_16	[p1l827t1394r881b1422],
18	PIA	NN	O	pium	prep_between	12	SENT_16	[p1l895t1389r973b1422],
19	“	CD	NUMBER	“	num	20	SENT_16	[p1l895t1389r973b1422],
20	platelets	NNS	O	platelet	dep	18	SENT_16	[p1l1022t1394r1152b1432],
21	.	.	O	.	_	0	SENT_16	[p1l1022t1394r1152b1432],

1	CONCLUSIONS	NNS	O	conclusion	dep	3	SENT_17	[p1l243t1435r461b1464],
2	The	DT	O	the	det	3	SENT_17	[p1l493t1435r555b1464],
3	combination	NN	O	combination	nsubj	9	SENT_17	[p1l567t1436r755b1464],
4	of	IN	O	of	_	0	SENT_17	[p1l766t1436r800b1464],
5	ASA	NN	O	asa	prep_of	3	SENT_17	[p1l804t1435r881b1464],
6	and	CC	O	and	_	0	SENT_17	[p1l892t1436r946b1464],
7	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_17	[p1l957t1436r1124b1473],
8	appears	VBZ	O	appear	cop	9	SENT_17	[p1l1134t1446r1245b1473],
9	superior	JJ	O	superior	_	0	SENT_17	[p1l1257t1437r1378b1473],
10	to	TO	O	to	_	0	SENT_17	[p1l1388t1443r1416b1464],
11	either	CC	O	either	advmod	12	SENT_17	[p1l1428t1436r1514b1464],
12	agent	NN	O	agent	prep_to	9	SENT_17	[p1l1525t1443r1606b1473],
13	alone	RB	O	alone	advmod	12	SENT_17	[p1l1617t1436r1695b1464],
14	in	IN	O	in	_	0	SENT_17	[p1l1706t1437r1735b1463],
15	inhibiting	VBG	O	inhibit	prepc_in	9	SENT_17	[p1l1745t1436r1894b1473],
16	platelet	NN	O	platelet	nn	17	SENT_17	[p1l494t1477r604b1515],
17	function	NN	O	function	dobj	15	SENT_17	[p1l615t1477r748b1505],
18	.	.	O	.	_	0	SENT_17	[p1l615t1477r748b1505],

1	PIA2	NN	O	pia2	nn	2	SENT_18	[p1l761t1472r828b1505],
2	functions	NNS	O	function	_	0	SENT_18	[p1l840t1477r978b1505],
3	as	IN	O	as	_	0	SENT_18	[p1l991t1488r1017b1505],
4	an	DT	O	a	det	6	SENT_18	[p1l1030t1488r1064b1505],
5	important	JJ	O	important	amod	6	SENT_18	[p1l1076t1479r1226b1515],
6	modiﬁer	NN	O	modiﬁer	prep_as	2	SENT_18	[p1l1237t1477r1364b1505],
7	for	IN	O	for	_	0	SENT_18	[p1l1375t1477r1418b1505],
8	platelet	NN	O	platelet	nn	9	SENT_18	[p1l1428t1477r1538b1515],
9	responsiveness	NN	O	responsiveness	prep_for	6	SENT_18	[p1l1549t1479r1765b1515],
10	to	TO	O	to	_	0	SENT_18	[p1l1777t1485r1806b1505],
11	ASA	NN	O	asa	prep_to	2	SENT_18	[p1l1817t1477r1894b1505],
12	but	CC	O	but	_	0	SENT_18	[p1l493t1519r543b1547],
13	not	RB	O	not	_	0	SENT_18	[p1l556t1526r606b1547],
14	to	TO	O	to	_	0	SENT_18	[p1l618t1526r647b1547],
15	clopidogrel	NN	O	clopidogrel	conj_negcc	11	SENT_18	[p1l661t1519r835b1557],
16	.	.	O	.	_	0	SENT_18	[p1l661t1519r835b1557],

1	These	DT	O	these	det	2	SENT_19	[p1l849t1518r940b1547],
2	ﬁndings	NNS	O	ﬁndings	nsubj	4	SENT_19	[p1l953t1519r1073b1557],
3	could	MD	O	could	aux	4	SENT_19	[p1l1087t1519r1168b1547],
4	have	VB	O	have	_	0	SENT_19	[p1l1181t1519r1248b1547],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_19	[p1l1262t1519r1416b1557],
6	impact	NN	O	impact	dobj	4	SENT_19	[p1l1428t1520r1531b1557],
7	on	IN	O	on	_	0	SENT_19	[p1l1543t1530r1580b1547],
8	the	DT	DATE	the	det	10	SENT_19	[p1l1593t1519r1640b1547],
9	future	JJ	DATE	future	amod	10	SENT_19	[p1l1653t1519r1742b1547],
10	design	NN	O	design	prep_on	6	SENT_19	[p1l1756t1519r1851b1557],
11	of	IN	O	of	_	0	SENT_19	[p1l1865t1519r1899b1547],
12	pharmacogenetic	JJ	O	pharmacogenetic	amod	14	SENT_19	[p1l494t1561r749b1599],
13	antithrombotic	JJ	O	antithrombotic	amod	14	SENT_19	[p1l763t1561r988b1589],
14	strategies	NNS	O	strategy	prep_of	10	SENT_19	[p1l1001t1562r1138b1599],
15	for	IN	O	for	_	0	SENT_19	[p1l1151t1561r1194b1589],
16	patients	NNS	O	patient	prep_for	14	SENT_19	[p1l1206t1562r1323b1599],
17	with	IN	O	with	_	0	SENT_19	[p1l1335t1561r1403b1589],
18	coronary	JJ	O	coronary	amod	20	SENT_19	[p1l1416t1572r1547b1599],
19	heart	NN	O	heart	nn	20	SENT_19	[p1l1558t1561r1635b1589],
20	disease	NN	O	disease	prep_with	16	SENT_19	[p1l1647t1561r1758b1589],
21	.	.	O	.	_	0	SENT_19	[p1l1647t1561r1758b1589],

1	(	NN	O	(	_	0	SENT_20	[p1l1802t1560r1824b1597],
2	I	CD	NUMBER	i	num	1	SENT_20	[p1l1802t1560r1824b1597],
3	Am	VBP	O	be	cop	5	SENT_20	[p1l1836t1560r1893b1589],
4	Coll	NNP	O	Coll	nn	5	SENT_20	[p1l495t1602r559b1630],
5	Cardiol	NNP	O	Cardiol	dep	1	SENT_20	[p1l573t1602r686b1630],
6	2006	CD	DATE	2006	num	5	SENT_20	[p1l699t1601r939b1636],
7	;	:	O	;	_	0	SENT_20	[p1l699t1601r939b1636],
8	47:541	CD	NUMBER	47:541	number	9	SENT_20	[p1l699t1601r939b1636],
9	—	CD	NUMBER	—	dep	1	SENT_20	[p1l699t1601r939b1636],
10	6	CD	NUMBER	6	num	11	SENT_20	[p1l699t1601r939b1636],
11	)	NN	O	)	dep	9	SENT_20	[p1l699t1601r939b1636],
12	©	CD	NUMBER	©	num	13	SENT_20	[p1l955t1602r983b1630],
13	2006	CD	DATE	2006	dep	9	SENT_20	[p1l997t1603r1070b1631],
14	by	IN	O	by	_	0	SENT_20	[p1l1084t1602r1121b1640],
15	the	DT	O	the	det	17	SENT_20	[p1l1133t1602r1179b1630],
16	American	NNP	ORGANIZATION	American	nn	17	SENT_20	[p1l1193t1601r1341b1630],
17	College	NNP	ORGANIZATION	College	prep_by	13	SENT_20	[p1l1355t1602r1469b1640],
18	of	IN	ORGANIZATION	of	_	0	SENT_20	[p1l1483t1602r1517b1630],
19	Cardiology	NNP	ORGANIZATION	Cardiology	nn	20	SENT_20	[p1l1526t1602r1694b1640],
20	Foundation	NNP	ORGANIZATION	Foundation	prep_of	17	SENT_20	[p1l1706t1602r1881b1630],

1	It	PRP	O	it	nsubj	4	SENT_21	[p1l10t1822r70b1887],
2	is	VBZ	O	be	cop	4	SENT_21	[p1l100t1824r150b1887],
3	well	RB	O	well	advmod	4	SENT_21	[p1l179t1821r325b1887],
4	established	VBN	O	establish	_	0	SENT_21	[p1l356t1821r744b1887],
5	that	IN	O	that	complm	9	SENT_21	[p1l774t1821r915b1887],
6	platelets	NNS	O	platelet	nsubj	9	SENT_21	[p1l944t1821r1233b1911],
7	and	CC	O	and	_	0	SENT_21	[p1l1267t1821r1395b1887],
8	inﬂammation	NN	O	inﬂammation	nsubj	9	SENT_21	[p1l1425t1821r1905b1887],
9	play	VBP	O	play	ccomp	4	SENT_21	[p1l1935t1821r2082b1911],
10	a	DT	O	a	det	12	SENT_21	[p1l2111t1847r2145b1887],
11	central	JJ	O	central	amod	12	SENT_21	[p1l11t1927r250b1993],
12	role	NN	O	role	nsubj	21	SENT_21	[p1l278t1927r410b1993],
13	in	IN	O	in	_	0	SENT_21	[p1l441t1930r508b1993],
14	coronary	JJ	O	coronary	amod	17	SENT_21	[p1l540t1953r849b2016],
15	atherosclerotic	JJ	O	atherosclerotic	amod	17	SENT_21	[p1l877t1927r1392b1993],
16	heart	NN	O	heart	nn	17	SENT_21	[p1l1421t1927r1603b1993],
17	disease	NN	O	disease	prep_in	12	SENT_21	[p1l1632t1927r1874b1993],
18	and	CC	O	and	_	0	SENT_21	[p1l1906t1927r2034b1993],
19	its	PRP$	O	its	poss	20	SENT_21	[p1l2063t1930r2142b1993],
20	consequences	NNS	O	consequence	conj_and	17	SENT_21	[p1l11t2060r485b2124],
21	(	VBP	O	(	ccomp	9	SENT_21	[p1l529t2032r679b2115],
22	i.e.	FW	O	i.e.	dobj	21	SENT_21	[p1l529t2032r679b2115],
23	,	,	O	,	_	0	SENT_21	[p1l529t2032r679b2115],
24	unstable	JJ	O	unstable	amod	25	SENT_21	[p1l720t2034r1013b2100],
25	angina	NN	O	angina	dobj	21	SENT_21	[p1l1055t2037r1308b2123],
26	,	,	O	,	_	0	SENT_21	[p1l1055t2037r1308b2123],
27	myocardial	JJ	O	myocardial	amod	28	SENT_21	[p1l1351t2034r1739b2123],
28	infarction	NN	O	infarction	dobj	21	SENT_21	[p1l1777t2034r2141b2115],
29	,	,	O	,	_	0	SENT_21	[p1l1777t2034r2141b2115],
30	and	CC	O	and	_	0	SENT_21	[p1l12t2140r140b2206],
31	sudden	JJ	O	sudden	amod	34	SENT_21	[p1l200t2140r450b2206],
32	cardiac	JJ	O	cardiac	amod	34	SENT_21	[p1l510t2140r756b2206],
33	death	NN	O	death	nn	34	SENT_21	[p1l816t2138r1036b2221],
34	)	NN	O	)	conj_and	22	SENT_21	[p1l816t2138r1036b2221],
35	(	CD	NUMBER	(	number	36	SENT_21	[p1l1102t2138r1286b2221],
36	1,2	CD	NUMBER	1,2	num	37	SENT_21	[p1l1102t2138r1286b2221],
37	)	NN	O	)	dep	34	SENT_21	[p1l1102t2138r1286b2221],
38	,	,	O	,	_	0	SENT_21	[p1l1102t2138r1286b2221],
39	with	IN	O	with	_	0	SENT_21	[p1l1344t2140r1506b2206],
40	numerous	JJ	O	numerous	amod	43	SENT_21	[p1l1566t2166r1914b2206],
41	large	JJ	O	large	amod	43	SENT_21	[p1l1973t2140r2143b2229],
42	clinical	JJ	O	clinical	amod	43	SENT_21	[p1l11t2246r260b2312],
43	trials	NNS	O	trial	prep_with	21	SENT_21	[p1l303t2246r473b2312],
44	demonstrating	VBG	O	demonstrate	partmod	43	SENT_21	[p1l519t2246r1036b2335],
45	signiﬁcant	JJ	O	signiﬁcant	amod	46	SENT_21	[p1l1079t2246r1445b2335],
46	beneﬁt	NN	O	beneﬁt	dobj	44	SENT_21	[p1l1485t2246r1730b2312],
47	of	IN	O	of	_	0	SENT_21	[p1l1774t2246r1853b2312],
48	platelet	NN	O	platelet	nn	49	SENT_21	[p1l1884t2246r2146b2336],
49	inhibition	NN	O	inhibition	prep_of	46	SENT_21	[p1l10t2352r362b2418],
50	with	IN	O	with	mark	53	SENT_21	[p1l414t2352r575b2418],
51	Various	JJ	O	various	amod	52	SENT_21	[p1l626t2355r876b2418],
52	agents	NNS	O	agent	nsubj	53	SENT_21	[p1l934t2369r1154b2441],
53	(	VBP	O	(	ccomp	4	SENT_21	[p1l1213t2350r1417b2432],
54	3-7	CD	NUMBER	3-7	num	55	SENT_21	[p1l1213t2350r1417b2432],
55	)	CD	NUMBER	)	dobj	53	SENT_21	[p1l1213t2350r1417b2432],
56	.	.	O	.	_	0	SENT_21	[p1l1213t2350r1417b2432],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	4	SENT_22	[p1l1478t2352r1902b2442],
2	is	VBZ	O	be	cop	4	SENT_22	[p1l1955t2355r2005b2418],
3	an	DT	O	a	det	4	SENT_22	[p1l2063t2378r2144b2418],
4	inhibitor	NN	O	inhibitor	_	0	SENT_22	[p1l10t2458r323b2524],
5	of	IN	O	of	_	0	SENT_22	[p1l351t2458r431b2524],
6	adenosine	NN	O	adenosine	nn	7	SENT_22	[p1l448t2458r798b2524],
7	diphosphate	NN	O	diphosphate	prep_of	4	SENT_22	[p1l828t2458r1260b2548],
8	(	CD	NUMBER	(	num	10	SENT_22	[p1l1293t2456r1858b2538],
9	ADP	NN	O	adp	nn	10	SENT_22	[p1l1293t2456r1858b2538],
10	)	NN	O	)	dep	7	SENT_22	[p1l1293t2456r1858b2538],
11	.	.	O	.	_	0	SENT_22	[p1l1293t2456r1858b2538],

1	—	NN	O	—	_	0	SENT_23	[p1l1293t2456r1858b2538],
2	.	.	O	.	_	0	SENT_23	[p1l1293t2456r1858b2538],

1	induced	VBN	O	induce	_	0	SENT_24	[p1l1293t2456r1858b2538],
2	platelet	NN	O	platelet	nn	3	SENT_24	[p1l1884t2458r2146b2548],
3	aggregation	NN	O	aggregation	dobj	1	SENT_24	[p1l12t2567r425b2653],
4	by	IN	O	by	_	0	SENT_24	[p1l453t2564r539b2653],
5	reducing	VBG	O	reduce	prepc_by	1	SENT_24	[p1l565t2564r874b2653],
6	ADP	NN	ORGANIZATION	adp	nn	7	SENT_24	[p1l900t2563r1092b2629],
7	binding	NN	O	binding	dobj	5	SENT_24	[p1l1120t2564r1397b2653],
8	to	TO	O	to	_	0	SENT_24	[p1l1425t2581r1494b2630],
9	its	PRP$	O	its	poss	13	SENT_24	[p1l1525t2567r1604b2630],
10	receptor	NN	O	receptor	nn	13	SENT_24	[p1l1636t2581r1926b2654],
11	(	NN	O	(	nn	13	SENT_24	[p1l1957t2562r2139b2645],
12	8,9	CD	NUMBER	8,9	num	13	SENT_24	[p1l1957t2562r2139b2645],
13	)	NN	O	)	prep_to	5	SENT_24	[p1l1957t2562r2139b2645],
14	.	.	O	.	_	0	SENT_24	[p1l1957t2562r2139b2645],

1	Clopidogrel	NNP	O	Clopidogrel	poss	4	SENT_25	[p1l12t2670r461b2759],
2	’s	POS	O	’s	_	0	SENT_25	[p1l12t2670r461b2759],
3	clinical	JJ	O	clinical	amod	4	SENT_25	[p1l494t2670r730b2736],
4	eﬂicacy	NN	O	eﬂicacy	nsubjpass	6	SENT_25	[p1l760t2670r1006b2759],
5	was	VBD	O	be	auxpass	6	SENT_25	[p1l1028t2696r1154b2736],
6	demonstrated	VBN	O	demonstrate	dep	19	SENT_25	[p1l1187t2670r1653b2736],
7	in	IN	O	in	_	0	SENT_25	[p1l1683t2673r1749b2735],
8	the	DT	O	the	det	11	SENT_25	[p1l1779t2670r1886b2736],
9	Clopidogrel	NNP	MISC	Clopidogrel	nn	11	SENT_25	[p1l1919t2670r2141b2760, p1l11t2776r225b2865],
10	Vs.	NNP	MISC	Vs.	nn	11	SENT_25	[p1l267t2802r352b2842],
11	Aspirin	NNP	MISC	Aspirin	prep_in	6	SENT_25	[p1l401t2775r658b2866],
12	in	IN	O	in	_	0	SENT_25	[p1l705t2779r771b2841],
13	Patients	NNS	O	patient	prep_in	6	SENT_25	[p1l818t2777r1090b2842],
14	at	IN	O	at	_	0	SENT_25	[p1l1140t2793r1202b2842],
15	Risk	NN	O	risk	prep_at	13	SENT_25	[p1l1249t2776r1403b2842],
16	of	IN	O	of	_	0	SENT_25	[p1l1448t2776r1525b2842],
17	Ischemic	JJ	O	ischemic	amod	18	SENT_25	[p1l1559t2776r1865b2842],
18	Events	NNS	O	event	prep_of	15	SENT_25	[p1l1912t2777r2142b2842],
19	(	VBP	O	(	_	0	SENT_25	[p1l13t2880r393b2963],
20	CAPRIE	JJ	O	caprie	acomp	19	SENT_25	[p1l13t2880r393b2963],
21	)	JJ	O	)	amod	22	SENT_25	[p1l13t2880r393b2963],
22	trial	NN	O	trial	nsubj	19	SENT_25	[p1l434t2882r594b2963],
23	,	,	O	,	_	0	SENT_25	[p1l434t2882r594b2963],
24	in	IN	O	in	_	0	SENT_25	[p1l636t2885r704b2948],
25	which	WDT	O	which	rel	37	SENT_25	[p1l740t2882r958b2949],
26	its	PRP$	O	its	poss	30	SENT_25	[p1l997t2885r1076b2948],
27	long	JJ	O	long	amod	30	SENT_25	[p1l1116t2882r1475b2971],
28	—	NN	O	—	nn	30	SENT_25	[p1l1116t2882r1475b2971],
29	term	NN	O	term	nn	30	SENT_25	[p1l1116t2882r1475b2971],
30	administration	NN	O	administration	nsubj	37	SENT_25	[p1l1516t2882r2035b2948],
31	to	TO	O	to	_	0	SENT_25	[p1l2074t2899r2142b2948],
32	patients	NNS	O	patient	prep_to	30	SENT_25	[p1l9t2991r287b3077],
33	with	IN	O	with	_	0	SENT_25	[p1l312t2988r474b3054],
34	atherosclerosis	NN	O	atherosclerosis	prep_with	32	SENT_25	[p1l503t2988r1014b3054],
35	was	VBD	O	be	cop	37	SENT_25	[p1l1040t3014r1169b3054],
36	more	RBR	O	more	advmod	37	SENT_25	[p1l1200t3014r1379b3054],
37	effective	JJ	O	effective	rcmod	22	SENT_25	[p1l1409t2988r1692b3054],
38	than	IN	O	than	mark	44	SENT_25	[p1l1720t2988r1879b3054],
39	aspirin	NN	O	aspirin	nsubj	44	SENT_25	[p1l1908t2991r2144b3078],
40	in	IN	O	in	_	0	SENT_25	[p1l10t3097r78b3159],
41	reducing	VBG	O	reduce	prepc_in	39	SENT_25	[p1l120t3094r429b3183],
42	atherothrombotic	JJ	O	atherothrombotic	amod	43	SENT_25	[p1l470t3094r1094b3160],
43	complications	NNS	O	complication	dobj	41	SENT_25	[p1l1136t3094r1625b3184],
44	(	VBP	O	(	ccomp	37	SENT_25	[p1l1671t3092r1831b3175],
45	10	CD	NUMBER	10	number	46	SENT_25	[p1l1671t3092r1831b3175],
46	)	CD	NUMBER	)	dobj	44	SENT_25	[p1l1671t3092r1831b3175],
47	.	.	O	.	_	0	SENT_25	[p1l1671t3092r1831b3175],

1	Animal	NN	O	animal	nn	2	SENT_26	[p1l1875t3093r2145b3160],
2	models	NNS	O	model	nsubj	5	SENT_26	[p1l11t3201r260b3267],
3	of	IN	O	of	_	0	SENT_26	[p1l314t3201r394b3267],
4	thrombosis	NN	O	thrombosis	prep_of	2	SENT_26	[p1l434t3201r828b3267],
5	suggest	VBP	O	suggest	_	0	SENT_26	[p1l883t3218r1141b3290],
6	that	IN	O	that	complm	20	SENT_26	[p1l1190t3201r1332b3267],
7	combination	NN	O	combination	nn	8	SENT_26	[p1l1382t3201r1828b3267],
8	therapy	NN	O	therapy	nsubj	20	SENT_26	[p1l1880t3201r2148b3291],
9	with	IN	O	with	_	0	SENT_26	[p1l7t3307r168b3373],
10	aspirin	NN	O	aspirin	prep_with	8	SENT_26	[p1l202t3310r438b3397],
11	is	VBZ	O	be	cop	20	SENT_26	[p1l469t3310r520b3373],
12	an	DT	O	a	det	20	SENT_26	[p1l555t3333r635b3373],
13	even	RB	O	even	advmod	15	SENT_26	[p1l668t3333r826b3373],
14	more	RBR	O	more	advmod	15	SENT_26	[p1l859t3333r1038b3373],
15	effective	JJ	O	effective	amod	20	SENT_26	[p1l1072t3307r1355b3373],
16	antithrombotic	JJ	O	antithrombotic	amod	20	SENT_26	[p1l1389t3307r1923b3373],
17	strategy	NN	O	strategy	nn	20	SENT_26	[p1l1956t3324r2141b3373, p1l11t3439r131b3502],
18	(	CD	NUMBER	(	number	19	SENT_26	[p1l155t3411r426b3493],
19	11-13	CD	NUMBER	11-13	num	20	SENT_26	[p1l155t3411r426b3493],
20	)	NN	O	)	ccomp	5	SENT_26	[p1l155t3411r426b3493],
21	and	CC	O	and	_	0	SENT_26	[p1l457t3413r603b3494],
22	,	,	O	,	_	0	SENT_26	[p1l457t3413r603b3494],
23	in	IN	O	in	ccomp	5	SENT_26	[p1l631t3416r699b3479],
24	a	DT	O	a	det	27	SENT_26	[p1l726t3439r760b3479],
25	large	JJ	O	large	amod	27	SENT_26	[p1l783t3413r952b3502],
26	randomized	JJ	O	randomized	amod	27	SENT_26	[p1l978t3413r1400b3479],
27	trial	NN	O	trial	pobj	23	SENT_26	[p1l1425t3413r1566b3479],
28	in	IN	O	in	_	0	SENT_26	[p1l1590t3416r1658b3478],
29	patients	NNS	O	patient	prep_in	27	SENT_26	[p1l1682t3416r1959b3503],
30	with	IN	O	with	_	0	SENT_26	[p1l1982t3413r2144b3479],
31	acute	JJ	O	acute	amod	33	SENT_26	[p1l12t3536r192b3585],
32	coronary	JJ	O	coronary	amod	33	SENT_26	[p1l218t3545r528b3608],
33	syndromes	NNS	O	syndrome	prep_with	29	SENT_26	[p1l549t3519r944b3608],
34	,	,	O	,	_	0	SENT_26	[p1l549t3519r944b3608],
35	the	DT	O	the	det	36	SENT_26	[p1l971t3519r1082b3585],
36	combination	NN	O	combination	appos	33	SENT_26	[p1l1107t3519r1553b3585],
37	of	IN	O	of	_	0	SENT_26	[p1l1578t3519r1658b3585],
38	acetylsalicylic	JJ	O	acetylsalicylic	prep_of	36	SENT_26	[p1l1672t3519r2145b3608],

1	From	IN	O	from	dep	80	SENT_27	[p2l72t21r209b67],
2	the	DT	O	the	det	5	SENT_27	[p2l234t21r311b67],
3	*	CD	NUMBER	*	num	5	SENT_27	[p2l336t21r496b67],
4	Davis	NNP	O	Davis	nn	5	SENT_27	[p2l336t21r496b67],
5	Heart	NNP	O	Heart	pobj	1	SENT_27	[p2l523t21r668b67],
6	and	CC	O	and	_	0	SENT_27	[p2l693t21r782b67],
7	Lung	NN	ORGANIZATION	lung	nn	9	SENT_27	[p2l807t22r942b83],
8	Research	NNP	ORGANIZATION	Research	nn	9	SENT_27	[p2l966t21r1188b67],
9	Institute	NNP	ORGANIZATION	Institute	conj_and	5	SENT_27	[p2l1213t21r1423b67],
10	and	CC	O	and	_	0	SENT_27	[p2l1449t21r1538b67],
11	Division	NNP	O	Division	conj_and	5	SENT_27	[p2l1562t22r1774b67],
12	of	IN	O	of	_	0	SENT_27	[p2l1799t21r1855b67],
13	Cardiovascular	NNP	O	Cardiovascular	nn	14	SENT_27	[p2l1872t21r2142b67, p2l10t98r130b144],
14	Medicine	NNP	O	Medicine	prep_of	11	SENT_27	[p2l157t98r409b155],
15	,	,	O	,	_	0	SENT_27	[p2l157t98r409b155],
16	Department	NNP	ORGANIZATION	Department	conj_and	5	SENT_27	[p2l442t99r747b160],
17	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l777t98r833b144],
18	Internal	NNP	ORGANIZATION	Internal	nn	19	SENT_27	[p2l854t98r1053b144],
19	Medicine	NNP	ORGANIZATION	Medicine	prep_of	16	SENT_27	[p2l1081t98r1333b155],
20	,	,	ORGANIZATION	,	_	0	SENT_27	[p2l1081t98r1333b155],
21	College	NNP	ORGANIZATION	College	conj_and	5	SENT_27	[p2l1366t98r1555b160],
22	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l1586t98r1642b144],
23	Medicine	NNP	ORGANIZATION	Medicine	prep_of	21	SENT_27	[p2l1663t98r1914b155],
24	,	,	O	,	_	0	SENT_27	[p2l1663t98r1914b155],
25	and	CC	O	and	_	0	SENT_27	[p2l1948t98r2037b144],
26	the	DT	O	the	det	28	SENT_27	[p2l2066t98r2144b144],
27	]	NN	O	]	nn	28	SENT_27	[p2l10t175r253b229],
28	LDivision	NN	O	ldivision	conj_and	5	SENT_27	[p2l10t175r253b229],
29	of	IN	O	of	_	0	SENT_27	[p2l271t175r327b221],
30	Epidemiology	NNP	O	Epidemiology	prep_of	28	SENT_27	[p2l337t175r690b237],
31	and	CC	O	and	_	0	SENT_27	[p2l706t175r795b221],
32	Biometrics	NNP	O	Biometrics	conj_and	30	SENT_27	[p2l813t176r1080b221],
33	of	IN	O	of	_	0	SENT_27	[p2l1100t175r1156b221],
34	the	DT	O	the	det	35	SENT_27	[p2l1165t175r1242b221],
35	School	NNP	ORGANIZATION	School	prep_of	28	SENT_27	[p2l1263t175r1431b221],
36	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l1448t175r1504b221],
37	Public	NNP	ORGANIZATION	Public	nn	38	SENT_27	[p2l1513t175r1670b221],
38	Health	NNP	ORGANIZATION	Health	prep_of	35	SENT_27	[p2l1688t175r1875b232],
39	,	,	O	,	_	0	SENT_27	[p2l1688t175r1875b232],
40	The	DT	O	the	det	47	SENT_27	[p2l1893t174r1996b221],
41	Ohio	NNP	ORGANIZATION	Ohio	dep	47	SENT_27	[p2l2015t175r2144b221],
42	State	NNP	ORGANIZATION	State	nn	41	SENT_27	[p2l12t252r134b298],
43	University	NNP	ORGANIZATION	University	nn	41	SENT_27	[p2l160t253r429b314],
44	,	,	O	,	_	0	SENT_27	[p2l160t253r429b314],
45	Columbus	NNP	LOCATION	Columbus	dep	41	SENT_27	[p2l459t252r729b308],
46	,	,	O	,	_	0	SENT_27	[p2l459t252r729b308],
47	Ohio	NNP	LOCATION	Ohio	appos	38	SENT_27	[p2l759t252r902b309],
48	;	:	O	;	_	0	SENT_27	[p2l759t252r902b309],
49	IlIThrombosis	NNP	ORGANIZATION	IlIThrombosis	nn	51	SENT_27	[p2l931t251r1261b306],
50	Research	NNP	ORGANIZATION	Research	nn	51	SENT_27	[p2l1291t252r1512b298],
51	Section	NNP	ORGANIZATION	Section	pobj	1	SENT_27	[p2l1541t252r1737b309],
52	,	,	O	,	_	0	SENT_27	[p2l1541t252r1737b309],
53	Department	NNP	ORGANIZATION	Department	appos	51	SENT_27	[p2l1766t253r2071b314],
54	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l2097t252r2153b298],
55	Medicine	NNP	ORGANIZATION	Medicine	prep_of	53	SENT_27	[p2l9t329r260b386],
56	,	,	O	,	_	0	SENT_27	[p2l9t329r260b386],
57	College	NNP	ORGANIZATION	College	pobj	1	SENT_27	[p2l290t329r478b391],
58	of	IN	ORGANIZATION	of	_	0	SENT_27	[p2l506t329r562b375],
59	Medicine	NNP	ORGANIZATION	Medicine	prep_of	57	SENT_27	[p2l578t329r830b386],
60	,	,	O	,	_	0	SENT_27	[p2l578t329r830b386],
61	Baylor	NNP	ORGANIZATION	Baylor	nn	62	SENT_27	[p2l858t329r1020b391],
62	University	NNP	ORGANIZATION	University	pobj	1	SENT_27	[p2l1044t330r1314b391],
63	,	,	O	,	_	0	SENT_27	[p2l1044t330r1314b391],
64	Houston	NNP	LOCATION	Houston	nn	66	SENT_27	[p2l1343t330r1576b385],
65	,	,	O	,	_	0	SENT_27	[p2l1343t330r1576b385],
66	Texas	NNP	LOCATION	Texas	appos	62	SENT_27	[p2l1602t328r1762b385],
67	;	:	O	;	_	0	SENT_27	[p2l1602t328r1762b385],
68	and	CC	O	and	_	0	SENT_27	[p2l1792t329r1881b375],
69	the	DT	O	the	quantmod	70	SENT_27	[p2l1907t329r1984b375],
70	§	CD	NUMBER	§	num	73	SENT_27	[p2l2014t329r2143b383],
71	De	NNP	O	De	nn	73	SENT_27	[p2l2014t329r2143b383],
72	—	CD	NUMBER	—	num	73	SENT_27	[p2l2014t329r2143b383],
73	partment	NN	O	partment	pobj	1	SENT_27	[p2l9t418r238b468],
74	of	IN	O	of	_	0	SENT_27	[p2l261t406r317b452],
75	Medicine	NNP	MISC	Medicine	prep_of	73	SENT_27	[p2l332t406r583b463],
76	,	,	O	,	_	0	SENT_27	[p2l332t406r583b463],
77	Duke	NNP	ORGANIZATION	Duke	nn	80	SENT_27	[p2l608t406r745b452],
78	University	NNP	ORGANIZATION	University	nn	80	SENT_27	[p2l768t407r1027b468],
79	Medical	NNP	ORGANIZATION	Medical	nn	80	SENT_27	[p2l1047t406r1252b452],
80	Center	NNP	ORGANIZATION	Center	_	0	SENT_27	[p2l1276t406r1460b463],
81	,	,	O	,	_	0	SENT_27	[p2l1276t406r1460b463],
82	Durham	NNP	LOCATION	Durham	appos	80	SENT_27	[p2l1485t406r1711b463],
83	,	,	O	,	_	0	SENT_27	[p2l1485t406r1711b463],
84	North	NNP	LOCATION	North	nn	85	SENT_27	[p2l1736t406r1890b452],
85	Carolina	NNP	LOCATION	Carolina	appos	80	SENT_27	[p2l1915t406r2141b452],
86	.	.	O	.	_	0	SENT_27	[p2l1915t406r2141b452],

1	This	DT	O	this	det	2	SENT_28	[p2l8t482r123b529],
2	study	NN	O	study	nsubjpass	4	SENT_28	[p2l157t483r290b545],
3	was	VBD	O	be	auxpass	4	SENT_28	[p2l317t501r408b529],
4	supported	VBN	O	support	_	0	SENT_28	[p2l443t483r689b545],
5	by	IN	O	by	_	0	SENT_28	[p2l719t483r780b545],
6	a	DT	O	a	det	8	SENT_28	[p2l810t501r835b529],
7	research	NN	O	research	nn	8	SENT_28	[p2l866t483r1068b529],
8	grant	NN	O	grant	agent	4	SENT_28	[p2l1099t495r1230b545],
9	from	IN	O	from	_	0	SENT_28	[p2l1261t483r1381b529],
10	Bristol	NNP	LOCATION	Bristol	prep_from	4	SENT_28	[p2l1414t483r1762b545],
11	.	.	O	.	_	0	SENT_28	[p2l1414t483r1762b545],

1	—	NN	O	—	_	0	SENT_29	[p2l1414t483r1762b545],
2	.	.	O	.	_	0	SENT_29	[p2l1414t483r1762b545],

1	Myers	NNP	PERSON	Myers	nn	4	SENT_30	[p2l1414t483r1762b545],
2	Squib/Sano	NNP	O	Squib/Sano	nn	4	SENT_30	[p2l1798t483r2142b545],
3	ﬁ	NNP	O	ﬁ	nn	4	SENT_30	[p2l1798t483r2142b545],
4	Synthelabo	NNP	ORGANIZATION	Synthelabo	_	0	SENT_30	[p2l12t560r300b622],
5	.	.	O	.	_	0	SENT_30	[p2l12t560r300b622],

1	Dr.	NNP	O	Dr.	nn	2	SENT_31	[p2l344t561r426b606],
2	Cooke	NNP	PERSON	Cooke	nsubjpass	4	SENT_31	[p2l472t560r634b606],
3	is	VBZ	O	be	auxpass	4	SENT_31	[p2l675t562r711b606],
4	supported	VBN	O	support	_	0	SENT_31	[p2l754t560r1000b622],
5	by	IN	O	by	_	0	SENT_31	[p2l1039t560r1100b622],
6	NIH	NNP	ORGANIZATION	NIH	nn	9	SENT_31	[p2l1138t561r1260b606],
7	career	NN	O	career	nn	9	SENT_31	[p2l1304t578r1449b606],
8	development	NN	O	development	nn	9	SENT_31	[p2l1490t560r1809b622],
9	grant	NN	O	grant	agent	4	SENT_31	[p2l1849t572r1980b622],
10	(	CD	NUMBER	(	num	13	SENT_31	[p2l2021t559r2141b616],
11	K23	NN	O	k23	nn	13	SENT_31	[p2l2021t559r2141b616],
12	HLOO4483	NN	O	hloo4483	nn	13	SENT_31	[p2l10t639r322b696],
13	)	NN	O	)	dep	9	SENT_31	[p2l10t639r322b696],
14	.	.	O	.	_	0	SENT_31	[p2l10t639r322b696],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_32	[p2l71t718r361b779],
2	received	VBD	O	receive	_	0	SENT_32	[p2l377t717r579b763],
3	February	NNP	DATE	February	tmod	2	SENT_32	[p2l596t717r819b779],
4	24	CD	DATE	24	num	3	SENT_32	[p2l833t719r908b774],
5	,	,	DATE	,	_	0	SENT_32	[p2l833t719r908b774],
6	2005	CD	DATE	2005	num	3	SENT_32	[p2l927t717r1064b774],
7	;	:	O	;	_	0	SENT_32	[p2l927t717r1064b774],
8	revised	VBN	O	revise	amod	9	SENT_32	[p2l1084t717r1255b763],
9	manuscript	NN	O	manuscript	dobj	2	SENT_32	[p2l1273t719r1550b779],
10	received	VBD	O	receive	rcmod	9	SENT_32	[p2l1566t717r1767b763],
11	September	NNP	DATE	September	tmod	10	SENT_32	[p2l1787t717r2052b779],
12	15	CD	DATE	15	num	11	SENT_32	[p2l2072t717r2143b773],
13	,	,	O	,	_	0	SENT_32	[p2l2072t717r2143b773],

1	2005	CD	DATE	2005	_	0	SENT_33	[p2l9t794r146b850],
2	,	,	O	,	_	0	SENT_33	[p2l9t794r146b850],
3	accepted	VBN	O	accept	partmod	1	SENT_33	[p2l172t794r384b856],
4	September	NNP	DATE	September	tmod	3	SENT_33	[p2l410t794r675b856],
5	19	CD	DATE	19	num	4	SENT_33	[p2l699t796r770b851],
6	,	,	DATE	,	_	0	SENT_33	[p2l699t796r770b851],
7	2005	CD	DATE	2005	num	4	SENT_33	[p2l794t794r930b841],
8	.	.	O	.	_	0	SENT_33	[p2l794t794r930b841],

1	acid	NN	O	acid	nn	3	SENT_34	[p2l12t1018r152b1084],
2	(	CD	NUMBER	(	num	3	SENT_34	[p2l180t1016r404b1099],
3	ASA	NN	O	asa	nsubjpass	12	SENT_34	[p2l180t1016r404b1099],
4	,	,	O	,	_	0	SENT_34	[p2l180t1016r404b1099],
5	i.e.	FW	O	i.e.	nsubjpass	12	SENT_34	[p2l432t1021r555b1099],
6	,	,	O	,	_	0	SENT_34	[p2l432t1021r555b1099],
7	aspirin	NN	O	aspirin	nn	8	SENT_34	[p2l585t1016r846b1107],
8	)	NN	O	)	nsubjpass	12	SENT_34	[p2l585t1016r846b1107],
9	and	CC	O	and	_	0	SENT_34	[p2l877t1018r1004b1084],
10	clopidogrel	NN	O	clopidogrel	conj_and	3	SENT_34	[p2l1030t1018r1424b1107],
11	was	VBD	O	be	auxpass	12	SENT_34	[p2l1445t1044r1574b1084],
12	shown	VBN	O	show	_	0	SENT_34	[p2l1603t1018r1830b1084],
13	superior	JJ	O	superior	acomp	12	SENT_34	[p2l1857t1021r2142b1108],
14	to	TO	O	to	_	0	SENT_34	[p2l10t1141r78b1190],
15	ASA	NN	O	asa	prep_to	13	SENT_34	[p2l101t1122r282b1191],
16	alone	RB	O	alone	advmod	15	SENT_34	[p2l305t1124r490b1190],
17	(	RB	O	(	advmod	19	SENT_34	[p2l517t1122r676b1205],
18	14	CD	NUMBER	14	num	19	SENT_34	[p2l517t1122r676b1205],
19	)	NN	O	)	rcmod	15	SENT_34	[p2l517t1122r676b1205],
20	.	.	O	.	_	0	SENT_34	[p2l517t1122r676b1205],

1	The	DT	O	the	det	2	SENT_35	[p2l701t1122r848b1190],
2	risk	NN	O	risk	nsubjpass	7	SENT_35	[p2l872t1124r1003b1190],
3	of	IN	O	of	_	0	SENT_35	[p2l1023t1124r1103b1190],
4	major	JJ	O	major	amod	5	SENT_35	[p2l1115t1126r1318b1213],
5	bleeding	NN	O	bleeding	prep_of	2	SENT_35	[p2l1338t1124r1642b1213],
6	was	VBD	O	be	auxpass	7	SENT_35	[p2l1660t1150r1789b1191],
7	increased	VBN	O	increase	_	0	SENT_35	[p2l1814t1124r2141b1190],
8	with	IN	O	with	_	0	SENT_35	[p2l7t1230r168b1296],
9	combination	NN	O	combination	nn	10	SENT_35	[p2l230t1230r675b1296],
10	therapy	NN	O	therapy	prep_with	7	SENT_35	[p2l736t1230r1003b1320],
11	relative	JJ	O	relative	advmod	10	SENT_35	[p2l1060t1230r1313b1297],
12	to	TO	O	to	_	0	SENT_35	[p2l1374t1247r1442b1296],
13	ASA	NN	O	asa	prep_to	11	SENT_35	[p2l1502t1228r1684b1297],
14	alone	RB	O	alone	advmod	7	SENT_35	[p2l1744t1230r1928b1296],
15	and	CC	O	and	cc	7	SENT_35	[p2l1992t1230r2137b1311],
16	,	,	O	,	_	0	SENT_35	[p2l1992t1230r2137b1311],
17	therefore	RB	O	therefore	advmod	21	SENT_35	[p2l10t1336r349b1417],
18	,	,	O	,	_	0	SENT_35	[p2l10t1336r349b1417],
19	it	PRP	O	it	nsubj	21	SENT_35	[p2l380t1339r431b1402],
20	becomes	VBZ	O	become	cop	21	SENT_35	[p2l455t1336r757b1402],
21	important	JJ	O	important	ccomp	7	SENT_35	[p2l787t1339r1143b1426],
22	to	TO	O	to	aux	23	SENT_35	[p2l1169t1353r1237b1402],
23	identify	VB	O	identify	xcomp	21	SENT_35	[p2l1267t1336r1541b1425],
24	means	NNS	O	means	dobj	23	SENT_35	[p2l1566t1362r1786b1402],
25	of	IN	O	of	_	0	SENT_35	[p2l1817t1336r1897b1402],
26	selecting	NN	O	selecting	nn	27	SENT_35	[p2l1915t1336r2138b1402, p2l10t1445r123b1531],
27	patients	NNS	O	patient	prep_of	24	SENT_35	[p2l143t1445r420b1531],
28	whose	WP$	O	whose	poss	29	SENT_35	[p2l442t1442r664b1509],
29	need	NN	O	need	nsubj	39	SENT_35	[p2l689t1442r855b1508],
30	for	IN	O	for	_	0	SENT_35	[p2l877t1442r978b1508],
31	clopidogrel	NN	O	clopidogrel	prep_for	29	SENT_35	[p2l1000t1442r1413b1531],
32	,	,	O	,	_	0	SENT_35	[p2l1000t1442r1413b1531],
33	in	IN	O	in	_	0	SENT_35	[p2l1439t1445r1507b1508],
34	addition	NN	O	addition	_	0	SENT_35	[p2l1532t1442r1825b1508],
35	to	TO	O	to	_	0	SENT_35	[p2l1848t1459r1916b1508],
36	ASA	NN	O	asa	prep_in_addition_to	39	SENT_35	[p2l1938t1440r2137b1523],
37	,	,	O	,	_	0	SENT_35	[p2l1938t1440r2137b1523],
38	is	VBZ	O	be	cop	39	SENT_35	[p2l10t1552r61b1615],
39	greatest	JJS	O	greatest	rcmod	24	SENT_35	[p2l94t1566r369b1638],
40	to	TO	O	to	aux	41	SENT_35	[p2l400t1566r468b1615],
41	achieve	VB	O	achieve	xcomp	39	SENT_35	[p2l504t1549r759b1615],
42	optimized	VBN	O	optimize	dep	41	SENT_35	[p2l793t1549r1150b1639],
43	platelet	NN	O	platelet	nn	44	SENT_35	[p2l1181t1549r1443b1639],
44	inhibition	NN	O	inhibition	dobj	42	SENT_35	[p2l1473t1549r1843b1615],
45	.	.	O	.	_	0	SENT_35	[p2l1473t1549r1843b1615],

1	We	PRP	O	we	nsubj	3	SENT_36	[p2l95t1656r226b1722],
2	have	VBP	O	have	aux	3	SENT_36	[p2l267t1655r425b1721],
3	hypothesized	VBN	O	hypothesize	_	0	SENT_36	[p2l466t1655r932b1745],
4	that	IN	O	that	complm	14	SENT_36	[p2l971t1655r1112b1721],
5	the	DT	O	the	det	6	SENT_36	[p2l1150t1655r1260b1721],
6	eﬂiciency	NN	O	eﬂiciency	nsubjpass	14	SENT_36	[p2l1303t1655r1629b1744],
7	and	CC	O	and	_	0	SENT_36	[p2l1666t1655r1794b1721],
8	safety	NN	O	safety	nsubjpass	14	SENT_36	[p2l1835t1655r2036b1744],
9	of	IN	O	of	_	0	SENT_36	[p2l2073t1655r2153b1721],
10	antithrombotic	JJ	O	antithrombotic	amod	11	SENT_36	[p2l12t1762r545b1828],
11	strategies	NNS	O	strategy	prep_of	6	SENT_36	[p2l599t1765r923b1851],
12	might	MD	O	might	aux	14	SENT_36	[p2l978t1762r1190b1851],
13	be	VB	O	be	auxpass	14	SENT_36	[p2l1239t1762r1320b1828],
14	impacted	VBN	O	impact	ccomp	3	SENT_36	[p2l1373t1762r1699b1851],
15	by	IN	O	by	_	0	SENT_36	[p2l1749t1762r1834b1851],
16	speciﬁc	NN	O	speciﬁc	nn	18	SENT_36	[p2l1885t1762r2141b1851],
17	gene	NN	O	gene	nn	18	SENT_36	[p2l9t1921r172b1984],
18	variants	NNS	O	variant	agent	14	SENT_36	[p2l229t1898r502b1961],
19	implicated	VBN	O	implicate	partmod	18	SENT_36	[p2l563t1895r934b1984],
20	in	IN	O	in	_	0	SENT_36	[p2l992t1898r1060b1960],
21	coronary	JJ	O	coronary	amod	22	SENT_36	[p2l1119t1921r1429b1984],
22	thrombosis	NN	O	thrombosis	prep_in	19	SENT_36	[p2l1483t1895r1877b1961],
23	under	IN	O	under	_	0	SENT_36	[p2l1936t1895r2142b1961],
24	various	JJ	O	various	amod	26	SENT_36	[p2l7t2004r257b2067],
25	clinical	JJ	O	clinical	amod	26	SENT_36	[p2l299t2001r547b2067],
26	circumstances	NNS	O	circumstance	prep_under	19	SENT_36	[p2l586t2004r1075b2067],
27	(	VBP	O	(	rcmod	26	SENT_36	[p2l1118t1999r1389b2082],
28	15,16	CD	NUMBER	15,16	number	29	SENT_36	[p2l1118t1999r1389b2082],
29	)	CD	NUMBER	)	dobj	27	SENT_36	[p2l1118t1999r1389b2082],
30	.	.	O	.	_	0	SENT_36	[p2l1118t1999r1389b2082],

1	This	DT	O	this	det	3	SENT_37	[p2l1430t1999r1593b2067],
2	pilot	NN	O	pilot	nn	3	SENT_37	[p2l1633t2001r1797b2090],
3	trial	NN	O	trial	nsubjpass	5	SENT_37	[p2l1835t2001r1976b2067],
4	was	VBD	O	be	auxpass	5	SENT_37	[p2l2010t2027r2139b2067],
5	designed	VBN	O	design	_	0	SENT_37	[p2l11t2108r322b2197],
6	to	TO	O	to	aux	7	SENT_37	[p2l345t2125r412b2174],
7	assess	VB	O	assess	xcomp	5	SENT_37	[p2l439t2134r635b2174],
8	the	DT	O	the	det	10	SENT_37	[p2l661t2108r770b2174],
9	relative	JJ	O	relative	amod	10	SENT_37	[p2l795t2108r1048b2174],
10	eﬂicacy	NN	O	eﬂicacy	dobj	7	SENT_37	[p2l1073t2108r1329b2197],
11	of	IN	O	of	_	0	SENT_37	[p2l1350t2108r1429b2174],
12	aspirin	NN	O	aspirin	prep_of	10	SENT_37	[p2l1442t2111r1697b2198],
13	,	,	O	,	_	0	SENT_37	[p2l1442t2111r1697b2198],
14	clopidogrel	NN	O	clopidogrel	conj_or	12	SENT_37	[p2l1725t2108r2138b2198],
15	,	,	O	,	_	0	SENT_37	[p2l1725t2108r2138b2198],
16	or	CC	O	or	_	0	SENT_37	[p2l11t2240r83b2280],
17	their	PRP$	O	they	poss	18	SENT_37	[p2l114t2214r280b2280],
18	combination	NN	O	combination	conj_or	12	SENT_37	[p2l312t2214r758b2280],
19	in	IN	O	in	_	0	SENT_37	[p2l791t2217r858b2279],
20	inhibiting	VBG	O	inhibit	prepc_in	7	SENT_37	[p2l890t2214r1242b2303],
21	ex	FW	O	ex	nn	24	SENT_37	[p2l1274t2240r1348b2280],
22	vivo	FW	O	vivo	nn	24	SENT_37	[p2l1376t2217r1519b2280],
23	platelet	NN	O	platelet	nn	24	SENT_37	[p2l1552t2214r1813b2303],
24	function	NN	O	function	dobj	20	SENT_37	[p2l1844t2214r2140b2280],
25	in	IN	O	in	_	0	SENT_37	[p2l10t2323r78b2385],
26	a	DT	O	a	det	27	SENT_37	[p2l133t2346r167b2386],
27	cohort	NN	O	cohort	prep_in	24	SENT_37	[p2l219t2320r449b2386],
28	of	IN	O	of	_	0	SENT_37	[p2l501t2320r580b2386],
29	patients	NNS	O	patient	prep_of	27	SENT_37	[p2l620t2323r897b2409],
30	with	IN	O	with	_	0	SENT_37	[p2l948t2320r1109b2386],
31	established	JJ	O	established	amod	33	SENT_37	[p2l1163t2320r1550b2386],
32	coronary	JJ	O	coronary	amod	33	SENT_37	[p2l1603t2346r1912b2409],
33	heart	NN	O	heart	prep_with	20	SENT_37	[p2l1962t2320r2142b2386],
34	disease	NN	O	disease	nn	37	SENT_37	[p2l11t2426r253b2492],
35	(	CD	NUMBER	(	num	37	SENT_37	[p2l297t2424r582b2506],
36	CHD	NN	O	chd	nn	37	SENT_37	[p2l297t2424r582b2506],
37	)	NN	O	)	dep	33	SENT_37	[p2l297t2424r582b2506],
38	.	.	O	.	_	0	SENT_37	[p2l297t2424r582b2506],

1	We	PRP	O	we	nsubj	2	SENT_38	[p2l623t2427r754b2493],
2	demonstrate	VBP	O	demonstrate	_	0	SENT_38	[p2l796t2426r1233b2492],
3	that	IN	O	that	complm	8	SENT_38	[p2l1274t2426r1415b2492],
4	platelet	NN	O	platelet	nn	5	SENT_38	[p2l1452t2426r1713b2515],
5	function	NN	O	function	nsubj	8	SENT_38	[p2l1752t2426r2048b2492],
6	is	VBZ	O	be	cop	8	SENT_38	[p2l2089t2429r2139b2492],
7	markedly	RB	O	markedly	advmod	8	SENT_38	[p2l11t2533r341b2622],
8	dependent	JJ	O	dependent	ccomp	2	SENT_38	[p2l368t2533r740b2623],
9	upon	IN	O	upon	_	0	SENT_38	[p2l767t2559r947b2622],
10	the	DT	O	the	det	11	SENT_38	[p2l977t2533r1088b2599],
11	type	NN	O	type	prep_upon	8	SENT_38	[p2l1118t2550r1265b2622],
12	of	IN	O	of	_	0	SENT_38	[p2l1297t2533r1377b2599],
13	agonist	NN	O	agonist	prep_of	11	SENT_38	[p2l1396t2536r1649b2622],
14	used	VBN	O	use	partmod	13	SENT_38	[p2l1676t2533r1855b2614],
15	,	,	O	,	_	0	SENT_38	[p2l1676t2533r1855b2614],
16	agonist	NN	O	agonist	nn	17	SENT_38	[p2l1889t2536r2143b2622],
17	concentration	NN	O	concentration	prep_upon	8	SENT_38	[p2l11t2669r517b2746],
18	,	,	O	,	_	0	SENT_38	[p2l11t2669r517b2746],
19	antiplatelet	JJ	O	antiplatelet	amod	20	SENT_38	[p2l550t2666r945b2759],
20	strategy	NN	O	strategy	appos	17	SENT_38	[p2l974t2683r1265b2755],
21	,	,	O	,	_	0	SENT_38	[p2l974t2683r1265b2755],
22	and	CC	O	and	_	0	SENT_38	[p2l1297t2666r1425b2732],
23	the	DT	O	the	det	28	SENT_38	[p2l1452t2666r1562b2732],
24	platelet	NN	O	platelet	nn	28	SENT_38	[p2l1591t2666r1852b2755],
25	antigen	NN	O	antigen	nn	28	SENT_38	[p2l1880t2669r2141b2755],
26	polymorphism	NN	O	polymorphism	nn	28	SENT_38	[p2l9t2800r525b2889],
27	(	NN	O	(	nn	28	SENT_38	[p2l552t2786r726b2880],
28	PIA	NN	ORGANIZATION	pium	prep_upon	8	SENT_38	[p2l552t2786r726b2880],
29	)	CD	NUMBER	)	num	30	SENT_38	[p2l552t2786r726b2880],
30	genotype	NN	O	genotype	dep	28	SENT_38	[p2l752t2817r1091b2889],
31	.	.	O	.	_	0	SENT_38	[p2l752t2817r1091b2889],

1	The	DT	O	the	det	3	SENT_39	[p2l1115t2798r1263b2865],
2	latter	JJ	O	latter	amod	3	SENT_39	[p2l1285t2800r1470b2865],
3	ﬁnding	NN	O	ﬁnding	nsubj	5	SENT_39	[p2l1491t2800r1746b2888],
4	could	MD	O	could	aux	5	SENT_39	[p2l1768t2800r1960b2865],
5	have	VB	O	have	_	0	SENT_39	[p2l1982t2800r2140b2866],
6	important	JJ	O	important	amod	8	SENT_39	[p2l10t2937r367b3023],
7	pharmacogenetic	JJ	O	pharmacogenetic	amod	8	SENT_39	[p2l396t2934r1001b3023],
8	consequences	NNS	O	consequence	dobj	5	SENT_39	[p2l1033t2960r1506b3024],
9	for	IN	O	for	_	0	SENT_39	[p2l1540t2934r1640b3000],
10	the	DT	O	the	det	11	SENT_39	[p2l1671t2934r1781b3000],
11	design	NN	O	design	prep_for	8	SENT_39	[p2l1815t2934r2040b3023],
12	of	IN	O	of	_	0	SENT_39	[p2l2073t2934r2153b3000],
13	antithrombotic	JJ	O	antithrombotic	amod	14	SENT_39	[p2l12t3040r545b3106],
14	strategies	NNS	O	strategy	prep_of	11	SENT_39	[p2l579t3043r903b3129],
15	for	IN	O	for	_	0	SENT_39	[p2l938t3040r1038b3106],
16	patients	NNS	O	patient	prep_for	5	SENT_39	[p2l1068t3043r1345b3130],
17	with	IN	O	with	_	0	SENT_39	[p2l1376t3040r1538b3106],
18	CHD	NN	O	chd	prep_with	16	SENT_39	[p2l1573t3040r1800b3106],
19	.	.	O	.	_	0	SENT_39	[p2l1573t3040r1800b3106],

1	METHODS	NNS	O	method	_	0	SENT_40	[p2l13t3290r399b3364],

1	Study	NNP	O	Study	_	0	SENT_41	[p3l13t60r228b150],
2	subjects	NNS	O	subject	dep	1	SENT_41	[p3l258t60r572b150],
3	.	.	O	.	_	0	SENT_41	[p3l258t60r572b150],

1	To	TO	O	to	aux	2	SENT_42	[p3l620t59r725b127],
2	study	VB	O	study	purpcl	16	SENT_42	[p3l761t61r950b150],
3	the	DT	O	the	det	4	SENT_42	[p3l978t61r1089b127],
4	effects	NNS	O	effect	dobj	2	SENT_42	[p3l1123t61r1336b127],
5	of	IN	O	of	_	0	SENT_42	[p3l1371t61r1451b127],
6	the	DT	O	the	det	8	SENT_42	[p3l1471t61r1582b127],
7	PIA	NNP	O	PIA	nn	8	SENT_42	[p3l1615t45r1739b126],
8	phenotype	NN	O	phenotype	prep_of	4	SENT_42	[p3l1769t61r2140b150],
9	on	IN	O	on	prep	2	SENT_42	[p3l11t193r99b233],
10	in	FW	O	in	nn	11	SENT_42	[p3l138t170r206b232],
11	vivo	FW	O	vivo	dep	13	SENT_42	[p3l243t170r386b233],
12	antiplatelet	JJ	O	antiplatelet	amod	13	SENT_42	[p3l429t167r824b256],
13	therapy	NN	O	therapy	dep	9	SENT_42	[p3l862t167r1146b256],
14	,	,	O	,	_	0	SENT_42	[p3l862t167r1146b256],
15	We	PRP	O	we	nsubj	16	SENT_42	[p3l1185t193r1283b233],
16	genotyped	VBD	O	genotype	_	0	SENT_42	[p3l1323t167r1690b256],
17	a	DT	O	a	det	18	SENT_42	[p3l1731t193r1766b233],
18	cohort	NN	O	cohort	dobj	16	SENT_42	[p3l1805t167r2034b233],
19	of	IN	O	of	_	0	SENT_42	[p3l2073t167r2153b233],
20	patients	NNS	O	patient	prep_of	18	SENT_42	[p3l9t276r286b362],
21	with	IN	O	with	_	0	SENT_42	[p3l314t273r475b339],
22	established	JJ	O	established	amod	27	SENT_42	[p3l506t273r893b339],
23	and	CC	O	and	_	0	SENT_42	[p3l923t273r1050b339],
24	stable	JJ	O	stable	amod	27	SENT_42	[p3l1081t273r1279b339],
25	coronary	JJ	O	coronary	amod	27	SENT_42	[p3l1310t298r1619b362],
26	artery	NN	O	artery	nn	27	SENT_42	[p3l1646t290r1849b362],
27	disease	NN	O	disease	prep_with	20	SENT_42	[p3l1875t273r2138b354],
28	,	,	O	,	_	0	SENT_42	[p3l1875t273r2138b354],
29	veriﬁed	VBN	O	veriﬁed	partmod	20	SENT_42	[p3l7t379r271b445],
30	by	IN	O	by	_	0	SENT_42	[p3l309t379r394b468],
31	cardiac	JJ	O	cardiac	amod	32	SENT_42	[p3l432t379r678b445],
32	catheterization	NN	O	catheterization	agent	29	SENT_42	[p3l718t379r1262b460],
33	,	,	O	,	_	0	SENT_42	[p3l718t379r1262b460],
34	who	WP	O	who	nsubj	35	SENT_42	[p3l1302t379r1454b445],
35	require	VBP	O	require	rcmod	20	SENT_42	[p3l1495t382r1742b468],
36	long	JJ	O	long	amod	37	SENT_42	[p3l1781t379r2140b468],
37	—	NN	O	—	nsubj	40	SENT_42	[p3l1781t379r2140b468],
38	term	NN	O	term	nn	40	SENT_42	[p3l1781t379r2140b468],
39	542	CD	NUMBER	542	num	40	SENT_42	[p3l9t470r135b529],
40	Cooke	NNP	PERSON	Cooke	xcomp	35	SENT_42	[p3l330t470r526b529],
41	et	FW	O	et	nn	42	SENT_42	[p3l551t473r616b529],
42	al.	FW	O	al.	dep	40	SENT_42	[p3l634t471r709b529],
43	.	.	O	.	_	0	SENT_42	[p3l634t471r709b529],

1	PI	NN	O	pi	_	0	SENT_43	[p3l333t543r427b611],
2	“	NN	O	“	dep	1	SENT_43	[p3l333t543r427b611],
3	and	CC	O	and	_	0	SENT_43	[p3l448t553r563b612],
4	Responsiveness	NN	O	responsiveness	dep	1	SENT_43	[p3l590t553r1092b623],
5	to	TO	O	to	_	0	SENT_43	[p3l1112t556r1176b612],
6	Aspirin	NN	MISC	aspirin	prep_to	2	SENT_43	[p3l1197t553r1419b623],
7	and	CC	O	and	_	0	SENT_43	[p3l1444t553r1558b612],
8	clopidogrel	NN	O	clopidogrel	prep_to	2	SENT_43	[p3l1584t552r1945b623],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_44	[p3l219t901r643b955],
2	and	CC	O	and	_	0	SENT_44	[p3l671t901r780b955],
3	Acronyms	NNS	O	acronym	conj_and	1	SENT_44	[p3l801t901r1107b974],

1	ADP	NN	O	adp	_	0	SENT_45	[p3l329t1008r483b1062],

1	ANOVA	NNP	ORGANIZATION	ANOVA	_	0	SENT_46	[p3l329t1097r602b1152],

1	ASA	NN	O	asa	_	0	SENT_47	[p3l329t1187r475b1241],

1	CHD	NN	O	chd	_	0	SENT_48	[p3l332t1277r499b1331],

1	GP	NN	O	gp	nn	3	SENT_49	[p3l332t1367r430b1420],
2	glycoprotein	NN	O	glycoprotein	nn	3	SENT_49	[p3l709t1367r1063b1438],
3	PlA	NN	O	plum	_	0	SENT_49	[p3l331t1445r431b1509],
4	=	JJ	O	=	amod	8	SENT_49	[p3l633t1476r676b1493],
5	platelet	NN	O	platelet	nn	8	SENT_49	[p3l709t1456r919b1528],
6	antigen	NN	O	antigen	nn	8	SENT_49	[p3l945t1458r1155b1527],
7	polymorphism	NN	O	polymorphism	nn	8	SENT_49	[p3l1180t1456r1595b1528],
8	PRP	NN	O	prp	dep	3	SENT_49	[p3l331t1546r465b1598],
9	=	JJ	O	=	amod	11	SENT_49	[p3l633t1565r676b1582],
10	platelet	NN	O	platelet	nn	11	SENT_49	[p3l709t1545r1058b1617],
11	—	NN	O	—	dep	8	SENT_49	[p3l709t1545r1058b1617],
12	rich	JJ	O	rich	amod	16	SENT_49	[p3l709t1545r1058b1617],
13	plasma	NN	O	plasma	nn	16	SENT_49	[p3l1083t1545r1282b1617],
14	adenosine	NN	O	adenosine	nn	16	SENT_49	[p3l711t1009r991b1062],
15	diphosphate	NN	O	diphosphate	nn	16	SENT_49	[p3l1019t1009r1366b1081],
16	analysis	NN	O	analysis	dep	3	SENT_49	[p3l711t1099r925b1170],
17	of	IN	O	of	_	0	SENT_49	[p3l953t1099r1017b1152],
18	variance	NN	O	variance	prep_of	16	SENT_49	[p3l1031t1101r1263b1152],
19	acetylsalicylic	JJ	O	acetylsalicylic	amod	20	SENT_49	[p3l711t1188r1091b1260],
20	acid	NN	O	acid	dep	3	SENT_49	[p3l1118t1188r1231b1241],
21	coronary	JJ	O	coronary	amod	23	SENT_49	[p3l711t1298r959b1349],
22	heart	NN	O	heart	nn	23	SENT_49	[p3l982t1277r1128b1330],
23	disease	NN	O	disease	dep	20	SENT_49	[p3l1154t1277r1348b1330],
24	antiplatelet	JJ	O	antiplatelet	amod	25	SENT_49	[p3l11t1871r409b1960],
25	therapy	NN	O	therapy	dep	3	SENT_49	[p3l462t1871r731b1960],
26	for	IN	O	for	_	0	SENT_49	[p3l782t1871r883b1937],
27	secondary	JJ	O	secondary	amod	28	SENT_49	[p3l938t1871r1290b1960],
28	prevention	NN	O	prevention	prep_for	25	SENT_49	[p3l1340t1874r1739b1960],
29	.	.	O	.	_	0	SENT_49	[p3l1340t1874r1739b1960],

1	All	DT	O	all	det	3	SENT_50	[p3l1796t1869r1909b1936],
2	study	NN	O	study	nn	3	SENT_50	[p3l1964t1871r2154b1960],
3	subjects	NNS	O	subject	nsubj	4	SENT_50	[p3l11t1977r283b2066],
4	provided	VBD	O	provide	_	0	SENT_50	[p3l314t1977r627b2066],
5	written	VBN	O	write	amod	7	SENT_50	[p3l653t1980r912b2043],
6	informed	VBN	O	inform	amod	7	SENT_50	[p3l942t1977r1270b2043],
7	consent	NN	O	consent	dobj	4	SENT_50	[p3l1300t1994r1590b2058],
8	,	,	O	,	_	0	SENT_50	[p3l1300t1994r1590b2058],
9	and	CC	O	and	_	0	SENT_50	[p3l1625t1977r1753b2043],
10	the	DT	O	the	det	11	SENT_50	[p3l1782t1977r1893b2043],
11	protocol	NN	O	protocol	nsubjpass	13	SENT_50	[p3l1923t1994r2148b2066, p3l10t2083r111b2149],
12	was	VBD	O	be	auxpass	13	SENT_50	[p3l154t2109r284b2149],
13	approved	VBN	O	approve	conj_and	4	SENT_50	[p3l335t2083r659b2172],
14	by	IN	O	by	_	0	SENT_50	[p3l704t2083r791b2172],
15	the	DT	O	the	det	18	SENT_50	[p3l834t2083r945b2149],
16	Institutional	JJ	ORGANIZATION	institutional	amod	18	SENT_50	[p3l993t2083r1435b2149],
17	Review	NNP	ORGANIZATION	Review	nn	18	SENT_50	[p3l1484t2084r1744b2149],
18	Board	NNP	ORGANIZATION	Board	agent	13	SENT_50	[p3l1788t2083r2004b2149],
19	for	IN	ORGANIZATION	for	_	0	SENT_50	[p3l2051t2083r2152b2149],
20	Human	JJ	ORGANIZATION	human	amod	21	SENT_50	[p3l10t2190r285b2255],
21	Subjects	NNS	ORGANIZATION	subject	prep_for	13	SENT_50	[p3l330t2189r617b2278],
22	of	IN	ORGANIZATION	of	_	0	SENT_50	[p3l660t2189r740b2255],
23	the	DT	ORGANIZATION	the	det	26	SENT_50	[p3l769t2189r879b2255],
24	Ohio	NNP	ORGANIZATION	Ohio	nn	26	SENT_50	[p3l923t2189r1106b2256],
25	State	NNP	ORGANIZATION	State	nn	26	SENT_50	[p3l1152t2189r1326b2256],
26	University	NNP	ORGANIZATION	University	prep_of	21	SENT_50	[p3l1366t2190r1750b2278],
27	.	.	O	.	_	0	SENT_50	[p3l1366t2190r1750b2278],

1	We	PRP	O	we	nsubj	2	SENT_51	[p3l1792t2190r1923b2256],
2	compared	VBD	O	compare	_	0	SENT_51	[p3l1965t2215r2147b2256, p3l8t2296r206b2386],
3	two	CD	NUMBER	two	num	4	SENT_51	[p3l248t2313r377b2363],
4	groups	NNS	O	group	dobj	2	SENT_51	[p3l421t2322r658b2386],
5	of	IN	O	of	_	0	SENT_51	[p3l703t2296r783b2363],
6	subjects	NNS	O	subject	prep_of	4	SENT_51	[p3l815t2296r1088b2386],
7	that	WDT	O	that	nsubjpass	9	SENT_51	[p3l1132t2296r1274b2363],
8	were	VBD	O	be	auxpass	9	SENT_51	[p3l1311t2322r1478b2363],
9	matched	VBN	O	match	rcmod	6	SENT_51	[p3l1523t2296r1827b2363],
10	for	IN	O	for	_	0	SENT_51	[p3l1869t2296r1971b2363],
11	age	NN	O	age	nn	18	SENT_51	[p3l2013t2323r2147b2386],
12	,	,	O	,	_	0	SENT_51	[p3l2013t2323r2147b2386],
13	gender	NN	O	gender	dep	18	SENT_51	[p3l8t2404r270b2493],
14	,	,	O	,	_	0	SENT_51	[p3l8t2404r270b2493],
15	race	NN	O	race	dep	18	SENT_51	[p3l304t2429r464b2485],
16	,	,	O	,	_	0	SENT_51	[p3l304t2429r464b2485],
17	medical	JJ	O	medical	amod	18	SENT_51	[p3l500t2404r775b2470],
18	history	NN	O	history	prep_for	9	SENT_51	[p3l805t2404r1068b2493],
19	,	,	O	,	_	0	SENT_51	[p3l805t2404r1068b2493],
20	and	CC	O	and	_	0	SENT_51	[p3l1104t2404r1232b2470],
21	blood	NN	O	blood	nn	22	SENT_51	[p3l1261t2404r1464b2470],
22	pressure	NN	O	pressure	conj_and	18	SENT_51	[p3l1493t2429r1801b2493],
23	.	.	O	.	_	0	SENT_51	[p3l1493t2429r1801b2493],

1	The	DT	O	the	det	3	SENT_52	[p3l1834t2402r1982b2470],
2	ﬁrst	JJ	O	ﬁrst	amod	3	SENT_52	[p3l2014t2404r2152b2470],
3	group	NN	O	group	nsubj	4	SENT_52	[p3l8t2537r214b2600],
4	consisted	VBD	O	consist	_	0	SENT_52	[p3l244t2511r570b2577],
5	of	IN	O	of	_	0	SENT_52	[p3l597t2511r677b2577],
6	30	CD	NUMBER	30	num	8	SENT_52	[p3l693t2514r777b2577],
7	PIA1/A1	NN	O	pia1/a1	nn	8	SENT_52	[p3l806t2495r1066b2576],
8	homozygotes	NNS	O	homozygote	prep_of	4	SENT_52	[p3l1097t2511r1586b2600],
9	,	,	O	,	_	0	SENT_52	[p3l1097t2511r1586b2600],
10	and	CC	O	and	_	0	SENT_52	[p3l1618t2511r1746b2577],
11	30	CD	NUMBER	30	num	13	SENT_52	[p3l1774t2514r1858b2577],
12	PIA1/A2	NN	O	pia1/a2	nn	13	SENT_52	[p3l1887t2495r2149b2576],
13	subjects	NNS	O	subject	nsubj	14	SENT_52	[p3l11t2618r284b2707],
14	comprised	VBD	O	comprise	conj_and	4	SENT_52	[p3l333t2618r699b2708],
15	the	DT	O	the	det	17	SENT_52	[p3l744t2618r855b2684],
16	second	JJ	ORDINAL	second	amod	17	SENT_52	[p3l904t2618r1145b2684],
17	group	NN	O	group	dobj	14	SENT_52	[p3l1189t2644r1415b2707],
18	.	.	O	.	_	0	SENT_52	[p3l1189t2644r1415b2707],

1	Ten	CD	NUMBER	ten	num	2	SENT_53	[p3l1462t2616r1611b2684],
2	subjects	NNS	O	subject	nsubjpass	7	SENT_53	[p3l1659t2618r1931b2707],
3	from	IN	O	from	_	0	SENT_53	[p3l1979t2618r2150b2684],
4	each	DT	O	each	det	5	SENT_53	[p3l10t2754r167b2820],
5	group	NN	O	group	prep_from	2	SENT_53	[p3l199t2780r404b2844],
6	were	VBD	O	be	auxpass	7	SENT_53	[p3l435t2780r602b2821],
7	assigned	VBN	O	assign	_	0	SENT_53	[p3l637t2754r933b2843],
8	randomly	RB	O	randomly	advmod	7	SENT_53	[p3l965t2754r1306b2843],
9	to	TO	O	to	aux	10	SENT_53	[p3l1335t2771r1403b2820],
10	receive	VB	O	receive	xcomp	7	SENT_53	[p3l1437t2757r1677b2821],
11	one	CD	TIME	one	dobj	10	SENT_53	[p3l1711t2780r1836b2820],
12	of	IN	TIME	of	_	0	SENT_53	[p3l1870t2754r1950b2820],
13	three	CD	TIME	three	num	15	SENT_53	[p3l1970t2754r2149b2820],
14	treatment	NN	O	treatment	nn	15	SENT_53	[p3l9t2878r358b2928],
15	regimens	NNS	O	regimen	prep_of	11	SENT_53	[p3l394t2864r714b2951],
16	for	IN	O	for	_	0	SENT_53	[p3l753t2861r854b2928],
17	10	CD	DURATION	10	num	18	SENT_53	[p3l895t2865r975b2928],
18	days	NNS	NUMBER	day	prep_for	15	SENT_53	[p3l1015t2861r1184b2951],
19	.	.	O	.	_	0	SENT_53	[p3l1015t2861r1184b2951],

1	The	DT	O	the	det	2	SENT_54	[p3l1224t2860r1372b2928],
2	regimens	NNS	O	regimen	nsubj	5	SENT_54	[p3l1410t2864r1730b2951],
3	were	VBD	O	be	cop	5	SENT_54	[p3l1766t2887r1933b2928],
4	ASA	NN	O	asa	nn	5	SENT_54	[p3l1969t2860r2152b2928],
5	(	NN	O	(	_	0	SENT_54	[p3l12t2967r166b3049],
6	325	CD	NUMBER	325	num	7	SENT_54	[p3l12t2967r166b3049],
7	mg	NN	O	mg	nsubjpass	63	SENT_54	[p3l209t2995r340b3058],
8	,	,	O	,	_	0	SENT_54	[p3l209t2995r340b3058],
9	daily	JJ	SET	daily	amod	10	SENT_54	[p3l382t2967r573b3058],
10	)	NN	O	)	dep	30	SENT_54	[p3l382t2967r573b3058],
11	alone	RB	O	alone	advmod	14	SENT_54	[p3l617t2969r803b3035],
12	(	RB	O	(	advmod	14	SENT_54	[p3l845t2967r956b3049],
13	10	CD	NUMBER	10	num	14	SENT_54	[p3l845t2967r956b3049],
14	PIA1/A1	NN	O	pia1/a1	dep	10	SENT_54	[p3l996t2952r1256b3034],
15	and	CC	O	and	_	0	SENT_54	[p3l1299t2969r1427b3035],
16	10	CD	NUMBER	10	num	18	SENT_54	[p3l1469t2972r1550b3035],
17	PIA1/A2	NN	O	pia1/a2	nn	18	SENT_54	[p3l1590t2952r1902b3050],
18	)	NN	O	)	conj_and	14	SENT_54	[p3l1590t2952r1902b3050],
19	,	,	O	,	_	0	SENT_54	[p3l1590t2952r1902b3050],
20	clopidogrel	NN	O	clopidogrel	appos	14	SENT_54	[p3l1945t2969r2147b3058, p3l10t3076r233b3165],
21	(	CD	NUMBER	(	number	22	SENT_54	[p3l265t3074r374b3156],
22	75	CD	NUMBER	75	dep	20	SENT_54	[p3l265t3074r374b3156],
23	mg	NN	O	mg	nn	26	SENT_54	[p3l409t3102r540b3165],
24	,	,	O	,	_	0	SENT_54	[p3l409t3102r540b3165],
25	daily	JJ	SET	daily	amod	26	SENT_54	[p3l574t3074r765b3165],
26	)	NN	O	)	dep	30	SENT_54	[p3l574t3074r765b3165],
27	alone	RB	O	alone	advmod	30	SENT_54	[p3l801t3076r986b3142],
28	(	RB	O	(	advmod	30	SENT_54	[p3l1020t3074r1132b3156],
29	10	CD	NUMBER	10	num	30	SENT_54	[p3l1020t3074r1132b3156],
30	PIA1/A1	NN	O	pia1/a1	dep	55	SENT_54	[p3l1163t3060r1423b3141],
31	and	CC	O	and	_	0	SENT_54	[p3l1458t3076r1586b3142],
32	10	CD	NUMBER	10	num	34	SENT_54	[p3l1620t3079r1701b3142],
33	PIA1/A2	NN	O	pia1/a2	nn	34	SENT_54	[p3l1733t3060r2045b3157],
34	)	NN	O	)	conj_and	30	SENT_54	[p3l1733t3060r2045b3157],
35	,	,	O	,	_	0	SENT_54	[p3l1733t3060r2045b3157],
36	or	CC	O	or	_	0	SENT_54	[p3l2079t3102r2152b3142],
37	ASA	NN	O	asa	nn	38	SENT_54	[p3l7t3182r189b3249],
38	(	NN	O	(	conj_or	30	SENT_54	[p3l241t3181r395b3263],
39	325	CD	NUMBER	325	num	40	SENT_54	[p3l241t3181r395b3263],
40	mg	NN	O	mg	dep	38	SENT_54	[p3l450t3209r581b3272],
41	,	,	O	,	_	0	SENT_54	[p3l450t3209r581b3272],
42	daily	JJ	SET	daily	amod	43	SENT_54	[p3l635t3181r827b3272],
43	)	NN	O	)	appos	30	SENT_54	[p3l635t3181r827b3272],
44	and	CC	O	and	_	0	SENT_54	[p3l883t3183r1010b3249],
45	clopidogrel	NN	O	clopidogrel	conj_and	43	SENT_54	[p3l1061t3183r1458b3272],
46	(	CD	NUMBER	(	number	47	SENT_54	[p3l1510t3181r1619b3263],
47	75	CD	NUMBER	75	dep	43	SENT_54	[p3l1510t3181r1619b3263],
48	mg	NN	O	mg	nn	50	SENT_54	[p3l1674t3209r1787b3272],
49	daily	JJ	SET	daily	amod	50	SENT_54	[p3l1836t3181r2028b3272],
50	)	NN	O	)	dep	47	SENT_54	[p3l1836t3181r2028b3272],
51	in	IN	O	in	_	0	SENT_54	[p3l2082t3186r2150b3248],
52	combination	NN	O	combination	nn	53	SENT_54	[p3l10t3290r458b3357],
53	(	NN	O	(	prep_in	30	SENT_54	[p3l505t3288r616b3371],
54	10	CD	NUMBER	10	num	55	SENT_54	[p3l505t3288r616b3371],
55	PlA1/A1	NN	O	pla1/a1	dep	63	SENT_54	[p3l662t3274r921b3356],
56	and	CC	O	and	_	0	SENT_54	[p3l971t3290r1098b3357],
57	10	CD	NUMBER	10	num	58	SENT_54	[p3l1146t3294r1227b3357],
58	PIA	NN	O	pium	dep	63	SENT_54	[p3l1272t3274r1583b3371],
59	“	CD	NUMBER	“	num	61	SENT_54	[p3l1272t3274r1583b3371],
60	Platelet	NN	O	platelet	nn	61	SENT_54	[p3l1632t3290r1901b3357],
61	assays	NNS	O	assay	nsubjpass	63	SENT_54	[p3l1945t3316r2148b3379],
62	were	VBD	O	be	auxpass	63	SENT_54	[p3l6t3422r173b3463],
63	performed	VBN	O	perform	rcmod	5	SENT_54	[p3l209t3396r581b3486],
64	after	IN	O	after	_	0	SENT_54	[p3l618t3396r777b3463],
65	10	CD	DURATION	10	num	66	SENT_54	[p3l816t3400r897b3463],
66	days	NNS	NUMBER	day	prep_after	63	SENT_54	[p3l934t3396r1084b3486],
67	of	IN	O	of	_	0	SENT_54	[p3l1122t3396r1202b3463],
68	therapy	NN	O	therapy	prep_of	66	SENT_54	[p3l1226t3397r1495b3486],
69	(	CD	NUMBER	(	num	68	SENT_54	[p3l1530t3394r1820b3486],
70	enough	JJ	O	enough	amod	71	SENT_54	[p3l1530t3394r1820b3486],
71	time	NN	O	time	tmod	66	SENT_54	[p3l1856t3399r2014b3463],
72	for	IN	O	for	_	0	SENT_54	[p3l2051t3396r2152b3463],
73	both	DT	O	both	det	74	SENT_54	[p3l7t3503r172b3569],
74	drugs	NNS	O	drug	prep_for	63	SENT_54	[p3l220t3503r412b3592],
75	to	TO	O	to	aux	76	SENT_54	[p3l460t3520r529b3569],
76	reach	VB	O	reach	xcomp	63	SENT_54	[p3l577t3503r766b3569],
77	steady	JJ	O	steady	amod	79	SENT_54	[p3l815t3503r1035b3592],
78	state	NN	O	state	nn	79	SENT_54	[p3l1081t3501r1288b3583],
79	)	NN	O	)	dobj	76	SENT_54	[p3l1081t3501r1288b3583],
80	.	.	O	.	_	0	SENT_54	[p3l1081t3501r1288b3583],

1	All	DT	O	all	det	3	SENT_55	[p3l1338t3501r1450b3568],
2	patient	NN	O	patient	nn	3	SENT_55	[p3l1495t3506r1745b3592],
3	data	NNS	O	datum	nsubjpass	5	SENT_55	[p3l1792t3503r1940b3569],
4	were	VBD	O	be	auxpass	5	SENT_55	[p3l1982t3528r2149b3569],
5	coded	VBN	O	code	_	0	SENT_55	[p3l10t3609r219b3674],
6	to	TO	O	to	aux	7	SENT_55	[p3l251t3626r320b3674],
7	maintain	VB	O	maintain	xcomp	5	SENT_55	[p3l355t3612r671b3674],
8	a	DT	O	a	det	10	SENT_55	[p3l705t3635r739b3674],
9	blinded	JJ	O	blinded	amod	10	SENT_55	[p3l769t3609r1039b3674],
10	evaluation	NN	O	evaluation	dobj	7	SENT_55	[p3l1072t3609r1452b3675],
11	.	.	O	.	_	0	SENT_55	[p3l1072t3609r1452b3675],

1	Platelet	NN	O	platelet	_	0	SENT_56	[p4l10t26r300b93],
2	preparation	NN	O	preparation	dep	1	SENT_56	[p4l343t31r799b117],
3	.	.	O	.	_	0	SENT_56	[p4l343t31r799b117],

1	Phlebotomy	NN	PERSON	phlebotomy	nsubjpass	3	SENT_57	[p4l852t27r1288b116],
2	was	VBD	O	be	auxpass	3	SENT_57	[p4l1328t53r1458b93],
3	performed	VBN	O	perform	conj_and	3	SENT_57	[p4l1505t27r1878b117],
4	in	IN	O	in	_	0	SENT_57	[p4l1924t30r1992b92],
5	the	DT	O	the	det	6	SENT_57	[p4l2039t27r2150b93],
6	morning	NN	TIME	morning	prep_in	3	SENT_57	[p4l10t137r317b223],
7	within	IN	O	within	_	0	SENT_57	[p4l349t134r582b201],
8	4	CD	NUMBER	4	num	9	SENT_57	[p4l619t138r661b199],
9	h	NN	O	h	prep_within	3	SENT_57	[p4l698t134r743b200],
10	of	IN	O	of	_	0	SENT_57	[p4l781t134r861b200],
11	the	DT	O	the	det	12	SENT_57	[p4l886t134r997b200],
12	patients	NNS	O	patient	prep_of	9	SENT_57	[p4l1033t137r1312b224],
13	ingesting	VBG	O	ingest	xcomp	3	SENT_57	[p4l1351t137r1677b223],
14	study	NN	O	study	nn	15	SENT_57	[p4l1713t134r1904b223],
15	medication	NN	O	medication	dobj	13	SENT_57	[p4l1938t134r2147b200, p4l10t243r245b321],
16	,	,	O	,	_	0	SENT_57	[p4l1938t134r2147b200, p4l10t243r245b321],
17	under	IN	O	under	_	0	SENT_57	[p4l272t240r480b307],
18	fasting	NN	O	fasting	nn	19	SENT_57	[p4l503t240r742b330],
19	conditions	NNS	O	condition	prep_under	3	SENT_57	[p4l767t240r1157b321],
20	,	,	O	,	_	0	SENT_57	[p4l767t240r1157b321],
21	and	CC	O	and	_	0	SENT_57	[p4l1187t240r1315b307],
22	without	IN	O	without	_	0	SENT_57	[p4l1336t240r1618b307],
23	caffeine	NN	O	caffeine	nn	24	SENT_57	[p4l1643t240r1907b307],
24	intake	NN	O	intake	prep_without	3	SENT_57	[p4l1933t240r2149b307],
25	for	IN	O	for	_	0	SENT_57	[p4l9t347r110b413],
26	at	IN	O	at	quantmod	28	SENT_57	[p4l145t364r209b413],
27	least	JJS	O	least	mwe	26	SENT_57	[p4l241t347r400b413],
28	12	CD	NUMBER	12	num	33	SENT_57	[p4l438t350r518b414],
29	h.	NN	O	h.	nn	33	SENT_57	[p4l555t347r618b413],
30	Platelet	NN	O	platelet	nn	33	SENT_57	[p4l658t347r1101b413],
31	—	CD	NUMBER	—	num	33	SENT_57	[p4l658t347r1101b413],
32	rich	JJ	O	rich	amod	33	SENT_57	[p4l658t347r1101b413],
33	plasma	NN	O	plasma	prep_for	24	SENT_57	[p4l1135t347r1383b436],
34	(	CD	NUMBER	(	num	36	SENT_57	[p4l1420t345r1639b427],
35	PRP	NN	O	prp	nn	36	SENT_57	[p4l1420t345r1639b427],
36	)	NN	O	)	nsubjpass	38	SENT_57	[p4l1420t345r1639b427],
37	was	VBD	O	be	auxpass	38	SENT_57	[p4l1675t373r1805b413],
38	obtained	VBN	O	obtain	rcmod	33	SENT_57	[p4l1842t347r2151b413],
39	from	IN	O	from	_	0	SENT_57	[p4l9t453r180b519],
40	citrated	VBN	O	citrate	prepc_from	38	SENT_57	[p4l219t453r486b519],
41	blood	NN	O	blood	dobj	40	SENT_57	[p4l521t453r724b519],
42	as	IN	O	as	_	0	SENT_57	[p4l762t479r825b519],
43	previously	RB	DATE	previously	advmod	44	SENT_57	[p4l863t453r1226b542],
44	reported	VBN	O	report	amod	45	SENT_57	[p4l1259t453r1559b542],
45	(	NN	O	(	prep_as	41	SENT_57	[p4l1599t451r1759b533],
46	17	CD	NUMBER	17	num	47	SENT_57	[p4l1599t451r1759b533],
47	)	NN	O	)	dep	41	SENT_57	[p4l1599t451r1759b533],
48	.	.	O	.	_	0	SENT_57	[p4l1599t451r1759b533],

1	Five	CD	NUMBER	five	num	2	SENT_58	[p4l1801t454r1951b519],
2	concentrations	NNS	O	concentration	nsubjpass	8	SENT_58	[p4l1990t479r2147b519, p4l10t562r400b625],
3	of	IN	O	of	_	0	SENT_58	[p4l455t559r535b625],
4	three	CD	NUMBER	three	num	6	SENT_58	[p4l575t559r755b625],
5	conventional	JJ	O	conventional	amod	6	SENT_58	[p4l809t559r1264b625],
6	agonists	NNS	O	agonist	prep_of	2	SENT_58	[p4l1317t562r1600b648],
7	Were	VBD	O	be	auxpass	8	SENT_58	[p4l1650t585r1818b625],
8	used	VBN	O	use	_	0	SENT_58	[p4l1870t559r2030b625],
9	in	IN	O	in	prep	8	SENT_58	[p4l2082t562r2150b624],

1	A	DT	O	a	det	2	SENT_59	[p4l758t792r820b853],
2	B	NN	O	b	_	0	SENT_59	[p4l1792t796r1844b857],

1	JACC	NNP	O	JACC	nn	2	SENT_60	[p4l1417t899r1551b956],
2	Vol	NNP	O	Vol	_	0	SENT_60	[p4l1575t900r1671b956],
3	.	.	O	.	_	0	SENT_60	[p4l1575t900r1671b956],

1	47	CD	NUMBER	47	_	0	SENT_61	[p4l1699t900r1786b965],
2	,	,	O	,	_	0	SENT_61	[p4l1699t900r1786b965],
3	No.	NN	O	no.	amod	1	SENT_61	[p4l1817t899r1900b956],
4	3	CD	NUMBER	3	number	3	SENT_61	[p4l1928t899r1977b965],
5	,	,	O	,	_	0	SENT_61	[p4l1928t899r1977b965],
6	2006	CD	DATE	2006	appos	1	SENT_61	[p4l2006t899r2150b956],
7	February	NNP	DATE	February	tmod	6	SENT_61	[p4l1472t997r1699b1067],
8	7	CD	DATE	7	num	7	SENT_61	[p4l1723t997r1770b1063],
9	,	,	O	,	_	0	SENT_61	[p4l1723t997r1770b1063],
10	2006:541	CD	NUMBER	2006:541	num	7	SENT_61	[p4l1799t996r2150b1054],
11	—	CD	NUMBER	—	num	12	SENT_61	[p4l1799t996r2150b1054],
12	6	CD	NUMBER	6	dep	1	SENT_61	[p4l1799t996r2150b1054],

1	separate	JJ	O	separate	amod	2	SENT_62	[p4l16t1236r299b1308],
2	assays	NNS	O	assay	_	0	SENT_62	[p4l325t1245r550b1308],
3	,	,	O	,	_	0	SENT_62	[p4l325t1245r550b1308],
4	including	VBG	O	include	_	0	SENT_62	[p4l576t1219r912b1308],
5	epinephrine	NN	O	epinephrine	nn	7	SENT_62	[p4l934t1219r1356b1308],
6	(	NN	O	(	nn	7	SENT_62	[p4l1383t1217r1471b1300],
7	o	NN	O	o	prep_including	2	SENT_62	[p4l1383t1217r1471b1300],
8	,	,	O	,	_	0	SENT_62	[p4l1383t1217r1471b1300],
9	0.5	CD	NUMBER	0.5	conj_and	7	SENT_62	[p4l1497t1219r1625b1300],
10	,	,	O	,	_	0	SENT_62	[p4l1497t1219r1625b1300],
11	1	CD	NUMBER	1	conj_and	7	SENT_62	[p4l1656t1222r1712b1300],
12	,	,	O	,	_	0	SENT_62	[p4l1656t1222r1712b1300],
13	2	CD	NUMBER	2	conj_and	7	SENT_62	[p4l1737t1222r1800b1300],
14	,	,	O	,	_	0	SENT_62	[p4l1737t1222r1800b1300],
15	5	CD	NUMBER	5	conj_and	7	SENT_62	[p4l1827t1219r1887b1300],
16	,	,	O	,	_	0	SENT_62	[p4l1827t1219r1887b1300],
17	and	CC	NUMBER	and	_	0	SENT_62	[p4l1915t1219r2043b1285],
18	10	CD	NUMBER	10	num	20	SENT_62	[p4l2070t1222r2150b1285],
19	p.	NN	O	p.	nn	20	SENT_62	[p4l18t1326r283b1410],
20	mol/1	NN	O	mol/1	prep_including	2	SENT_62	[p4l18t1326r283b1410],
21	;	:	O	;	_	0	SENT_62	[p4l18t1326r283b1410],
22	Sigma	NNP	ORGANIZATION	Sigma	nn	24	SENT_62	[p4l329t1326r549b1415],
23	Chemical	NNP	ORGANIZATION	Chemical	nn	24	SENT_62	[p4l588t1326r930b1392],
24	Co.	NNP	ORGANIZATION	Co.	dep	2	SENT_62	[p4l969t1326r1117b1407],
25	,	,	O	,	_	0	SENT_62	[p4l969t1326r1117b1407],
26	St.	NNP	LOCATION	St.	nn	27	SENT_62	[p4l1162t1326r1251b1392],
27	Louis	NNP	LOCATION	Louis	appos	24	SENT_62	[p4l1295t1327r1514b1407],
28	,	,	O	,	_	0	SENT_62	[p4l1295t1327r1514b1407],
29	Missouri	NNP	LOCATION	Missouri	nn	30	SENT_62	[p4l1555t1324r1920b1407],
30	)	NN	O	)	appos	24	SENT_62	[p4l1555t1324r1920b1407],
31	,	,	O	,	_	0	SENT_62	[p4l1555t1324r1920b1407],
32	ADP	NN	O	adp	appos	24	SENT_62	[p4l1959t1324r2151b1391],
33	(	CD	NUMBER	(	number	34	SENT_62	[p4l18t1432r172b1515],
34	0.5	CD	NUMBER	0.5	dep	32	SENT_62	[p4l18t1432r172b1515],
35	,	,	O	,	_	0	SENT_62	[p4l18t1432r172b1515],
36	1	CD	NUMBER	1	appos	24	SENT_62	[p4l222t1437r279b1515],
37	,	,	O	,	_	0	SENT_62	[p4l222t1437r279b1515],
38	2	CD	NUMBER	2	appos	24	SENT_62	[p4l322t1437r385b1515],
39	,	,	O	,	_	0	SENT_62	[p4l322t1437r385b1515],
40	5	CD	NUMBER	5	conj_and	36	SENT_62	[p4l430t1434r491b1515],
41	,	,	O	,	_	0	SENT_62	[p4l430t1434r491b1515],
42	and	CC	NUMBER	and	_	0	SENT_62	[p4l537t1434r665b1500],
43	10	CD	NUMBER	10	num	44	SENT_62	[p4l711t1437r791b1500],
44	umol/1	NN	O	umol/1	appos	24	SENT_62	[p4l838t1434r1104b1517],
45	;	:	O	;	_	0	SENT_62	[p4l838t1434r1104b1517],
46	Sigma	NNP	ORGANIZATION	Sigma	nn	48	SENT_62	[p4l1153t1434r1372b1523],
47	Chemical	NNP	ORGANIZATION	Chemical	nn	48	SENT_62	[p4l1416t1434r1757b1500],
48	Co.	NNP	ORGANIZATION	Co.	dep	2	SENT_62	[p4l1800t1432r1978b1515],
49	)	NN	O	)	dep	48	SENT_62	[p4l1800t1432r1978b1515],
50	,	,	O	,	_	0	SENT_62	[p4l1800t1432r1978b1515],
51	and	CC	O	and	_	0	SENT_62	[p4l2024t1434r2152b1500],
52	collagen	NN	O	collagen	nn	54	SENT_62	[p4l16t1541r305b1630],
53	(	NN	O	(	nn	54	SENT_62	[p4l336t1538r509b1630],
54	type	NN	O	type	conj_and	48	SENT_62	[p4l336t1538r509b1630],
55	1	CD	NUMBER	1	dep	54	SENT_62	[p4l543t1544r599b1621],
56	;	:	O	;	_	0	SENT_62	[p4l543t1544r599b1621],
57	o	NN	O	o	dep	2	SENT_62	[p4l631t1544r691b1621],
58	,	,	O	,	_	0	SENT_62	[p4l631t1544r691b1621],
59	0.5	CD	NUMBER	0.5	dep	2	SENT_62	[p4l723t1540r850b1621],
60	,	,	O	,	_	0	SENT_62	[p4l723t1540r850b1621],
61	1	CD	NUMBER	1	dep	2	SENT_62	[p4l886t1544r942b1621],
62	,	,	O	,	_	0	SENT_62	[p4l886t1544r942b1621],
63	2	CD	NUMBER	2	conj_and	57	SENT_62	[p4l972t1544r1034b1621],
64	,	,	O	,	_	0	SENT_62	[p4l972t1544r1034b1621],
65	5	CD	NUMBER	5	dep	2	SENT_62	[p4l1066t1541r1126b1621],
66	,	,	O	,	_	0	SENT_62	[p4l1066t1541r1126b1621],
67	and	CC	NUMBER	and	_	0	SENT_62	[p4l1159t1540r1287b1607],
68	10	CD	NUMBER	10	num	69	SENT_62	[p4l1319t1544r1399b1607],
69	pug/ml	NN	O	pug/ml	dep	2	SENT_62	[p4l1431t1540r1673b1630],
70	;	:	O	;	_	0	SENT_62	[p4l1431t1540r1673b1630],
71	Chrono	NNP	O	Chrono	nn	73	SENT_62	[p4l1707t1540r2148b1630],
72	—	CD	NUMBER	—	num	73	SENT_62	[p4l1707t1540r2148b1630],
73	log	NN	O	log	dep	2	SENT_62	[p4l1707t1540r2148b1630],
74	,	,	O	,	_	0	SENT_62	[p4l1707t1540r2148b1630],
75	Havertovvn	NN	O	havertovvn	appos	73	SENT_62	[p4l16t1648r434b1728],
76	,	,	O	,	_	0	SENT_62	[p4l16t1648r434b1728],
77	Pennsylvania	NNP	LOCATION	Pennsylvania	nn	78	SENT_62	[p4l470t1645r980b1736],
78	)	NN	O	)	appos	73	SENT_62	[p4l470t1645r980b1736],
79	.	.	O	.	_	0	SENT_62	[p4l470t1645r980b1736],

1	Platelet	NN	O	platelet	_	0	SENT_63	[p4l15t1753r304b1821],
2	aggregation	NN	O	aggregation	dep	1	SENT_63	[p4l349t1758r808b1843],
3	.	.	O	.	_	0	SENT_63	[p4l349t1758r808b1843],

1	A	DT	O	a	det	4	SENT_64	[p4l857t1753r924b1820],
2	standardized	JJ	O	standardized	amod	4	SENT_64	[p4l971t1754r1420b1820],
3	platelet	NN	O	platelet	nn	4	SENT_64	[p4l1465t1754r1727b1844],
4	concentration	NN	O	concentration	_	0	SENT_64	[p4l1772t1771r2149b1820, p4l15t1864r155b1927],
5	of	IN	O	of	_	0	SENT_64	[p4l211t1861r292b1927],
6	300,000	CD	NUMBER	300,000	num	7	SENT_64	[p4l335t1864r620b1942],
7	plate1ets	NNS	O	plate1et	prep_of	4	SENT_64	[p4l676t1861r1000b1951],
8	/	:	O	/	punct	32	SENT_64	[p4l676t1861r1000b1951],
9	;	:	O	;	_	0	SENT_64	[p4l1005t1861r1082b1945],
10	u.l	NN	O	u.l	nsubjpass	32	SENT_64	[p4l1005t1861r1082b1945],
11	for	IN	O	for	_	0	SENT_64	[p4l1136t1861r1237b1927],
12	a	DT	O	a	det	14	SENT_64	[p4l1292t1887r1326b1927],
13	250-pd	JJ	O	250-pd	amod	14	SENT_64	[p4l1379t1861r1630b1945],
14	reaction	NN	O	reaction	prep_for	10	SENT_64	[p4l1684t1864r1968b1927],
15	was	VBD	O	be	auxpass	16	SENT_64	[p4l2020t1887r2149b1927],
16	prepared	VBN	O	prepare	rcmod	14	SENT_64	[p4l14t1968r325b2057],
17	by	IN	O	by	_	0	SENT_64	[p4l363t1968r450b2057],
18	dilution	NN	O	dilution	agent	16	SENT_64	[p4l487t1968r766b2034],
19	of	IN	O	of	_	0	SENT_64	[p4l807t1968r888b2034],
20	PRP	NN	O	prp	prep_of	18	SENT_64	[p4l916t1969r1083b2033],
21	with	IN	O	with	_	0	SENT_64	[p4l1120t1968r1282b2034],
22	autologous	JJ	O	autologous	amod	23	SENT_64	[p4l1325t1968r1706b2057],
23	plasma	NN	O	plasma	prep_with	10	SENT_64	[p4l1747t1968r1995b2057],
24	depleted	VBN	O	deplete	partmod	23	SENT_64	[p4l2035t1968r2149b2034, p4l14t2076r232b2165],
25	of	IN	O	of	_	0	SENT_64	[p4l256t2076r336b2142],
26	platelets	NNS	O	platelet	prep_of	24	SENT_64	[p4l347t2076r637b2165],
27	after	IN	O	after	_	0	SENT_64	[p4l665t2076r824b2142],
28	a	DT	O	a	det	30	SENT_64	[p4l848t2102r882b2142],
29	platelet	NN	O	platelet	nn	30	SENT_64	[p4l904t2076r1166b2165],
30	count	NN	O	count	prep_after	24	SENT_64	[p4l1190t2093r1389b2142],
31	was	VBD	O	be	auxpass	32	SENT_64	[p4l1408t2102r1538b2142],
32	determined	VBN	O	determine	dep	7	SENT_64	[p4l1565t2076r1970b2142],
33	with	IN	O	with	_	0	SENT_64	[p4l1990t2076r2151b2142],
34	a	DT	O	a	det	37	SENT_64	[p4l17t2209r51b2249],
35	Z1	NN	O	z1	nn	37	SENT_64	[p4l102t2183r199b2249],
36	Coulter	NN	O	coulter	nn	37	SENT_64	[p4l257t2182r529b2249],
37	counter	NN	O	counter	prep_with	32	SENT_64	[p4l579t2200r847b2249],
38	(	CD	NUMBER	(	num	40	SENT_64	[p4l899t2180r1199b2263],
39	Coulter	NNP	ORGANIZATION	Coulter	nn	40	SENT_64	[p4l899t2180r1199b2263],
40	Corp.	NNP	ORGANIZATION	Corp.	dep	37	SENT_64	[p4l1250t2182r1475b2272],
41	,	,	O	,	_	0	SENT_64	[p4l1250t2182r1475b2272],
42	Miami	NNP	LOCATION	Miami	dep	32	SENT_64	[p4l1527t2183r1789b2263],
43	,	,	O	,	_	0	SENT_64	[p4l1527t2183r1789b2263],
44	Florida	NNP	LOCATION	Florida	nn	45	SENT_64	[p4l1844t2180r2147b2263],
45	)	NN	O	)	appos	42	SENT_64	[p4l1844t2180r2147b2263],
46	.	.	O	.	_	0	SENT_64	[p4l1844t2180r2147b2263],

1	Samples	NNS	O	sample	nsubjpass	3	SENT_65	[p4l19t2289r307b2379],
2	were	VBD	O	be	auxpass	3	SENT_65	[p4l361t2315r528b2356],
3	incubated	VBN	O	incubate	_	0	SENT_65	[p4l584t2289r930b2355],
4	at	IN	O	at	_	0	SENT_65	[p4l987t2306r1050b2355],
5	37	CD	NUMBER	37	num	6	SENT_65	[p4l1105t2289r1215b2356],
6	°	NN	O	°	prep_at	3	SENT_65	[p4l1105t2289r1215b2356],
7	for	IN	O	for	_	0	SENT_65	[p4l1272t2289r1373b2355],
8	30	CD	DURATION	30	num	9	SENT_65	[p4l1429t2293r1512b2356],
9	min	NN	DURATION	min	prep_for	6	SENT_65	[p4l1570t2292r1709b2355],
10	before	IN	O	before	_	0	SENT_65	[p4l1762t2289r1984b2355],
11	the	DT	O	the	det	13	SENT_65	[p4l2040t2289r2151b2355],
12	aggregation	NN	O	aggregation	nn	13	SENT_65	[p4l17t2399r430b2485],
13	assay	NN	O	assay	prep_before	3	SENT_65	[p4l464t2422r641b2485],
14	using	VBG	O	use	partmod	13	SENT_65	[p4l668t2399r859b2485],
15	the	DT	O	the	det	16	SENT_65	[p4l889t2396r1000b2462],
16	method	NN	O	method	dobj	14	SENT_65	[p4l1034t2396r1307b2462],
17	of	IN	O	of	_	0	SENT_65	[p4l1340t2396r1420b2462],
18	Born	NNP	O	Born	dep	21	SENT_65	[p4l1440t2397r1617b2462],
19	(	CD	NUMBER	(	num	21	SENT_65	[p4l1653t2394r1812b2476],
20	18	CD	NUMBER	18	num	21	SENT_65	[p4l1653t2394r1812b2476],
21	)	NN	O	)	prepc_of	16	SENT_65	[p4l1653t2394r1812b2476],
22	.	.	O	.	_	0	SENT_65	[p4l1653t2394r1812b2476],

1	Separate	JJ	O	separate	amod	4	SENT_66	[p4l1853t2396r2151b2486],
2	platelet	NN	O	platelet	nn	4	SENT_66	[p4l14t2504r276b2593],
3	aggregation	NN	O	aggregation	nn	4	SENT_66	[p4l328t2507r741b2593],
4	assays	NNS	O	assay	nsubjpass	6	SENT_66	[p4l795t2530r999b2593],
5	were	VBD	O	be	auxpass	6	SENT_66	[p4l1050t2530r1217b2570],
6	performed	VBN	O	perform	_	0	SENT_66	[p4l1269t2504r1640b2593],
7	with	IN	O	with	_	0	SENT_66	[p4l1688t2504r1850b2570],
8	various	JJ	O	various	amod	9	SENT_66	[p4l1899t2507r2150b2570],
9	concentrations	NNS	O	concentration	prep_with	6	SENT_66	[p4l16t2614r533b2678],
10	of	IN	O	of	_	0	SENT_66	[p4l561t2611r641b2678],
11	agonists	NNS	O	agonist	prep_of	9	SENT_66	[p4l655t2614r937b2701],
12	under	IN	O	under	_	0	SENT_66	[p4l963t2611r1170b2678],
13	constant	JJ	O	constant	amod	14	SENT_66	[p4l1194t2629r1494b2678],
14	shear	NN	O	shear	prep_under	6	SENT_66	[p4l1519t2612r1702b2678],
15	(	CD	NUMBER	(	number	16	SENT_66	[p4l1728t2609r1951b2692],
16	1,000	CD	NUMBER	1,000	num	18	SENT_66	[p4l1728t2609r1951b2692],
17	rpm	NN	O	rpm	nn	18	SENT_66	[p4l1977t2609r2148b2701],
18	)	NN	O	)	dep	14	SENT_66	[p4l1977t2609r2148b2701],
19	and	CC	O	and	_	0	SENT_66	[p4l17t2718r144b2784],
20	temperature	NN	O	temperature	nn	21	SENT_66	[p4l174t2735r603b2808],
21	(	NN	O	(	conj_and	14	SENT_66	[p4l637t2716r802b2799],
22	37	CD	NUMBER	37	number	23	SENT_66	[p4l637t2716r802b2799],
23	°	CD	NUMBER	°	num	24	SENT_66	[p4l637t2716r802b2799],
24	)	NN	O	)	dep	21	SENT_66	[p4l637t2716r802b2799],
25	for	IN	O	for	_	0	SENT_66	[p4l836t2718r937b2784],
26	15	CD	DURATION	15	num	27	SENT_66	[p4l971t2718r1049b2785],
27	min	NN	DURATION	min	prep_for	6	SENT_66	[p4l1084t2721r1223b2784],
28	in	IN	O	in	_	0	SENT_66	[p4l1253t2721r1321b2784],
29	a	DT	O	a	det	35	SENT_66	[p4l1354t2745r1388b2784],
30	Chrono-log	JJ	O	chrono-log	amod	35	SENT_66	[p4l1420t2718r1844b2807],
31	470-VS	NN	O	470-v	nn	35	SENT_66	[p4l1873t2718r2148b2785],
32	4	CD	NUMBER	4	num	35	SENT_66	[p4l14t2825r372b2891],
33	—	NN	O	—	nn	35	SENT_66	[p4l14t2825r372b2891],
34	channel	NN	O	channel	nn	35	SENT_66	[p4l14t2825r372b2891],
35	aggregometer	NN	O	aggregometer	prep_in	27	SENT_66	[p4l405t2842r889b2914],
36	(	CD	NUMBER	(	num	38	SENT_66	[p4l923t2823r1422b2914],
37	Chrono-log	JJ	O	chrono-log	amod	38	SENT_66	[p4l923t2823r1422b2914],
38	)	NN	O	)	dep	35	SENT_66	[p4l923t2823r1422b2914],
39	.	.	O	.	_	0	SENT_66	[p4l923t2823r1422b2914],

1	Platelet	NN	O	platelet	nn	2	SENT_67	[p4l15t2931r316b2998],
2	glycoprotein	NN	O	glycoprotein	_	0	SENT_67	[p4l373t2931r861b3021],
3	(	CD	NUMBER	(	num	4	SENT_67	[p4l922t2930r1112b3012],
4	GP	NN	O	gp	dep	2	SENT_67	[p4l922t2930r1112b3012],
5	)	CD	NUMBER	)	num	6	SENT_67	[p4l922t2930r1112b3012],
6	IIb	NN	O	iib	dep	4	SENT_67	[p4l1175t2931r1340b2998],
7	/	:	O	/	punct	9	SENT_67	[p4l1175t2931r1340b2998],
8	Illa	NN	PERSON	illum	nn	9	SENT_67	[p4l1355t2933r1509b2998],
9	activation	NN	O	activation	dep	6	SENT_67	[p4l1568t2936r1952b2998],
10	and	CC	O	and	_	0	SENT_67	[p4l2013t2931r2153b2998],
11	at-granule	NN	O	at-granule	nn	12	SENT_67	[p4l18t3038r404b3129],
12	release	NN	O	release	dep	6	SENT_67	[p4l455t3039r728b3106],
13	.	.	O	.	_	0	SENT_67	[p4l455t3039r728b3106],

1	Platelets	NNS	O	platelet	nsubjpass	5	SENT_68	[p4l780t3040r1077b3106],
2	from	IN	O	from	_	0	SENT_68	[p4l1130t3040r1300b3106],
3	PRP	NN	O	prp	prep_from	1	SENT_68	[p4l1352t3041r1518b3105],
4	were	VBD	O	be	auxpass	5	SENT_68	[p4l1565t3065r1732b3106],
5	diluted	VBN	O	dilute	_	0	SENT_68	[p4l1785t3040r2032b3106],
6	to	TO	O	to	_	0	SENT_68	[p4l2082t3057r2150b3106],
7	1,000	CD	NUMBER	1,000	num	8	SENT_68	[p4l19t3150r211b3227],
8	platelets/p	NN	O	platelets/p	prep_to	5	SENT_68	[p4l261t3146r668b3236],
9	.	.	O	.	_	0	SENT_68	[p4l261t3146r668b3236],

1	l	NN	O	l	_	0	SENT_69	[p4l261t3146r668b3236],
2	with	IN	O	with	_	0	SENT_69	[p4l713t3146r875b3213],
3	Tyrode	NN	PERSON	tyrode	poss	5	SENT_69	[p4l922t3144r1229b3235],
4	’s	POS	O	’s	_	0	SENT_69	[p4l922t3144r1229b3235],
5	buffer	NN	O	buffer	prep_with	1	SENT_69	[p4l1279t3146r1485b3212],
6	in	IN	O	in	_	0	SENT_69	[p4l1533t3149r1601b3212],
7	polypropylene	NN	O	polypropylene	nn	8	SENT_69	[p4l1650t3146r2151b3236],
8	tubes	NNS	O	tube	prep_in	1	SENT_69	[p4l15t3253r218b3319],
9	.	.	O	.	_	0	SENT_69	[p4l15t3253r218b3319],

1	To	TO	O	to	aux	2	SENT_70	[p4l268t3251r373b3319],
2	assess	VB	O	assess	purpcl	11	SENT_70	[p4l425t3279r621b3319],
3	GP	NN	O	gp	nn	6	SENT_70	[p4l673t3253r795b3320],
4	IIb/IIIa	NN	O	iib/iiia	nn	6	SENT_70	[p4l843t3253r1122b3320],
5	receptor	NN	O	receptor	nn	6	SENT_70	[p4l1169t3270r1460b3343],
6	activation	NN	O	activation	dobj	2	SENT_70	[p4l1508t3256r1871b3334],
7	,	,	O	,	_	0	SENT_70	[p4l1508t3256r1871b3334],
8	resting	VBG	O	rest	amod	9	SENT_70	[p4l1922t3256r2153b3342],
9	platelets	NNS	O	platelet	nsubjpass	11	SENT_70	[p4l14t3361r290b3450],
10	were	VBD	O	be	auxpass	11	SENT_70	[p4l326t3387r487b3427],
11	supplemented	VBN	O	supplement	_	0	SENT_70	[p4l527t3361r1003b3450],
12	with	IN	O	with	_	0	SENT_70	[p4l1036t3361r1193b3427],
13	ﬂuorescein	NN	O	ﬂuorescein	nn	14	SENT_70	[p4l1231t3361r1596b3427],
14	isothiocyanateﬁbrinogen	NN	O	isothiocyanateﬁbrinogen	prep_with	11	SENT_70	[p4l1633t3361r2149b3450, p4l15t3469r366b3558],
15	(	CD	NUMBER	(	number	16	SENT_70	[p4l402t3467r532b3549],
16	4.7	CD	NUMBER	4.7	dep	14	SENT_70	[p4l402t3467r532b3549],
17	;	:	O	;	_	0	SENT_70	[p4l567t3468r693b3558],
18	.1	CD	NUMBER	.1	dep	14	SENT_70	[p4l567t3468r693b3558],
19	.	.	O	.	_	0	SENT_70	[p4l567t3468r693b3558],

1	g	NN	O	g	_	0	SENT_71	[p4l567t3468r693b3558],
2	/	:	O	/	punct	1	SENT_71	[p4l567t3468r693b3558],
3	ml	NN	O	ml	dep	1	SENT_71	[p4l694t3469r784b3534],
4	ﬁnal	JJ	O	ﬁnal	amod	5	SENT_71	[p4l815t3469r965b3535],
5	concentration	NN	O	concentration	dep	3	SENT_71	[p4l998t3472r1482b3550],
6	,	,	O	,	_	0	SENT_71	[p4l998t3472r1482b3550],
7	Molecular	JJ	O	molecular	amod	8	SENT_71	[p4l1516t3469r1868b3535],
8	Probes	NNS	O	probe	appos	5	SENT_71	[p4l1899t3469r2148b3550],
9	,	,	O	,	_	0	SENT_71	[p4l1899t3469r2148b3550],
10	Eugene	NNP	PERSON	Eugene	appos	5	SENT_71	[p4l17t3576r294b3664],
11	,	,	O	,	_	0	SENT_71	[p4l17t3576r294b3664],
12	Oregon	NNP	LOCATION	Oregon	nn	13	SENT_71	[p4l347t3573r633b3664],
13	)	NN	O	)	appos	5	SENT_71	[p4l347t3573r633b3664],
14	before	IN	O	before	_	0	SENT_71	[p4l683t3575r895b3641],
15	agonist	NN	O	agonist	nn	16	SENT_71	[p4l946t3578r1189b3664],
16	stimulation	NN	O	stimulation	prep_before	13	SENT_71	[p4l1237t3575r1637b3641],
17	.	.	O	.	_	0	SENT_71	[p4l1237t3575r1637b3641],

1	Ten	CD	DURATION	ten	num	2	SENT_72	[p4l1687t3573r1831b3641],
2	minutes	NNS	DURATION	minute	npadvmod	11	SENT_72	[p4l1880t3578r2150b3641],
3	after	IN	O	after	_	0	SENT_72	[p4l16t3683r169b3749],
4	exposure	NN	O	exposure	prep_after	11	SENT_72	[p4l205t3709r500b3773],
5	to	TO	O	to	_	0	SENT_72	[p4l537t3700r604b3749],
6	agonist	NN	O	agonist	prep_to	4	SENT_72	[p4l644t3686r904b3772],
7	,	,	O	,	_	0	SENT_72	[p4l644t3686r904b3772],
8	the	DT	O	the	det	9	SENT_72	[p4l943t3683r1050b3749],
9	reaction	NN	O	reaction	nsubjpass	11	SENT_72	[p4l1087t3686r1359b3749],
10	was	VBD	O	be	auxpass	11	SENT_72	[p4l1392t3709r1519b3749],
11	stopped	VBN	O	stop	_	0	SENT_72	[p4l1559t3683r1842b3773],
12	,	,	O	,	_	0	SENT_72	[p4l1559t3683r1842b3773],
13	and	CC	O	and	_	0	SENT_72	[p4l1883t3683r2008b3749],
14	the	DT	O	the	det	15	SENT_72	[p4l2044t3683r2151b3749],
15	platelets	NNS	O	platelet	nsubjpass	17	SENT_72	[p5l14t16r290b105],
16	were	VBD	O	be	auxpass	17	SENT_72	[p5l312t42r474b82],
17	ﬁxed	VBN	O	ﬁxed	conj_and	11	SENT_72	[p5l498t16r663b82],
18	in	IN	O	in	_	0	SENT_72	[p5l686t19r753b81],
19	formaldehyde	NN	O	formaldehyde	prep_in	17	SENT_72	[p5l776t16r1244b105],
20	(	CD	PERCENT	(	number	21	SENT_72	[p5l1272t14r1466b96],
21	1.5	CD	PERCENT	1.5	dep	22	SENT_72	[p5l1272t14r1466b96],
22	%	NN	PERCENT	%	dep	19	SENT_72	[p5l1272t14r1466b96],
23	ﬁnal	JJ	O	ﬁnal	amod	24	SENT_72	[p5l1491t16r1641b82],
24	concentration	NN	O	concentration	dep	17	SENT_72	[p5l1664t19r2148b97],
25	,	,	O	,	_	0	SENT_72	[p5l1664t19r2148b97],
26	Fisher	NNP	PERSON	Fisher	nn	27	SENT_72	[p5l15t124r230b190],
27	Scientiﬁc	NNP	PERSON	Scientiﬁc	appos	24	SENT_72	[p5l281t124r611b205],
28	,	,	O	,	_	0	SENT_72	[p5l281t124r611b205],
29	Pittsburgh	NNP	LOCATION	Pittsburgh	appos	24	SENT_72	[p5l664t124r1040b213],
30	,	,	O	,	_	0	SENT_72	[p5l664t124r1040b213],
31	Pennsylvania	NNP	LOCATION	Pennsylvania	nn	32	SENT_72	[p5l1094t122r1581b213],
32	)	NN	O	)	appos	24	SENT_72	[p5l1094t122r1581b213],
33	.	.	O	.	_	0	SENT_72	[p5l1094t122r1581b213],

1	Fixed	VBN	O	fix	_	0	SENT_73	[p5l1635t124r1826b190],
2	platelets	NNS	O	platelet	dobj	1	SENT_73	[p5l1874t124r2150b213],
3	were	VBD	O	be	auxpass	5	SENT_73	[p5l11t257r173b298],
4	then	RB	O	then	advmod	5	SENT_73	[p5l199t231r352b298],
5	incubated	VBN	O	incubate	auxpass	1	SENT_73	[p5l377t231r710b298],
6	with	IN	O	with	_	0	SENT_73	[p5l731t231r888b298],
7	phycoerythrin-conjugated	JJ	O	phycoerythrin-conjugated	amod	10	SENT_73	[p5l912t231r1795b321],
8	monoclonal	JJ	O	monoclonal	amod	10	SENT_73	[p5l1820t231r2149b298, p5l16t338r117b404],
9	antibody	NN	O	antibody	nn	10	SENT_73	[p5l162t338r461b427],
10	CD62P	NN	O	cd62p	prep_with	5	SENT_73	[p5l503t338r773b405],
11	(	CD	NUMBER	(	number	12	SENT_73	[p5l821t336r991b419],
12	0.09	CD	NUMBER	0.09	num	27	SENT_73	[p5l821t336r991b419],
13	p.	NN	O	p.	nn	27	SENT_73	[p5l1040t338r1166b427],
14	g	NN	O	g	nn	27	SENT_73	[p5l1040t338r1166b427],
15	/	:	O	/	punct	18	SENT_73	[p5l1040t338r1166b427],
16	ml	NN	O	ml	nn	18	SENT_73	[p5l1167t338r1257b404],
17	ﬁnal	JJ	O	ﬁnal	amod	18	SENT_73	[p5l1300t338r1450b404],
18	concentration	NN	O	concentration	dep	27	SENT_73	[p5l1494t341r1978b419],
19	,	,	O	,	_	0	SENT_73	[p5l1494t341r1978b419],
20	BD	NN	O	bd	nn	21	SENT_73	[p5l2026t339r2149b404],
21	PharMingen	NN	O	pharmingen	appos	18	SENT_73	[p5l15t445r472b534],
22	,	,	O	,	_	0	SENT_73	[p5l15t445r472b534],
23	San	NNP	LOCATION	San	nn	24	SENT_73	[p5l519t445r643b511],
24	Diego	NNP	LOCATION	Diego	appos	18	SENT_73	[p5l684t446r913b534],
25	,	,	O	,	_	0	SENT_73	[p5l684t446r913b534],
26	California	NNP	LOCATION	California	appos	18	SENT_73	[p5l960t443r1325b525],
27	)	NN	O	)	dep	10	SENT_73	[p5l960t443r1325b525],
28	and	CC	O	and	_	0	SENT_73	[p5l1372t445r1496b511],
29	analyzed	VBN	O	analyze	auxpass	1	SENT_73	[p5l1538t445r1830b534],
30	by	IN	O	by	_	0	SENT_73	[p5l1868t445r1953b534],
31	tvVo	NN	O	tvvo	nn	34	SENT_73	[p5l1990t462r2149b511],
32	—	CD	NUMBER	—	num	34	SENT_73	[p5l1990t462r2149b511],
33	color	NN	O	color	nn	34	SENT_73	[p5l16t553r185b619],
34	flow	NN	O	flow	prep_by	29	SENT_73	[p5l212t553r363b619],
35	cytometry	NN	O	cytometry	nn	38	SENT_73	[p5l390t570r731b642],
36	(	CD	NUMBER	(	num	38	SENT_73	[p5l760t551r1008b633],
37	FACS	NN	O	fac	nn	38	SENT_73	[p5l760t551r1008b633],
38	Calibur	NN	O	calibur	nsubjpass	1	SENT_73	[p5l1042t553r1316b634],
39	,	,	O	,	_	0	SENT_73	[p5l1042t553r1316b634],
40	Becton	NNP	PERSON	Becton	nn	41	SENT_73	[p5l1348t554r1590b619],
41	Dickinson	NNP	PERSON	Dickinson	appos	38	SENT_73	[p5l1619t553r1992b634],
42	,	,	O	,	_	0	SENT_73	[p5l1619t553r1992b634],
43	San	NNP	LOCATION	San	nn	44	SENT_73	[p5l2028t553r2151b619],
44	Jose	NNP	LOCATION	Jose	appos	38	SENT_73	[p5l6t660r168b744],
45	,	,	O	,	_	0	SENT_73	[p5l6t660r168b744],
46	California	NNP	LOCATION	California	nn	47	SENT_73	[p5l213t657r599b740],
47	)	NN	O	)	appos	38	SENT_73	[p5l213t657r599b740],
48	.	.	O	.	_	0	SENT_73	[p5l213t657r599b740],

1	Ten	CD	NUMBER	ten	number	2	SENT_74	[p5l641t658r785b726],
2	thousand	CD	NUMBER	thousand	num	4	SENT_74	[p5l825t659r1141b726],
3	gated	JJ	O	gated	amod	4	SENT_74	[p5l1179t659r1365b749],
4	events	NNS	O	event	nsubjpass	8	SENT_74	[p5l1406t676r1613b726],
5	were	VBD	O	be	auxpass	6	SENT_74	[p5l1651t685r1813b726],
6	collected	VBN	O	collect	_	0	SENT_74	[p5l1855t659r2152b726],
7	and	CC	O	and	_	0	SENT_74	[p5l17t766r141b832],
8	analyzed	VBN	O	analyze	conj_and	6	SENT_74	[p5l167t766r459b855],
9	using	VBG	O	use	xcomp	6	SENT_74	[p5l483t769r667b855],
10	Cellquest	NNP	MISC	Cellquest	nn	11	SENT_74	[p5l693t766r1014b856],
11	software	NN	O	software	dobj	9	SENT_74	[p5l1039t766r1338b833],
12	.	.	O	.	_	0	SENT_74	[p5l1039t766r1338b833],

1	All	DT	O	all	det	2	SENT_75	[p5l1366t765r1475b832],
2	data	NNS	O	datum	nsubjpass	4	SENT_75	[p5l1500t766r1643b832],
3	were	VBD	O	be	auxpass	4	SENT_75	[p5l1664t792r1826b833],
4	stored	VBN	O	store	_	0	SENT_75	[p5l1853t766r2060b832],
5	in	IN	O	in	_	0	SENT_75	[p5l2085t769r2151b832],
6	listmode	JJ	O	listmode	amod	7	SENT_75	[p5l13t873r306b939],
7	fashion	NN	O	fashion	prep_in	4	SENT_75	[p5l336t873r584b939],
8	for	IN	O	for	_	0	SENT_75	[p5l613t873r710b939],
9	archiving	NN	O	archiving	prep_for	7	SENT_75	[p5l740t873r1067b962],
10	.	.	O	.	_	0	SENT_75	[p5l740t873r1067b962],

1	%	NN	O	%	nn	2	SENT_76	[p5l331t1532r360b1562],
2	Aggregation	NN	O	aggregation	_	0	SENT_76	[p5l330t1313r369b1519],
3	p.M	NN	O	p.m	nn	5	SENT_76	[p5l575t1737r633b1774],
4	ADP	NN	O	adp	nn	5	SENT_76	[p5l646t1737r728b1766],
5	pg/mL	NN	O	pg/ml	dep	2	SENT_76	[p5l996t1738r1109b1776],
6	Collagen	NNP	O	Collagen	nn	8	SENT_76	[p5l1121t1737r1271b1776],
7	MM	NN	O	mm	nn	8	SENT_76	[p5l1491t1738r1549b1775],
8	Epinephrine	NN	O	epinephrine	dep	2	SENT_76	[p5l1562t1737r1766b1775],

1	.	.	O	.	_	0	SENT_77	[p5l826t1852r909b1863],

1	—	NN	O	—	_	0	SENT_78	[p5l826t1852r909b1863],
2	.	.	O	.	_	0	SENT_78	[p5l826t1852r909b1863],
3	'	''	O	'	_	0	SENT_78	[p5l826t1852r909b1863],

1	.	.	O	.	_	0	SENT_79	[p5l826t1852r909b1863],

1	—	NN	O	—	_	0	SENT_80	[p5l826t1852r909b1863],
2	.	.	O	.	_	0	SENT_80	[p5l826t1852r909b1863],

1	*	NN	O	*	_	0	SENT_81	[p5l826t1852r909b1863],
2	ASA	NN	O	asa	prep	1	SENT_81	[p5l953t1846r1028b1872],
3	—	CD	NUMBER	—	dep	2	SENT_81	[p5l826t1901r909b1913],
4	*	SYM	O	*	dep	1	SENT_81	[p5l826t1901r909b1913],
5	-	:	O	-	_	0	SENT_81	[p5l826t1901r909b1913],
6	Clopidogrel	NN	O	clopidogrel	dep	1	SENT_81	[p5l954t1895r1133b1929],
7	.	.	O	.	_	0	SENT_81	[p5l826t1952r909b1963],

1	—	NN	O	—	_	0	SENT_82	[p5l826t1952r909b1963],
2	.	.	O	.	_	0	SENT_82	[p5l826t1952r909b1963],
3	'	''	O	'	_	0	SENT_82	[p5l826t1952r909b1963],

1	-	:	O	-	_	0	SENT_83	[p5l826t1952r909b1963],
2	ASA	NN	O	asa	_	0	SENT_83	[p5l953t1945r1027b1971],
3	+	CC	O	+	_	0	SENT_83	[p5l1039t1951r1059b1971],
4	Clopidogrel	NN	O	clopidogrel	conj_+	2	SENT_83	[p5l1070t1945r1249b1979],

1	Figure	NNP	O	Figure	_	0	SENT_84	[p5l43t2022r126b2051],
2	1	CD	NUMBER	1	dep	1	SENT_84	[p5l139t2022r162b2046],
3	.	.	O	.	_	0	SENT_84	[p5l139t2022r162b2046],

1	Aggregation	NN	O	aggregation	nn	4	SENT_85	[p5l179t2021r346b2055],
2	(	CD	NUMBER	(	num	4	SENT_85	[p5l358t2021r440b2052],
3	mean	NN	O	mean	nn	4	SENT_85	[p5l358t2021r440b2052],
4	percent	NN	O	percent	_	0	SENT_85	[p5l451t2028r550b2055],
5	i	FW	O	i	dep	4	SENT_85	[p5l563t2025r584b2045],
6	SEM	NN	O	sem	nn	7	SENT_85	[p5l599t2021r680b2052],
7	)	NN	O	)	dep	5	SENT_85	[p5l599t2021r680b2052],
8	with	IN	O	with	_	0	SENT_85	[p5l692t2022r752b2047],
9	adenosine	NN	O	adenosine	nn	10	SENT_85	[p5l764t2022r895b2046],
10	diphosphate	NN	O	diphosphate	prep_with	7	SENT_85	[p5l907t2022r1069b2055],
11	(	CD	NUMBER	(	dep	4	SENT_85	[p5l1081t2021r1133b2052],
12	A	DT	O	a	det	13	SENT_85	[p5l1081t2021r1133b2052],
13	)	NN	O	)	dep	11	SENT_85	[p5l1081t2021r1133b2052],
14	,	,	O	,	_	0	SENT_85	[p5l1081t2021r1133b2052],
15	collagen	NN	O	collagen	nn	18	SENT_85	[p5l1145t2022r1253b2055],
16	(	NN	O	(	nn	18	SENT_85	[p5l1265t2021r1316b2052],
17	B	NN	O	b	nn	18	SENT_85	[p5l1265t2021r1316b2052],
18	)	NN	O	)	conj_or	4	SENT_85	[p5l1265t2021r1316b2052],
19	,	,	O	,	_	0	SENT_85	[p5l1265t2021r1316b2052],
20	or	CC	O	or	_	0	SENT_85	[p5l1328t2031r1355b2046],
21	epinephrine	NN	O	epinephrine	nn	24	SENT_85	[p5l1366t2022r1524b2055],
22	(	NN	O	(	nn	24	SENT_85	[p5l1536t2021r1580b2052],
23	C	NN	O	c	nn	24	SENT_85	[p5l1536t2021r1580b2052],
24	)	NN	O	)	conj_or	4	SENT_85	[p5l1536t2021r1580b2052],
25	in	IN	O	in	_	0	SENT_85	[p5l1592t2023r1618b2046],
26	study	NN	O	study	nn	27	SENT_85	[p5l1629t2022r1701b2055],
27	subjects	NNS	O	subject	prep_in	24	SENT_85	[p5l1711t2022r1812b2055],
28	by	IN	O	by	_	0	SENT_85	[p5l1823t2022r1856b2055],
29	treatment	NN	O	treatment	nn	30	SENT_85	[p5l1866t2028r1996b2047],
30	strategy	NN	O	strategy	prep_by	27	SENT_85	[p5l2007t2028r2115b2055],
31	.	.	O	.	_	0	SENT_85	[p5l2007t2028r2115b2055],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_86	[p5l44t2059r187b2092],
2	differences	NNS	O	difference	nsubjpass	9	SENT_86	[p5l200t2059r339b2084],
3	under	IN	O	under	_	0	SENT_86	[p5l353t2059r431b2084],
4	different	JJ	O	different	amod	5	SENT_86	[p5l445t2059r556b2084],
5	conditions	NNS	O	condition	prep_under	2	SENT_86	[p5l569t2059r707b2083],
6	of	IN	O	of	_	0	SENT_86	[p5l722t2059r752b2083],
7	blockade	NN	O	blockade	prep_of	5	SENT_86	[p5l760t2059r878b2084],
8	were	VBD	O	be	auxpass	9	SENT_86	[p5l890t2068r953b2083],
9	noted	VBN	O	note	_	0	SENT_86	[p5l968t2059r1049b2084],
10	.	.	O	.	_	0	SENT_86	[p5l968t2059r1049b2084],

1	Multiple	JJ	O	multiple	amod	2	SENT_87	[p5l1064t2059r1181b2092],
2	comparisons	NNS	O	comparison	nsubj	3	SENT_87	[p5l1195t2060r1360b2092],
3	(	VBP	O	(	_	0	SENT_87	[p5l1376t2058r1420b2089],
4	six	CD	NUMBER	six	nsubj	16	SENT_87	[p5l1376t2058r1420b2089],
5	included	VBN	O	include	partmod	4	SENT_87	[p5l1433t2059r1547b2084],
6	in	IN	O	in	_	0	SENT_87	[p5l1561t2060r1587b2083],
7	adjustment	NN	O	adjustment	prep_in	5	SENT_87	[p5l1601t2059r1748b2092],
8	per	IN	O	per	_	0	SENT_87	[p5l1761t2068r1804b2092],
9	plot	NN	O	plot	nn	10	SENT_87	[p5l1816t2058r1878b2092],
10	)	NN	O	)	prep_per	7	SENT_87	[p5l1816t2058r1878b2092],
11	at	IN	O	at	_	0	SENT_87	[p5l1894t2065r1918b2083],
12	each	DT	O	each	det	13	SENT_87	[p5l1931t2059r1990b2084],
13	agonist	NN	O	agonist	poss	15	SENT_87	[p5l2004t2059r2116b2092],
14	’s	POS	O	’s	_	0	SENT_87	[p5l2004t2059r2116b2092],
15	concentrations	NNS	O	concentration	prep_at	5	SENT_87	[p5l43t2097r237b2121],
16	revealed	VBD	O	reveal	ccomp	3	SENT_87	[p5l253t2096r361b2121],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_87	[p5l377t2096r514b2129],
18	differences	NNS	O	difference	nsubj	19	SENT_87	[p5l530t2096r669b2121],
19	(	VBP	O	(	ccomp	16	SENT_87	[p5l686t2095r711b2129],
20	p	NN	O	p	nsubj	28	SENT_87	[p5l686t2095r711b2129],
21	<	JJR	O	<	dep	28	SENT_87	[p5l730t2099r752b2119],
22	0.05	CD	NUMBER	0.05	num	23	SENT_87	[p5l770t2095r837b2126],
23	)	NN	O	)	npadvmod	27	SENT_87	[p5l770t2095r837b2126],
24	between	IN	O	between	_	0	SENT_87	[p5l854t2096r964b2120],
25	treatment	NN	O	treatment	nn	26	SENT_87	[p5l980t2102r1110b2121],
26	strategies	NNS	O	strategy	prep_between	23	SENT_87	[p5l1125t2097r1247b2129],
27	as	IN	O	as	advmod	28	SENT_87	[p5l1264t2105r1288b2120],
28	indicated	VBN	O	indicate	xcomp	19	SENT_87	[p5l1304t2096r1433b2121],
29	.	.	O	.	_	0	SENT_87	[p5l1304t2096r1433b2121],

1	*	NN	O	*	nsubj	2	SENT_88	[p5l1450t2095r1562b2129],
2	Applies	VBZ	O	apply	_	0	SENT_88	[p5l1450t2095r1562b2129],
3	for	IN	O	for	_	0	SENT_88	[p5l1578t2096r1616b2120],
4	differences	NNS	O	difference	prep_for	2	SENT_88	[p5l1632t2096r1771b2121],
5	between	IN	O	between	_	0	SENT_88	[p5l1787t2096r1897b2121],
6	treatment	NN	O	treatment	prep_between	4	SENT_88	[p5l1913t2102r2043b2120],
7	with	IN	O	with	_	0	SENT_88	[p5l2057t2096r2117b2121],
8	acetylsalicylic	JJ	O	acetylsalicylic	amod	12	SENT_88	[p5l43t2133r221b2166],
9	acid	NN	O	acid	nn	12	SENT_88	[p5l230t2133r283b2158],
10	(	NN	O	(	nn	12	SENT_88	[p5l293t2132r379b2163],
11	ASA	NN	O	asa	nn	12	SENT_88	[p5l293t2132r379b2163],
12	)	NN	O	)	prep_with	2	SENT_88	[p5l293t2132r379b2163],
13	and	CC	O	and	_	0	SENT_88	[p5l390t2133r438b2158],
14	with	IN	O	with	_	0	SENT_88	[p5l445t2133r506b2157],
15	clopidogrel	NN	O	clopidogrel	conj_and	12	SENT_88	[p5l515t2133r670b2166],
16	.	.	O	.	_	0	SENT_88	[p5l515t2133r670b2166],
17	'	''	O	'	_	0	SENT_88	[p5l681t2132r798b2166],

1	l‘Applies	NNS	O	l‘applies	_	0	SENT_89	[p5l681t2132r798b2166],
2	for	IN	O	for	_	0	SENT_89	[p5l808t2133r846b2157],
3	differences	NNS	O	difference	prep_for	1	SENT_89	[p5l854t2133r993b2158],
4	between	IN	O	between	_	0	SENT_89	[p5l1002t2133r1113b2157],
5	treatment	NN	O	treatment	prep_between	3	SENT_89	[p5l1122t2139r1252b2158],
6	with	IN	O	with	_	0	SENT_89	[p5l1259t2133r1320b2158],
7	clopidogrel	NN	O	clopidogrel	prep_with	1	SENT_89	[p5l1329t2133r1477b2166],
8	and	CC	O	and	_	0	SENT_89	[p5l1486t2133r1534b2157],
9	with	IN	O	with	_	0	SENT_89	[p5l1541t2133r1602b2157],
10	ASA	NN	O	asa	prep_with	1	SENT_89	[p5l1610t2132r1679b2158],
11	plus	CC	O	plus	prep	10	SENT_89	[p5l1686t2133r1740b2166],
12	clopidogrel	NN	O	clopidogrel	dep	11	SENT_89	[p5l1750t2133r1898b2166],
13	in	IN	O	in	_	0	SENT_89	[p5l1906t2134r1932b2157],
14	combination	NN	O	combination	prep_in	1	SENT_89	[p5l1941t2133r2115b2157],
15	.	.	O	.	_	0	SENT_89	[p5l1941t2133r2115b2157],

1	:	:	O	:	_	0	SENT_90	[p5l43t2169r160b2203],
2	.	.	O	.	_	0	SENT_90	[p5l43t2169r160b2203],

1	l	NN	O	l	_	0	SENT_91	[p5l43t2169r160b2203],
2	:	:	O	:	_	0	SENT_91	[p5l43t2169r160b2203],
3	Applies	NNS	O	apply	dep	1	SENT_91	[p5l43t2169r160b2203],
4	for	IN	O	for	_	0	SENT_91	[p5l173t2170r211b2194],
5	differences	NNS	O	difference	prep_for	3	SENT_91	[p5l223t2170r362b2194],
6	between	IN	O	between	_	0	SENT_91	[p5l374t2170r484b2195],
7	treatment	NN	O	treatment	prep_between	5	SENT_91	[p5l497t2176r627b2194],
8	with	IN	O	with	_	0	SENT_91	[p5l637t2170r698b2195],
9	ASA	NN	O	asa	prep_with	7	SENT_91	[p5l709t2169r777b2195],
10	and	CC	O	and	_	0	SENT_91	[p5l789t2170r837b2195],
11	with	IN	O	with	_	0	SENT_91	[p5l847t2170r908b2194],
12	ASA	NN	O	asa	conj_and	9	SENT_91	[p5l919t2169r988b2195],
13	plus	CC	O	plus	_	0	SENT_91	[p5l999t2170r1052b2203],
14	clopidogrel	NN	O	clopidogrel	dep	1	SENT_91	[p5l1065t2170r1213b2203],
15	in	IN	O	in	_	0	SENT_91	[p5l1225t2171r1251b2194],
16	combination	NN	O	combination	prep_in	14	SENT_91	[p5l1263t2170r1437b2195],
17	.	.	O	.	_	0	SENT_91	[p5l1263t2170r1437b2195],

1	JACC	NNP	O	JACC	nn	2	SENT_92	[p5l9t2363r143b2420],
2	Vol	NNP	O	Vol	_	0	SENT_92	[p5l172t2363r269b2420],
3	.	.	O	.	_	0	SENT_92	[p5l172t2363r269b2420],

1	47	CD	NUMBER	47	_	0	SENT_93	[p5l302t2363r389b2429],
2	,	,	O	,	_	0	SENT_93	[p5l302t2363r389b2429],
3	No.	NN	O	no.	amod	1	SENT_93	[p5l425t2363r509b2420],
4	3	CD	NUMBER	3	number	3	SENT_93	[p5l543t2363r592b2429],
5	,	,	O	,	_	0	SENT_93	[p5l543t2363r592b2429],
6	2006	CD	DATE	2006	appos	1	SENT_93	[p5l626t2363r770b2420],
7	February	NNP	DATE	February	tmod	6	SENT_93	[p5l13t2452r239b2521],
8	7	CD	DATE	7	num	7	SENT_93	[p5l269t2452r316b2517],
9	,	,	O	,	_	0	SENT_93	[p5l269t2452r316b2517],
10	2006:541	CD	NUMBER	2006:541	num	7	SENT_93	[p5l351t2451r701b2508],
11	—	CD	NUMBER	—	num	12	SENT_93	[p5l351t2451r701b2508],
12	6	CD	NUMBER	6	dep	1	SENT_93	[p5l351t2451r701b2508],

1	Data	NN	O	datum	_	0	SENT_94	[p5l10t2674r196b2739],
2	analysis	NN	O	analysis	dep	1	SENT_94	[p5l231t2672r539b2762],
3	.	.	O	.	_	0	SENT_94	[p5l231t2672r539b2762],

1	All	DT	O	all	det	3	SENT_95	[p5l588t2671r700b2738],
2	patient	NN	O	patient	nn	3	SENT_95	[p5l735t2676r983b2762],
3	data	NNS	O	datum	nsubjpass	5	SENT_95	[p5l1020t2673r1167b2739],
4	were	VBD	O	be	auxpass	5	SENT_95	[p5l1199t2699r1366b2739],
5	coded	VBN	O	code	_	0	SENT_95	[p5l1404t2673r1612b2739],
6	to	TO	O	to	aux	7	SENT_95	[p5l1648t2690r1716b2739],
7	maintain	VB	O	maintain	xcomp	5	SENT_95	[p5l1755t2676r2069b2739],
8	a	DT	O	a	det	10	SENT_95	[p5l2107t2699r2142b2739],
9	blinded	JJ	O	blinded	amod	10	SENT_95	[p5l8t2780r277b2846],
10	evaluation	NN	O	evaluation	dobj	7	SENT_95	[p5l314t2780r691b2846],
11	.	.	O	.	_	0	SENT_95	[p5l314t2780r691b2846],

1	For	IN	O	for	_	0	SENT_96	[p5l733t2781r858b2846],
2	baseline	NN	O	baseline	nn	4	SENT_96	[p5l891t2780r1173b2846],
3	clinical	JJ	O	clinical	amod	4	SENT_96	[p5l1211t2780r1459b2846],
4	data	NNS	O	datum	prep_for	10	SENT_96	[p5l1496t2780r1661b2861],
5	,	,	O	,	_	0	SENT_96	[p5l1496t2780r1661b2861],
6	a	DT	O	a	det	8	SENT_96	[p5l1703t2806r1737b2846],
7	chi-square	JJ	O	chi-square	amod	8	SENT_96	[p5l1773t2780r2140b2869],
8	analysis	NN	O	analysis	nsubjpass	10	SENT_96	[p5l12t2887r277b2976],
9	was	VBD	O	be	auxpass	10	SENT_96	[p5l299t2913r429b2953],
10	used	VBN	O	use	_	0	SENT_96	[p5l454t2887r613b2953],
11	for	IN	O	for	_	0	SENT_96	[p5l636t2887r737b2953],
12	categorical	JJ	O	categorical	amod	13	SENT_96	[p5l761t2887r1137b2976],
13	data	NNS	O	datum	prep_for	10	SENT_96	[p5l1161t2887r1308b2953],
14	and	CC	O	and	_	0	SENT_96	[p5l1333t2887r1460b2953],
15	a	DT	O	a	det	16	SENT_96	[p5l1486t2913r1520b2953],
16	Student	NN	O	student	prep_for	10	SENT_96	[p5l1547t2887r1823b2953],
17	2	CD	NUMBER	2	number	18	SENT_96	[p5l1847t2903r1876b2953],
18	‘	CD	NUMBER	‘	num	19	SENT_96	[p5l1847t2903r1876b2953],
19	test	NN	O	test	dep	16	SENT_96	[p5l1895t2904r2019b2953],
20	for	IN	O	for	_	0	SENT_96	[p5l2042t2887r2142b2953],
21	continuous	JJ	O	continuous	amod	22	SENT_96	[p5l11t2997r399b3060],
22	variables	NNS	O	variable	prep_for	10	SENT_96	[p5l458t2994r782b3060],
23	.	.	O	.	_	0	SENT_96	[p5l458t2994r782b3060],

1	For	IN	O	for	_	0	SENT_97	[p5l848t2995r974b3060],
2	platelet	NN	O	platelet	nn	3	SENT_97	[p5l1032t2994r1293b3083],
3	aggregation	NN	O	aggregation	pobj	1	SENT_97	[p5l1354t2997r1767b3083],
4	and	CC	O	and	_	0	SENT_97	[p5l1829t2994r1957b3060],
5	GP	NN	O	gp	nn	8	SENT_97	[p5l2019t2994r2140b3060],
6	Ilb/Illa	NN	O	ilb/illa	nn	8	SENT_97	[p5l10t3102r287b3168],
7	activation	NN	O	activation	nn	8	SENT_97	[p5l316t3105r657b3168],
8	data	NNS	O	datum	conj_and	3	SENT_97	[p5l686t3102r852b3183],
9	,	,	O	,	_	0	SENT_97	[p5l686t3102r852b3183],
10	a	DT	O	a	quantmod	11	SENT_97	[p5l885t3128r919b3168],
11	three	CD	NUMBER	three	num	16	SENT_97	[p5l946t3102r1368b3168],
12	—	NN	O	—	nn	16	SENT_97	[p5l946t3102r1368b3168],
13	factor	NN	O	factor	nn	16	SENT_97	[p5l946t3102r1368b3168],
14	(	CD	NUMBER	(	num	16	SENT_97	[p5l1397t3085r1548b3182],
15	PIA	NNP	O	PIA	nn	16	SENT_97	[p5l1397t3085r1548b3182],
16	genotype	NN	O	genotype	appos	8	SENT_97	[p5l1574t3119r1914b3191],
17	,	,	O	,	_	0	SENT_97	[p5l1574t3119r1914b3191],
18	treatment	NN	O	treatment	appos	8	SENT_97	[p5l1945t3119r2137b3168, p6l11t50r194b99],

1	strategy	NN	O	strategy	nsubjpass	22	SENT_98	[p6l230t50r521b122],
2	,	,	O	,	_	0	SENT_98	[p6l230t50r521b122],
3	and	CC	O	and	_	0	SENT_98	[p6l563t33r690b99],
4	agonist	NN	O	agonist	nn	7	SENT_98	[p6l727t36r980b122],
5	concentration	NN	O	concentration	nn	7	SENT_98	[p6l1016t31r1527b113],
6	)	NN	O	)	nn	7	SENT_98	[p6l1016t31r1527b113],
7	analysis	NN	O	analysis	conj_and	1	SENT_98	[p6l1569t33r1834b122],
8	of	IN	O	of	_	0	SENT_98	[p6l1873t33r1953b99],
9	variance	NN	O	variance	prep_of	7	SENT_98	[p6l1975t36r2138b99, p6l12t166r166b206],
10	(	CD	NUMBER	(	num	9	SENT_98	[p6l203t138r590b220],
11	ANOVA	NNP	ORGANIZATION	ANOVA	dep	7	SENT_98	[p6l203t138r590b220],
12	)	CD	NUMBER	)	num	11	SENT_98	[p6l203t138r590b220],
13	with	IN	O	with	_	0	SENT_98	[p6l623t140r784b206],
14	one	CD	NUMBER	one	num	17	SENT_98	[p6l818t166r943b206],
15	repeated	JJ	O	repeated	amod	17	SENT_98	[p6l976t140r1276b229],
16	factor	NN	O	factor	nn	17	SENT_98	[p6l1308t140r1512b206],
17	(	NN	O	(	prep_with	11	SENT_98	[p6l1546t138r1827b229],
18	agonist	NN	O	agonist	nn	20	SENT_98	[p6l1546t138r1827b229],
19	concentration	NN	O	concentration	nn	20	SENT_98	[p6l1859t166r2138b206, p6l10t246r290b328],
20	)	NN	O	)	dep	17	SENT_98	[p6l1859t166r2138b206, p6l10t246r290b328],
21	was	VBD	O	be	auxpass	22	SENT_98	[p6l356t274r490b314],
22	performed	VBN	O	perform	_	0	SENT_98	[p6l558t248r947b337],
23	separately	RB	O	separately	advmod	22	SENT_98	[p6l1014t248r1384b337],
24	for	IN	O	for	_	0	SENT_98	[p6l1447t248r1552b314],
25	each	DT	O	each	det	26	SENT_98	[p6l1618t248r1781b314],
26	agonist	NN	O	agonist	prep_for	22	SENT_98	[p6l1849t251r2135b337],
27	.	.	O	.	_	0	SENT_98	[p6l1849t251r2135b337],

1	Modeling	NN	O	modeling	nsubjpass	3	SENT_99	[p6l9t354r361b444],
2	was	VBD	O	be	auxpass	3	SENT_99	[p6l399t381r529b421],
3	performed	VBN	O	perform	dep	6	SENT_99	[p6l573t354r943b444],
4	by	IN	O	by	_	0	SENT_99	[p6l984t355r1070b444],
5	PROC	NNP	O	PROC	agent	3	SENT_99	[p6l1110t354r1359b421],
6	l\/lixed	VBD	O	l\/lixed	_	0	SENT_99	[p6l1403t354r1636b421],
7	procedure	NN	O	procedure	dobj	6	SENT_99	[p6l1678t354r2029b444],
8	in	IN	O	in	_	0	SENT_99	[p6l2073t357r2141b420],
9	SAS	NNP	ORGANIZATION	SAS	nn	10	SENT_99	[p6l14t460r167b528],
10	Version	NNP	O	Version	prep_in	6	SENT_99	[p6l218t462r492b528],
11	8.1	CD	NUMBER	8.1	num	14	SENT_99	[p6l541t465r642b528],
12	(	CD	NUMBER	(	num	14	SENT_99	[p6l697t459r880b542],
13	SAS	NNP	ORGANIZATION	SAS	nn	14	SENT_99	[p6l697t459r880b542],
14	Institute	NNP	ORGANIZATION	Institute	nsubj	6	SENT_99	[p6l929t462r1250b543],
15	,	,	O	,	_	0	SENT_99	[p6l929t462r1250b543],
16	Cary	NNP	PERSON	Cary	nn	19	SENT_99	[p6l1302t461r1489b551],
17	,	,	O	,	_	0	SENT_99	[p6l1302t461r1489b551],
18	North	NNP	LOCATION	North	appos	19	SENT_99	[p6l1539t462r1757b528],
19	Carolina	NNP	LOCATION	Carolina	appos	14	SENT_99	[p6l1806t459r2137b542],
20	)	CD	NUMBER	)	num	19	SENT_99	[p6l1806t459r2137b542],
21	(	CD	NUMBER	(	number	22	SENT_99	[p6l13t566r284b649],
22	19,20	CD	NUMBER	19,20	num	23	SENT_99	[p6l13t566r284b649],
23	)	NN	O	)	dep	19	SENT_99	[p6l13t566r284b649],
24	.	.	O	.	_	0	SENT_99	[p6l13t566r284b649],

1	Multiple	JJ	O	multiple	amod	2	SENT_100	[p6l338t569r648b658],
2	comparisons	NNS	O	comparison	nsubjpass	4	SENT_100	[p6l701t571r1140b658],
3	were	VBD	O	be	auxpass	4	SENT_100	[p6l1189t594r1355b635],
4	made	VBN	O	make	_	0	SENT_100	[p6l1407t569r1596b635],
5	(	RB	O	(	advmod	4	SENT_100	[p6l1651t566r1737b649],
6	if	IN	O	if	mark	10	SENT_100	[p6l1651t566r1737b649],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_100	[p6l1777t568r2143b658],
8	differences	NNS	O	difference	nsubjpass	10	SENT_100	[p6l11t675r382b742],
9	were	VBD	O	be	auxpass	10	SENT_100	[p6l427t701r594b742],
10	found	VBN	O	find	advcl	4	SENT_100	[p6l641t673r874b756],
11	)	NN	O	)	dobj	10	SENT_100	[p6l641t673r874b756],
12	with	IN	O	with	_	0	SENT_100	[p6l921t675r1082b742],
13	least	JJS	O	least	nn	16	SENT_100	[p6l1128t675r1286b742],
14	square	JJ	O	square	amod	16	SENT_100	[p6l1333t701r1555b765],
15	means	NN	O	means	nn	16	SENT_100	[p6l1603t702r1824b742],
16	analysis	NN	O	analysis	prep_with	11	SENT_100	[p6l1874t675r2139b765],
17	with	IN	O	with	_	0	SENT_100	[p6l7t782r168b849],
18	the	DT	O	the	det	20	SENT_100	[p6l221t782r331b849],
19	Bonferroni	NNP	LOCATION	Bonferroni	nn	20	SENT_100	[p6l385t782r772b849],
20	adjustment	NN	O	adjustment	prep_with	10	SENT_100	[p6l827t782r1220b871],
21	(	CD	NUMBER	(	number	22	SENT_100	[p6l1274t780r1433b863],
22	21	CD	NUMBER	21	num	23	SENT_100	[p6l1274t780r1433b863],
23	)	NN	O	)	dep	10	SENT_100	[p6l1274t780r1433b863],
24	.	.	O	.	_	0	SENT_100	[p6l1274t780r1433b863],

1	Data	NNS	O	datum	nsubjpass	3	SENT_101	[p6l1490t783r1665b849],
2	were	VBD	O	be	auxpass	3	SENT_101	[p6l1712t808r1879b849],
3	transformed	VBN	O	transform	_	0	SENT_101	[p6l1932t799r2138b849, p6l10t889r266b955],
4	if	IN	O	if	mark	14	SENT_101	[p6l288t889r348b955],
5	normality	NN	O	normality	nn	8	SENT_101	[p6l360t889r705b978],
6	and	CC	O	and	_	0	SENT_101	[p6l726t889r853b955],
7	equal	JJ	O	equal	conj_and	5	SENT_101	[p6l876t889r1062b979],
8	variances	NNS	O	variance	nsubjpass	14	SENT_101	[p6l1080t892r1400b956],
9	of	IN	O	of	_	0	SENT_101	[p6l1426t889r1506b955],
10	the	DT	O	the	det	11	SENT_101	[p6l1516t889r1626b955],
11	residuals	NNS	O	residual	prep_of	8	SENT_101	[p6l1650t889r1953b955],
12	were	VBD	O	be	auxpass	14	SENT_101	[p6l1974t915r2140b956],
13	not	RB	O	not	neg	14	SENT_101	[p6l12t1013r129b1062],
14	met	VBN	O	meet	advcl	3	SENT_101	[p6l151t1013r303b1062],
15	.	.	O	.	_	0	SENT_101	[p6l151t1013r303b1062],

1	In	IN	O	in	_	0	SENT_102	[p6l330t997r408b1061],
2	all	DT	O	all	det	4	SENT_102	[p6l433t996r513b1062],
3	ANOVA	NNP	O	ANOVA	nn	4	SENT_102	[p6l533t995r872b1062],
4	models	NNS	O	model	prep_in	23	SENT_102	[p6l894t996r1143b1062],
5	on	IN	O	on	_	0	SENT_102	[p6l1169t1022r1256b1062],
6	the	DT	O	the	det	8	SENT_102	[p6l1279t996r1390b1062],
7	raw	JJ	O	raw	amod	8	SENT_102	[p6l1414t1022r1543b1062],
8	data	NNS	O	datum	prep_on	4	SENT_102	[p6l1564t996r1730b1077],
9	,	,	O	,	_	0	SENT_102	[p6l1564t996r1730b1077],
10	neither	CC	O	neither	preconj	13	SENT_102	[p6l1758t996r2008b1062],
11	the	DT	O	the	det	13	SENT_102	[p6l2030t996r2140b1062],
12	equal	JJ	O	equal	amod	13	SENT_102	[p6l11t1104r197b1194],
13	variances	NNS	O	variance	nsubjpass	23	SENT_102	[p6l224t1107r544b1171],
14	nor	CC	O	nor	_	0	SENT_102	[p6l578t1130r697b1170],
15	the	DT	O	the	det	17	SENT_102	[p6l727t1104r837b1170],
16	normality	NN	O	normality	nn	17	SENT_102	[p6l870t1104r1215b1193],
17	assumptions	NNS	O	assumption	nsubjpass	23	SENT_102	[p6l1244t1107r1676b1194],
18	on	IN	O	on	_	0	SENT_102	[p6l1710t1130r1797b1170],
19	the	DT	O	the	det	21	SENT_102	[p6l1829t1104r1939b1170],
20	error	NN	O	error	nn	21	SENT_102	[p6l1972t1130r2142b1170],
21	terms	NNS	O	term	prep_on	17	SENT_102	[p6l10t1264r205b1313],
22	were	VBD	O	be	auxpass	23	SENT_102	[p6l228t1273r395b1313],
23	met	VBN	O	meet	_	0	SENT_102	[p6l421t1264r573b1313],
24	.	.	O	.	_	0	SENT_102	[p6l421t1264r573b1313],

1	The	DT	O	the	det	2	SENT_103	[p6l599t1245r746b1313],
2	normality	NN	O	normality	nsubjpass	8	SENT_103	[p6l773t1247r1117b1336],
3	and	CC	O	and	_	0	SENT_103	[p6l1140t1247r1267b1313],
4	equal	JJ	O	equal	amod	6	SENT_103	[p6l1292t1247r1478b1337],
5	variances	NNS	O	variance	nn	6	SENT_103	[p6l1498t1250r1818b1313],
6	assumptions	NNS	O	assumption	conj_and	2	SENT_103	[p6l1846t1273r2138b1337, p6l10t1356r181b1419],
7	were	VBD	O	be	auxpass	8	SENT_103	[p6l221t1378r387b1419],
8	examined	VBN	O	examine	_	0	SENT_103	[p6l431t1353r769b1419],
9	on	IN	O	on	_	0	SENT_103	[p6l811t1379r899b1419],
10	the	DT	O	the	det	11	SENT_103	[p6l941t1353r1051b1419],
11	residuals	NNS	O	residual	prep_on	8	SENT_103	[p6l1094t1353r1396b1419],
12	from	IN	O	from	_	0	SENT_103	[p6l1440t1353r1610b1419],
13	the	DT	O	the	det	14	SENT_103	[p6l1653t1353r1763b1419],
14	ANOVA	NNP	O	ANOVA	prep_from	8	SENT_103	[p6l1803t1352r2142b1419],

1	with	IN	O	with	_	0	SENT_104	[p6l7t1460r168b1526],
2	the	DT	O	the	det	3	SENT_104	[p6l213t1460r323b1526],
3	Shapiro	NNP	PERSON	Shapiro	pobj	1	SENT_104	[p6l373t1460r931b1549],
4	.	.	O	.	_	0	SENT_104	[p6l373t1460r931b1549],

1	—	NN	O	—	_	0	SENT_105	[p6l373t1460r931b1549],
2	.	.	O	.	_	0	SENT_105	[p6l373t1460r931b1549],

1	Wilkes	NNP	PERSON	Wilkes	_	0	SENT_106	[p6l373t1460r931b1549],
2	test	NN	O	test	dep	1	SENT_106	[p6l978t1477r1103b1526],
3	and	CC	O	and	_	0	SENT_106	[p6l1147t1460r1274b1526],
4	the	DT	O	the	det	5	SENT_106	[p6l1319t1460r1429b1526],
5	plots	NNS	O	plot	dep	1	SENT_106	[p6l1473t1460r1664b1549],
6	,	,	O	,	_	0	SENT_106	[p6l1473t1460r1664b1549],
7	respectively	RB	O	respectively	advmod	5	SENT_106	[p6l1711t1460r2136b1549],
8	.	.	O	.	_	0	SENT_106	[p6l1711t1460r2136b1549],

1	Therefore	RB	O	therefore	advmod	6	SENT_107	[p6l8t1566r383b1649],
2	,	,	O	,	_	0	SENT_107	[p6l8t1566r383b1649],
3	the	DT	O	the	det	4	SENT_107	[p6l425t1568r535b1634],
4	data	NNS	O	datum	nsubjpass	6	SENT_107	[p6l576t1568r723b1634],
5	were	VBD	O	be	auxpass	6	SENT_107	[p6l758t1593r924b1634],
6	transformed	VBN	O	transform	_	0	SENT_107	[p6l964t1568r1395b1634],
7	using	VBG	O	use	xcomp	6	SENT_107	[p6l1432t1571r1622b1657],
8	a	DT	O	a	det	12	SENT_107	[p6l1661t1594r1695b1634],
9	square	JJ	O	square	amod	12	SENT_107	[p6l1735t1585r2142b1657],
10	—	NN	O	—	nn	12	SENT_107	[p6l1735t1585r2142b1657],
11	root	NN	O	root	nn	12	SENT_107	[p6l1735t1585r2142b1657],
12	transformation	NN	O	transformation	dobj	7	SENT_107	[p6l10t1674r558b1755],
13	,	,	O	,	_	0	SENT_107	[p6l10t1674r558b1755],
14	and	CC	O	and	_	0	SENT_107	[p6l595t1674r723b1741],
15	all	DT	O	all	det	17	SENT_107	[p6l757t1674r836b1741],
16	statistical	JJ	O	statistical	amod	17	SENT_107	[p6l870t1674r1197b1741],
17	analyses	NNS	O	analysis	nsubjpass	19	SENT_107	[p6l1230t1674r1510b1764],
18	are	VBP	O	be	auxpass	19	SENT_107	[p6l1546t1700r1646b1741],
19	based	VBN	O	base	conj_and	6	SENT_107	[p6l1678t1674r1876b1741],
20	on	IN	O	on	_	0	SENT_107	[p6l1910t1701r1997b1741],
21	the	DT	O	the	det	23	SENT_107	[p6l2030t1674r2140b1741],
22	transformed	VBN	O	transform	amod	23	SENT_107	[p6l10t1781r441b1848],
23	data	NNS	O	datum	prep_on	19	SENT_107	[p6l494t1781r659b1848],
24	.	.	O	.	_	0	SENT_107	[p6l494t1781r659b1848],

1	The	DT	O	the	det	2	SENT_108	[p6l713t1780r860b1848],
2	assumptions	NNS	O	assumption	nsubjpass	5	SENT_108	[p6l915t1784r1347b1871],
3	were	VBD	O	be	auxpass	5	SENT_108	[p6l1398t1807r1564b1848],
4	again	RB	O	again	advmod	5	SENT_108	[p6l1619t1784r1804b1871],
5	checked	VBN	O	check	_	0	SENT_108	[p6l1858t1781r2141b1848],
6	after	IN	O	after	_	0	SENT_108	[p6l12t1889r171b1955],
7	the	DT	O	the	det	11	SENT_108	[p6l203t1889r313b1955],
8	square	JJ	O	square	amod	11	SENT_108	[p6l350t1906r758b1979],
9	—	NN	O	—	nn	11	SENT_108	[p6l350t1906r758b1979],
10	root	NN	O	root	nn	11	SENT_108	[p6l350t1906r758b1979],
11	transformation	NN	O	transformation	prep_after	5	SENT_108	[p6l790t1889r1337b1970],
12	,	,	O	,	_	0	SENT_108	[p6l790t1889r1337b1970],
13	and	CC	O	and	_	0	SENT_108	[p6l1376t1889r1504b1955],
14	they	PRP	O	they	nsubj	15	SENT_108	[p6l1537t1889r1690b1978],
15	appeared	VBD	O	appear	conj_and	5	SENT_108	[p6l1722t1889r2038b1979],
16	to	TO	O	to	aux	18	SENT_108	[p6l2071t1906r2139b1955],
17	be	VB	O	be	auxpass	18	SENT_108	[p6l8t1996r89b2062],
18	met	VBN	O	meet	xcomp	15	SENT_108	[p6l123t2013r275b2062],
19	.	.	O	.	_	0	SENT_108	[p6l123t2013r275b2062],

1	RESULTS	NNS	O	result	_	0	SENT_109	[p6l13t2222r363b2295],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	2	SENT_110	[p6l12t2389r436b2478],
2	provided	VBD	O	provide	_	0	SENT_110	[p6l495t2389r806b2478],
3	signiﬁcantly	RB	O	signiﬁcantly	advmod	4	SENT_110	[p6l869t2389r1298b2478],
4	greater	JJR	O	greater	amod	5	SENT_110	[p6l1354t2406r1599b2478],
5	inhibition	NN	O	inhibition	dobj	2	SENT_110	[p6l1659t2389r2010b2455],
6	of	IN	O	of	_	0	SENT_110	[p6l2073t2389r2153b2455],
7	platelet	NN	O	platelet	nn	8	SENT_110	[p6l9t2496r271b2585],
8	aggregation	NN	O	aggregation	prep_of	5	SENT_110	[p6l319t2499r731b2585],
9	induced	VBN	O	induce	partmod	8	SENT_110	[p6l780t2496r1061b2562],
10	with	IN	O	with	_	0	SENT_110	[p6l1105t2496r1267b2562],
11	ADP	NN	ORGANIZATION	adp	prep_with	9	SENT_110	[p6l1313t2494r1524b2577],
12	,	,	O	,	_	0	SENT_110	[p6l1313t2494r1524b2577],
13	and	CC	O	and	_	0	SENT_110	[p6l1577t2496r1704b2562],
14	even	RB	O	even	advmod	15	SENT_110	[p6l1754t2522r1911b2562],
15	more	RBR	O	more	amod	16	SENT_110	[p6l1961t2522r2140b2562],
16	inhibition	NN	O	inhibition	nsubjpass	18	SENT_110	[p6l10t2604r362b2670],
17	was	VBD	O	be	auxpass	18	SENT_110	[p6l408t2630r537b2670],
18	observed	VBN	O	observe	conj_and	2	SENT_110	[p6l590t2604r898b2670],
19	when	WRB	O	when	advmod	22	SENT_110	[p6l944t2604r1138b2670],
20	clopidogrel	NN	O	clopidogrel	nsubjpass	22	SENT_110	[p6l1190t2604r1584b2693],
21	was	VBD	O	be	auxpass	22	SENT_110	[p6l1629t2630r1758b2670],
22	added	VBN	O	add	advcl	18	SENT_110	[p6l1812t2604r2022b2670],
23	to	TO	O	to	_	0	SENT_110	[p6l2071t2621r2139b2670],
24	ASA	NN	O	asa	prep_to	22	SENT_110	[p6l8t2709r186b2777],
25	as	IN	O	as	_	0	SENT_110	[p6l213t2737r275b2777],
26	compared	VBN	O	compare	prepc_as	22	SENT_110	[p6l304t2710r639b2800],
27	with	IN	O	with	pcomp	26	SENT_110	[p6l662t2711r818b2777],
28	treatment	NN	O	treatment	pobj	27	SENT_110	[p6l845t2727r1178b2777],
29	with	IN	O	with	_	0	SENT_110	[p6l1200t2710r1356b2777],
30	ASA	NN	O	asa	prep_with	28	SENT_110	[p6l1381t2709r1558b2777],
31	only	RB	O	only	advmod	30	SENT_110	[p6l1585t2711r1732b2800],
32	(	CD	NUMBER	(	num	33	SENT_110	[p6l1759t2708r1913b2800],
33	Fig	NN	O	fig	pobj	31	SENT_110	[p6l1759t2708r1913b2800],
34	.	.	O	.	_	0	SENT_110	[p6l1759t2708r1913b2800],

1	1A	NN	O	1a	_	0	SENT_111	[p6l1949t2709r2068b2791],
2	;	:	O	;	_	0	SENT_111	[p6l1949t2709r2068b2791],
3	p	NN	O	p	dep	4	SENT_111	[p6l2097t2737r2139b2800],
4	<	JJR	O	<	dep	1	SENT_111	[p6l15t2828r75b2879],
5	0.0001	CD	NUMBER	0.0001	num	6	SENT_111	[p6l115t2815r391b2898],
6	)	NN	O	)	dep	4	SENT_111	[p6l115t2815r391b2898],
7	.	.	O	.	_	0	SENT_111	[p6l115t2815r391b2898],

1	With	IN	O	with	_	0	SENT_112	[p6l425t2817r613b2884],
2	collagen	NN	O	collagen	prep_with	7	SENT_112	[p6l647t2817r941b2906],
3	,	,	O	,	_	0	SENT_112	[p6l647t2817r941b2906],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_112	[p6l979t2817r1329b2906],
5	differences	NNS	O	difference	nsubjpass	7	SENT_112	[p6l1361t2817r1714b2883],
6	were	VBD	O	be	auxpass	7	SENT_112	[p6l1745t2843r1907b2884],
7	found	VBN	O	find	_	0	SENT_112	[p6l1941t2817r2141b2883],
8	between	IN	O	between	_	0	SENT_112	[p6l8t2924r292b2991],
9	treatments	NNS	O	treatment	prep_between	7	SENT_112	[p6l331t2941r690b2990],
10	(	CD	NUMBER	(	num	11	SENT_112	[p6l733t2922r887b3013],
11	Fig	NN	O	fig	dep	9	SENT_112	[p6l733t2922r887b3013],
12	.	.	O	.	_	0	SENT_112	[p6l733t2922r887b3013],

1	1B	NN	O	1b	_	0	SENT_113	[p6l935t2925r1047b3005],
2	;	:	O	;	_	0	SENT_113	[p6l935t2925r1047b3005],
3	p	NN	O	p	dep	19	SENT_113	[p6l1087t2951r1129b3014],
4	<	JJR	O	<	amod	3	SENT_113	[p6l1175t2935r1235b2986],
5	0.0001	CD	NUMBER	0.0001	num	17	SENT_113	[p6l1280t2922r1558b3005],
6	)	NN	O	)	nn	17	SENT_113	[p6l1280t2922r1558b3005],
7	,	,	O	,	_	0	SENT_113	[p6l1280t2922r1558b3005],
8	with	IN	O	with	_	0	SENT_113	[p6l1596t2924r1752b2991],
9	ASA	NN	O	asa	prep_with	6	SENT_113	[p6l1789t2923r1967b2991],
10	plus	CC	O	plus	prep	9	SENT_113	[p6l2003t2924r2139b3014],
11	clopidogrel	NN	O	clopidogrel	dep	10	SENT_113	[p6l11t3031r388b3121],
12	and	CC	O	and	_	0	SENT_113	[p6l422t3031r546b3097],
13	also	RB	O	also	advmod	14	SENT_113	[p6l580t3031r705b3097],
14	ASA	NN	O	asa	conj_and	6	SENT_113	[p6l737t3029r1097b3120],
15	—	CD	NUMBER	—	num	14	SENT_113	[p6l737t3029r1097b3120],
16	only	RB	O	only	advmod	14	SENT_113	[p6l737t3029r1097b3120],
17	treatments	NNS	O	treatment	dep	19	SENT_113	[p6l1127t3048r1506b3112],
18	,	,	O	,	_	0	SENT_113	[p6l1127t3048r1506b3112],
19	providing	VBG	O	provide	dep	1	SENT_113	[p6l1541t3031r1869b3121],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	21	SENT_113	[p6l1902t3031r2138b3120, p6l11t3138r214b3227],
21	greater	JJR	O	greater	amod	22	SENT_113	[p6l258t3155r492b3227],
22	inhibition	NN	O	inhibition	dobj	19	SENT_113	[p6l539t3138r875b3204],
23	when	WRB	O	when	advmod	24	SENT_113	[p6l921t3138r1110b3204],
24	compared	VBN	O	compare	advcl	19	SENT_113	[p6l1159t3138r1494b3227],
25	with	IN	O	with	_	0	SENT_113	[p6l1538t3138r1695b3204],
26	clopidogrel	NN	O	clopidogrel	prep_with	24	SENT_113	[p6l1744t3138r2136b3227],
27	.	.	O	.	_	0	SENT_113	[p6l1744t3138r2136b3227],

1	With	IN	O	with	_	0	SENT_114	[p6l7t3246r195b3313],
2	epinephrine	NN	O	epinephrine	prep_with	6	SENT_114	[p6l243t3246r664b3335],
3	,	,	O	,	_	0	SENT_114	[p6l243t3246r664b3335],
4	ASA	NN	ORGANIZATION	asa	nsubj	6	SENT_114	[p6l712t3244r890b3312],
5	significantly	RB	O	significantly	advmod	6	SENT_114	[p6l938t3246r1347b3335],
6	inhibited	VBD	O	inhibit	_	0	SENT_114	[p6l1390t3246r1698b3312],
7	aggregation	NN	O	aggregation	dobj	6	SENT_114	[p6l1746t3249r2141b3335],
8	when	WRB	O	when	advmod	9	SENT_114	[p6l7t3353r196b3419],
9	compared	VBN	O	compare	advcl	6	SENT_114	[p6l218t3353r553b3442],
10	with	IN	O	with	_	0	SENT_114	[p6l570t3353r726b3419],
11	clopidogrel	NN	O	clopidogrel	nn	13	SENT_114	[p6l748t3353r1142b3442],
12	(	CD	NUMBER	(	num	13	SENT_114	[p6l1167t3351r1328b3442],
13	Fig	NN	O	fig	prep_with	9	SENT_114	[p6l1167t3351r1328b3442],
14	.	.	O	.	_	0	SENT_114	[p6l1167t3351r1328b3442],

1	1C	NN	O	1c	_	0	SENT_115	[p6l1359t3353r1482b3434],
2	;	:	O	;	_	0	SENT_115	[p6l1359t3353r1482b3434],
3	p	NN	O	p	dep	4	SENT_115	[p6l1507t3379r1549b3442],
4	<	JJR	O	<	dep	1	SENT_115	[p6l1578t3363r1638b3414],
5	0.0001	CD	NUMBER	0.0001	num	6	SENT_115	[p6l1667t3351r1957b3434],
6	)	NN	O	)	dep	4	SENT_115	[p6l1667t3351r1957b3434],
7	,	,	O	,	_	0	SENT_115	[p6l1667t3351r1957b3434],
8	with	IN	O	with	_	0	SENT_115	[p6l1979t3353r2140b3419],
9	no	DT	O	no	det	11	SENT_115	[p6l12t3486r97b3526],
10	added	VBN	O	add	amod	11	SENT_115	[p6l124t3459r335b3526],
11	beneﬁt	NN	O	beneﬁt	prep_with	4	SENT_115	[p6l356t3459r601b3526],
12	of	IN	O	of	_	0	SENT_115	[p6l624t3459r704b3526],
13	clopidogrel	NN	O	clopidogrel	prep_of	11	SENT_115	[p6l716t3459r1111b3549],
14	in	IN	O	in	_	0	SENT_115	[p6l1133t3462r1202b3525],
15	combination	NN	O	combination	nn	16	SENT_115	[p6l1226t3459r1672b3526],
16	therapy	NN	O	therapy	prep_in	13	SENT_115	[p6l1695t3459r1963b3549],
17	with	IN	O	with	_	0	SENT_115	[p6l1979t3459r2141b3526],
18	ASA	NN	O	asa	prep_with	16	SENT_115	[p6l8t3565r206b3633],
19	.	.	O	.	_	0	SENT_115	[p6l8t3565r206b3633],

1	Similar	JJ	O	similar	nsubjpass	10	SENT_116	[p6l264t3566r517b3633],
2	to	TO	O	to	_	0	SENT_116	[p6l565t3583r633b3632],
3	aggregation	NN	O	aggregation	prep_to	1	SENT_116	[p6l686t3569r1118b3655],
4	,	,	O	,	_	0	SENT_116	[p6l686t3569r1118b3655],
5	ﬂuorescein	NN	O	ﬂuorescein	nn	7	SENT_116	[p6l1170t3566r1550b3632],
6	isothiocyanateﬁbrinogen	NN	O	isothiocyanateﬁbrinogen	nn	7	SENT_116	[p6l1599t3566r2138b3655, p6l10t3674r374b3763],
7	binding	NN	O	binding	appos	3	SENT_116	[p6l404t3674r680b3763],
8	was	VBD	O	be	auxpass	10	SENT_116	[p6l707t3700r836b3740],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_116	[p6l871t3674r1299b3763],
10	reduced	VBN	O	reduce	_	0	SENT_116	[p6l1326t3674r1604b3740],
11	by	IN	O	by	_	0	SENT_116	[p6l1633t3674r1719b3763],
12	clopidogrel	NN	O	clopidogrel	agent	10	SENT_116	[p6l1748t3674r2142b3764],
13	and	CC	O	and	_	0	SENT_116	[p7l12t16r139b82],
14	the	DT	O	the	det	15	SENT_116	[p7l180t16r290b82],
15	clopidogrel	NN	O	clopidogrel	conj_and	12	SENT_116	[p7l332t14r1125b106],
16	.	.	O	.	_	0	SENT_116	[p7l332t14r1125b106],

1	—	NN	O	—	_	0	SENT_117	[p7l332t14r1125b106],
2	.	.	O	.	_	0	SENT_117	[p7l332t14r1125b106],

1	plus	CC	O	plus	_	0	SENT_118	[p7l332t14r1125b106],
2	.	.	O	.	_	0	SENT_118	[p7l332t14r1125b106],

1	—	NN	O	—	_	0	SENT_119	[p7l332t14r1125b106],
2	.	.	O	.	_	0	SENT_119	[p7l332t14r1125b106],

1	ASA	NN	O	asa	nn	3	SENT_120	[p7l332t14r1125b106],
2	combination	NN	O	combination	nn	3	SENT_120	[p7l1165t16r1610b82],
3	therapy	NN	O	therapy	_	0	SENT_120	[p7l1651t16r1919b106],
4	compared	VBN	O	compare	_	0	SENT_120	[p7l1957t42r2138b82, p7l9t123r206b212],
5	with	IN	O	with	prepc_compared_with	3	SENT_120	[p7l237t123r399b189],
6	ASA	NN	O	asa	pobj	3	SENT_120	[p7l432t121r614b189],
7	only	RB	O	only	_	0	SENT_120	[p7l648t123r801b212],
8	with	IN	O	with	_	0	SENT_120	[p7l829t123r991b189],
9	ADP	NN	O	adp	nn	10	SENT_120	[p7l1024t121r1215b188],
10	stimulation	NN	O	stimulation	conj_only	3	SENT_120	[p7l1253t123r1652b189],
11	(	CD	NUMBER	(	num	12	SENT_120	[p7l1691t121r1852b212],
12	Fig	NN	O	fig	dep	10	SENT_120	[p7l1691t121r1852b212],
13	.	.	O	.	_	0	SENT_120	[p7l1691t121r1852b212],

1	2	CD	NUMBER	2	_	0	SENT_121	[p7l1891t126r1953b204],
2	;	:	O	;	_	0	SENT_121	[p7l1891t126r1953b204],
3	p	NN	O	p	dep	4	SENT_121	[p7l1991t149r2033b212],
4	<	JJR	O	<	dep	1	SENT_121	[p7l2075t133r2135b184],
5	0.01	CD	NUMBER	0.01	num	6	SENT_121	[p7l11t229r211b311],
6	)	NN	O	)	dep	4	SENT_121	[p7l11t229r211b311],
7	.	.	O	.	_	0	SENT_121	[p7l11t229r211b311],

1	However	RB	O	however	advmod	11	SENT_122	[p7l259t232r600b311],
2	,	,	O	,	_	0	SENT_122	[p7l259t232r600b311],
3	this	DT	O	this	det	5	SENT_122	[p7l645t231r772b296],
4	treatment	NN	O	treatment	nn	5	SENT_122	[p7l816t248r1163b296],
5	effect	NN	O	effect	nsubjpass	11	SENT_122	[p7l1206t231r1390b296],
6	in	IN	O	in	_	0	SENT_122	[p7l1432t234r1499b295],
7	ADP-stimulated	JJ	O	adp-stimulated	amod	8	SENT_122	[p7l1540t229r2141b296],
8	platelets	NNS	O	platelet	prep_in	5	SENT_122	[p7l9t337r298b427],
9	was	VBD	O	be	auxpass	11	SENT_122	[p7l329t364r458b404],
10	not	RB	O	not	neg	11	SENT_122	[p7l493t354r611b404],
11	observed	VBN	O	observe	_	0	SENT_122	[p7l642t337r950b404],
12	between	IN	O	between	_	0	SENT_122	[p7l980t338r1273b404],
13	treatment	NN	O	treatment	nn	14	SENT_122	[p7l1305t354r1652b404],
14	strategies	NNS	O	strategy	prep_between	11	SENT_122	[p7l1684t340r2008b427],
15	for	IN	O	for	_	0	SENT_122	[p7l2042t337r2142b404],
16	on-granule	JJ	O	on-granule	amod	17	SENT_122	[p7l13t445r361b534],
17	release	NN	O	release	prep_for	14	SENT_122	[p7l386t445r618b510],
18	as	IN	O	as	mark	19	SENT_122	[p7l645t471r708b510],
19	assessed	VBN	O	assess	advcl	11	SENT_122	[p7l735t444r1018b510],
20	by	IN	O	by	_	0	SENT_122	[p7l1039t445r1125b534],
21	CD62P	NN	O	cd62p	nn	22	SENT_122	[p7l1148t444r1424b511],
22	binding	NN	O	binding	prep_by	19	SENT_122	[p7l1446t444r1723b534],
23	(	CD	NUMBER	(	num	24	SENT_122	[p7l1749t442r1815b534],
24	p	NN	O	p	dep	22	SENT_122	[p7l1749t442r1815b534],
25	=	JJ	O	=	amod	27	SENT_122	[p7l1850t470r1903b490],
26	0.89	CD	NUMBER	0.89	number	25	SENT_122	[p7l1937t443r2136b524],
27	)	NN	O	)	dobj	19	SENT_122	[p7l1937t443r2136b524],
28	.	.	O	.	_	0	SENT_122	[p7l1937t443r2136b524],

1	We	PRP	O	we	nsubj	3	SENT_123	[p7l95t553r226b619],
2	then	RB	O	then	advmod	3	SENT_123	[p7l251t552r410b645],
3	investigated	VBD	O	investigate	_	0	SENT_123	[p7l435t552r857b641],
4	the	DT	O	the	det	5	SENT_123	[p7l881t552r991b618],
5	effect	NN	O	effect	dobj	3	SENT_123	[p7l1018t552r1203b618],
6	of	IN	O	of	_	0	SENT_123	[p7l1227t552r1307b618],
7	the	DT	O	the	det	9	SENT_123	[p7l1320t552r1429b618],
8	PIA	NNP	O	PIA	nn	9	SENT_123	[p7l1456t536r1580b617],
9	polymorphism	NN	O	polymorphism	prep_of	5	SENT_123	[p7l1602t552r2136b642],
10	.	.	O	.	_	0	SENT_123	[p7l1602t552r2136b642],

1	The	DT	O	the	det	4	SENT_124	[p7l8t697r154b765],
2	PIA	NNP	O	PIA	nn	4	SENT_124	[p7l182t684r306b764],
3	genotype	NN	O	genotype	nn	4	SENT_124	[p7l329t716r649b789],
4	effect	NN	O	effect	nsubj	23	SENT_124	[p7l677t699r862b765],
5	on	IN	O	on	_	0	SENT_124	[p7l887t725r974b765],
6	platelet	NN	O	platelet	nn	7	SENT_124	[p7l999t699r1260b789],
7	inhibition	NN	O	inhibition	prep_on	4	SENT_124	[p7l1284t699r1635b765],
8	was	VBD	O	be	cop	10	SENT_124	[p7l1658t725r1787b765],
9	markedly	RB	O	markedly	advmod	10	SENT_124	[p7l1815t699r2144b788],
10	stronger	JJR	O	stronger	_	0	SENT_124	[p7l12t859r290b931],
11	when	WRB	O	when	advmod	14	SENT_124	[p7l308t842r497b908],
12	collagen	NN	O	collagen	nsubjpass	14	SENT_124	[p7l522t842r798b931],
13	was	VBD	O	be	auxpass	14	SENT_124	[p7l818t868r944b908],
14	used	VBN	O	use	ccomp	10	SENT_124	[p7l968t842r1122b908],
15	as	IN	O	as	_	0	SENT_124	[p7l1146t868r1207b908],
16	the	DT	O	the	det	17	SENT_124	[p7l1232t842r1339b908],
17	agonist	NN	O	agonist	prep_as	14	SENT_124	[p7l1365t845r1608b931],
18	compared	VBN	O	compare	_	0	SENT_124	[p7l1631t842r1965b931],
19	with	IN	O	with	prepc_compared_with	14	SENT_124	[p7l1985t842r2141b908],
20	epinephrine	NN	O	epinephrine	pobj	14	SENT_124	[p7l11t949r414b1038],
21	and	CC	O	and	_	0	SENT_124	[p7l456t949r580b1015],
22	less	JJR	O	less	dep	23	SENT_124	[p7l618t949r733b1015],
23	strong	JJ	O	strong	conj_and	10	SENT_124	[p7l776t966r989b1038],
24	with	IN	O	with	_	0	SENT_124	[p7l1023t949r1179b1015],
25	ADP	NN	O	adp	prep_with	10	SENT_124	[p7l1216t947r1420b1015],
26	.	.	O	.	_	0	SENT_124	[p7l1216t947r1420b1015],

1	An	DT	O	a	det	2	SENT_125	[p7l1462t947r1573b1014],
2	interaction	NN	O	interaction	nsubjpass	4	SENT_125	[p7l1612t952r1977b1015],
3	was	VBD	O	be	auxpass	4	SENT_125	[p7l2013t975r2139b1015],
4	noted	VBN	O	note	_	0	SENT_125	[p7l12t1057r205b1123],
5	between	IN	O	between	_	0	SENT_125	[p7l243t1057r526b1123],
6	ADP	NN	ORGANIZATION	adp	nn	7	SENT_125	[p7l564t1055r752b1122],
7	concentration	NN	O	concentration	prep_between	4	SENT_125	[p7l794t1060r1258b1123],
8	and	CC	O	and	_	0	SENT_125	[p7l1301t1057r1425b1123],
9	genotype	NN	O	genotype	nn	11	SENT_125	[p7l1463t1074r1771b1146],
10	(	CD	NUMBER	(	num	11	SENT_125	[p7l1816t1055r1970b1146],
11	Fig	NN	O	fig	prep_between	4	SENT_125	[p7l1816t1055r1970b1146],
12	.	.	O	.	_	0	SENT_125	[p7l1816t1055r1970b1146],

1	3A	NN	O	3a	_	0	SENT_126	[p7l2015t1055r2137b1138],
2	;	:	O	;	_	0	SENT_126	[p7l2015t1055r2137b1138],
3	p	NN	O	p	dep	1	SENT_126	[p7l9t1190r51b1253],
4	<	JJR	O	<	amod	3	SENT_126	[p7l86t1174r145b1225],
5	0.005	CD	NUMBER	0.005	num	6	SENT_126	[p7l179t1161r392b1244],
6	)	NN	O	)	nsubj	19	SENT_126	[p7l179t1161r392b1244],
7	in	IN	O	in	_	0	SENT_126	[p7l424t1166r489b1229],
8	terms	NNS	O	term	prep_in	6	SENT_126	[p7l517t1181r711b1230],
9	of	IN	O	of	_	0	SENT_126	[p7l744t1163r823b1230],
10	aggregation	NN	O	aggregation	prep_of	8	SENT_126	[p7l842t1167r1273b1253],
11	,	,	O	,	_	0	SENT_126	[p7l842t1167r1273b1253],
12	but	CC	O	but	_	0	SENT_126	[p7l1304t1164r1422b1230],
13	this	DT	O	this	det	15	SENT_126	[p7l1450t1164r1576b1230],
14	genotype	NN	O	genotype	nn	15	SENT_126	[p7l1606t1181r1926b1253],
15	effect	NN	O	effect	conj_but	10	SENT_126	[p7l1957t1163r2142b1230],
16	was	VBD	O	be	cop	19	SENT_126	[p7l7t1297r136b1337],
17	not	RB	O	not	neg	19	SENT_126	[p7l185t1288r302b1337],
18	statistically	RB	O	statistically	advmod	19	SENT_126	[p7l348t1270r739b1360],
19	signiﬁcant	JJ	O	signiﬁcant	ccomp	4	SENT_126	[p7l783t1270r1148b1360],
20	in	IN	O	in	_	0	SENT_126	[p7l1193t1273r1260b1336],
21	GP	NN	O	gp	nn	23	SENT_126	[p7l1308t1270r1430b1337],
22	IIb/IIIa	NN	O	iib/iiia	nn	23	SENT_126	[p7l1475t1270r1752b1337],
23	activation	NN	O	activation	prep_in	4	SENT_126	[p7l1799t1273r2140b1337],
24	(	CD	NUMBER	(	num	25	SENT_126	[p7l13t1375r81b1467],
25	p	NN	O	p	dep	23	SENT_126	[p7l13t1375r81b1467],
26	=	JJ	O	=	amod	36	SENT_126	[p7l145t1403r198b1423],
27	0.21	CD	NUMBER	0.21	number	28	SENT_126	[p7l263t1375r440b1457],
28	)	CD	NUMBER	)	amod	36	SENT_126	[p7l263t1375r440b1457],
29	or	CC	O	or	dep	30	SENT_126	[p7l500t1403r571b1443],
30	in	IN	O	in	dep	28	SENT_126	[p7l624t1380r692b1442],
31	a	DT	O	a	det	32	SENT_126	[p7l750t1377r1097b1466],
32	—	NN	O	—	pobj	30	SENT_126	[p7l750t1377r1097b1466],
33	granule	NN	O	granule	nn	36	SENT_126	[p7l750t1377r1097b1466],
34	release	NN	O	release	nn	36	SENT_126	[p7l1152t1377r1385b1443],
35	(	CD	NUMBER	(	num	36	SENT_126	[p7l1443t1375r1510b1467],
36	p	NN	O	p	dep	25	SENT_126	[p7l1443t1375r1510b1467],
37	=	JJ	O	=	amod	36	SENT_126	[p7l1575t1403r1628b1423],
38	0.31	CD	NUMBER	0.31	num	39	SENT_126	[p7l1692t1375r1892b1457],
39	)	NN	O	)	dep	37	SENT_126	[p7l1692t1375r1892b1457],
40	.	.	O	.	_	0	SENT_126	[p7l1692t1375r1892b1457],

1	With	IN	O	with	_	0	SENT_127	[p7l1947t1377r2140b1444],
2	collagen	NN	O	collagen	prep_with	9	SENT_127	[p7l11t1485r319b1573],
3	,	,	O	,	_	0	SENT_127	[p7l11t1485r319b1573],
4	PIA1/A1	NN	O	pia1/a1	nn	5	SENT_127	[p7l352t1469r610b1550],
5	platelets	NNS	O	platelet	nsubj	9	SENT_127	[p7l642t1485r931b1574],
6	were	VBD	O	be	cop	9	SENT_127	[p7l958t1510r1125b1551],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_127	[p7l1157t1485r1585b1573],
8	more	RBR	O	more	advmod	9	SENT_127	[p7l1611t1510r1791b1550],
9	inhibited	VBN	O	inhibit	_	0	SENT_127	[p7l1820t1485r2141b1550],
10	by	IN	O	by	_	0	SENT_127	[p7l8t1592r95b1681],
11	ASA	NN	O	asa	prep_by	9	SENT_127	[p7l116t1590r297b1658],
12	than	IN	O	than	_	0	SENT_127	[p7l323t1592r481b1658],
13	PlA1/A2	NN	O	pla1/a2	nn	14	SENT_127	[p7l509t1576r770b1657],
14	platelets	NNS	O	platelet	prep_than	9	SENT_127	[p7l797t1592r1087b1681],
15	in	IN	O	in	_	0	SENT_127	[p7l1116t1595r1184b1657],
16	terms	NNS	O	term	prep_in	9	SENT_127	[p7l1211t1609r1406b1658],
17	of	IN	O	of	_	0	SENT_127	[p7l1436t1592r1515b1658],
18	aggregation	NN	O	aggregation	nn	20	SENT_127	[p7l1532t1595r1944b1681],
19	(	CD	NUMBER	(	num	20	SENT_127	[p7l1975t1590r2136b1681],
20	Fig	NN	O	fig	prep_of	16	SENT_127	[p7l1975t1590r2136b1681],
21	.	.	O	.	_	0	SENT_127	[p7l1975t1590r2136b1681],

1	Cooke	NNP	PERSON	Cooke	_	0	SENT_128	[p7l1437t1683r1633b1742],
2	et	FW	O	et	nn	3	SENT_128	[p7l1665t1686r1730b1742],
3	al.	FW	O	al.	dep	1	SENT_128	[p7l1753t1684r1829b1742],
4	543	CD	NUMBER	543	dep	1	SENT_128	[p7l2023t1683r2150b1742],

1	PI	NN	O	pi	_	0	SENT_129	[p7l179t1756r274b1824],
2	“	NN	O	“	dep	1	SENT_129	[p7l179t1756r274b1824],
3	and	CC	O	and	_	0	SENT_129	[p7l301t1766r416b1825],
4	Responsiveness	NN	O	responsiveness	dep	1	SENT_129	[p7l450t1766r951b1836],
5	to	TO	O	to	_	0	SENT_129	[p7l976t1769r1041b1825],
6	Aspirin	NNP	O	Aspirin	prep_to	2	SENT_129	[p7l1068t1766r1290b1836],
7	and	CC	O	and	_	0	SENT_129	[p7l1321t1766r1435b1825],
8	Clopidogrel	NNP	O	Clopidogrel	prep_to	2	SENT_129	[p7l1466t1765r1827b1836],

1	2	LS	NUMBER	2	_	0	SENT_130	[p7l496t2075r559b2231],
2	.	.	O	.	_	0	SENT_130	[p7l496t2075r559b2231],

1	300	CD	NUMBER	300	num	2	SENT_131	[p7l614t2132r675b2161],
2	:1	NN	O	:1	dep	13	SENT_131	[p7l515t2255r558b2299],
3	250	CD	NUMBER	250	number	4	SENT_131	[p7l614t2265r675b2294],
4	230	CD	NUMBER	230	num	8	SENT_131	[p7l515t2302r579b2384],
5	Q	NNP	O	Q	nn	8	SENT_131	[p7l515t2388r560b2430],
6	200	CD	NUMBER	200	num	8	SENT_131	[p7l615t2394r675b2424],
7	_	NN	O	_	nn	8	SENT_131	[p7l496t2434r559b2496],
8	C	NN	O	c	dep	2	SENT_131	[p7l496t2434r559b2496],
9	E	NN	O	e	dep	8	SENT_131	[p7l496t2479r560b2602],
10	150	CD	NUMBER	150	num	11	SENT_131	[p7l618t2526r675b2556],
11	ES	NN	O	e	dep	13	SENT_131	[p7l497t2603r560b2745],
12	100	CD	NUMBER	100	num	13	SENT_131	[p7l619t2655r676b2684],
13	E	NN	O	e	_	0	SENT_131	[p7l498t2748r560b2884],
14	50	CD	NUMBER	50	num	15	SENT_131	[p7l637t2787r678b2817],
15	o	NN	O	o	dep	13	SENT_131	[p7l661t2916r681b2945],

1	11M	CD	NUMBER	11m	num	2	SENT_132	[p7l1008t3098r1141b3178],
2	ADP	NN	O	adp	_	0	SENT_132	[p7l1181t3098r1365b3160],

1	.	.	O	.	_	0	SENT_133	[p7l737t3274r919b3298],

1	—	NN	O	—	_	0	SENT_134	[p7l737t3274r919b3298],
2	.	.	O	.	_	0	SENT_134	[p7l737t3274r919b3298],

1	~	NN	O	~	_	0	SENT_135	[p7l737t3274r919b3298],
2	AsA	NN	O	asa	dep	1	SENT_135	[p7l1017t3259r1182b3317],
3	.	.	O	.	_	0	SENT_135	[p7l737t3333r919b3356],

1	—	NN	O	—	_	0	SENT_136	[p7l737t3333r919b3356],
2	.	.	O	.	_	0	SENT_136	[p7l737t3333r919b3356],

1	-	:	O	-	_	0	SENT_137	[p7l737t3333r919b3356],
2	*	NN	O	*	_	0	SENT_137	[p7l737t3333r919b3356],
3	.	.	O	.	_	0	SENT_137	[p7l737t3333r919b3356],

1	—	NN	O	—	_	0	SENT_138	[p7l737t3333r919b3356],
2	.	.	O	.	_	0	SENT_138	[p7l737t3333r919b3356],

1	-	:	O	-	_	0	SENT_139	[p7l737t3333r919b3356],
2	Clopidogrel	NN	O	clopidogrel	_	0	SENT_139	[p7l1019t3319r1413b3394],
3	.	.	O	.	_	0	SENT_139	[p7l737t3421r919b3445],

1	—	NN	O	—	_	0	SENT_140	[p7l737t3421r919b3445],
2	.	.	O	.	_	0	SENT_140	[p7l737t3421r919b3445],

1	-	:	O	-	_	0	SENT_141	[p7l737t3421r919b3445],
2	ASA	NN	O	asa	_	0	SENT_141	[p7l1017t3407r1182b3464],
3	+	CC	O	+	_	0	SENT_141	[p7l1206t3422r1249b3463],
4	Clopidogrel	NN	O	clopidogrel	conj_+	2	SENT_141	[p7l1273t3406r1669b3481],

1	Figure	NN	O	figure	_	0	SENT_142	[p8l10t54r187b116],
2	2	CD	NUMBER	2	dep	1	SENT_142	[p8l226t53r279b106],
3	.	.	O	.	_	0	SENT_142	[p8l226t53r279b106],

1	Fluorescein	NN	O	fluorescein	nn	2	SENT_143	[p8l320t53r647b106],
2	isothiocyanate	NN	O	isothiocyanate	_	0	SENT_143	[p8l686t53r1092b125],
3	(	CD	NUMBER	(	num	5	SENT_143	[p8l1135t52r1674b125],
4	FITC	NN	O	fitc	nn	5	SENT_143	[p8l1135t52r1674b125],
5	)	NN	O	)	dep	2	SENT_143	[p8l1135t52r1674b125],
6	.	.	O	.	_	0	SENT_143	[p8l1135t52r1674b125],

1	—	NN	O	—	_	0	SENT_144	[p8l1135t52r1674b125],
2	.	.	O	.	_	0	SENT_144	[p8l1135t52r1674b125],

1	ﬁbrinogen	NN	O	ﬁbrinogen	nn	2	SENT_145	[p8l1135t52r1674b125],
2	binding	NN	O	binding	_	0	SENT_145	[p8l1712t53r1934b125],
3	(	CD	NUMBER	(	num	6	SENT_145	[p8l1975t52r2150b118],
4	mean	NN	O	mean	nn	6	SENT_145	[p8l1975t52r2150b118],
5	ﬂuorescence	NN	O	ﬂuorescence	nn	6	SENT_145	[p8l9t132r355b185],
6	units	NNS	O	unit	dep	2	SENT_145	[p8l383t135r521b185],
7	i	FW	O	i	dep	6	SENT_145	[p8l558t140r601b183],
8	SEM	NN	O	sem	nn	9	SENT_145	[p8l640t130r813b197],
9	)	NN	O	)	dep	2	SENT_145	[p8l640t130r813b197],
10	with	IN	O	with	_	0	SENT_145	[p8l842t132r972b185],
11	adenosine	NN	O	adenosine	nn	12	SENT_145	[p8l1002t132r1282b185],
12	diphosphate	NN	O	diphosphate	prep_with	9	SENT_145	[p8l1312t132r1660b204],
13	(	CD	NUMBER	(	num	15	SENT_145	[p8l1692t130r1885b197],
14	ADP	NN	O	adp	nn	15	SENT_145	[p8l1692t130r1885b197],
15	)	NN	O	)	dep	2	SENT_145	[p8l1692t130r1885b197],
16	in	IN	O	in	_	0	SENT_145	[p8l1917t135r1972b185],
17	study	NN	O	study	nn	18	SENT_145	[p8l2002t132r2153b204],
18	subjects	NNS	O	subject	prep_in	15	SENT_145	[p8l10t212r228b284],
19	by	IN	O	by	_	0	SENT_145	[p8l276t212r345b284],
20	treatment	NN	O	treatment	nn	21	SENT_145	[p8l389t226r668b265],
21	strategy	NN	O	strategy	prep_by	18	SENT_145	[p8l715t226r948b284],
22	.	.	O	.	_	0	SENT_145	[p8l715t226r948b284],

1	Signiﬁcant	JJ	O	signiﬁcant	amod	2	SENT_146	[p8l1003t212r1308b284],
2	differences	NNS	O	difference	nsubjpass	9	SENT_146	[p8l1355t212r1653b265],
3	under	IN	O	under	_	0	SENT_146	[p8l1701t212r1867b265],
4	different	JJ	O	different	amod	5	SENT_146	[p8l1914t212r2152b265],
5	conditions	NNS	O	condition	prep_under	2	SENT_146	[p8l10t291r305b344],
6	of	IN	O	of	_	0	SENT_146	[p8l334t291r398b344],
7	blockade	NN	O	blockade	prep_of	5	SENT_146	[p8l413t291r664b344],
8	were	VBD	O	be	auxpass	9	SENT_146	[p8l689t312r823b344],
9	noted	VBN	O	note	_	0	SENT_146	[p8l851t291r1012b344],
10	(	RB	O	(	advmod	11	SENT_146	[p8l1040t290r1094b363],
11	p	NN	O	p	nsubj	14	SENT_146	[p8l1040t290r1094b363],
12	<	JJR	O	<	amod	11	SENT_146	[p8l1126t300r1174b340],
13	0.01	CD	NUMBER	0.01	num	14	SENT_146	[p8l1205t289r1366b356],
14	)	NN	O	)	xcomp	9	SENT_146	[p8l1205t289r1366b356],
15	.	.	O	.	_	0	SENT_146	[p8l1205t289r1366b356],

1	Multiple	JJ	O	multiple	amod	2	SENT_147	[p8l1395t291r1645b363],
2	comparisons	NNS	O	comparison	nsubj	3	SENT_147	[p8l1673t294r2026b363],
3	(	VBP	O	(	_	0	SENT_147	[p8l2056t290r2152b356],
4	six	CD	NUMBER	six	nsubj	16	SENT_147	[p8l2056t290r2152b356],
5	included	VBN	O	include	partmod	4	SENT_147	[p8l9t370r253b423],
6	in	IN	O	in	_	0	SENT_147	[p8l279t372r333b423],
7	adjustment	NN	O	adjustment	prep_in	5	SENT_147	[p8l361t370r677b442],
8	per	IN	O	per	_	0	SENT_147	[p8l701t391r792b442],
9	plot	NN	O	plot	nn	10	SENT_147	[p8l816t369r949b442],
10	)	NN	O	)	prep_per	7	SENT_147	[p8l816t369r949b442],
11	at	IN	O	at	_	0	SENT_147	[p8l980t384r1030b423],
12	each	DT	O	each	det	13	SENT_147	[p8l1056t370r1182b423],
13	agonist	NN	O	agonist	poss	15	SENT_147	[p8l1210t370r1449b442],
14	’s	POS	O	’s	_	0	SENT_147	[p8l1210t370r1449b442],
15	concentrations	NNS	O	concentration	prep_at	5	SENT_147	[p8l1478t372r1893b423],
16	revealed	VBD	O	reveal	ccomp	3	SENT_147	[p8l1920t370r2151b423],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_147	[p8l10t449r304b521],
18	dilferences	NNS	O	dilference	nsubj	19	SENT_147	[p8l323t449r621b502],
19	(	VBP	O	(	ccomp	16	SENT_147	[p8l645t448r699b521],
20	p	NN	O	p	nsubj	28	SENT_147	[p8l645t448r699b521],
21	<	JJR	O	<	dep	28	SENT_147	[p8l724t458r772b499],
22	0.05	CD	NUMBER	0.05	num	23	SENT_147	[p8l797t448r940b514],
23	)	NN	O	)	npadvmod	27	SENT_147	[p8l797t448r940b514],
24	between	IN	O	between	_	0	SENT_147	[p8l962t449r1198b502],
25	treatment	NN	O	treatment	nn	26	SENT_147	[p8l1217t463r1496b502],
26	strategies	NNS	O	strategy	prep_between	23	SENT_147	[p8l1516t452r1777b521],
27	as	IN	O	as	advmod	28	SENT_147	[p8l1799t470r1850b502],
28	indicated	VBN	O	indicate	xcomp	19	SENT_147	[p8l1871t449r2147b502],
29	.	.	O	.	_	0	SENT_147	[p8l1871t449r2147b502],

1	*	NN	O	*	nsubj	2	SENT_148	[p8l8t527r248b600],
2	Applies	VBZ	O	apply	_	0	SENT_148	[p8l8t527r248b600],
3	for	IN	O	for	_	0	SENT_148	[p8l275t528r356b581],
4	differences	NNS	O	difference	prep_for	2	SENT_148	[p8l380t528r677b581],
5	between	IN	O	between	_	0	SENT_148	[p8l702t528r938b581],
6	treatment	NN	O	treatment	prep_between	4	SENT_148	[p8l963t542r1242b581],
7	with	IN	O	with	_	0	SENT_148	[p8l1262t528r1392b581],
8	acetylsalicylic	JJ	O	acetylsalicylic	amod	12	SENT_148	[p8l1418t528r1798b600],
9	acid	NN	O	acid	nn	12	SENT_148	[p8l1824t528r1936b581],
10	(	NN	O	(	nn	12	SENT_148	[p8l1963t527r2148b593],
11	ASA	NN	O	asa	nn	12	SENT_148	[p8l1963t527r2148b593],
12	)	NN	O	)	prep_with	2	SENT_148	[p8l1963t527r2148b593],
13	and	CC	O	and	_	0	SENT_148	[p8l10t608r112b661],
14	with	IN	O	with	_	0	SENT_148	[p8l129t608r259b661],
15	clopidogrel	NN	O	clopidogrel	conj_and	12	SENT_148	[p8l279t608r610b680],
16	.	.	O	.	_	0	SENT_148	[p8l279t608r610b680],

1	1IApplies	NNS	O	1iapply	_	0	SENT_149	[p8l634t607r885b680],
2	for	IN	O	for	_	0	SENT_149	[p8l906t608r988b661],
3	dilferences	NNS	O	dilference	nn	4	SENT_149	[p8l1007t608r1305b661],
4	treatment	NN	O	treatment	prep_for	1	SENT_149	[p8l1326t622r1605b661],
5	with	IN	O	with	_	0	SENT_149	[p8l1620t608r1750b661],
6	acetylsalicylic	JJ	O	acetylsalicylic	amod	10	SENT_149	[p8l1771t608r2151b680],
7	acid	NN	O	acid	nn	10	SENT_149	[p8l10t687r123b740],
8	(	NN	O	(	nn	10	SENT_149	[p8l152t685r336b752],
9	ASA	NN	O	asa	nn	10	SENT_149	[p8l152t685r336b752],
10	)	NN	O	)	prep_with	1	SENT_149	[p8l152t685r336b752],
11	and	CC	O	and	_	0	SENT_149	[p8l367t687r469b740],
12	with	IN	O	with	_	0	SENT_149	[p8l492t687r622b740],
13	ASA	NN	O	asa	conj_and	10	SENT_149	[p8l646t686r792b740],
14	plus	CC	O	plus	prep	13	SENT_149	[p8l816t687r930b759],
15	clopidogrel	NN	O	clopidogrel	dep	14	SENT_149	[p8l958t687r1275b759],
16	in	IN	O	in	_	0	SENT_149	[p8l1301t689r1355b740],
17	combination	NN	O	combination	prep_in	1	SENT_149	[p8l1382t687r1755b740],
18	.	.	O	.	_	0	SENT_149	[p8l1382t687r1755b740],

1	3B	NN	O	3b	_	0	SENT_150	[p8l10t898r129b978],
2	;	:	O	;	_	0	SENT_150	[p8l10t898r129b978],
3	p	NN	O	p	dep	1	SENT_150	[p8l173t924r215b987],
4	=	JJ	O	=	amod	6	SENT_150	[p8l266t923r320b943],
5	0.005	CD	NUMBER	0.005	tmod	4	SENT_150	[p8l370t895r594b978],
6	)	NN	O	)	dep	3	SENT_150	[p8l370t895r594b978],
7	and	CC	O	and	_	0	SENT_150	[p8l640t897r768b963],
8	GP	NN	O	gp	nn	10	SENT_150	[p8l811t897r933b964],
9	Ilb/Illa	NN	O	ilb/illa	nn	10	SENT_150	[p8l974t897r1253b963],
10	activation	NN	O	activation	conj_and	3	SENT_150	[p8l1294t900r1638b964],
11	(	CD	NUMBER	(	num	12	SENT_150	[p8l1682t895r1844b986],
12	Fig	NN	O	fig	dep	10	SENT_150	[p8l1682t895r1844b986],
13	.	.	O	.	_	0	SENT_150	[p8l1682t895r1844b986],

1	4	CD	NUMBER	4	_	0	SENT_151	[p8l1889t901r1951b978],
2	;	:	O	;	_	0	SENT_151	[p8l1889t901r1951b978],
3	p	NN	O	p	dep	4	SENT_151	[p8l1994t924r2036b987],
4	<	JJR	O	<	dep	1	SENT_151	[p8l2084t908r2144b959],
5	0.0001	CD	NUMBER	0.0001	num	6	SENT_151	[p8l10t1001r278b1083],
6	)	NN	O	)	npadvmod	7	SENT_151	[p8l10t1001r278b1083],
7	as	IN	O	as	advmod	8	SENT_151	[p8l324t1030r387b1069],
8	assessed	VBN	O	assess	partmod	4	SENT_151	[p8l431t1003r715b1069],
9	by	IN	O	by	_	0	SENT_151	[p8l753t1003r840b1092],
10	ﬁbrinogen	NN	O	ﬁbrinogen	nn	11	SENT_151	[p8l876t1003r1242b1092],
11	binding	NN	O	binding	agent	8	SENT_151	[p8l1281t1003r1575b1092],
12	.	.	O	.	_	0	SENT_151	[p8l1281t1003r1575b1092],

1	The	DT	O	the	det	2	SENT_152	[p8l1618t1002r1765b1069],
2	difference	NN	O	difference	nsubj	9	SENT_152	[p8l1808t1003r2150b1069],
3	between	IN	O	between	_	0	SENT_152	[p8l8t1110r304b1177],
4	PIA1/A1	NN	O	pia1/a1	nn	7	SENT_152	[p8l367t1094r628b1176],
5	and	CC	O	and	_	0	SENT_152	[p8l695t1110r824b1177],
6	PlA1/A2	NN	O	pla1/a2	nn	7	SENT_152	[p8l886t1094r1149b1176],
7	platelets	NNS	O	platelet	prep_between	2	SENT_152	[p8l1212t1110r1504b1200],
8	was	VBD	O	be	cop	9	SENT_152	[p8l1564t1137r1694b1177],
9	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_152	[p8l1760t1110r2147b1200],
10	,	,	O	,	_	0	SENT_152	[p8l1760t1110r2147b1200],
11	whether	IN	O	whether	complm	12	SENT_152	[p8l6t1216r301b1283],
12	with	IN	O	with	dep	9	SENT_152	[p8l323t1216r485b1283],
13	ASA	NN	O	asa	pobj	12	SENT_152	[p8l510t1215r692b1283],
14	alone	RB	O	alone	advmod	13	SENT_152	[p8l720t1216r905b1282],
15	or	CC	O	or	_	0	SENT_152	[p8l934t1242r1006b1282],
16	combination	NN	O	combination	nn	17	SENT_152	[p8l1033t1216r1481b1282],
17	therapy	NN	O	therapy	pobj	12	SENT_152	[p8l1509t1216r1777b1306],
18	(	CD	NUMBER	(	num	19	SENT_152	[p8l1804t1214r1966b1305],
19	Fig	NN	O	fig	dep	17	SENT_152	[p8l1804t1214r1966b1305],
20	.	.	O	.	_	0	SENT_152	[p8l1804t1214r1966b1305],

1	3B	NN	O	3b	_	0	SENT_153	[p8l1998t1214r2146b1297],
2	)	NN	O	)	dep	1	SENT_153	[p8l1998t1214r2146b1297],
3	.	.	O	.	_	0	SENT_153	[p8l1998t1214r2146b1297],

1	No	DT	O	no	det	4	SENT_154	[p8l9t1323r120b1388],
2	statistically	RB	O	statistically	advmod	3	SENT_154	[p8l167t1322r560b1411],
3	signiﬁcant	JJ	O	signiﬁcant	amod	4	SENT_154	[p8l602t1322r969b1411],
4	interaction	NN	O	interaction	nsubjpass	6	SENT_154	[p8l1011t1325r1395b1388],
5	was	VBD	O	be	auxpass	6	SENT_154	[p8l1436t1348r1566b1389],
6	noted	VBN	O	note	_	0	SENT_154	[p8l1613t1322r1814b1389],
7	between	IN	O	between	_	0	SENT_154	[p8l1855t1322r2150b1389],
8	epinephrine	NN	O	epinephrine	nn	9	SENT_154	[p8l10t1429r433b1519],
9	concentration	NN	O	concentration	prep_between	6	SENT_154	[p8l464t1432r952b1495],
10	and	CC	O	and	_	0	SENT_154	[p8l983t1429r1111b1495],
11	genotype	NN	O	genotype	prep_between	6	SENT_154	[p8l1139t1446r1461b1519],
12	with	IN	O	with	_	0	SENT_154	[p8l1488t1429r1650b1496],
13	the	DT	O	the	det	16	SENT_154	[p8l1679t1429r1790b1495],
14	dosage	NN	O	dosage	nn	16	SENT_154	[p8l1822t1427r2147b1518],
15	(	NN	O	(	nn	16	SENT_154	[p8l1822t1427r2147b1518],
16	s	NNS	O	s	prep_with	6	SENT_154	[p8l1822t1427r2147b1518],
17	)	CD	NUMBER	)	nsubjpass	24	SENT_154	[p8l1822t1427r2147b1518],
18	of	IN	O	of	_	0	SENT_154	[p8l10t1535r91b1601],
19	antiplatelet	JJ	O	antiplatelet	amod	21	SENT_154	[p8l113t1535r511b1625],
20	drug	NN	O	drug	nn	21	SENT_154	[p8l543t1533r791b1624],
21	(	NN	O	(	prep_of	17	SENT_154	[p8l543t1533r791b1624],
22	s	VBZ	O	s	auxpass	24	SENT_154	[p8l543t1533r791b1624],
23	)	RB	O	)	advmod	24	SENT_154	[p8l543t1533r791b1624],
24	used	VBN	O	use	rcmod	16	SENT_154	[p8l827t1535r1004b1601],
25	.	.	O	.	_	0	SENT_154	[p8l827t1535r1004b1601],

1	Finally	RB	O	finally	advmod	8	SENT_155	[p8l99t1642r350b1731],
2	,	,	O	,	_	0	SENT_155	[p8l99t1642r350b1731],
3	alpha-granule	JJ	O	alpha-granule	amod	4	SENT_155	[p8l389t1642r857b1732],
4	release	NN	O	release	nsubj	8	SENT_155	[p8l891t1642r1114b1708],
5	in	IN	O	in	_	0	SENT_155	[p8l1149t1645r1215b1707],
6	collagen	NN	O	collagen	nn	7	SENT_155	[p8l1249t1642r1920b1731],
7	—	NN	O	—	prep_in	4	SENT_155	[p8l1249t1642r1920b1731],
8	stimulated	VBD	O	stimulate	_	0	SENT_155	[p8l1249t1642r1920b1731],
9	platelets	NNS	O	platelet	nsubj	11	SENT_155	[p8l1952t1642r2148b1732, p8l8t1749r120b1815],
10	was	VBD	O	be	cop	11	SENT_155	[p8l152t1775r278b1816],
11	dependent	JJ	O	dependent	ccomp	8	SENT_155	[p8l314t1749r674b1839],
12	on	IN	O	on	_	0	SENT_155	[p8l707t1775r793b1815],
13	PIA	NNP	ORGANIZATION	PIA	nn	14	SENT_155	[p8l826t1733r947b1814],
14	genotype	NN	O	genotype	prep_on	11	SENT_155	[p8l978t1767r1307b1839],
15	,	,	O	,	_	0	SENT_155	[p8l978t1767r1307b1839],
16	treatment	NN	O	treatment	nn	17	SENT_155	[p8l1343t1766r1677b1816],
17	strategy	NN	O	strategy	prep_on	11	SENT_155	[p8l1710t1766r1989b1839],
18	,	,	O	,	_	0	SENT_155	[p8l1710t1766r1989b1839],
19	and	CC	O	and	_	0	SENT_155	[p8l2026t1749r2151b1816],
20	agonist	NN	O	agonist	nn	21	SENT_155	[p8l11t1859r255b1945],
21	concentration	NN	O	concentration	prep_on	11	SENT_155	[p8l289t1859r756b1922],
22	(	CD	NUMBER	(	num	23	SENT_155	[p8l794t1854r949b1945],
23	Fig	NN	O	fig	dep	21	SENT_155	[p8l794t1854r949b1945],
24	.	.	O	.	_	0	SENT_155	[p8l794t1854r949b1945],

1	5	CD	NUMBER	5	_	0	SENT_156	[p8l988t1856r1047b1937],
2	;	:	O	;	_	0	SENT_156	[p8l988t1856r1047b1937],
3	p	NN	O	p	dep	1	SENT_156	[p8l1084t1883r1126b1946],
4	=	JJ	O	=	amod	6	SENT_156	[p8l1173t1882r1226b1902],
5	0.005	CD	NUMBER	0.005	tmod	4	SENT_156	[p8l1273t1854r1517b1937],
6	)	NN	O	)	dep	3	SENT_156	[p8l1273t1854r1517b1937],
7	.	.	O	.	_	0	SENT_156	[p8l1273t1854r1517b1937],

1	PIA1/A2	NN	O	pia1/a2	nn	2	SENT_157	[p8l1559t1840r1822b1922],
2	platelets	NNS	O	platelet	nsubj	3	SENT_157	[p8l1858t1856r2149b1946],
3	had	VBD	O	have	_	0	SENT_157	[p8l9t1963r140b2029],
4	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_157	[p8l197t1963r627b2052],
5	higher	JJR	O	higher	amod	7	SENT_157	[p8l680t1963r910b2052],
6	alpha-granule	NN	O	alpha-granule	nn	7	SENT_157	[p8l966t1963r1455b2053],
7	release	NN	O	release	dobj	3	SENT_157	[p8l1512t1963r1745b2029],
8	regardless	RB	O	regardless	_	0	SENT_157	[p8l1802t1963r2149b2052],
9	of	IN	O	of	_	0	SENT_157	[p8l10t2069r91b2135],
10	treatment	NN	O	treatment	nn	11	SENT_157	[p8l115t2086r463b2135],
11	strategy	NN	O	strategy	prep_regardless_of	7	SENT_157	[p8l499t2086r776b2158],
12	at	IN	O	at	_	0	SENT_157	[p8l811t2086r874b2135],
13	higher	JJR	O	higher	amod	14	SENT_157	[p8l909t2069r1139b2158],
14	concentrations	NNS	O	concentration	prep_at	3	SENT_157	[p8l1175t2072r1693b2135],
15	of	IN	O	of	_	0	SENT_157	[p8l1733t2069r1812b2135],
16	collagen	NN	O	collagen	prep_of	14	SENT_157	[p8l1838t2069r2147b2158],
17	,	,	O	,	_	0	SENT_157	[p8l1838t2069r2147b2158],
18	whereas	IN	O	whereas	mark	30	SENT_157	[p8l6t2176r301b2243],
19	in	IN	O	in	_	0	SENT_157	[p8l341t2179r410b2242],
20	PIA1/A1	NN	O	pia1/a1	nn	21	SENT_157	[p8l450t2160r718b2242],
21	platelets	NNS	O	platelet	prep_in	30	SENT_157	[p8l758t2176r1086b2266],
22	,	,	O	,	_	0	SENT_157	[p8l758t2176r1086b2266],
23	the	DT	O	the	det	24	SENT_157	[p8l1127t2176r1242b2243],
24	addition	NN	O	addition	nsubj	30	SENT_157	[p8l1282t2176r1589b2243],
25	of	IN	O	of	_	0	SENT_157	[p8l1628t2176r1710b2243],
26	clopidogrel	NN	O	clopidogrel	prep_of	24	SENT_157	[p8l1737t2176r2151b2266],
27	to	TO	O	to	_	0	SENT_157	[p8l9t2299r79b2348],
28	ASA	NN	O	asa	nn	29	SENT_157	[p8l135t2281r321b2349],
29	therapy	NN	O	therapy	prep_to	26	SENT_157	[p8l376t2282r656b2372],
30	yielded	VBD	O	yield	advcl	3	SENT_157	[p8l705t2282r971b2371],
31	further	JJ	O	further	amod	32	SENT_157	[p8l1027t2282r1285b2348],
32	decreases	NNS	O	decrease	dobj	30	SENT_157	[p8l1341t2282r1678b2348],
33	in	IN	O	in	_	0	SENT_157	[p8l1737t2285r1807b2348],
34	CD621	NN	O	cd621	nn	36	SENT_157	[p8l1866t2282r2150b2349],
35	’	NN	O	’	nn	36	SENT_157	[p8l1866t2282r2150b2349],
36	expression	NN	O	expression	prep_in	30	SENT_157	[p8l10t2391r413b2478],
37	.	.	O	.	_	0	SENT_157	[p8l10t2391r413b2478],

1	DISCUSSION	NN	O	discussion	_	0	SENT_158	[p8l12t2639r493b2713],

1	In	IN	O	in	_	0	SENT_159	[p8l9t2808r87b2872],
2	this	DT	O	this	det	3	SENT_159	[p8l116t2807r243b2873],
3	report	NN	O	report	prep_in	6	SENT_159	[p8l274t2824r509b2896],
4	,	,	O	,	_	0	SENT_159	[p8l274t2824r509b2896],
5	we	PRP	O	we	nsubj	6	SENT_159	[p8l537t2833r636b2873],
6	demonstrate	VBP	O	demonstrate	_	0	SENT_159	[p8l667t2807r1106b2873],
7	that	IN	O	that	complm	12	SENT_159	[p8l1136t2807r1278b2873],
8	the	DT	O	the	det	10	SENT_159	[p8l1305t2807r1416b2873],
9	PIAZ	NN	ORGANIZATION	piaz	nn	10	SENT_159	[p8l1447t2791r1602b2872],
10	polymorphism	NN	O	polymorphism	nsubj	12	SENT_159	[p8l1632t2807r2150b2896],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_159	[p8l11t2913r442b3002],
12	modiﬁes	VBZ	O	modiﬁes	ccomp	6	SENT_159	[p8l492t2913r792b2979],
13	the	DT	O	the	det	14	SENT_159	[p8l846t2913r957b2979],
14	inhibition	NN	O	inhibition	nsubj	26	SENT_159	[p8l1011t2913r1364b2979],
15	of	IN	O	of	_	0	SENT_159	[p8l1418t2913r1498b2979],
16	platelet	NN	O	platelet	nn	17	SENT_159	[p8l1538t2913r1801b3002],
17	function	NN	O	function	prep_of	14	SENT_159	[p8l1852t2913r2150b2979],
18	brought	VBD	O	bring	ccomp	12	SENT_159	[p8l7t3019r293b3108],
19	about	RB	O	about	advmod	18	SENT_159	[p8l319t3019r517b3085],
20	by	IN	O	by	_	0	SENT_159	[p8l539t3019r626b3108],
21	ASA	NN	ORGANIZATION	asa	prep_by	18	SENT_159	[p8l645t3017r828b3085],
22	and	CC	O	and	_	0	SENT_159	[p8l854t3019r982b3085],
23	clopidogrel	NN	O	clopidogrel	prep_by	18	SENT_159	[p8l1008t3019r1404b3108],
24	and	CC	O	and	_	0	SENT_159	[p8l1430t3019r1559b3085],
25	is	VBZ	O	be	cop	26	SENT_159	[p8l1584t3022r1634b3085],
26	dependent	JJ	O	dependent	conj_and	18	SENT_159	[p8l1663t3019r2037b3108],
27	on	IN	O	on	_	0	SENT_159	[p8l2062t3045r2150b3085],
28	the	DT	O	the	det	29	SENT_159	[p8l9t3126r120b3192],
29	agonist	NN	O	agonist	prep_on	26	SENT_159	[p8l170t3129r424b3215],
30	used	VBN	O	use	partmod	29	SENT_159	[p8l469t3126r646b3192],
31	.	.	O	.	_	0	SENT_159	[p8l469t3126r646b3192],

1	When	WRB	O	when	advmod	3	SENT_160	[p8l694t3126r922b3193],
2	collagen	NN	O	collagen	nsubj	3	SENT_160	[p8l970t3126r1260b3215],
3	stimulates	VBZ	O	stimulate	advcl	7	SENT_160	[p8l1308t3126r1662b3192],
4	aggregation	NN	O	aggregation	dobj	3	SENT_160	[p8l1713t3129r2147b3215],
5	,	,	O	,	_	0	SENT_160	[p8l1713t3129r2147b3215],
6	clopidogrel	NN	O	clopidogrel	nsubj	7	SENT_160	[p8l10t3232r407b3321],
7	behaves	VBZ	O	behave	_	0	SENT_160	[p8l448t3232r722b3298],
8	as	IN	O	as	_	0	SENT_160	[p8l770t3258r833b3298],
9	a	DT	O	a	det	11	SENT_160	[p8l880t3258r915b3298],
10	weak	JJ	O	weak	amod	11	SENT_160	[p8l954t3232r1140b3298],
11	inhibitor	NN	O	inhibitor	prep_as	7	SENT_160	[p8l1180t3232r1494b3298],
12	relative	JJ	O	relative	advmod	11	SENT_160	[p8l1536t3232r1791b3298],
13	to	TO	O	to	_	0	SENT_160	[p8l1835t3249r1903b3298],
14	ASA	NN	O	asa	prep_to	12	SENT_160	[p8l1947t3230r2146b3298],
15	.	.	O	.	_	0	SENT_160	[p8l1947t3230r2146b3298],

1	However	RB	O	however	advmod	17	SENT_161	[p8l10t3339r353b3419],
2	,	,	O	,	_	0	SENT_161	[p8l10t3339r353b3419],
3	when	WRB	O	when	advmod	4	SENT_161	[p8l380t3338r575b3405],
4	added	VBN	O	add	advcl	17	SENT_161	[p8l604t3338r816b3404],
5	to	TO	O	to	_	0	SENT_161	[p8l843t3355r911b3404],
6	ASA	NN	O	asa	prep_to	4	SENT_161	[p8l938t3336r1138b3419],
7	,	,	O	,	_	0	SENT_161	[p8l938t3336r1138b3419],
8	the	DT	O	the	det	9	SENT_161	[p8l1169t3338r1279b3404],
9	combination	NN	O	combination	nsubj	17	SENT_161	[p8l1308t3338r1756b3404],
10	of	IN	O	of	_	0	SENT_161	[p8l1785t3338r1865b3404],
11	the	DT	O	the	det	13	SENT_161	[p8l1880t3338r1991b3404],
12	two	CD	NUMBER	two	num	13	SENT_161	[p8l2019t3355r2149b3405],
13	drugs	NNS	O	drug	prep_of	9	SENT_161	[p9l10t21r202b110],
14	is	VBZ	O	be	cop	17	SENT_161	[p9l257t24r308b87],
15	marginally	RB	O	marginally	advmod	17	SENT_161	[p9l364t21r742b110],
16	more	RBR	O	more	advmod	17	SENT_161	[p9l793t47r973b87],
17	eﬂicient	JJ	O	eﬂicient	_	0	SENT_161	[p9l1028t21r1307b87],
18	than	IN	O	than	_	0	SENT_161	[p9l1359t21r1518b87],
19	ASA	NN	O	asa	prep_than	17	SENT_161	[p9l1569t19r1752b87],
20	alone	RB	O	alone	advmod	19	SENT_161	[p9l1805t21r2011b102],
21	,	,	O	,	_	0	SENT_161	[p9l1805t21r2011b102],
22	an	DT	O	a	det	24	SENT_161	[p9l2069t47r2150b87],
23	incremental	JJ	O	incremental	amod	24	SENT_161	[p9l9t127r431b193],
24	effect	NN	O	effect	appos	19	SENT_161	[p9l464t127r650b193],
25	that	WDT	O	that	nsubjpass	28	SENT_161	[p9l682t127r824b193],
26	is	VBZ	O	be	auxpass	28	SENT_161	[p9l855t130r906b193],
27	not	RB	O	not	neg	28	SENT_161	[p9l942t144r1060b193],
28	observed	VBN	O	observe	rcmod	24	SENT_161	[p9l1092t127r1402b193],
29	with	IN	O	with	_	0	SENT_161	[p9l1431t127r1593b193],
30	epinephrine	NN	O	epinephrine	prep_with	28	SENT_161	[p9l1627t127r2049b216],
31	as	IN	O	as	_	0	SENT_161	[p9l2085t153r2148b193],
32	the	DT	O	the	det	33	SENT_161	[p9l9t233r120b299],
33	agonist	NN	O	agonist	prep_as	17	SENT_161	[p9l150t236r421b322],
34	.	.	O	.	_	0	SENT_161	[p9l150t236r421b322],

1	These	DT	O	these	det	2	SENT_162	[p9l450t231r667b299],
2	interactions	NNS	O	interaction	nsubj	9	SENT_162	[p9l695t236r1110b299],
3	between	IN	O	between	_	0	SENT_162	[p9l1137t233r1432b299],
4	agonists	NNS	O	agonist	prep_between	2	SENT_162	[p9l1461t236r1744b322],
5	and	CC	O	and	_	0	SENT_162	[p9l1774t233r1902b299],
6	inhibitors	NNS	O	inhibitor	conj_and	4	SENT_162	[p9l1929t233r2148b299, p9l9t342r164b405],
7	are	VBP	O	be	cop	9	SENT_162	[p9l215t364r316b405],
8	highly	RB	O	highly	advmod	9	SENT_162	[p9l365t339r591b428],
9	instructive	JJ	O	instructive	_	0	SENT_162	[p9l636t342r1004b405],
10	and	CC	O	and	_	0	SENT_162	[p9l1055t339r1202b420],
11	,	,	O	,	_	0	SENT_162	[p9l1055t339r1202b420],
12	in	IN	O	in	dep	9	SENT_162	[p9l1254t342r1321b404],
13	the	DT	O	the	det	14	SENT_162	[p9l1370t339r1481b405],
14	case	NN	O	case	pobj	12	SENT_162	[p9l1531t365r1670b405],
15	of	IN	O	of	_	0	SENT_162	[p9l1721t339r1800b405],
16	collagen	NN	O	collagen	prep_of	14	SENT_162	[p9l1838t339r2147b428],
17	,	,	O	,	_	0	SENT_162	[p9l1838t339r2147b428],
18	associated	VBN	O	associate	conj_and	9	SENT_162	[p9l11t445r365b511],
19	with	IN	O	with	_	0	SENT_162	[p9l422t445r584b511],
20	strong	JJ	O	strong	amod	22	SENT_162	[p9l647t462r870b534],
21	concurrent	JJ	O	concurrent	amod	22	SENT_162	[p9l931t462r1314b511],
22	interaction	NN	O	interaction	prep_with	18	SENT_162	[p9l1373t448r1758b511],
23	with	IN	O	with	_	0	SENT_162	[p9l1815t445r1977b511],
24	the	DT	O	the	det	29	SENT_162	[p9l2038t445r2149b511],
25	platelet	NN	O	platelet	nn	29	SENT_162	[p9l8t552r271b641],
26	SNP	NN	O	snp	nn	29	SENT_162	[p9l306t552r473b618],
27	(	CD	NUMBER	(	num	29	SENT_162	[p9l509t550r889b633],
28	T1565C	NN	O	t1565c	nn	29	SENT_162	[p9l509t550r889b633],
29	)	NN	O	)	prep_with	18	SENT_162	[p9l509t550r889b633],
30	,	,	O	,	_	0	SENT_162	[p9l509t550r889b633],
31	PIA	NNP	O	PIA	appos	29	SENT_162	[p9l926t536r1067b618],
32	.	.	O	.	_	0	SENT_162	[p9l926t536r1067b618],

1	We	PRP	O	we	nsubj	2	SENT_163	[p9l95t659r226b725],
2	demonstrate	VBP	O	demonstrate	_	0	SENT_163	[p9l262t658r701b724],
3	that	IN	O	that	complm	14	SENT_163	[p9l736t658r877b724],
4	with	IN	O	with	_	0	SENT_163	[p9l906t658r1068b724],
5	collagen	NN	O	collagen	nn	6	SENT_163	[p9l1103t658r1392b747],
6	stimulation	NN	O	stimulation	prep_with	14	SENT_163	[p9l1428t658r1850b739],
7	,	,	O	,	_	0	SENT_163	[p9l1428t658r1850b739],
8	PIA1/A2	NN	O	pia1/a2	nn	9	SENT_163	[p9l1887t642r2149b723],
9	platelets	NNS	O	platelet	nsubjpass	14	SENT_163	[p9l8t764r299b853],
10	are	VBP	O	be	auxpass	14	SENT_163	[p9l341t790r442b830],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_163	[p9l484t764r915b853],
12	less	RBR	O	less	advmod	13	SENT_163	[p9l949t764r1070b830],
13	well	RB	O	well	advmod	14	SENT_163	[p9l1108t764r1254b830],
14	inhibited	VBN	O	inhibit	ccomp	2	SENT_163	[p9l1292t764r1615b830],
15	by	IN	O	by	_	0	SENT_163	[p9l1651t764r1738b853],
16	ASA	NN	O	asa	agent	14	SENT_163	[p9l1771t762r1954b830],
17	than	IN	O	than	prep	14	SENT_163	[p9l1991t764r2150b830],

1	544	CD	NUMBER	544	num	2	SENT_164	[p9l6t979r105b1025],
2	Cooke	NNP	PERSON	Cooke	_	0	SENT_164	[p9l257t979r410b1025],
3	et	FW	O	et	nn	4	SENT_164	[p9l430t981r481b1025],
4	al.	FW	O	al.	dep	2	SENT_164	[p9l495t979r554b1025],
5	.	.	O	.	_	0	SENT_164	[p9l495t979r554b1025],

1	PI	NN	O	pi	_	0	SENT_165	[p9l259t1040r333b1094],
2	“	NN	O	“	dep	1	SENT_165	[p9l259t1040r333b1094],
3	and	CC	O	and	_	0	SENT_165	[p9l349t1048r439b1094],
4	Responsiveness	NN	O	responsiveness	dep	1	SENT_165	[p9l461t1048r853b1103],
5	to	TO	O	to	_	0	SENT_165	[p9l868t1050r919b1095],
6	Aspirin	NNP	O	Aspirin	prep_to	2	SENT_165	[p9l935t1048r1109b1103],
7	and	CC	O	and	_	0	SENT_165	[p9l1128t1048r1218b1095],
8	Clopidogrel	NNP	O	Clopidogrel	prep_to	2	SENT_165	[p9l1237t1047r1520b1103],

1	A	DT	O	a	det	3	SENT_166	[p9l536t1131r586b1179],
2	Aspirin	NNP	O	Aspirin	nn	3	SENT_166	[p9l936t1130r1143b1194],
3	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_166	[p9l1653t1129r1985b1194],

1	ﬁ	NN	O	ﬁ	nn	2	SENT_167	[p9l552t1433r586b1466],
2	pj7	NN	O	pj7	_	0	SENT_167	[p9l537t1468r586b1520],
3	*	CD	NUMBER	*	number	4	SENT_167	[p9l537t1468r586b1520],
4	75	CD	NUMBER	75	dep	2	SENT_167	[p9l631t1487r660b1508],
5	—	NN	O	—	dep	4	SENT_167	[p9l1032t1497r1053b1503],
6	75	CD	NUMBER	75	num	7	SENT_167	[p9l1431t1486r1461b1508],
7	T	NN	O	t	dep	2	SENT_167	[p9l2127t1474r2148b1495],
8	‘	CD	NUMBER	‘	num	10	SENT_167	[p9l545t1520r586b1568],
9	E	NN	O	e	nn	10	SENT_167	[p9l545t1520r586b1568],
10	’	NN	O	’	dep	7	SENT_167	[p9l545t1520r586b1568],
11	.	.	O	.	_	0	SENT_167	[p9l1032t1537r1053b1548],

1	.	.	O	.	_	0	SENT_168	[p9l1032t1537r1053b1548],

1	OD	NN	O	od	nn	2	SENT_169	[p9l553t1572r602b1604],
2	*	NN	O	*	_	0	SENT_169	[p9l859t1576r879b1597],
3	1	CD	NUMBER	1	num	4	SENT_169	[p9l2128t1572r2148b1600],
4	<	JJR	O	<	dep	12	SENT_169	[p9l553t1607r587b1634],
5	1	CD	NUMBER	1	num	7	SENT_169	[p9l553t1607r587b1634],
6	)	NN	O	)	nn	7	SENT_169	[p9l553t1607r587b1634],
7	lab	NN	O	lab	dep	4	SENT_169	[p9l554t1635r602b1692],
8	50	CD	NUMBER	50	num	9	SENT_169	[p9l632t1660r663b1682],
9	T	NN	O	t	dep	12	SENT_169	[p9l858t1654r878b1670],
10	50	CD	NUMBER	50	number	11	SENT_169	[p9l1432t1659r1463b1682],
11	013	CD	NUMBER	013	num	12	SENT_169	[p9l554t1696r602b1727],
12	=	JJ	O	=	dep	2	SENT_169	[p9l1659t1710r1679b1732],
13	1	CD	NUMBER	1	dep	12	SENT_169	[p9l1659t1710r1679b1732],
14	:	:	O	:	_	0	SENT_169	[p9l1659t1710r1679b1732],
15	<	JJR	O	<	amod	16	SENT_169	[p9l540t1731r587b1777],
16	ﬁ	NN	O	ﬁ	dep	2	SENT_169	[p9l540t1731r587b1777],
17	=	JJ	O	=	amod	18	SENT_169	[p9l802t1742r821b1763],
18	x	NN	O	x	dep	19	SENT_169	[p9l802t1742r821b1763],
19	<	JJR	O	<	dep	16	SENT_169	[p9l802t1742r821b1763],
20	50	CD	NUMBER	50	number	21	SENT_169	[p9l539t1799r589b1849],
21	25	CD	NUMBER	25	dep	16	SENT_169	[p9l633t1833r662b1855],
22	25	CD	NUMBER	25	num	23	SENT_169	[p9l1433t1832r1462b1854],
23	*	NN	O	*	dep	21	SENT_169	[p9l1602t1824r1622b1846],

1	o	NN	O	o	nn	3	SENT_170	[p9l651t2006r666b2029],
2	o	NN	O	o	nn	3	SENT_170	[p9l1451t2005r1466b2028],
3	o	NN	O	o	_	0	SENT_170	[p9l744t2045r759b2067],
4	1	CD	NUMBER	1	number	5	SENT_170	[p9l807t2046r816b2067],
5	2	CD	NUMBER	2	dep	3	SENT_170	[p9l864t2045r878b2067],
6	5	CD	NUMBER	5	number	7	SENT_170	[p9l1038t2045r1052b2067],
7	10	CD	NUMBER	10	num	8	SENT_170	[p9l1323t2045r1351b2067],
8	o	NN	O	o	dep	3	SENT_170	[p9l1544t2044r1560b2067],
9	1	CD	NUMBER	1	number	10	SENT_170	[p9l1608t2044r1617b2066],
10	2	CD	NUMBER	2	num	12	SENT_170	[p9l1665t2044r1679b2066],
11	5	CD	NUMBER	5	number	12	SENT_170	[p9l1840t2043r1854b2066],
12	10	CD	NUMBER	10	dep	8	SENT_170	[p9l2125t2041r2153b2065],

1	MM	NN	O	mm	nn	4	SENT_171	[p9l917t2121r1014b2182],
2	ADP	NN	O	adp	nn	4	SENT_171	[p9l1034t2120r1174b2168],
3	uM	NN	O	um	nn	4	SENT_171	[p9l1697t2119r1795b2181],
4	ADP	NN	O	adp	_	0	SENT_171	[p9l1816t2118r1955b2167],

1	__	NN	O	__	_	0	SENT_172	[p9l1541t2217r1668b2235],
2	¢	NN	O	¢	dep	1	SENT_172	[p9l1541t2217r1668b2235],
3	.	.	O	.	_	0	SENT_172	[p9l1541t2217r1668b2235],

1	_	NN	O	_	nn	2	SENT_173	[p9l1541t2217r1668b2235],
2	Dh7	NN	O	dh7	_	0	SENT_173	[p9l1693t2204r1744b2248],
3	*	CD	NUMBER	*	num	5	SENT_173	[p9l1693t2204r1744b2248],
4	Al/A1	NN	O	al/a1	nn	5	SENT_173	[p9l1762t2201r1871b2230],
5	__	NN	O	__	dep	2	SENT_173	[p9l1541t2278r1668b2297],
6	.	.	O	.	_	0	SENT_173	[p9l1541t2278r1668b2297],

1	_	NN	O	_	_	0	SENT_174	[p9l1541t2278r1668b2297],
2	.	.	O	.	_	0	SENT_174	[p9l1541t2278r1668b2297],

1	.	.	O	.	_	0	SENT_175	[p9l1541t2278r1668b2297],

1	Al/A2	NN	O	al/a2	_	0	SENT_176	[p9l1762t2263r1875b2292],

1	B	NN	O	b	_	0	SENT_177	[p9l537t2438r577b2486],
2	Aspirin	NN	O	aspirin	nn	3	SENT_177	[p9l935t2437r1144b2501],
3	Clopidogrel	NN	O	clopidogrel	dep	1	SENT_177	[p9l1674t2436r2006b2501],

1	\	NN	O	\	_	0	SENT_178	[p9l631t2789r645b2811],
2	l	NN	O	l	dep	1	SENT_178	[p9l631t2789r645b2811],
3	U1	NN	O	u1	dep	1	SENT_178	[p9l647t2789r660b2811],

1	%	NN	O	%	nsubj	2	SENT_179	[p9l538t3101r588b3151],
2	Aggregation	NN	O	aggregation	_	0	SENT_179	[p9l537t2735r602b3078],
3	l	NN	O	l	nsubj	8	SENT_179	[p9l1034t3084r1055b3122],
4	-	:	O	-	_	0	SENT_179	[p9l1034t3084r1055b3122],
5	—	SYM	O	—	dep	7	SENT_179	[p9l1034t3011r1055b3051],
6	-	:	O	-	_	0	SENT_179	[p9l1034t3011r1055b3051],
7	I	PRP	O	I	dep	3	SENT_179	[p9l1034t3011r1055b3051],
8	I	PRP	O	I	xcomp	2	SENT_179	[p9l1033t2936r1055b2980],
9	-	:	O	-	_	0	SENT_179	[p9l1033t2936r1055b2980],
10	-	:	O	-	_	0	SENT_179	[p9l1033t2855r1054b2902],
11	.	.	O	.	_	0	SENT_179	[p9l1033t2855r1054b2902],

1	—	NN	O	—	_	0	SENT_180	[p9l1033t2855r1054b2902],
2	.	.	O	.	_	0	SENT_180	[p9l1033t2855r1054b2902],

1	|	NN	O	|	nn	2	SENT_181	[p9l1033t2855r1054b2902],
2	*	NN	O	*	_	0	SENT_181	[p9l1034t2791r1054b2812],
3	l	NN	O	l	dep	2	SENT_181	[p9l1327t2995r1347b3043],
4	—	CD	NUMBER	—	num	5	SENT_181	[p9l1326t2913r1347b2962],
5	l	NN	O	l	rcmod	3	SENT_181	[p9l1326t2913r1347b2962],
6	l	NN	O	l	dep	5	SENT_181	[p9l1326t2850r1347b2884],
7	--	:	O	--	_	0	SENT_181	[p9l1326t2850r1347b2884],
8	--	:	O	--	_	0	SENT_181	[p9l1326t2782r1347b2816],
9	i	FW	O	i	dep	3	SENT_181	[p9l1326t2782r1347b2816],
10	#	#	MONEY	#	number	11	SENT_181	[p9l1327t2717r1347b2739],
11	9	CD	MONEY	9	amod	9	SENT_181	[p9l1327t2717r1347b2739],

1	ug/mL	NN	O	ug/ml	_	0	SENT_182	[p9l815t3427r1003b3490],
2	Collagen	NNP	O	Collagen	nn	3	SENT_182	[p9l1023t3426r1274b3490],
3	ug/ml	NN	O	ug/ml	dep	1	SENT_182	[p9l1616t3426r1805b3490],
4	.	.	O	.	_	0	SENT_182	[p9l1616t3426r1805b3490],

1	Collagen	NNP	O	Collagen	_	0	SENT_183	[p9l1825t3425r2076b3489],

1	:	:	O	:	_	0	SENT_184	[p9l1540t3523r1668b3542],
2	¢	CD	NUMBER	¢	num	3	SENT_184	[p9l1540t3523r1668b3542],
3	_	CD	NUMBER	_	_	0	SENT_184	[p9l1540t3523r1668b3542],
4	]	NN	O	]	nn	7	SENT_184	[p9l1693t3510r1743b3554],
5	7	CD	NUMBER	7	num	7	SENT_184	[p9l1693t3510r1743b3554],
6	*	NN	O	*	nn	7	SENT_184	[p9l1693t3510r1743b3554],
7	Al/Al	NN	O	al/al	dep	3	SENT_184	[p9l1761t3508r1871b3537],
8	:	:	O	:	_	0	SENT_184	[p9l1540t3598r1668b3616],
9	o	NN	O	o	dep	7	SENT_184	[p9l1540t3598r1668b3616],
10	.	.	O	.	_	0	SENT_184	[p9l1540t3598r1668b3616],

1	—	NN	O	—	_	0	SENT_185	[p9l1540t3598r1668b3616],
2	.	.	O	.	_	0	SENT_185	[p9l1540t3598r1668b3616],

1	-	:	O	-	_	0	SENT_186	[p9l1540t3598r1668b3616],
2	.	.	O	.	_	0	SENT_186	[p9l1540t3598r1668b3616],

1	—	NN	O	—	_	0	SENT_187	[p9l1540t3598r1668b3616],
2	.	.	O	.	_	0	SENT_187	[p9l1540t3598r1668b3616],

1	-	:	O	-	_	0	SENT_188	[p9l1540t3598r1668b3616],
2	`	``	O	`	_	0	SENT_188	[p9l1693t3585r1743b3629],
3	m	NN	O	m	_	0	SENT_188	[p9l1693t3585r1743b3629],
4	]	NN	O	]	nn	7	SENT_188	[p9l1693t3585r1743b3629],
5	7	CD	NUMBER	7	num	7	SENT_188	[p9l1693t3585r1743b3629],
6	*	NN	O	*	nn	7	SENT_188	[p9l1693t3585r1743b3629],
7	Al/A2	NN	O	al/a2	dep	3	SENT_188	[p9l1761t3583r1874b3612],

1	JACC	NNP	O	JACC	nn	2	SENT_189	[p10l1182t116r1359b191],
2	Vol	NNP	O	Vol	_	0	SENT_189	[p10l1391t116r1518b191],
3	.	.	O	.	_	0	SENT_189	[p10l1391t116r1518b191],

1	47	CD	NUMBER	47	_	0	SENT_190	[p10l1556t116r1671b204],
2	,	,	O	,	_	0	SENT_190	[p10l1556t116r1671b204],
3	No.	NN	O	no.	amod	1	SENT_190	[p10l1712t116r1821b191],
4	3	CD	NUMBER	3	number	3	SENT_190	[p10l1859t116r1923b204],
5	,	,	O	,	_	0	SENT_190	[p10l1859t116r1923b204],
6	2006	CD	DATE	2006	appos	1	SENT_190	[p10l1963t116r2153b191],
7	February	NNP	DATE	February	tmod	6	SENT_190	[p10l1255t235r1555b328],
8	7	CD	DATE	7	num	7	SENT_190	[p10l1587t235r1650b323],
9	,	,	O	,	_	0	SENT_190	[p10l1587t235r1650b323],
10	2006:541	CD	NUMBER	2006:541	num	7	SENT_190	[p10l1688t234r2154b311],
11	—	CD	NUMBER	—	num	12	SENT_190	[p10l1688t234r2154b311],
12	6	CD	NUMBER	6	dep	1	SENT_190	[p10l1688t234r2154b311],

1	Aspirin	NN	O	aspirin	_	0	SENT_191	[p10l204t389r557b497],
2	+	CC	O	+	_	0	SENT_191	[p10l591t409r654b469],
3	Clopidogrel	NNP	O	Clopidogrel	nn	4	SENT_191	[p10l688t385r1249b494],
4	uM	NNP	O	uM	conj_+	1	SENT_191	[p10l523t2062r690b2166],
5	ADP	NN	O	adp	dep	1	SENT_191	[p10l726t2060r961b2141],

1	Aspirin	NN	O	aspirin	_	0	SENT_192	[p10l203t2383r557b2490],
2	+	CC	O	+	cc	3	SENT_192	[p10l592t2403r654b2463],
3	Clopidogrel	NN	O	clopidogrel	dep	1	SENT_192	[p10l688t2379r1250b2487],

1	=	JJ	O	=	_	0	SENT_193	[p11l1223t426r1257b461],
2	i	FW	O	i	dep	1	SENT_193	[p11l1223t426r1257b461],
3	<	JJR	O	<	dep	1	SENT_193	[p11l1223t426r1257b461],

1	T	NN	O	t	_	0	SENT_194	[p11l1221t532r1257b560],
2	*	NN	O	*	dep	1	SENT_194	[p11l727t578r760b614],
3	.	.	O	.	_	0	SENT_194	[p11l1223t616r1257b645],

1	L.	NNP	O	L.	_	0	SENT_195	[p11l1223t616r1257b645],

1	50	CD	NUMBER	50	num	2	SENT_196	[p11l41t688r94b725],
2	T	NN	O	t	_	0	SENT_196	[p11l725t687r760b725],
3	T	NN	O	t	dep	2	SENT_196	[p11l1223t731r1259b788],

1	.	.	O	.	_	0	SENT_197	[p11l725t783r761b823],

1	L	NN	O	l	_	0	SENT_198	[p11l725t783r761b823],

1	,1	NN	O	,1	_	0	SENT_199	[p11l430t878r464b914],
2	.	.	O	.	_	0	SENT_199	[p11l430t878r464b914],

1	l	NN	O	l	_	0	SENT_200	[p11l1226t844r1260b903],

1	25	CD	NUMBER	25	number	2	SENT_201	[p11l43t980r94b1017],
2	*	CD	NUMBER	*	num	3	SENT_201	[p11l427t986r464b1002],
3	T	NN	O	t	_	0	SENT_201	[p11l727t932r761b983],
4	-	:	O	-	_	0	SENT_201	[p11l428t1061r464b1077],
5	1	CD	DATE	1	dep	3	SENT_201	[p11l728t1041r763b1099],

1	o	NN	O	o	nn	2	SENT_202	[p11l233t1338r260b1374],
2	l	NN	O	l	_	0	SENT_202	[p11l340t1338r356b1374],
3	2	CD	NUMBER	2	number	4	SENT_202	[p11l437t1337r461b1374],
4	5	CD	NUMBER	5	dep	2	SENT_202	[p11l733t1337r756b1373],
5	10	CD	NUMBER	10	dep	4	SENT_202	[p11l1217t1334r1263b1370],

1	ug/mL	NN	O	ug/ml	_	0	SENT_203	[p11l350t1473r672b1579],
2	Collagen	NNP	O	Collagen	dep	1	SENT_203	[p11l705t1470r1130b1593],

1	Figure	NNP	O	Figure	_	0	SENT_204	[p11l43t1673r125b1702],
2	3	CD	NUMBER	3	dep	1	SENT_204	[p11l134t1673r159b1698],
3	.	.	O	.	_	0	SENT_204	[p11l134t1673r159b1698],

1	Aggregation	NN	O	aggregation	nsubj	3	SENT_205	[p11l177t1672r344b1706],
2	(	FW	O	(	dep	1	SENT_205	[p11l354t1672r436b1703],
3	mean	VB	O	mean	_	0	SENT_205	[p11l354t1672r436b1703],
4	percent	NN	O	percent	dobj	3	SENT_205	[p11l445t1679r544b1706],
5	:	:	O	:	_	0	SENT_205	[p11l556t1676r576b1696],
6	SEM	NN	O	sem	nn	7	SENT_205	[p11l590t1672r671b1703],
7	)	NN	O	)	dep	14	SENT_205	[p11l590t1672r671b1703],
8	with	IN	O	with	_	0	SENT_205	[p11l680t1673r741b1698],
9	adenosine	NN	O	adenosine	nn	10	SENT_205	[p11l751t1673r882b1698],
10	diphosphate	NN	O	diphosphate	prep_with	7	SENT_205	[p11l892t1673r1054b1706],
11	(	CD	NUMBER	(	num	12	SENT_205	[p11l1065t1672r1155b1703],
12	ADP	NN	O	adp	dep	14	SENT_205	[p11l1065t1672r1155b1703],
13	)	CD	NUMBER	)	num	14	SENT_205	[p11l1065t1672r1155b1703],
14	(	CD	NUMBER	(	dep	21	SENT_205	[p11l1166t1672r1210b1703],
15	A	DT	O	a	det	16	SENT_205	[p11l1166t1672r1210b1703],
16	)	NN	O	)	dep	14	SENT_205	[p11l1166t1672r1210b1703],
17	or	CC	O	or	_	0	SENT_205	[p11l1220t1682r1248b1698],
18	collagen	NN	O	collagen	nn	20	SENT_205	[p11l1257t1673r1365b1706],
19	(	NN	O	(	nn	20	SENT_205	[p11l1375t1672r1417b1703],
20	B	NN	O	b	dep	14	SENT_205	[p11l1375t1672r1417b1703],
21	)	CD	NUMBER	)	dep	3	SENT_205	[p11l1375t1672r1417b1703],
22	dichotornized	VBN	O	dichotornize	partmod	21	SENT_205	[p11l1428t1673r1610b1698],
23	according	VBG	O	accord	_	0	SENT_205	[p11l1620t1673r1748b1706],
24	to	TO	O	to	prepc_according_to	22	SENT_205	[p11l1757t1679r1783b1698],
25	the	DT	O	the	det	27	SENT_205	[p11l1792t1673r1834b1698],
26	PIA	NNP	O	PIA	nn	27	SENT_205	[p11l1844t1668r1890b1697],
27	genotype	NN	O	genotype	pobj	22	SENT_205	[p11l1899t1679r2026b1706],
28	.	.	O	.	_	0	SENT_205	[p11l1899t1679r2026b1706],

1	There	EX	O	there	expl	5	SENT_206	[p11l2036t1672r2117b1698],
2	is	VBZ	O	be	cop	5	SENT_206	[p11l42t1711r61b1735],
3	a	DT	O	a	det	5	SENT_206	[p11l74t1720r86b1735],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_206	[p11l98t1710r235b1744],
5	interaction	NN	O	interaction	_	0	SENT_206	[p11l245t1711r388b1735],
6	between	IN	O	between	_	0	SENT_206	[p11l399t1710r509b1735],
7	agonist	NN	O	agonist	nn	8	SENT_206	[p11l521t1711r616b1744],
8	concentration	NN	O	concentration	prep_between	5	SENT_206	[p11l626t1711r809b1735],
9	and	CC	O	and	_	0	SENT_206	[p11l820t1710r868b1735],
10	indicated	VBD	O	indicate	conj_and	5	SENT_206	[p11l879t1710r1001b1735],
11	PIA	NNP	O	PIA	nn	12	SENT_206	[p11l1012t1706r1059b1735],
12	genotype	NN	O	genotype	dobj	10	SENT_206	[p11l1069t1717r1189b1744],
13	for	IN	O	for	_	0	SENT_206	[p11l1200t1710r1238b1735],
14	aggregation	NN	O	aggregation	prep_for	10	SENT_206	[p11l1249t1711r1404b1744],
15	induced	VBN	O	induce	partmod	14	SENT_206	[p11l1415t1710r1520b1735],
16	with	IN	O	with	_	0	SENT_206	[p11l1529t1710r1590b1735],
17	ADP	NN	O	adp	nn	19	SENT_206	[p11l1600t1710r1672b1735],
18	(	CD	NUMBER	(	num	19	SENT_206	[p11l1684t1709r1724b1741],
19	A	NN	O	a	prep_with	15	SENT_206	[p11l1684t1709r1724b1741],
20	,	,	O	,	_	0	SENT_206	[p11l1684t1709r1724b1741],
21	p	NN	O	p	dep	22	SENT_206	[p11l1736t1720r1752b1744],
22	<	JJR	O	<	prep_with	15	SENT_206	[p11l1765t1714r1788b1733],
23	0.005	CD	NUMBER	0.005	num	24	SENT_206	[p11l1801t1710r1885b1740],
24	)	NN	O	)	dep	22	SENT_206	[p11l1801t1710r1885b1740],
25	and	CC	O	and	_	0	SENT_206	[p11l1897t1710r1945b1735],
26	collagen	NN	O	collagen	nn	28	SENT_206	[p11l1957t1710r2065b1744],
27	(	NN	O	(	nn	28	SENT_206	[p11l2077t1709r2116b1741],
28	B	NN	O	b	prep_with	15	SENT_206	[p11l2077t1709r2116b1741],
29	,	,	O	,	_	0	SENT_206	[p11l2077t1709r2116b1741],
30	p	NN	O	p	appos	28	SENT_206	[p11l42t1758r58b1781],
31	=	JJ	O	=	acomp	5	SENT_206	[p11l72t1757r92b1765],
32	0005	CD	DATE	0005	number	33	SENT_206	[p11l106t1747r197b1778],
33	)	CD	NUMBER	)	dep	31	SENT_206	[p11l106t1747r197b1778],
34	.	.	O	.	_	0	SENT_206	[p11l106t1747r197b1778],

1	Multiple	JJ	O	multiple	amod	2	SENT_207	[p11l208t1748r325b1797],
2	comparisons	NNS	O	comparison	nsubj	3	SENT_207	[p11l336t1749r501b1781],
3	(	VBP	O	(	_	0	SENT_207	[p11l513t1747r557b1778],
4	six	CD	NUMBER	six	nsubj	16	SENT_207	[p11l513t1747r557b1778],
5	included	VBN	O	include	partmod	4	SENT_207	[p11l567t1748r681b1773],
6	in	IN	O	in	_	0	SENT_207	[p11l691t1749r716b1772],
7	adjustment	NN	O	adjustment	prep_in	5	SENT_207	[p11l727t1748r875b1781],
8	per	IN	O	per	_	0	SENT_207	[p11l883t1757r926b1781],
9	plot	NN	O	plot	nn	10	SENT_207	[p11l935t1747r997b1781],
10	)	NN	O	)	prep_per	7	SENT_207	[p11l935t1747r997b1781],
11	at	IN	O	at	_	0	SENT_207	[p11l1009t1754r1033b1773],
12	each	DT	O	each	det	13	SENT_207	[p11l1043t1748r1102b1773],
13	agonist	NN	O	agonist	poss	15	SENT_207	[p11l1112t1748r1224b1781],
14	’s	POS	O	’s	_	0	SENT_207	[p11l1112t1748r1224b1781],
15	concentrations	NNS	O	concentration	prep_at	5	SENT_207	[p11l1236t1749r1429b1773],
16	revealed	VBD	O	reveal	ccomp	3	SENT_207	[p11l1440t1748r1548b1773],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_207	[p11l1558t1748r1695b1781],
18	differences	NNS	O	difference	nsubj	19	SENT_207	[p11l1705t1748r1844b1773],
19	(	VBP	O	(	ccomp	16	SENT_207	[p11l1856t1747r1882b1781],
20	p	NN	O	p	nsubj	29	SENT_207	[p11l1856t1747r1882b1781],
21	<	JJR	O	<	dep	29	SENT_207	[p11l1894t1752r1917b1771],
22	0.05	CD	NUMBER	0.05	num	23	SENT_207	[p11l1929t1747r1996b1778],
23	)	NN	O	)	npadvmod	28	SENT_207	[p11l1929t1747r1996b1778],
24	between	IN	O	between	_	0	SENT_207	[p11l2007t1748r2117b1773],
25	PIAI/A1	NN	O	piai/a1	prep_between	23	SENT_207	[p11l42t1780r140b1810],
26	and	CC	O	and	_	0	SENT_207	[p11l154t1785r202b1810],
27	PIAN	NN	O	pian	conj_and	25	SENT_207	[p11l214t1780r282b1810],
28	as	IN	O	as	advmod	29	SENT_207	[p11l325t1795r349b1810],
29	indicated	VBN	O	indicate	xcomp	19	SENT_207	[p11l362t1785r490b1810],
30	.	.	O	.	_	0	SENT_207	[p11l362t1785r490b1810],

1	*	NN	O	*	nsubj	2	SENT_208	[p11l504t1785r616b1819],
2	Applies	VBZ	O	apply	_	0	SENT_208	[p11l504t1785r616b1819],
3	for	IN	O	for	_	0	SENT_208	[p11l629t1785r667b1810],
4	differences	NNS	O	difference	prep_for	2	SENT_208	[p11l679t1785r818b1810],
5	between	IN	O	between	_	0	SENT_208	[p11l830t1785r940b1810],
6	PIAI/A1	NN	O	piai/a1	prep_between	4	SENT_208	[p11l952t1780r1050b1810],
7	and	CC	O	and	_	0	SENT_208	[p11l1064t1785r1112b1810],
8	PIA1/A2	NN	O	pia1/a2	prep_between	4	SENT_208	[p11l1124t1780r1229b1810],
9	.	.	O	.	_	0	SENT_208	[p11l1124t1780r1229b1810],

1	their	PRP$	O	they	poss	3	SENT_209	[p11l9t1980r177b2046],
2	PIA1/A1	NN	O	pia1/a1	nn	3	SENT_209	[p11l230t1964r490b2045],
3	counterparts	NNS	O	counterpart	nsubj	4	SENT_209	[p11l548t1997r988b2069],
4	(	VBP	O	(	_	0	SENT_209	[p11l1047t1978r1241b2069],
5	Figs	NNS	O	fig	dobj	4	SENT_209	[p11l1047t1978r1241b2069],
6	.	.	O	.	_	0	SENT_209	[p11l1047t1978r1241b2069],

1	3B	NN	O	3b	_	0	SENT_210	[p11l1301t1981r1420b2061],
2	,	,	O	,	_	0	SENT_210	[p11l1301t1981r1420b2061],
3	4	CD	NUMBER	4	num	1	SENT_210	[p11l1476t1983r1538b2061],
4	,	,	O	,	_	0	SENT_210	[p11l1476t1983r1538b2061],
5	and	CC	NUMBER	and	_	0	SENT_210	[p11l1597t1980r1725b2046],
6	5	CD	NUMBER	5	conj_and	1	SENT_210	[p11l1779t1978r1868b2060],
7	)	NN	O	)	dep	1	SENT_210	[p11l1779t1978r1868b2060],
8	.	.	O	.	_	0	SENT_210	[p11l1779t1978r1868b2060],

1	When	WRB	O	when	advmod	4	SENT_211	[p11l1922t1980r2150b2047],
2	clopidogrel	NN	O	clopidogrel	nsubjpass	4	SENT_211	[p11l10t2087r407b2176],
3	is	VBZ	O	be	auxpass	4	SENT_211	[p11l457t2090r508b2153],
4	added	VBN	O	add	advcl	15	SENT_211	[p11l562t2087r774b2153],
5	to	TO	O	to	_	0	SENT_211	[p11l825t2104r893b2153],
6	ASA	NN	MISC	asa	prep_to	4	SENT_211	[p11l944t2085r1144b2168],
7	,	,	O	,	_	0	SENT_211	[p11l944t2085r1144b2168],
8	the	DT	O	the	det	9	SENT_211	[p11l1198t2087r1309b2153],
9	inhibition	NN	O	inhibition	nsubj	15	SENT_211	[p11l1361t2087r1715b2153],
10	of	IN	O	of	_	0	SENT_211	[p11l1767t2087r1847b2153],
11	PIA1/A2	NN	O	pia1/a2	nn	12	SENT_211	[p11l1887t2071r2149b2152],
12	platelets	NNS	O	platelet	prep_of	9	SENT_211	[p11l8t2194r299b2284],
13	is	VBZ	O	be	cop	15	SENT_211	[p11l336t2197r387b2260],
14	still	RB	O	still	advmod	15	SENT_211	[p11l426t2194r552b2260],
15	less	JJR	O	less	_	0	SENT_211	[p11l585t2194r705b2260],
16	than	IN	O	than	_	0	SENT_211	[p11l742t2194r901b2260],
17	that	DT	O	that	prep_than	15	SENT_211	[p11l937t2194r1079b2260],
18	of	IN	O	of	_	0	SENT_211	[p11l1113t2194r1194b2260],
19	their	PRP$	O	they	poss	21	SENT_211	[p11l1217t2194r1384b2260],
20	PIA1/A1	NN	O	pia1/a1	nn	21	SENT_211	[p11l1418t2178r1678b2260],
21	counterpart	NN	O	counterpart	prep_of	17	SENT_211	[p11l1718t2211r2147b2284],
22	;	:	O	;	_	0	SENT_211	[p11l1718t2211r2147b2284],
23	although	IN	O	although	mark	26	SENT_211	[p11l11t2301r325b2391],
24	PIA1/A1	NN	O	pia1/a1	nn	25	SENT_211	[p11l384t2285r644b2367],
25	platelets	NNS	O	platelet	nsubj	26	SENT_211	[p11l706t2301r996b2391],
26	beneﬁt	VBP	O	beneﬁt	advcl	38	SENT_211	[p11l1054t2301r1301b2367],
27	incrementally	RB	O	incrementally	advmod	26	SENT_211	[p11l1358t2301r1844b2391],
28	by	IN	O	by	_	0	SENT_211	[p11l1897t2301r1984b2391],
29	the	DT	O	the	det	30	SENT_211	[p11l2039t2301r2150b2367],
30	addition	NN	O	addition	prep_by	26	SENT_211	[p11l11t2409r305b2474],
31	of	IN	O	of	_	0	SENT_211	[p11l347t2408r427b2474],
32	clopidogrel	NN	O	clopidogrel	prep_of	30	SENT_211	[p11l457t2409r853b2498],
33	to	TO	O	to	_	0	SENT_211	[p11l893t2426r961b2474],
34	ASA	NN	O	asa	prep_to	26	SENT_211	[p11l1001t2407r1201b2489],
35	,	,	O	,	_	0	SENT_211	[p11l1001t2407r1201b2489],
36	PIA1/A2	NN	O	pia1/a2	nn	37	SENT_211	[p11l1246t2392r1508b2474],
37	platelets	NNS	O	platelet	nsubj	38	SENT_211	[p11l1548t2408r1839b2498],
38	do	VBP	O	do	parataxis	15	SENT_211	[p11l1883t2409r1968b2474],
39	not	RB	O	not	neg	38	SENT_211	[p11l2011t2426r2146b2474],
40	.	.	O	.	_	0	SENT_211	[p11l2011t2426r2146b2474],

1	Considering	VBG	O	consider	dep	18	SENT_212	[p11l11t2516r452b2605],
2	that	IN	O	that	complm	5	SENT_212	[p11l490t2516r632b2582],
3	most	JJS	O	most	amod	4	SENT_212	[p11l671t2533r846b2582],
4	patients	NNS	O	patient	nsubj	5	SENT_212	[p11l883t2519r1162b2605],
5	display	VBP	O	display	pcomp	1	SENT_212	[p11l1204t2516r1452b2605],
6	the	DT	O	the	det	8	SENT_212	[p11l1488t2516r1599b2582],
7	PIA1/A1	NN	O	pia1/a1	nn	8	SENT_212	[p11l1640t2499r1900b2581],
8	genotype	NN	O	genotype	dobj	5	SENT_212	[p11l1943t2542r2147b2605, p11l9t2640r177b2712],
9	,	,	O	,	_	0	SENT_212	[p11l1943t2542r2147b2605, p11l9t2640r177b2712],
10	this	DT	O	this	det	12	SENT_212	[p11l224t2623r351b2689],
11	mild	JJ	O	mild	amod	12	SENT_212	[p11l397t2623r559b2689],
12	effect	NN	O	effect	nsubj	18	SENT_212	[p11l603t2623r789b2689],
13	of	IN	O	of	_	0	SENT_212	[p11l832t2623r912b2689],
14	clopidogrel	NN	O	clopidogrel	nn	15	SENT_212	[p11l944t2623r1341b2712],
15	inhibition	NN	O	inhibition	prep_of	12	SENT_212	[p11l1383t2623r1736b2689],
16	also	RB	O	also	advmod	18	SENT_212	[p11l1782t2623r1912b2689],
17	could	MD	O	could	aux	18	SENT_212	[p11l1959t2623r2151b2689],
18	account	VB	O	account	_	0	SENT_212	[p11l11t2747r285b2796],
19	for	IN	O	for	_	0	SENT_212	[p11l321t2730r422b2796],
20	some	DT	O	some	prep_for	18	SENT_212	[p11l460t2756r641b2796],
21	of	IN	O	of	_	0	SENT_212	[p11l680t2730r761b2796],
22	the	DT	O	the	det	25	SENT_212	[p11l786t2730r897b2796],
23	relative	JJ	O	relative	amod	25	SENT_212	[p11l935t2730r1190b2796],
24	clinical	JJ	O	clinical	amod	25	SENT_212	[p11l1230t2730r1479b2796],
25	superiority	NN	O	superiority	prep_of	20	SENT_212	[p11l1517t2733r1898b2819],
26	of	IN	O	of	_	0	SENT_212	[p11l1933t2730r2013b2796],
27	the	DT	O	the	det	29	SENT_212	[p11l2038t2730r2149b2796],
28	ASA	NN	O	asa	nn	29	SENT_212	[p11l7t2834r807b2925],
29	—	NN	O	—	prep_of	25	SENT_212	[p11l7t2834r807b2925],
30	plus	CC	O	plus	prep	29	SENT_212	[p11l7t2834r807b2925],
31	—	NN	O	—	nn	33	SENT_212	[p11l7t2834r807b2925],
32	clopidogrel	NN	O	clopidogrel	nn	33	SENT_212	[p11l7t2834r807b2925],
33	combination	NN	O	combination	dep	30	SENT_212	[p11l845t2836r1293b2902],
34	compared	VBN	O	compare	_	0	SENT_212	[p11l1333t2836r1670b2925],
35	with	IN	O	with	prepc_compared_with	18	SENT_212	[p11l1703t2836r1859b2902],
36	the	DT	O	the	det	37	SENT_212	[p11l1897t2836r2004b2902],
37	use	NN	O	use	pobj	18	SENT_212	[p11l2041t2862r2150b2902],
38	of	IN	O	of	_	0	SENT_212	[p11l10t2942r89b3008],
39	only	RB	O	only	advmod	40	SENT_212	[p11l104t2942r253b3031],
40	ASA	NN	O	asa	prep_of	37	SENT_212	[p11l273t2940r467b3008],
41	.	.	O	.	_	0	SENT_212	[p11l273t2940r467b3008],

1	In	IN	O	in	_	0	SENT_213	[p11l498t2943r574b3007],
2	a	DT	O	a	det	3	SENT_213	[p11l602t2968r637b3008],
3	study	NN	O	study	prep_in	21	SENT_213	[p11l664t2942r847b3031],
4	of	IN	O	of	_	0	SENT_213	[p11l871t2942r949b3008],
5	ADP	NN	O	adp	nn	6	SENT_213	[p11l962t2940r1543b3008],
6	—	NN	O	—	prep_of	3	SENT_213	[p11l962t2940r1543b3008],
7	stimulated	VBD	O	stimulate	partmod	6	SENT_213	[p11l962t2940r1543b3008],
8	platelet	NN	O	platelet	nn	9	SENT_213	[p11l1568t2942r1818b3031],
9	reactivity	NN	O	reactivity	iobj	7	SENT_213	[p11l1843t2945r2154b3031],
10	in	IN	O	in	_	0	SENT_213	[p11l9t3051r76b3113],
11	patients	NNS	O	patient	prep_in	9	SENT_213	[p11l111t3051r377b3137],
12	with	IN	O	with	_	0	SENT_213	[p11l411t3048r568b3114],
13	stents	NNS	O	stent	prep_with	11	SENT_213	[p11l606t3065r816b3129],
14	,	,	O	,	_	0	SENT_213	[p11l606t3065r816b3129],
15	Angiollilo	NNP	O	Angiollilo	appos	13	SENT_213	[p11l853t3046r1197b3137],
16	et	FW	O	et	nn	18	SENT_213	[p11l1236t3065r1298b3114],
17	al.	FW	O	al.	nn	18	SENT_213	[p11l1334t3048r1405b3114],
18	(	FW	O	(	dobj	7	SENT_213	[p11l1449t3046r1582b3128],
19	22	CD	NUMBER	22	num	20	SENT_213	[p11l1449t3046r1582b3128],
20	)	NN	O	)	nsubj	21	SENT_213	[p11l1449t3046r1582b3128],
21	reported	VBD	O	report	_	0	SENT_213	[p11l1621t3048r1909b3137],
22	that	IN	O	that	complm	28	SENT_213	[p11l1944t3048r2081b3114],
23	a	DT	O	a	det	25	SENT_213	[p11l2117t3074r2151b3114],
24	300-mg	JJ	O	300-mg	amod	25	SENT_213	[p11l10t3157r285b3243],
25	clopidogrel	NN	O	clopidogrel	nsubj	28	SENT_213	[p11l330t3154r708b3243],
26	loading	VBG	O	load	partmod	25	SENT_213	[p11l752t3154r1008b3243],
27	dose	NN	O	dose	dobj	26	SENT_213	[p11l1053t3154r1209b3220],
28	had	VBD	O	have	ccomp	21	SENT_213	[p11l1257t3154r1387b3220],
29	less	JJR	O	less	dobj	28	SENT_213	[p11l1433t3154r1553b3220],
30	of	IN	O	of	_	0	SENT_213	[p11l1604t3154r1684b3220],
31	an	DT	O	a	det	32	SENT_213	[p11l1721t3180r1802b3220],
32	effect	NN	O	effect	prep_of	29	SENT_213	[p11l1850t3154r2036b3220],
33	in	IN	O	in	_	0	SENT_213	[p11l2082t3157r2150b3219],
34	PIA1/A2	NN	O	pia1/a2	nn	35	SENT_213	[p11l10t3244r272b3326],
35	subjects	NNS	O	subject	prep_in	32	SENT_213	[p11l317t3261r609b3350],
36	.	.	O	.	_	0	SENT_213	[p11l317t3261r609b3350],

1	One	CD	NUMBER	one	num	3	SENT_214	[p11l657t3261r810b3327],
2	main	JJ	O	main	amod	3	SENT_214	[p11l853t3264r1031b3327],
3	difference	NN	O	difference	nsubj	10	SENT_214	[p11l1073t3261r1415b3327],
4	between	IN	O	between	_	0	SENT_214	[p11l1455t3261r1750b3327],
5	this	DT	O	this	det	6	SENT_214	[p11l1792t3261r1919b3327],
6	study	NN	O	study	prep_between	3	SENT_214	[p11l1964t3261r2154b3350],
7	and	CC	O	and	_	0	SENT_214	[p11l11t3367r139b3433],
8	our	PRP$	O	we	poss	9	SENT_214	[p11l164t3393r282b3433],
9	report	NN	O	report	prep_between	3	SENT_214	[p11l306t3384r522b3456],
10	is	VBZ	O	be	_	0	SENT_214	[p11l545t3370r596b3433],
11	that	IN	O	that	complm	13	SENT_214	[p11l623t3367r765b3433],
12	We	PRP	O	we	nsubj	13	SENT_214	[p11l785t3393r884b3433],
13	treated	VBD	O	treat	ccomp	10	SENT_214	[p11l909t3367r1155b3433],
14	subjects	NNS	O	subject	dobj	13	SENT_214	[p11l1181t3367r1453b3456],
15	for	IN	O	for	_	0	SENT_214	[p11l1481t3367r1582b3433],
16	10	CD	DURATION	10	num	17	SENT_214	[p11l1609t3370r1690b3433],
17	days	NNS	NUMBER	day	prep_for	13	SENT_214	[p11l1718t3367r1888b3456],
18	,	,	O	,	_	0	SENT_214	[p11l1718t3367r1888b3456],
19	during	IN	O	during	_	0	SENT_214	[p11l1918t3367r2152b3456],
20	which	WDT	O	which	det	21	SENT_214	[p11l6t3473r224b3539],
21	time	NN	O	time	rel	26	SENT_214	[p11l254t3476r413b3539],
22	steady	JJ	O	steady	amod	23	SENT_214	[p11l445t3473r666b3562],
23	state	NN	O	state	nsubjpass	26	SENT_214	[p11l695t3490r854b3539],
24	clearly	RB	O	clearly	advmod	26	SENT_214	[p11l886t3473r1114b3562],
25	is	VBZ	O	be	auxpass	26	SENT_214	[p11l1140t3476r1191b3539],
26	achieved	VBN	O	achieve	rcmod	17	SENT_214	[p11l1224t3473r1546b3539],
27	.	.	O	.	_	0	SENT_214	[p11l1224t3473r1546b3539],

1	It	PRP	O	it	nsubj	3	SENT_215	[p11l1580t3474r1641b3539],
2	would	MD	O	would	aux	3	SENT_215	[p11l1666t3473r1887b3539],
3	appear	VB	O	appear	_	0	SENT_215	[p11l1918t3499r2152b3562],
4	that	IN	O	that	complm	11	SENT_215	[p11l9t3579r151b3645],
5	the	DT	O	the	det	8	SENT_215	[p11l176t3579r287b3645],
6	300-mg	JJ	O	300-mg	amod	8	SENT_215	[p11l315t3582r598b3668],
7	loading	NN	O	loading	nn	8	SENT_215	[p11l622t3579r888b3668],
8	dose	NN	O	dose	nsubj	11	SENT_215	[p11l914t3579r1070b3645],
9	is	VBZ	O	be	cop	11	SENT_215	[p11l1098t3582r1148b3645],
10	not	RB	O	not	neg	11	SENT_215	[p11l1178t3596r1296b3645],
11	enough	JJ	O	enough	ccomp	3	SENT_215	[p11l1322t3579r1584b3668],
12	to	TO	O	to	aux	13	SENT_215	[p11l1610t3596r1679b3645],
13	induce	VB	O	induce	xcomp	11	SENT_215	[p11l1707t3579r1941b3645],
14	rapid	JJ	O	rapid	amod	15	SENT_215	[p11l1968t3579r2151b3668],
15	inhibition	NN	O	inhibition	dobj	13	SENT_215	[p11l9t3685r363b3751],
16	for	IN	O	for	_	0	SENT_215	[p11l408t3685r509b3751],
17	patients	NNS	O	patient	prep_for	13	SENT_215	[p11l551t3688r829b3774],
18	who	WP	O	who	nsubj	19	SENT_215	[p11l872t3685r1025b3751],
19	need	VBP	O	need	rcmod	17	SENT_215	[p11l1073t3685r1239b3751],
20	it	PRP	O	it	nsubj	21	SENT_215	[p11l1283t3688r1334b3751],
21	(	NN	O	(	xcomp	19	SENT_215	[p11l1381t3683r1541b3765],
22	22	CD	NUMBER	22	num	23	SENT_215	[p11l1381t3683r1541b3765],
23	)	NN	O	)	dep	21	SENT_215	[p11l1381t3683r1541b3765],
24	.	.	O	.	_	0	SENT_215	[p11l1381t3683r1541b3765],

1	This	DT	O	this	det	2	SENT_216	[p11l1587t3683r1751b3751],
2	ﬁnding	NN	O	ﬁnding	nsubj	4	SENT_216	[p11l1798t3685r2054b3774],
3	is	VBZ	O	be	cop	4	SENT_216	[p11l2098t3688r2149b3751],
4	consistent	JJ	O	consistent	_	0	SENT_216	[p12l10t26r366b89],
5	with	IN	O	with	_	0	SENT_216	[p12l387t23r549b89],
6	our	PRP$	O	we	poss	8	SENT_216	[p12l575t49r693b89],
7	previous	JJ	O	previous	amod	8	SENT_216	[p12l716t26r1010b112],
8	statement	NN	O	statement	prep_with	4	SENT_216	[p12l1039t40r1387b89],
9	that	IN	O	that	complm	18	SENT_216	[p12l1411t23r1553b89],
10	PIAI/A2	NN	O	piai/a2	nn	11	SENT_216	[p12l1577t7r1840b88],
11	individuals	NNS	O	individual	nsubj	18	SENT_216	[p12l1867t23r2147b89, p12l8t129r142b195],
12	treated	VBN	O	treat	partmod	11	SENT_216	[p12l179t129r423b195],
13	with	IN	O	with	_	0	SENT_216	[p12l455t129r616b195],
14	250	CD	NUMBER	250	num	15	SENT_216	[p12l650t129r781b196],
15	mg	NN	O	mg	prep_with	12	SENT_216	[p12l818t155r931b218],
16	of	IN	O	of	_	0	SENT_216	[p12l965t129r1045b195],
17	ticlopidine	NN	O	ticlopidine	prep_of	15	SENT_216	[p12l1068t129r1445b218],
18	had	VBD	O	have	ccomp	4	SENT_216	[p12l1481t129r1611b195],
19	ﬁve	JJ	O	ﬁve	amod	20	SENT_216	[p12l1646t129r1767b195],
20	times	NNS	O	time	dobj	18	SENT_216	[p12l1803t132r1991b195],
21	the	DT	O	the	det	36	SENT_216	[p12l2028t129r2139b195],
22	rate	NN	O	rate	amod	36	SENT_216	[p12l9t252r140b301],
23	of	IN	O	of	_	0	SENT_216	[p12l180t235r260b301],
24	stent	JJ	O	stent	amod	25	SENT_216	[p12l287t252r457b301],
25	thrombosis	NN	O	thrombosis	prep_of	22	SENT_216	[p12l494t235r888b301],
26	as	IN	O	as	_	0	SENT_216	[p12l930t261r993b301],
27	that	DT	O	that	prep_as	22	SENT_216	[p12l1032t235r1174b301],
28	observed	VBN	O	observe	partmod	27	SENT_216	[p12l1211t235r1519b301],
29	with	IN	O	with	_	0	SENT_216	[p12l1553t235r1715b301],
30	500	CD	NUMBER	500	num	31	SENT_216	[p12l1753t235r1881b301],
31	mg	NN	O	mg	prep_with	28	SENT_216	[p12l1922t261r2035b324],
32	of	IN	O	of	_	0	SENT_216	[p12l2072t235r2151b301],
33	ticlopidine	NN	O	ticlopidine	prep_of	31	SENT_216	[p12l9t341r386b430],
34	(	CD	NUMBER	(	number	35	SENT_216	[p12l422t339r582b421],
35	16	CD	NUMBER	16	num	36	SENT_216	[p12l422t339r582b421],
36	)	NN	O	)	dep	20	SENT_216	[p12l422t339r582b421],
37	.	.	O	.	_	0	SENT_216	[p12l422t339r582b421],

1	Since	IN	O	since	_	0	SENT_217	[p12l102t447r288b513],
2	our	PRP$	O	we	poss	4	SENT_217	[p12l330t473r447b513],
3	initial	JJ	O	initial	amod	4	SENT_217	[p12l485t447r690b513],
4	report	NN	O	report	prep_since	25	SENT_217	[p12l729t464r944b536],
5	on	IN	O	on	_	0	SENT_217	[p12l983t473r1071b513],
6	the	DT	O	the	det	8	SENT_217	[p12l1110t447r1221b513],
7	differential	JJ	O	differential	amod	8	SENT_217	[p12l1262t447r1642b513],
8	sensitivity	NN	O	sensitivity	prep_on	4	SENT_217	[p12l1682t450r2035b536],
9	of	IN	O	of	_	0	SENT_217	[p12l2072t447r2151b513],
10	platelets	NNS	O	platelet	prep_of	8	SENT_217	[p12l8t554r297b643],
11	to	TO	O	to	_	0	SENT_217	[p12l334t571r403b620],
12	aspirin	NN	O	aspirin	prep_to	10	SENT_217	[p12l441t557r677b643],
13	as	IN	O	as	_	0	SENT_217	[p12l713t580r776b620],
14	a	DT	O	a	det	15	SENT_217	[p12l815t580r850b620],
15	function	NN	O	function	prep_as	12	SENT_217	[p12l884t554r1181b620],
16	of	IN	O	of	_	0	SENT_217	[p12l1217t554r1297b620],
17	the	DT	O	the	det	22	SENT_217	[p12l1320t554r1430b620],
18	PlA	NN	O	plum	nn	22	SENT_217	[p12l1467t538r1591b619],
19	polymorphism	NN	O	polymorphism	nn	22	SENT_217	[p12l1624t554r2139b643],
20	(	NN	O	(	nn	22	SENT_217	[p12l12t658r173b741],
21	15	CD	NUMBER	15	num	22	SENT_217	[p12l12t658r173b741],
22	)	NN	O	)	prep_of	15	SENT_217	[p12l12t658r173b741],
23	,	,	O	,	_	0	SENT_217	[p12l12t658r173b741],
24	it	PRP	O	it	nsubj	25	SENT_217	[p12l200t663r250b726],
25	appears	VBZ	O	appear	_	0	SENT_217	[p12l274t686r534b749],
26	that	IN	O	that	complm	31	SENT_217	[p12l559t660r701b726],
27	there	EX	O	there	expl	31	SENT_217	[p12l723t660r901b726],
28	have	VBP	O	have	aux	31	SENT_217	[p12l925t660r1083b726],
29	been	VBN	O	be	cop	31	SENT_217	[p12l1106t660r1272b726],
30	discordant	JJ	O	discordant	amod	31	SENT_217	[p12l1297t660r1667b726],
31	results	NNS	O	result	ccomp	25	SENT_217	[p12l1689t660r1911b726],
32	either	CC	O	either	prep	31	SENT_217	[p12l1938t660r2141b726],
33	substantiating	VBG	O	substantiate	dep	32	SENT_217	[p12l11t766r507b855],
34	(	CD	NUMBER	(	number	35	SENT_217	[p12l553t764r691b846],
35	23	CD	NUMBER	23	num	36	SENT_217	[p12l553t764r691b846],
36	)	NN	O	)	dobj	33	SENT_217	[p12l553t764r691b846],
37	or	CC	O	or	_	0	SENT_217	[p12l740t792r812b832],
38	conﬂicting	VBG	O	conﬂicting	conj_or	33	SENT_217	[p12l857t766r1233b855],
39	our	PRP$	O	we	poss	40	SENT_217	[p12l1277t792r1395b832],
40	results	NNS	O	result	nsubj	41	SENT_217	[p12l1437t766r1660b832],
41	(	VBP	O	(	ccomp	38	SENT_217	[p12l1710t764r2013b846],
42	24-26	CD	NUMBER	24-26	num	43	SENT_217	[p12l1710t764r2013b846],
43	)	CD	NUMBER	)	dobj	41	SENT_217	[p12l1710t764r2013b846],
44	.	.	O	.	_	0	SENT_217	[p12l1710t764r2013b846],

1	In	IN	O	in	_	0	SENT_218	[p12l2062t767r2139b831],
2	their	PRP$	O	they	poss	4	SENT_218	[p12l9t872r176b938],
3	initial	JJ	O	initial	amod	4	SENT_218	[p12l222t872r427b938],
4	study	NN	O	study	prep_in	12	SENT_218	[p12l475t872r680b961],
5	,	,	O	,	_	0	SENT_218	[p12l475t872r680b961],
6	Undas	NNP	O	Undas	nsubj	12	SENT_218	[p12l729t872r955b938],
7	et	FW	O	et	dep	6	SENT_218	[p12l1006t889r1070b938],
8	al.	FW	O	al.	nn	9	SENT_218	[p12l1117t872r1191b938],
9	(	FW	O	(	dep	6	SENT_218	[p12l1246t870r1384b952],
10	24	CD	NUMBER	24	num	11	SENT_218	[p12l1246t870r1384b952],
11	)	NN	O	)	dep	9	SENT_218	[p12l1246t870r1384b952],
12	found	VBD	O	find	_	0	SENT_218	[p12l1435t872r1643b938],
13	that	IN	O	that	complm	16	SENT_218	[p12l1690t872r1831b938],
14	PIA1/A1	NN	O	pia1/a1	nn	15	SENT_218	[p12l1878t856r2136b937],
15	individuals	NNS	O	individual	nsubj	16	SENT_218	[p12l9t978r391b1044],
16	had	VBD	O	have	ccomp	12	SENT_218	[p12l423t978r553b1044],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_218	[p12l584t978r1013b1067],
18	greater	JJR	O	greater	amod	20	SENT_218	[p12l1038t995r1283b1067],
19	platelet	NN	O	platelet	nn	20	SENT_218	[p12l1311t978r1572b1067],
20	inhibition	NN	O	inhibition	dobj	16	SENT_218	[p12l1600t978r1952b1044],
21	with	IN	O	with	_	0	SENT_218	[p12l1978t978r2139b1044],
22	ASA	NN	O	asa	prep_with	16	SENT_218	[p12l7t1083r189b1151],
23	than	IN	O	than	_	0	SENT_218	[p12l222t1085r381b1150],
24	PIAI/A2	NN	O	piai/a2	nn	25	SENT_218	[p12l417t1068r678b1150],
25	individuals	NNS	O	individual	prep_than	16	SENT_218	[p12l715t1085r1116b1150],
26	.	.	O	.	_	0	SENT_218	[p12l715t1085r1116b1150],

1	They	PRP	O	they	nsubj	2	SENT_219	[p12l1154t1083r1344b1173],
2	reported	VBD	O	report	_	0	SENT_219	[p12l1376t1085r1674b1173],
3	that	IN	O	that	complm	9	SENT_219	[p12l1709t1085r1850b1150],
4	carriers	NNS	O	carrier	nsubj	9	SENT_219	[p12l1885t1088r2138b1150],
5	of	IN	O	of	_	0	SENT_219	[p12l10t1191r90b1257],
6	the	DT	O	the	det	8	SENT_219	[p12l108t1191r218b1257],
7	PIAZ	NN	O	piaz	nn	8	SENT_219	[p12l249t1175r404b1256],
8	polymorphism	NN	O	polymorphism	prep_of	4	SENT_219	[p12l434t1191r950b1280],
9	appeared	VBD	O	appear	ccomp	2	SENT_219	[p12l982t1191r1298b1280],
10	to	TO	O	to	aux	13	SENT_219	[p12l1326t1208r1395b1257],
11	be	VB	O	be	cop	13	SENT_219	[p12l1424t1191r1505b1257],
12	more	RBR	O	more	advmod	13	SENT_219	[p12l1536t1217r1716b1257],
13	resistant	JJ	O	resistant	xcomp	9	SENT_219	[p12l1746t1194r2042b1257],
14	to	TO	O	to	aux	15	SENT_219	[p12l2070t1208r2138b1257],
15	ASA	NN	O	asa	xcomp	13	SENT_219	[p12l7t1295r189b1363],
16	than	IN	O	than	_	0	SENT_219	[p12l217t1297r375b1363],
17	noncarriers	NNS	O	noncarrier	prep_than	15	SENT_219	[p12l406t1300r819b1378],
18	,	,	O	,	_	0	SENT_219	[p12l406t1300r819b1378],
19	as	IN	O	as	mark	20	SENT_219	[p12l853t1323r916b1363],
20	measured	VBN	O	measure	advcl	13	SENT_219	[p12l949t1297r1284b1363],
21	by	IN	O	by	_	0	SENT_219	[p12l1310t1297r1397b1386],
22	bleeding	VBG	O	bleed	prepc_by	20	SENT_219	[p12l1421t1297r1725b1386],
23	times	NNS	O	time	dobj	22	SENT_219	[p12l1753t1300r1941b1363],
24	(	CD	NUMBER	(	number	23	SENT_219	[p12l1976t1295r2135b1377],
25	25	CD	NUMBER	25	num	26	SENT_219	[p12l1976t1295r2135b1377],
26	)	NN	O	)	dep	23	SENT_219	[p12l1976t1295r2135b1377],
27	.	.	O	.	_	0	SENT_219	[p12l1976t1295r2135b1377],

1	In	IN	O	in	_	0	SENT_220	[p12l9t1404r86b1468],
2	this	DT	O	this	det	3	SENT_220	[p12l113t1403r240b1469],
3	setting	NN	O	setting	prep_in	7	SENT_220	[p12l271t1406r526b1492],
4	,	,	O	,	_	0	SENT_220	[p12l271t1406r526b1492],
5	collagen	NN	O	collagen	nsubj	7	SENT_220	[p12l557t1403r845b1492],
6	is	VBZ	O	be	cop	7	SENT_220	[p12l873t1406r923b1469],
7	likely	JJ	O	likely	_	0	SENT_220	[p12l951t1403r1142b1492],
8	to	TO	O	to	aux	9	SENT_220	[p12l1166t1420r1234b1469],
9	function	VB	O	function	xcomp	7	SENT_220	[p12l1262t1403r1559b1469],
10	as	IN	O	as	_	0	SENT_220	[p12l1588t1429r1651b1469],
11	a	DT	O	a	det	13	SENT_220	[p12l1681t1429r1716b1469],
12	key	JJ	O	key	amod	13	SENT_220	[p12l1742t1403r1863b1492],
13	agonist	NN	O	agonist	prep_as	9	SENT_220	[p12l1888t1406r2141b1492],
14	for	IN	O	for	_	0	SENT_220	[p12l9t1509r110b1575],
15	platelets	NNS	O	platelet	prep_for	13	SENT_220	[p12l132t1509r421b1598],
16	that	WDT	O	that	nsubj	17	SENT_220	[p12l448t1509r589b1575],
17	escape	VBP	O	escape	rcmod	15	SENT_220	[p12l613t1535r836b1598],
18	disrupted	VBN	O	disrupt	dep	17	SENT_220	[p12l862t1509r1194b1598],
19	vessels	NNS	O	vessel	dobj	18	SENT_220	[p12l1215t1509r1445b1575],
20	in	IN	O	in	_	0	SENT_220	[p12l1472t1512r1539b1574],
21	the	DT	O	the	det	22	SENT_220	[p12l1564t1509r1674b1575],
22	skin	NN	O	skin	prep_in	19	SENT_220	[p12l1702t1509r1863b1590],
23	,	,	O	,	_	0	SENT_220	[p12l1702t1509r1863b1590],
24	and	CC	O	and	_	0	SENT_220	[p12l1893t1509r2020b1575],
25	we	PRP	O	we	nsubj	27	SENT_220	[p12l2041t1535r2139b1575],
26	have	VBP	O	have	aux	27	SENT_220	[p12l9t1615r167b1681],
27	shown	VBN	O	show	conj_and	7	SENT_220	[p12l194t1615r421b1681],
28	in	IN	O	in	_	0	SENT_220	[p12l445t1618r513b1680],
29	this	DT	O	this	det	30	SENT_220	[p12l537t1615r663b1681],
30	study	NN	O	study	prep_in	27	SENT_220	[p12l691t1615r880b1704],
31	that	WDT	O	that	rel	36	SENT_220	[p12l900t1615r1041b1681],
32	inhibition	NN	O	inhibition	nsubj	36	SENT_220	[p12l1063t1615r1415b1681],
33	of	IN	O	of	_	0	SENT_220	[p12l1440t1615r1520b1681],
34	collagen	NN	O	collagen	nn	35	SENT_220	[p12l1532t1615r2140b1704],
35	—	NN	O	—	prep_of	32	SENT_220	[p12l1532t1615r2140b1704],
36	induced	VBD	O	induce	rcmod	30	SENT_220	[p12l1532t1615r2140b1704],
37	aggregationwith	JJ	O	aggregationwith	amod	38	SENT_220	[p12l11t1722r610b1815],
38	ASA	NN	O	asa	nsubj	41	SENT_220	[p12l637t1720r818b1788],
39	is	VBZ	O	be	cop	41	SENT_220	[p12l845t1725r896b1788],
40	more	RBR	O	more	advmod	41	SENT_220	[p12l928t1747r1107b1788],
41	eﬂicient	JJ	O	eﬂicient	ccomp	36	SENT_220	[p12l1138t1722r1415b1788],
42	for	IN	O	for	_	0	SENT_220	[p12l1442t1722r1543b1788],
43	PIA1/A1	NN	O	pia1/a1	nn	44	SENT_220	[p12l1571t1706r1829b1787],
44	patients	NNS	O	patient	prep_for	41	SENT_220	[p12l1861t1725r2137b1815],
45	than	IN	O	than	prep	41	SENT_220	[p12l9t1851r167b1916],
46	for	IN	O	for	pcomp	45	SENT_220	[p12l203t1851r304b1916],
47	PlA1/A2	NN	O	pla1/a2	nn	48	SENT_220	[p12l338t1837r599b1916],
48	patients	NNS	O	patient	pobj	46	SENT_220	[p12l635t1854r932b1939],
49	.	.	O	.	_	0	SENT_220	[p12l635t1854r932b1939],

1	However	RB	O	however	advmod	5	SENT_221	[p12l973t1852r1314b1931],
2	,	,	O	,	_	0	SENT_221	[p12l973t1852r1314b1931],
3	we	PRP	O	we	nsubj	5	SENT_221	[p12l1349t1876r1447b1916],
4	also	RB	O	also	advmod	5	SENT_221	[p12l1485t1851r1616b1916],
5	show	VBP	O	show	_	0	SENT_221	[p12l1654t1851r1838b1916],
6	the	DT	O	the	det	8	SENT_221	[p12l1870t1851r1980b1916],
7	PlA	NN	O	plum	nn	8	SENT_221	[p12l2017t1837r2141b1915],
8	polymorphism	NN	O	polymorphism	nsubj	9	SENT_221	[p12l8t1957r524b2046],
9	has	VBZ	O	have	ccomp	5	SENT_221	[p12l554t1957r666b2023],
10	modiﬁer	JJ	O	modiﬁer	amod	11	SENT_221	[p12l699t1957r999b2023],
11	effects	NNS	O	effect	dobj	9	SENT_221	[p12l1028t1957r1241b2023],
12	on	IN	O	on	_	0	SENT_221	[p12l1273t1983r1361b2023],
13	platelet	NN	O	platelet	nn	14	SENT_221	[p12l1389t1957r1650b2046],
14	inhibition	NN	O	inhibition	prep_on	11	SENT_221	[p12l1678t1957r2030b2023],
15	by	IN	O	by	_	0	SENT_221	[p12l2057t1957r2144b2046],
16	JACC	NNP	O	JACC	nn	17	SENT_221	[p12l7t2059r160b2124],
17	Vol	NNP	O	Vol	prep_by	9	SENT_221	[p12l194t2059r304b2124],
18	.	.	O	.	_	0	SENT_221	[p12l194t2059r304b2124],

1	47	CD	NUMBER	47	_	0	SENT_222	[p12l343t2059r442b2135],
2	,	,	O	,	_	0	SENT_222	[p12l343t2059r442b2135],
3	No.	NN	O	no.	amod	1	SENT_222	[p12l484t2059r579b2124],
4	3	CD	NUMBER	3	number	3	SENT_222	[p12l618t2059r674b2135],
5	,	,	O	,	_	0	SENT_222	[p12l618t2059r674b2135],
6	2006	CD	DATE	2006	appos	1	SENT_222	[p12l714t2059r878b2124],
7	February	NNP	DATE	February	tmod	6	SENT_222	[p12l12t2161r270b2241],
8	7	CD	DATE	7	num	7	SENT_222	[p12l305t2161r359b2237],
9	,	,	O	,	_	0	SENT_222	[p12l305t2161r359b2237],
10	2006:541	CD	NUMBER	2006:541	num	7	SENT_222	[p12l399t2160r800b2226],
11	—	CD	NUMBER	—	num	12	SENT_222	[p12l399t2160r800b2226],
12	6	CD	NUMBER	6	dep	1	SENT_222	[p12l399t2160r800b2226],

1	Aspirin	NN	O	aspirin	_	0	SENT_223	[p12l1275t2285r1579b2377],

1	D	NN	O	d	_	0	SENT_224	[p12l743t2651r813b2742],
2	-	:	O	-	_	0	SENT_224	[p12l743t2651r813b2742],
3	300	CD	NUMBER	300	number	4	SENT_224	[p12l874t2714r941b2746],
4	300	CD	NUMBER	300	npadvmod	5	SENT_224	[p12l2039t2719r2106b2751],
5	<	JJR	O	<	amod	1	SENT_224	[p12l742t2752r812b2824],
6	$	$	MONEY	$	dep	16	SENT_224	[p12l764t2849r812b2898],
7	21 250 250	CD	MONEY	21 250 250	num	6	SENT_224	[p12l2039t2865r2106b2898],[p12l764t2849r812b2898],
8	CD	NNP	O	CD	nn	10	SENT_224	[p12l764t2902r813b2942],
9	DD	NNP	O	DD	nn	10	SENT_224	[p12l764t2946r835b2991],
10	o	NN	O	o	dep	6	SENT_224	[p12l764t2996r813b3041],
11	200	CD	NUMBER	200	number	12	SENT_224	[p12l874t3001r942b3034],
12	200	CD	NUMBER	200	dep	10	SENT_224	[p12l2038t3006r2106b3040],
13	.5	CD	NUMBER	.5	num	14	SENT_224	[p12l742t3046r812b3122],
14	*	NN	O	*	dep	16	SENT_224	[p12l1910t3052r1938b3084],
15	3-4	CD	NUMBER	3-4	num	16	SENT_224	[p12l764t3122r812b3156],
16	re	NN	O	re	dep	18	SENT_224	[p12l742t3158r813b3233],
17	150	CD	NUMBER	150	dep	16	SENT_224	[p12l878t3149r942b3182],
18	*	NN	O	*	dep	21	SENT_224	[p12l1485t3198r1514b3228],
19	‘	CD	NUMBER	‘	num	18	SENT_224	[p12l1909t3145r1938b3226],
20	I	PRP	O	I	nsubj	21	SENT_224	[p12l1909t3145r1938b3226],
21	’	VBP	O	’	ccomp	5	SENT_224	[p12l1909t3145r1938b3226],
22	150	CD	NUMBER	150	num	23	SENT_224	[p12l2043t3154r2106b3185],
23	E3	NN	O	e3	dobj	21	SENT_224	[p12l742t3235r815b3389],
24	100	CD	NUMBER	100	number	25	SENT_224	[p12l879t3290r942b3323],
25	1	CD	NUMBER	1	num	23	SENT_224	[p12l1484t3291r1514b3340],
26	'	''	O	'	_	0	SENT_224	[p12l1484t3291r1514b3340],
27	_	CD	NUMBER	_	dep	23	SENT_224	[p12l1909t3275r1938b3350],
28	|	CD	NUMBER	|	num	29	SENT_224	[p12l1909t3275r1938b3350],
29	_	NN	O	_	dep	36	SENT_224	[p12l1909t3275r1938b3350],
30	100	CD	NUMBER	100	num	33	SENT_224	[p12l2043t3295r2107b3327],
31	F	NN	ORGANIZATION	f	nn	33	SENT_224	[p12l745t3393r813b3453],
32	L	NN	ORGANIZATION	l	nn	33	SENT_224	[p12l1484t3388r1514b3457],
33	T	NN	ORGANIZATION	t	dep	29	SENT_224	[p12l1909t3387r1938b3419],
34	E	NN	ORGANIZATION	e	dep	36	SENT_224	[p12l745t3456r813b3545],
35	50	CD	NUMBER	50	num	34	SENT_224	[p12l900t3437r944b3469],
36	T.	NNP	O	T.	dep	43	SENT_224	[p12l1061t3450r1175b3490],
37	,	,	O	,	_	0	SENT_224	[p12l1061t3450r1175b3490],
38	_	CD	NUMBER	_	appos	36	SENT_224	[p12l1061t3450r1175b3490],
39	,	,	O	,	_	0	SENT_224	[p12l1061t3450r1175b3490],
40	__	CD	NUMBER	__	num	41	SENT_224	[p12l1061t3450r1175b3490],
41	__	CD	NUMBER	__	appos	36	SENT_224	[p12l1229t3482r1259b3491],
42	_	NN	O	_	nn	43	SENT_224	[p12l1909t3466r1938b3498],
43	L	NN	O	l	dep	44	SENT_224	[p12l1909t3466r1938b3498],
44	50	CD	NUMBER	50	dep	21	SENT_224	[p12l2065t3441r2110b3475],

1	‘	NN	O	‘	nsubj	2	SENT_225	[p12l1061t3524r1091b3545],
2	L	NN	O	l	_	0	SENT_225	[p12l1061t3524r1091b3545],
3	.	.	O	.	_	0	SENT_225	[p12l1484t3506r1514b3531],

1	|	NN	O	|	_	0	SENT_226	[p12l1484t3506r1514b3531],
2	.	.	O	.	_	0	SENT_226	[p12l1484t3506r1514b3531],

1	Mg/mL	NNP	O	Mg/mL	nn	2	SENT_227	[p13l1155t59r1430b151],
2	Collagen	NNP	O	Collagen	_	0	SENT_227	[p13l1458t59r1824b153],

1	Cooke	NNP	PERSON	Cooke	_	0	SENT_228	[p13l1543t290r1712b341],
2	et	FW	O	et	nn	3	SENT_228	[p13l1739t293r1794b341],
3	al.	FW	O	al.	dep	1	SENT_228	[p13l1814t290r1879b341],
4	545	CD	NUMBER	545	dep	1	SENT_228	[p13l2046t291r2154b341],

1	PI	NN	O	pi	_	0	SENT_229	[p13l466t357r547b416],
2	“	NN	O	“	dep	1	SENT_229	[p13l466t357r547b416],
3	and	CC	O	and	_	0	SENT_229	[p13l570t366r668b417],
4	Responsiveness	NN	O	responsiveness	dep	1	SENT_229	[p13l697t366r1127b426],
5	to	TO	O	to	_	0	SENT_229	[p13l1149t368r1204b417],
6	Aspirin	NN	MISC	aspirin	prep_to	2	SENT_229	[p13l1227t366r1418b426],
7	and	CC	O	and	_	0	SENT_229	[p13l1444t366r1542b417],
8	clopidogrel	NN	O	clopidogrel	prep_to	2	SENT_229	[p13l1568t365r1878b426],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_230	[p13l104t455r468b524],
2	Aspirin	NNP	O	Aspirin	dep	1	SENT_230	[p13l867t456r1096b525],
3	+	CC	O	+	_	0	SENT_230	[p13l1118t470r1159b509],
4	Clopidogrel	NNP	O	Clopidogrel	dep	1	SENT_230	[p13l1181t456r1546b525],

1	150	CD	NUMBER	150	num	2	SENT_231	[p13l749t1100r796b1125],
2	T	NN	O	t	_	0	SENT_231	[p13l1207t1125r1230b1177],
3	100	CD	NUMBER	100	number	4	SENT_231	[p13l749t1207r796b1231],
4	50	CD	NUMBER	50	num	5	SENT_231	[p13l765t1316r798b1342],
5	T	NN	O	t	dep	2	SENT_231	[p13l1013t1303r1036b1326],
6	i	FW	O	i	dep	5	SENT_231	[p13l1531t1233r1554b1351],

1	o	NN	O	o	_	0	SENT_232	[p13l11t1472r28b1496],
2	l	NN	O	l	num	7	SENT_232	[p13l80t1473r90b1496],
3	2	CD	NUMBER	2	number	2	SENT_232	[p13l143t1472r158b1496],
4	5	CD	NUMBER	5	number	2	SENT_232	[p13l335t1472r350b1496],
5	10	CD	NUMBER	10	number	2	SENT_232	[p13l647t1472r678b1496],
6	O	NN	O	o	nn	7	SENT_232	[p13l890t1472r906b1496],
7	l	NN	O	l	dep	1	SENT_232	[p13l960t1473r969b1496],
8	2	CD	NUMBER	2	dep	7	SENT_232	[p13l1022t1472r1037b1496],
9	A	DT	O	a	det	11	SENT_232	[p13l1138t1445r1140b1447],
10	5	CD	NUMBER	5	num	11	SENT_232	[p13l1215t1472r1229b1496],
11	lo	NN	O	lo	dep	1	SENT_232	[p13l1528t1472r1558b1496],

1	ug/mL	NN	O	ug/ml	_	0	SENT_233	[p13l86t1576r293b1647],
2	Collagen	NNP	O	Collagen	nn	4	SENT_233	[p13l315t1576r591b1647],
3	ug/mL	NNP	O	ug/mL	nn	4	SENT_233	[p13l960t1576r1167b1646],
4	Collagen	NNP	O	Collagen	dep	1	SENT_233	[p13l1189t1576r1465b1646],

1	,	,	O	,	_	0	SENT_234	[p13l6t1683r145b1704],
2	a	DT	O	a	dep	5	SENT_234	[p13l6t1683r145b1704],
3	_	NN	O	_	nn	5	SENT_234	[p13l6t1683r145b1704],
4	P1A1/A1	NN	O	p1a1/a1	nn	5	SENT_234	[p13l173t1667r368b1718],
5	—	NN	O	—	_	0	SENT_234	[p13l6t1753r145b1773],
6	+	CC	O	+	_	0	SENT_234	[p13l6t1753r145b1773],
7	_	NN	O	_	nn	9	SENT_234	[p13l6t1753r145b1773],
8	p1A1/A2	NN	O	p1a1/a2	nn	9	SENT_234	[p13l173t1737r372b1788],
9	J.	NNP	O	J.	conj_+	5	SENT_234	[p13l331t1359r354b1386],

1	Figure	NNP	O	Figure	_	0	SENT_235	[p13l43t1833r126b1862],
2	4	CD	NUMBER	4	dep	1	SENT_235	[p13l138t1833r164b1857],
3	.	.	O	.	_	0	SENT_235	[p13l138t1833r164b1857],

1	Collagen	NNP	O	Collagen	nn	2	SENT_236	[p13l183t1833r456b1866],
2	—	NN	O	—	nsubj	3	SENT_236	[p13l183t1833r456b1866],
3	stimulated	VBD	O	stimulate	_	0	SENT_236	[p13l183t1833r456b1866],
4	PIA1/A1	NN	O	pia1/a1	nn	5	SENT_236	[p13l469t1828r566b1857],
5	platelets	NNS	O	platelet	nsubj	9	SENT_236	[p13l580t1833r689b1866],
6	were	VBD	O	be	cop	9	SENT_236	[p13l701t1842r764b1857],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_236	[p13l778t1833r939b1866],
8	more	RBR	O	more	advmod	9	SENT_236	[p13l951t1842r1019b1857],
9	inhibited	VBN	O	inhibit	ccomp	3	SENT_236	[p13l1032t1833r1153b1858],
10	by	IN	O	by	_	0	SENT_236	[p13l1165t1833r1198b1866],
11	acetylsalicylic	JJ	O	acetylsalicylic	amod	15	SENT_236	[p13l1210t1833r1387b1866],
12	acid	NN	O	acid	nn	15	SENT_236	[p13l1401t1833r1454b1858],
13	(	NN	O	(	nn	15	SENT_236	[p13l1468t1832r1576b1866],
14	aspirin	NN	O	aspirin	nn	15	SENT_236	[p13l1468t1832r1576b1866],
15	)	NN	O	)	prep_by	9	SENT_236	[p13l1468t1832r1576b1866],
16	than	IN	O	than	mark	19	SENT_236	[p13l1591t1833r1650b1858],
17	PIA1/A2	NN	O	pia1/a2	nn	18	SENT_236	[p13l1664t1828r1762b1857],
18	platelets	NNS	O	platelet	nsubj	19	SENT_236	[p13l1775t1833r1884b1866],
19	(	VBP	O	(	ccomp	9	SENT_236	[p13l1899t1832r1924b1866],
20	p	NN	O	p	nsubj	25	SENT_236	[p13l1899t1832r1924b1866],
21	<	JJR	O	<	dep	25	SENT_236	[p13l1940t1836r1962b1856],
22	0.0001	CD	NUMBER	0.0001	num	23	SENT_236	[p13l1978t1832r2078b1863],
23	)	NN	O	)	npadvmod	24	SENT_236	[p13l1978t1832r2078b1863],
24	as	IN	O	as	advmod	25	SENT_236	[p13l2093t1842r2117b1857],
25	assessed	VBN	O	assess	xcomp	19	SENT_236	[p13l43t1870r149b1895],
26	by	IN	O	by	_	0	SENT_236	[p13l161t1870r193b1903],
27	ﬂuorescein	NN	O	ﬂuorescein	nn	28	SENT_236	[p13l203t1870r346b1895],
28	isothiocyanate	NN	O	isothiocyanate	prep_by	25	SENT_236	[p13l358t1870r699b1903],
29	—	CD	NUMBER	—	num	31	SENT_236	[p13l358t1870r699b1903],
30	ﬁbrinogen	NN	O	ﬁbrinogen	nn	31	SENT_236	[p13l358t1870r699b1903],
31	binding	NN	O	binding	dobj	25	SENT_236	[p13l710t1870r814b1903],
32	(	CD	NUMBER	(	num	35	SENT_236	[p13l827t1869r909b1900],
33	mean	NN	O	mean	nn	35	SENT_236	[p13l827t1869r909b1900],
34	ﬂuorescence	NN	O	ﬂuorescence	nn	35	SENT_236	[p13l921t1870r1082b1895],
35	units	NNS	O	unit	dep	31	SENT_236	[p13l1094t1871r1159b1895],
36	:	:	O	:	_	0	SENT_236	[p13l1174t1873r1195b1893],
37	SEM	NN	O	sem	nn	38	SENT_236	[p13l1211t1869r1301b1900],
38	)	NN	O	)	dep	31	SENT_236	[p13l1211t1869r1301b1900],
39	.	.	O	.	_	0	SENT_236	[p13l1211t1869r1301b1900],

1	Multiple	JJ	O	multiple	amod	2	SENT_237	[p13l1314t1870r1431b1903],
2	comparisons	NNS	O	comparison	nsubj	3	SENT_237	[p13l1443t1871r1608b1903],
3	(	VBP	O	(	dep	16	SENT_237	[p13l1622t1869r1667b1900],
4	six	CD	NUMBER	six	dobj	3	SENT_237	[p13l1622t1869r1667b1900],
5	included	VBN	O	include	partmod	4	SENT_237	[p13l1678t1870r1792b1895],
6	in	IN	O	in	_	0	SENT_237	[p13l1804t1871r1830b1894],
7	adjustment	NN	O	adjustment	prep_in	5	SENT_237	[p13l1842t1870r1990b1903],
8	per	IN	O	per	_	0	SENT_237	[p13l2001t1879r2043b1903],
9	plot	NN	O	plot	nn	10	SENT_237	[p13l2054t1869r2116b1903],
10	)	NN	O	)	prep_per	7	SENT_237	[p13l2054t1869r2116b1903],
11	at	IN	O	at	_	0	SENT_237	[p13l43t1914r67b1932],
12	each	DT	O	each	det	13	SENT_237	[p13l79t1907r138b1932],
13	concentrations	NNS	O	concentration	prep_at	5	SENT_237	[p13l151t1908r344b1932],
14	of	IN	O	of	_	0	SENT_237	[p13l358t1907r388b1932],
15	collagen	NN	O	collagen	prep_of	13	SENT_237	[p13l396t1907r504b1941],
16	revealed	VBD	O	reveal	_	0	SENT_237	[p13l516t1907r624b1932],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_237	[p13l637t1907r774b1941],
18	differences	NNS	O	difference	nsubj	19	SENT_237	[p13l786t1907r925b1932],
19	(	VBP	O	(	ccomp	16	SENT_237	[p13l939t1907r965b1941],
20	p	NN	O	p	dep	21	SENT_237	[p13l939t1907r965b1941],
21	<	JJR	O	<	dobj	19	SENT_237	[p13l980t1911r1002b1931],
22	0.05	CD	NUMBER	0.05	num	23	SENT_237	[p13l1017t1907r1084b1938],
23	)	NN	O	)	nsubj	16	SENT_237	[p13l1017t1907r1084b1938],
24	between	IN	O	between	_	0	SENT_237	[p13l1097t1908r1207b1932],
25	PIA	NNP	O	PIA	prep_between	23	SENT_237	[p13l1219t1903r1287b1932],
26	“	CD	NUMBER	“	num	25	SENT_237	[p13l1219t1903r1287b1932],
27	A1	NN	O	a1	nn	30	SENT_237	[p13l1287t1903r1317b1918],
28	and	CC	O	and	_	0	SENT_237	[p13l1331t1907r1379b1932],
29	PIAI/A2	NN	O	piai/a2	nn	30	SENT_237	[p13l1391t1903r1489b1932],
30	platelets	NNS	O	platelet	dep	23	SENT_237	[p13l1501t1907r1610b1941],
31	as	IN	O	as	_	0	SENT_237	[p13l1624t1917r1647b1932],
32	indicated	VBN	O	indicate	prep_as	30	SENT_237	[p13l1660t1907r1789b1932],
33	.	.	O	.	_	0	SENT_237	[p13l1660t1907r1789b1932],

1	*	NN	O	*	nsubj	2	SENT_238	[p13l1803t1907r1915b1941],
2	Applies	VBZ	O	apply	_	0	SENT_238	[p13l1803t1907r1915b1941],
3	for	IN	O	for	_	0	SENT_238	[p13l1928t1907r1966b1932],
4	differences	NNS	O	difference	prep_for	2	SENT_238	[p13l1978t1907r2117b1932],
5	between	IN	O	between	_	0	SENT_238	[p13l42t1945r152b1970],
6	PIA1/A1	NN	O	pia1/a1	prep_between	4	SENT_238	[p13l165t1940r262b1970],
7	and	CC	O	and	_	0	SENT_238	[p13l276t1945r324b1970],
8	PIA1/A2	NN	O	pia1/a2	prep_between	4	SENT_238	[p13l336t1940r441b1970],
9	.	.	O	.	_	0	SENT_238	[p13l336t1940r441b1970],

1	ASA	NN	O	asa	_	0	SENT_239	[p13l8t2077r190b2145],
2	that	WDT	O	that	nsubj	4	SENT_239	[p13l250t2078r392b2145],
3	can	MD	O	can	aux	4	SENT_239	[p13l453t2105r571b2145],
4	Vary	VB	O	vary	ccomp	1	SENT_239	[p13l629t2104r779b2168],
5	with	IN	O	with	_	0	SENT_239	[p13l833t2078r995b2145],
6	the	DT	O	the	det	9	SENT_239	[p13l1057t2079r1167b2145],
7	agonist	NN	O	agonist	nn	9	SENT_239	[p13l1231t2081r1486b2168],
8	(	NN	O	(	nn	9	SENT_239	[p13l1549t2076r1998b2168],
9	epinephrine	NN	O	epinephrine	prep_with	4	SENT_239	[p13l1549t2076r1998b2168],
10	vs.	CC	O	vs.	prep	9	SENT_239	[p13l2057t2105r2146b2145],
11	collagen	NN	O	collagen	nn	12	SENT_239	[p13l11t2182r349b2274],
12	)	NN	O	)	dep	10	SENT_239	[p13l11t2182r349b2274],
13	.	.	O	.	_	0	SENT_239	[p13l11t2182r349b2274],

1	Macchi	NNP	PERSON	Macchi	nsubj	8	SENT_240	[p13l387t2185r656b2251],
2	et	FW	O	et	dep	1	SENT_240	[p13l693t2201r757b2251],
3	al.	FW	O	al.	nn	4	SENT_240	[p13l792t2185r866b2251],
4	(	FW	O	(	dep	1	SENT_240	[p13l909t2182r1048b2265],
5	26	CD	NUMBER	26	number	6	SENT_240	[p13l909t2182r1048b2265],
6	)	CD	NUMBER	)	dep	4	SENT_240	[p13l909t2182r1048b2265],
7	further	JJ	O	further	quantmod	6	SENT_240	[p13l1087t2184r1334b2251],
8	substantiate	VB	O	substantiate	_	0	SENT_240	[p13l1369t2185r1788b2251],
9	this	DT	O	this	det	10	SENT_240	[p13l1824t2184r1952b2251],
10	concept	NN	O	concept	dobj	8	SENT_240	[p13l1990t2211r2147b2251, p13l11t2308r158b2380],
11	in	IN	O	in	_	0	SENT_240	[p13l197t2293r265b2355],
12	a	DT	O	a	det	13	SENT_240	[p13l307t2317r342b2356],
13	study	NN	O	study	prep_in	10	SENT_240	[p13l383t2290r573b2380],
14	that	WDT	O	that	nsubj	15	SENT_240	[p13l609t2290r751b2356],
15	demonstrated	VBD	O	demonstrate	rcmod	13	SENT_240	[p13l791t2290r1278b2356],
16	ASA-resistant	JJ	O	asa-resistant	amod	17	SENT_240	[p13l1316t2289r1832b2356],
17	patients	NNS	O	patient	nsubj	20	SENT_240	[p13l1870t2293r2149b2380],
18	were	VBD	O	be	cop	20	SENT_240	[p13l7t2423r174b2464],
19	more	RBR	O	more	advmod	20	SENT_240	[p13l201t2423r380b2464],
20	likely	JJ	O	likely	ccomp	15	SENT_240	[p13l404t2397r597b2487],
21	to	TO	O	to	aux	22	SENT_240	[p13l618t2414r686b2464],
22	be	VB	O	be	xcomp	20	SENT_240	[p13l711t2397r791b2464],
23	of	IN	O	of	_	0	SENT_240	[p13l818t2397r898b2464],
24	the	DT	O	the	det	26	SENT_240	[p13l910t2397r1021b2464],
25	PlA1/A1	NN	O	pla1/a1	nn	26	SENT_240	[p13l1047t2381r1307b2463],
26	genotype	NN	O	genotype	prep_of	22	SENT_240	[p13l1334t2414r1674b2487],
27	.	.	O	.	_	0	SENT_240	[p13l1334t2414r1674b2487],

1	In	IN	O	in	_	0	SENT_241	[p13l1703t2398r1779b2463],
2	this	DT	O	this	det	3	SENT_241	[p13l1802t2397r1924b2464],
3	study	NN	O	study	prep_in	9	SENT_241	[p13l1950t2397r2147b2487],
4	,	,	O	,	_	0	SENT_241	[p13l1950t2397r2147b2487],
5	resistance	NN	O	resistance	nsubjpass	9	SENT_241	[p13l10t2506r335b2570],
6	to	TO	O	to	_	0	SENT_241	[p13l369t2521r436b2570],
7	ASA	NN	O	asa	prep_to	5	SENT_241	[p13l467t2502r646b2570],
8	was	VBD	O	be	auxpass	9	SENT_241	[p13l674t2530r800b2570],
9	determined	VBN	O	determine	_	0	SENT_241	[p13l836t2503r1226b2570],
10	with	IN	O	with	_	0	SENT_241	[p13l1254t2503r1411b2570],
11	the	DT	O	the	det	17	SENT_241	[p13l1444t2503r1551b2570],
12	platelet	NN	O	platelet	nn	17	SENT_241	[p13l1583t2503r1833b2593],
13	function	NN	O	function	nn	17	SENT_241	[p13l1865t2503r2150b2570],
14	analyzer	NN	O	analyzer	nn	17	SENT_241	[p13l12t2609r289b2699],
15	(	CD	NUMBER	(	num	17	SENT_241	[p13l333t2607r734b2690],
16	PFA	NN	ORGANIZATION	pfa	nn	17	SENT_241	[p13l333t2607r734b2690],
17	—	NN	O	—	prep_with	9	SENT_241	[p13l333t2607r734b2690],
18	100	CD	NUMBER	100	number	19	SENT_241	[p13l333t2607r734b2690],
19	)	CD	NUMBER	)	dep	17	SENT_241	[p13l333t2607r734b2690],
20	,	,	O	,	_	0	SENT_241	[p13l333t2607r734b2690],
21	utilizing	VBG	O	utilize	partmod	17	SENT_241	[p13l778t2610r1061b2699],
22	a	DT	O	a	det	24	SENT_241	[p13l1103t2636r1138b2676],
23	collagen/epinephrine-coated	JJ	O	collagen/epinephrine-coated	amod	24	SENT_241	[p13l1180t2609r2151b2699],
24	cartridge	NN	O	cartridge	dobj	21	SENT_241	[p13l11t2716r325b2806],
25	.	.	O	.	_	0	SENT_241	[p13l11t2716r325b2806],

1	It	PRP	O	it	nsubj	3	SENT_242	[p13l365t2717r425b2783],
2	is	VBZ	O	be	cop	3	SENT_242	[p13l460t2719r511b2783],
3	possible	JJ	O	possible	_	0	SENT_242	[p13l549t2716r829b2806],
4	that	IN	O	that	complm	14	SENT_242	[p13l867t2716r1009b2783],
5	in	IN	O	in	_	0	SENT_242	[p13l1044t2719r1112b2782],
6	stimulating	VBG	O	stimulate	prepc_in	14	SENT_242	[p13l1150t2716r1553b2806],
7	platelets	NNS	O	platelet	dobj	6	SENT_242	[p13l1587t2716r1878b2806],
8	in	IN	O	in	_	0	SENT_242	[p13l1916t2719r1984b2782],
9	this	DT	O	this	det	10	SENT_242	[p13l2021t2716r2149b2783],
10	system	NN	O	system	prep_in	6	SENT_242	[p13l12t2877r268b2950],
11	,	,	O	,	_	0	SENT_242	[p13l12t2877r268b2950],
12	epinephrine	NN	O	epinephrine	nsubj	14	SENT_242	[p13l334t2861r756b2950],
13	may	MD	O	may	aux	14	SENT_242	[p13l820t2887r968b2950],
14	yield	VB	O	yield	ccomp	3	SENT_242	[p13l1024t2860r1194b2950],
15	the	DT	O	the	nsubj	16	SENT_242	[p13l1256t2860r1366b2927],
16	predominate	VBP	O	predominate	ccomp	14	SENT_242	[p13l1428t2860r1878b2950],
17	effect	NN	O	effect	dobj	16	SENT_242	[p13l1942t2860r2145b2927],
18	.	.	O	.	_	0	SENT_242	[p13l1942t2860r2145b2927],

1	These	DT	O	these	det	2	SENT_243	[p13l8t2965r225b3033],
2	results	NNS	O	result	nsubj	4	SENT_243	[p13l273t2967r497b3033],
3	may	MD	O	may	aux	4	SENT_243	[p13l547t2993r696b3056],
4	help	VB	O	help	_	0	SENT_243	[p13l739t2966r889b3056],
5	to	TO	O	to	aux	6	SENT_243	[p13l938t2983r1007b3033],
6	understand	VB	O	understand	xcomp	4	SENT_243	[p13l1055t2966r1453b3033],
7	and	CC	O	and	_	0	SENT_243	[p13l1501t2966r1629b3033],
8	reconcile	VB	O	reconcile	xcomp	4	SENT_243	[p13l1676t2967r1991b3033],
9	the	DT	O	the	det	11	SENT_243	[p13l2039t2966r2149b3033],
10	divergent	JJ	O	divergent	amod	11	SENT_243	[p13l11t3073r344b3163],
11	results	NNS	O	result	dobj	6	SENT_243	[p13l375t3073r598b3140],
12	reported	VBD	O	report	rcmod	11	SENT_243	[p13l633t3073r950b3163],
13	.	.	O	.	_	0	SENT_243	[p13l633t3073r950b3163],

1	In	IN	O	in	_	0	SENT_244	[p13l99t3180r177b3245],
2	their	PRP$	O	they	poss	4	SENT_244	[p13l206t3179r373b3246],
3	interesting	JJ	O	interesting	amod	4	SENT_244	[p13l400t3182r780b3269],
4	study	NN	O	study	pobj	1	SENT_244	[p13l809t3179r998b3269],
5	of	IN	O	of	_	0	SENT_244	[p13l1025t3179r1104b3246],
6	post	NN	O	post	prep_of	4	SENT_244	[p13l1120t3180r1424b3269],
7	.	.	O	.	_	0	SENT_244	[p13l1120t3180r1424b3269],

1	—	NN	O	—	_	0	SENT_245	[p13l1120t3180r1424b3269],
2	.	.	O	.	_	0	SENT_245	[p13l1120t3180r1424b3269],

1	MI	NN	O	mi	nn	2	SENT_246	[p13l1120t3180r1424b3269],
2	patients	NNS	O	patient	nsubj	28	SENT_246	[p13l1453t3182r1753b3269],
3	,	,	O	,	_	0	SENT_246	[p13l1453t3182r1753b3269],
4	Moshfegh	NNP	O	Moshfegh	appos	2	SENT_246	[p13l1783t3179r2150b3269],
5	et	FW	O	et	nsubj	10	SENT_246	[p13l11t3303r75b3352],
6	al.	FW	O	al.	nn	9	SENT_246	[p13l110t3285r184b3352],
7	(	FW	O	(	dep	9	SENT_246	[p13l225t3283r363b3366],
8	27	CD	NUMBER	27	num	9	SENT_246	[p13l225t3283r363b3366],
9	)	NN	O	)	advmod	10	SENT_246	[p13l225t3283r363b3366],
10	reported	VBD	O	report	rcmod	4	SENT_246	[p13l401t3285r701b3375],
11	greater	JJR	O	greater	amod	12	SENT_246	[p13l733t3303r979b3375],
12	inhibition	NN	O	inhibition	dobj	10	SENT_246	[p13l1012t3286r1365b3352],
13	with	IN	O	with	_	0	SENT_246	[p13l1395t3285r1557b3352],
14	clopidogrel	NN	O	clopidogrel	prep_with	10	SENT_246	[p13l1592t3285r1988b3375],
15	and	CC	O	and	_	0	SENT_246	[p13l2023t3286r2151b3352],
16	combination	NN	O	combination	conj_and	14	SENT_246	[p13l11t3391r459b3458],
17	of	IN	O	of	_	0	SENT_246	[p13l491t3391r572b3458],
18	ASA	NN	O	asa	prep_of	14	SENT_246	[p13l589t3390r771b3458],
19	plus	CC	O	plus	_	0	SENT_246	[p13l800t3392r941b3481],
20	clopidogrel	NN	O	clopidogrel	appos	2	SENT_246	[p13l975t3391r1372b3481],
21	compared	VBN	O	compare	_	0	SENT_246	[p13l1403t3391r1752b3481],
22	with	IN	O	with	prepc_compared_with	20	SENT_246	[p13l1779t3391r1941b3458],
23	ASA	NN	O	asa	pobj	20	SENT_246	[p13l1970t3390r2152b3458],
24	alone	RB	O	alone	advmod	23	SENT_246	[p13l12t3498r197b3564],
25	in	IN	O	in	_	0	SENT_246	[p13l244t3500r312b3563],
26	ADP	NN	O	adp	nn	27	SENT_246	[p13l356t3496r960b3564],
27	—	NN	O	—	prep_in	23	SENT_246	[p13l356t3496r960b3564],
28	stimulated	VBD	O	stimulate	_	0	SENT_246	[p13l356t3496r960b3564],
29	aggregation	NN	O	aggregation	dobj	28	SENT_246	[p13l1007t3500r1421b3587],
30	in	IN	O	in	_	0	SENT_246	[p13l1467t3500r1535b3563],
31	Vitro	NNP	O	Vitro	prep_in	28	SENT_246	[p13l1577t3500r1761b3564],
32	.	.	O	.	_	0	SENT_246	[p13l1577t3500r1761b3564],

1	We	PRP	O	we	nsubj	3	SENT_247	[p13l1808t3498r1939b3564],
2	were	VBD	O	be	cop	3	SENT_247	[p13l1982t3523r2149b3564],
3	able	JJ	O	able	_	0	SENT_247	[p13l12t3603r150b3670],
4	to	TO	O	to	aux	5	SENT_247	[p13l174t3620r243b3670],
5	confirm	VB	O	confirm	xcomp	3	SENT_247	[p13l268t3603r543b3670],
6	their	PRP$	O	they	poss	7	SENT_247	[p13l567t3603r735b3670],
7	findings	NNS	O	finding	dobj	5	SENT_247	[p13l756t3603r1040b3693],
8	with	IN	O	with	_	0	SENT_247	[p13l1061t3603r1223b3670],
9	our	PRP$	O	we	poss	10	SENT_247	[p13l1248t3629r1365b3670],
10	study	NN	O	study	prep_with	5	SENT_247	[p13l1388t3603r1578b3693],
11	of	IN	O	of	_	0	SENT_247	[p13l1599t3603r1679b3670],
12	patients	NNS	O	patient	prep_of	10	SENT_247	[p13l1689t3606r1967b3693],
13	with	IN	O	with	prep	5	SENT_247	[p13l1988t3603r2150b3670],

1	Aspirin	NN	O	aspirin	_	0	SENT_248	[p14l860t123r1329b263],

1	100	CD	NUMBER	100	num	2	SENT_249	[p14l140t859r235b909],
2	l	NN	O	l	_	0	SENT_249	[p14l281t902r300b903],
3	i	FW	O	i	dep	2	SENT_249	[p14l1782t734r1827b1003],
4	100	CD	NUMBER	100	dep	2	SENT_249	[p14l1977t863r2074b913],

1	D.	NNP	O	D.	dep	6	SENT_250	[p14l8t982r118b1124],
2	<	JJR	O	<	dep	1	SENT_250	[p14l8t1138r116b1246],
3	75	CD	NUMBER	75	num	4	SENT_250	[p14l174t1174r237b1223],
4	J	NN	O	j	dep	6	SENT_250	[p14l1782t1064r1829b1333],
5	75	CD	NUMBER	75	num	6	SENT_250	[p14l2009t1177r2076b1227],
6	9-4	CD	NUMBER	9-4	_	0	SENT_250	[p14l10t1287r116b1371],
7	as	IN	O	as	_	0	SENT_250	[p14l6t1376r118b1526],
8	T	NN	O	t	nn	9	SENT_250	[p14l1127t1325r1172b1439],
9	T	NN	O	t	prep_as	6	SENT_250	[p14l1784t1460r1829b1534],

1	50	CD	NUMBER	50	num	3	SENT_251	[p14l173t1486r241b1537],
2	n	NN	O	n	nn	3	SENT_251	[p14l2009t1534r2010b1537],
3	np	NN	O	np	_	0	SENT_251	[p14l2045t1510r2046b1521],
4	+	CC	O	+	_	0	SENT_251	[p14l2045t1510r2046b1521],
5	Q	NNP	O	Q	conj_+	3	SENT_251	[p14l10t1535r118b1643],
6	-	:	O	-	_	0	SENT_251	[p14l472t1499r646b1647],
7	I-TT	NN	O	i-tt	dep	3	SENT_251	[p14l472t1499r646b1647],
8	T	NN	O	t	dep	7	SENT_251	[p14l731t1552r777b1615],
9	-	:	O	-	_	0	SENT_251	[p14l1784t1594r1829b1679],
10	L	NN	O	l	dep	3	SENT_251	[p14l1784t1594r1829b1679],
11	50	CD	NUMBER	50	num	14	SENT_251	[p14l2011t1490r2079b1541],
12	U	NNP	O	U	nn	14	SENT_251	[p14l8t1651r118b1746],
13	l	NN	O	l	nn	14	SENT_251	[p14l472t1647r518b1738],
14	_	NN	O	_	dep	10	SENT_251	[p14l536t1706r646b1782],
15	,	,	O	,	_	0	SENT_251	[p14l536t1706r646b1782],
16	__	NN	O	__	appos	14	SENT_251	[p14l536t1706r646b1782],
17	4	CD	NUMBER	4	num	16	SENT_251	[p14l731t1674r777b1732],
18	.	.	O	.	_	0	SENT_251	[p14l731t1674r777b1732],

1	ug/mL	NN	O	ug/ml	nsubj	4	SENT_252	[p14l585t2471r1011b2613],
2	Collagen	NNP	O	Collagen	dep	4	SENT_252	[p14l1055t2471r1619b2615],
3	stable	JJ	O	stable	amod	4	SENT_252	[p14l12t2776r210b2843],
4	CI-ID	NN	O	ci-id	_	0	SENT_252	[p14l243t2776r470b2843],
5	.	.	O	.	_	0	SENT_252	[p14l243t2776r470b2843],

1	Thus	RB	O	thus	advmod	5	SENT_253	[p14l502t2775r708b2857],
2	,	,	O	,	_	0	SENT_253	[p14l502t2775r708b2857],
3	it	PRP	O	it	nsubj	5	SENT_253	[p14l741t2779r791b2843],
4	is	VBZ	O	be	cop	5	SENT_253	[p14l820t2779r870b2843],
5	possible	JJ	O	possible	_	0	SENT_253	[p14l901t2777r1180b2866],
6	that	IN	O	that	complm	27	SENT_253	[p14l1211t2776r1353b2843],
7	the	DT	O	the	det	9	SENT_253	[p14l1381t2777r1491b2843],
8	clinical	JJ	O	clinical	amod	9	SENT_253	[p14l1523t2776r1771b2843],
9	beneﬁt	NN	O	beneﬁt	nsubj	27	SENT_253	[p14l1799t2776r2044b2843],
10	of	IN	O	of	_	0	SENT_253	[p14l2073t2776r2153b2843],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_253	[p14l11t2882r424b2972],
12	,	,	O	,	_	0	SENT_253	[p14l11t2882r424b2972],
13	when	WRB	O	when	advmod	19	SENT_253	[p14l483t2882r677b2949],
14	added	VBN	O	add	dep	19	SENT_253	[p14l737t2882r948b2949],
15	to	TO	O	to	_	0	SENT_253	[p14l1006t2899r1074b2949],
16	ASA	NN	O	asa	prep_to	14	SENT_253	[p14l1132t2881r1332b2963],
17	,	,	O	,	_	0	SENT_253	[p14l1132t2881r1332b2963],
18	is	VBZ	O	be	auxpass	19	SENT_253	[p14l1394t2885r1444b2949],
19	mediated	VBN	O	mediate	dep	11	SENT_253	[p14l1506t2882r1832b2949],
20	by	IN	O	by	_	0	SENT_253	[p14l1888t2882r1975b2972],
21	the	DT	O	the	det	23	SENT_253	[p14l2030t2882r2140b2949],
22	incremental	JJ	O	incremental	amod	23	SENT_253	[p14l10t2988r435b3055],
23	inhibition	NN	O	inhibition	agent	19	SENT_253	[p14l496t2988r852b3055],
24	of	IN	O	of	_	0	SENT_253	[p14l916t2988r996b3055],
25	ADP	NN	O	adp	nn	26	SENT_253	[p14l1045t2987r1652b3055],
26	—	NN	O	—	prep_of	23	SENT_253	[p14l1045t2987r1652b3055],
27	stimulated	VBD	O	stimulate	ccomp	5	SENT_253	[p14l1045t2987r1652b3055],
28	platelet	NN	O	platelet	nn	29	SENT_253	[p14l1713t2988r1978b3078],
29	response	NN	O	response	dobj	27	SENT_253	[p14l2039t3014r2138b3055, p14l12t3121r263b3184],
30	.	.	O	.	_	0	SENT_253	[p14l2039t3014r2138b3055, p14l12t3121r263b3184],

1	In	IN	O	in	_	0	SENT_254	[p14l302t3095r379b3160],
2	the	DT	O	the	det	4	SENT_254	[p14l414t3094r524b3161],
3	CAPRIE	JJ	O	caprie	amod	4	SENT_254	[p14l562t3093r898b3161],
4	trial	NN	O	trial	prep_in	12	SENT_254	[p14l934t3095r1093b3176],
5	,	,	O	,	_	0	SENT_254	[p14l934t3095r1093b3176],
6	the	DT	O	the	det	7	SENT_254	[p14l1130t3094r1240b3161],
7	use	NN	O	use	nsubjpass	12	SENT_254	[p14l1275t3121r1386b3161],
8	of	IN	O	of	_	0	SENT_254	[p14l1422t3094r1502b3161],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_254	[p14l1526t3094r1920b3184],
10	alone	RB	O	alone	advmod	12	SENT_254	[p14l1955t3094r2140b3161],
11	was	VBD	O	be	auxpass	12	SENT_254	[p14l7t3227r136b3267],
12	shown	VBN	O	show	_	0	SENT_254	[p14l181t3201r409b3267],
13	superior	JJ	O	superior	acomp	12	SENT_254	[p14l453t3203r738b3290],
14	to	TO	O	to	_	0	SENT_254	[p14l778t3217r847b3267],
15	ASA	NN	O	asa	prep_to	12	SENT_254	[p14l888t3199r1087b3281],
16	,	,	O	,	_	0	SENT_254	[p14l888t3199r1087b3281],
17	although	IN	O	although	mark	26	SENT_254	[p14l1134t3200r1446b3290],
18	the	DT	O	the	det	19	SENT_254	[p14l1488t3200r1598b3267],
19	difference	NN	O	difference	nsubj	26	SENT_254	[p14l1643t3200r1982b3267],
20	between	IN	O	between	_	0	SENT_254	[p14l2023t3200r2138b3267, p14l10t3323r219b3373],
21	the	DT	O	the	det	23	SENT_254	[p14l252t3307r362b3373],
22	two	CD	NUMBER	two	num	23	SENT_254	[p14l395t3324r524b3373],
23	inhibitors	NNS	O	inhibitor	prep_between	19	SENT_254	[p14l558t3306r899b3373],
24	was	VBD	O	be	cop	26	SENT_254	[p14l929t3333r1058b3373],
25	marginal	JJ	O	marginal	amod	26	SENT_254	[p14l1093t3307r1405b3396],
26	(	NN	O	(	advcl	12	SENT_254	[p14l1439t3304r1599b3387],
27	10	CD	NUMBER	10	num	28	SENT_254	[p14l1439t3304r1599b3387],
28	)	NN	O	)	dep	26	SENT_254	[p14l1439t3304r1599b3387],
29	.	.	O	.	_	0	SENT_254	[p14l1439t3304r1599b3387],

1	In	IN	O	in	_	0	SENT_255	[p14l1635t3307r1712b3372],
2	the	DT	O	the	det	4	SENT_255	[p14l1744t3306r1855b3373],
3	CURE	NN	O	cure	nn	4	SENT_255	[p14l1890t3306r2139b3373],
4	trial	NN	O	trial	prep_in	30	SENT_255	[p14l10t3413r170b3493],
5	,	,	O	,	_	0	SENT_255	[p14l10t3413r170b3493],
6	the	DT	O	the	det	10	SENT_255	[p14l226t3412r332b3479],
7	first	JJ	ORDINAL	first	amod	10	SENT_255	[p14l384t3412r517b3479],
8	primary	JJ	O	primary	amod	10	SENT_255	[p14l565t3415r835b3502],
9	outcome	NN	O	outcome	nn	10	SENT_255	[p14l883t3430r1175b3479],
10	difference	NN	O	difference	nsubj	30	SENT_255	[p14l1228t3412r1553b3479],
11	between	IN	O	between	_	0	SENT_255	[p14l1603t3413r1886b3479],
12	ASA	NN	O	asa	prepc_between	10	SENT_255	[p14l1935t3411r2142b3479],
13	/	:	O	/	punct	14	SENT_255	[p14l1935t3411r2142b3479],
14	placebo	NN	O	placebo	dep	12	SENT_255	[p14l9t3519r265b3608],
15	Versus	NNP	O	Versus	nn	18	SENT_255	[p14l283t3544r488b3585],
16	ASA/clopidogrel	NNP	O	ASA/clopidogrel	nn	18	SENT_255	[p14l507t3517r1093b3608],
17	combination	NN	O	combination	nn	18	SENT_255	[p14l1113t3519r1541b3585],
18	(	NN	O	(	dep	14	SENT_255	[p14l1564t3516r1737b3599],
19	20	CD	PERCENT	20	number	20	SENT_255	[p14l1564t3516r1737b3599],
20	%	NN	PERCENT	%	amod	24	SENT_255	[p14l1564t3516r1737b3599],
21	relative	JJ	O	relative	amod	24	SENT_255	[p14l1757t3518r1998b3585],
22	risk	NN	O	risk	nn	24	SENT_255	[p14l2019t3519r2145b3585],
23	reduction	NN	O	reduction	nn	24	SENT_255	[p14l10t3622r357b3705],
24	)	NN	O	)	dobj	12	SENT_255	[p14l10t3622r357b3705],
25	was	VBD	O	be	cop	30	SENT_255	[p14l392t3651r518b3691],
26	two	CD	NUMBER	two	number	29	SENT_255	[p14l555t3641r681b3691],
27	to	TO	O	to	dep	29	SENT_255	[p14l718t3641r784b3691],
28	three	CD	NUMBER	three	number	29	SENT_255	[p14l821t3625r992b3691],
29	times	NNS	O	time	npadvmod	30	SENT_255	[p14l1029t3627r1210b3691],
30	greater	JJR	O	greater	_	0	SENT_255	[p14l1246t3641r1481b3714],
31	than	IN	O	than	_	0	SENT_255	[p14l1515t3625r1668b3691],
32	the	DT	O	the	det	34	SENT_255	[p14l1704t3625r1810b3691],
33	outcome	NN	O	outcome	nn	34	SENT_255	[p14l1848t3641r2140b3691],
34	difference	NN	O	difference	prep_than	30	SENT_255	[p14l11t3730r336b3797],
35	between	IN	O	between	_	0	SENT_255	[p14l382t3731r665b3797],
36	ASA	NN	O	asa	prep_between	34	SENT_255	[p14l711t3729r889b3797],
37	and	CC	O	and	_	0	SENT_255	[p14l937t3730r1060b3797],
38	clopidogrel	NN	O	clopidogrel	nn	40	SENT_255	[p14l1109t3730r1486b3820],
39	(	CD	NUMBER	(	num	40	SENT_255	[p14l1535t3728r1907b3811],
40	CAPRIE	NNP	O	CAPRIE	prep_than	30	SENT_255	[p14l1535t3728r1907b3811],
41	:	:	O	:	_	0	SENT_255	[p14l1535t3728r1907b3811],
42	~	CD	PERCENT	~	number	43	SENT_255	[p14l1964t3734r2140b3797],
43	9	CD	PERCENT	9	num	44	SENT_255	[p14l1964t3734r2140b3797],
44	%	NN	PERCENT	%	dep	40	SENT_255	[p14l1964t3734r2140b3797],

1	relative	JJ	O	relative	amod	3	SENT_256	[p15l10t16r263b83],
2	risk	NN	O	risk	nn	3	SENT_256	[p15l305t16r436b83],
3	reduction	NN	O	reduction	_	0	SENT_256	[p15l472t14r835b97],
4	)	CD	NUMBER	)	number	5	SENT_256	[p15l472t14r835b97],
5	(	CD	NUMBER	(	dep	3	SENT_256	[p15l882t14r1153b98],
6	10,14	CD	NUMBER	10,14	num	7	SENT_256	[p15l882t14r1153b98],
7	)	NN	O	)	dep	5	SENT_256	[p15l882t14r1153b98],
8	.	.	O	.	_	0	SENT_256	[p15l882t14r1153b98],

1	Synergy	NN	O	synergy	nsubj	7	SENT_257	[p15l1202t16r1483b106],
2	between	IN	O	between	_	0	SENT_257	[p15l1518t16r1812b83],
3	receptor	NN	O	receptor	nn	4	SENT_257	[p15l1852t33r2142b106],
4	pathways	NNS	O	pathway	prep_between	1	SENT_257	[p15l9t122r335b212],
5	is	VBZ	O	be	cop	7	SENT_257	[p15l375t125r425b189],
6	plausibly	RB	O	plausibly	advmod	7	SENT_257	[p15l464t122r778b212],
7	responsible	JJ	O	responsible	_	0	SENT_257	[p15l813t122r1206b212],
8	for	IN	O	for	_	0	SENT_257	[p15l1246t122r1346b189],
9	the	DT	O	the	det	11	SENT_257	[p15l1383t122r1493b189],
10	additive	JJ	O	additive	amod	11	SENT_257	[p15l1533t122r1811b189],
11	effect	NN	O	effect	prep_for	7	SENT_257	[p15l1851t122r2036b189],
12	of	IN	O	of	_	0	SENT_257	[p15l2073t122r2153b189],
13	ASA	NN	O	asa	prep_of	11	SENT_257	[p15l8t227r190b295],
14	on	IN	O	on	_	0	SENT_257	[p15l231t255r319b295],
15	platelet	NN	O	platelet	nn	16	SENT_257	[p15l360t228r621b318],
16	inhibition	NN	O	inhibition	prep_on	7	SENT_257	[p15l662t228r1014b295],
17	(	CD	NUMBER	(	num	20	SENT_257	[p15l1060t226r1512b318],
18	TX	NNP	O	TX	nn	20	SENT_257	[p15l1060t226r1512b318],
19	—	NN	O	—	nn	20	SENT_257	[p15l1060t226r1512b318],
20	receptor	NN	O	receptor	dep	16	SENT_257	[p15l1060t226r1512b318],
21	pathway	NN	O	pathway	nn	22	SENT_257	[p15l1552t226r1873b318],
22	)	NN	O	)	dep	16	SENT_257	[p15l1552t226r1873b318],
23	in	IN	O	in	_	0	SENT_257	[p15l1919t231r1987b294],
24	the	DT	O	the	det	25	SENT_257	[p15l2030t228r2140b295],
25	presence	NN	O	presence	prep_in	22	SENT_257	[p15l9t361r311b425],
26	of	IN	O	of	_	0	SENT_257	[p15l368t335r448b402],
27	ADP	NN	O	adp	prep_of	25	SENT_257	[p15l489t334r680b401],
28	as	IN	O	as	_	0	SENT_257	[p15l737t362r801b402],
29	an	DT	O	a	det	30	SENT_257	[p15l859t362r940b402],
30	agonist	NN	O	agonist	prep_as	27	SENT_257	[p15l997t338r1250b425],
31	and	CC	O	and	_	0	SENT_257	[p15l1305t335r1432b402],
32	clopidogrel	NN	O	clopidogrel	conj_and	16	SENT_257	[p15l1488t335r1883b425],
33	as	IN	O	as	_	0	SENT_257	[p15l1938t362r2002b402],
34	an	DT	O	a	det	35	SENT_257	[p15l2060t362r2141b402],
35	inhibitor	NN	O	inhibitor	prep_as	32	SENT_257	[p15l10t478r323b545],
36	of	IN	O	of	_	0	SENT_257	[p15l355t478r435b545],
37	the	DT	O	the	det	40	SENT_257	[p15l455t479r565b545],
38	purinergic	JJ	O	purinergic	amod	40	SENT_257	[p15l598t481r960b568],
39	receptor	NN	O	receptor	nn	40	SENT_257	[p15l992t495r1282b568],
40	pathway	NN	O	pathway	prep_of	35	SENT_257	[p15l1312t478r1625b568],
41	.	.	O	.	_	0	SENT_257	[p15l1312t478r1625b568],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_258	[p15l197t690r686b784],
2	Aspirin	NNP	O	Aspirin	dep	1	SENT_258	[p15l1193t690r1500b783],
3	+	CC	O	+	_	0	SENT_258	[p15l1529t707r1584b760],
4	Clopidogrel	NNP	O	Clopidogrel	dep	1	SENT_258	[p15l1615t689r2102b782],

1	Mg/mL	NN	O	mg/ml	_	0	SENT_259	[p15l108t2222r387b2317],
2	Collagen	NNP	O	Collagen	nn	4	SENT_259	[p15l417t2221r786b2316],
3	ug/mL	NNP	O	ug/mL	nn	4	SENT_259	[p15l1318t2220r1596b2313],
4	Collagen	NNP	O	Collagen	dep	1	SENT_259	[p15l1626t2219r1996b2312],

1	__	NN	O	__	_	0	SENT_260	[p15l6t2366r193b2393],
2	.	.	O	.	_	0	SENT_260	[p15l6t2366r193b2393],

1	—	NN	O	—	_	0	SENT_261	[p15l6t2366r193b2393],
2	.	.	O	.	_	0	SENT_261	[p15l6t2366r193b2393],

1	¢	NN	O	¢	_	0	SENT_262	[p15l6t2366r193b2393],
2	.	.	O	.	_	0	SENT_262	[p15l6t2366r193b2393],

1	—	NN	O	—	_	0	SENT_263	[p15l6t2366r193b2393],
2	.	.	O	.	_	0	SENT_263	[p15l6t2366r193b2393],

1	.	.	O	.	_	0	SENT_264	[p15l6t2366r193b2393],

1	—	NN	O	—	_	0	SENT_265	[p15l6t2366r193b2393],
2	.	.	O	.	_	0	SENT_265	[p15l6t2366r193b2393],

1	-	:	O	-	_	0	SENT_266	[p15l6t2366r193b2393],
2	Y	NN	O	y	_	0	SENT_266	[p15l231t2348r306b2412],
3	*	CD	NUMBER	*	num	4	SENT_266	[p15l231t2348r306b2412],
4	Al/Al	NN	O	al/al	dep	2	SENT_266	[p15l332t2343r494b2386],
5	.	.	O	.	_	0	SENT_266	[p15l6t2473r193b2499],

1	—	NN	O	—	_	0	SENT_267	[p15l6t2473r193b2499],
2	.	.	O	.	_	0	SENT_267	[p15l6t2473r193b2499],

1	.	.	O	.	_	0	SENT_268	[p15l6t2473r193b2499],

1	—	NN	O	—	_	0	SENT_269	[p15l6t2473r193b2499],
2	.	.	O	.	_	0	SENT_269	[p15l6t2473r193b2499],

1	-	:	O	-	_	0	SENT_270	[p15l6t2473r193b2499],
2	o	NN	O	o	dep	9	SENT_270	[p15l6t2473r193b2499],
3	--	:	O	--	_	0	SENT_270	[p15l6t2473r193b2499],
4	oh	UH	O	oh	dep	7	SENT_270	[p15l231t2456r305b2519],
5	Z	NN	O	z	dep	7	SENT_270	[p15l231t2456r305b2519],
6	*	CD	NUMBER	*	amod	5	SENT_270	[p15l231t2456r305b2519],
7	Al/A2	NN	O	al/a2	dep	2	SENT_270	[p15l332t2451r499b2493],
8	Figure	NN	O	figure	dep	7	SENT_270	[p15l43t2559r125b2589],
9	5	CD	NUMBER	5	_	0	SENT_270	[p15l137t2559r162b2584],
10	.	.	O	.	_	0	SENT_270	[p15l137t2559r162b2584],

1	In	IN	O	in	_	0	SENT_271	[p15l181t2559r210b2584],
2	collagen-stimulated	JJ	O	collagen-stimulated	amod	3	SENT_271	[p15l223t2559r485b2593],
3	platelets	NNS	O	platelet	prep_in	9	SENT_271	[p15l496t2559r613b2593],
4	,	,	O	,	_	0	SENT_271	[p15l496t2559r613b2593],
5	oz-granule	JJ	O	oz-granule	amod	6	SENT_271	[p15l628t2559r758b2593],
6	release	NN	O	release	nsubj	9	SENT_271	[p15l771t2559r858b2584],
7	(	RB	O	(	advmod	9	SENT_271	[p15l872t2558r906b2589],
8	as	IN	O	as	advmod	9	SENT_271	[p15l872t2558r906b2589],
9	measured	VBN	O	measure	_	0	SENT_271	[p15l919t2559r1045b2584],
10	by	IN	O	by	_	0	SENT_271	[p15l1056t2559r1089b2593],
11	CD62P	NN	O	cd62p	prep_by	9	SENT_271	[p15l1100t2559r1211b2590],
12	;	:	O	;	_	0	SENT_271	[p15l1100t2559r1211b2590],
13	P-selectin	NN	O	p-selectin	nn	15	SENT_271	[p15l1225t2559r1357b2584],
14	expression	NN	O	expression	nn	15	SENT_271	[p15l1370t2558r1516b2593],
15	)	NN	O	)	nsubj	17	SENT_271	[p15l1370t2558r1516b2593],
16	was	VBD	O	be	cop	17	SENT_271	[p15l1529t2569r1577b2584],
17	dependent	JJ	O	dependent	parataxis	9	SENT_271	[p15l1591t2559r1730b2593],
18	on	IN	O	on	_	0	SENT_271	[p15l1742t2569r1775b2584],
19	PIA	NNP	O	PIA	nn	20	SENT_271	[p15l1788t2554r1835b2584],
20	genotype	NN	O	genotype	prep_on	17	SENT_271	[p15l1846t2565r1974b2593],
21	,	,	O	,	_	0	SENT_271	[p15l1846t2565r1974b2593],
22	treatment	NN	O	treatment	nn	23	SENT_271	[p15l1987t2565r2117b2584],
23	strategy	NN	O	strategy	prep_on	17	SENT_271	[p15l43t2603r152b2631],
24	,	,	O	,	_	0	SENT_271	[p15l43t2603r152b2631],
25	and	CC	O	and	_	0	SENT_271	[p15l166t2597r214b2622],
26	agonist	NN	O	agonist	nn	27	SENT_271	[p15l227t2598r322b2631],
27	concentration	NN	O	concentration	prep_on	17	SENT_271	[p15l334t2598r516b2622],
28	(	CD	NUMBER	(	num	31	SENT_271	[p15l529t2596r611b2628],
29	mean	NN	O	mean	nn	31	SENT_271	[p15l529t2596r611b2628],
30	ﬂuorescence	NN	O	ﬂuorescence	nn	31	SENT_271	[p15l623t2597r784b2622],
31	units	NNS	O	unit	nn	33	SENT_271	[p15l797t2598r861b2622],
32	i	FW	O	i	dep	31	SENT_271	[p15l877t2600r897b2621],
33	SEM	NN	O	sem	dep	27	SENT_271	[p15l914t2597r993b2628],
34	;	:	O	;	_	0	SENT_271	[p15l914t2597r993b2628],
35	p	NN	O	p	dep	27	SENT_271	[p15l1006t2607r1022b2631],
36	=	JJ	O	=	amod	38	SENT_271	[p15l1038t2606r1058b2615],
37	0.005	CD	NUMBER	0.005	tmod	36	SENT_271	[p15l1074t2596r1165b2628],
38	)	NN	O	)	dep	35	SENT_271	[p15l1074t2596r1165b2628],
39	.	.	O	.	_	0	SENT_271	[p15l1074t2596r1165b2628],

1	546	CD	NUMBER	546	num	2	SENT_272	[p15l9t2791r135b2850],
2	Cooke	NNP	PERSON	Cooke	_	0	SENT_272	[p15l328t2791r524b2850],
3	et	FW	O	et	nn	4	SENT_272	[p15l550t2794r614b2850],
4	al.	FW	O	al.	dep	2	SENT_272	[p15l632t2792r707b2850],
5	.	.	O	.	_	0	SENT_272	[p15l632t2792r707b2850],

1	PI	NN	O	pi	_	0	SENT_273	[p15l331t2864r426b2932],
2	“	NN	O	“	dep	1	SENT_273	[p15l331t2864r426b2932],
3	and	CC	O	and	_	0	SENT_273	[p15l447t2874r561b2933],
4	Responsiveness	NN	O	responsiveness	dep	1	SENT_273	[p15l588t2874r1088b2944],
5	to	TO	O	to	_	0	SENT_273	[p15l1108t2877r1172b2933],
6	Aspirin	NNP	O	Aspirin	prep_to	2	SENT_273	[p15l1193t2874r1414b2944],
7	and	CC	O	and	_	0	SENT_273	[p15l1439t2874r1553b2933],
8	Clopidogrel	NNP	O	Clopidogrel	prep_to	2	SENT_273	[p15l1578t2873r1938b2944],

1	Our	PRP$	O	we	poss	2	SENT_274	[p15l101t3098r245b3164],
2	study	NN	O	study	nsubj	3	SENT_274	[p15l299t3098r488b3187],
3	provides	VBZ	O	provide	_	0	SENT_274	[p15l537t3098r831b3187],
4	the	DT	O	the	det	5	SENT_274	[p15l886t3098r997b3164],
5	rationale	NN	O	rationale	dobj	3	SENT_274	[p15l1051t3098r1358b3164],
6	for	IN	O	for	_	0	SENT_274	[p15l1412t3098r1513b3164],
7	additional	JJ	O	additional	amod	10	SENT_274	[p15l1566t3098r1921b3164],
8	large	JJ	O	large	amod	10	SENT_274	[p15l1972t3098r2142b3187],
9	pharmacogenetic	JJ	O	pharmacogenetic	amod	10	SENT_274	[p15l8t3204r615b3293],
10	trials	NNS	O	trial	prep_for	5	SENT_274	[p15l644t3204r835b3285],
11	,	,	O	,	_	0	SENT_274	[p15l644t3204r835b3285],
12	trials	NNS	O	trial	appos	10	SENT_274	[p15l868t3204r1038b3270],
13	that	WDT	O	that	nsubj	14	SENT_274	[p15l1070t3204r1211b3270],
14	represent	VBP	O	represent	rcmod	12	SENT_274	[p15l1239t3221r1565b3293],
15	a	DT	O	a	det	17	SENT_274	[p15l1595t3230r1629b3270],
16	true	JJ	O	true	amod	17	SENT_274	[p15l1658t3221r1795b3270],
17	opportunity	NN	O	opportunity	nsubj	19	SENT_274	[p15l1827t3221r2140b3293, p15l11t3313r148b3399],
18	to	TO	O	to	aux	19	SENT_274	[p15l173t3327r241b3376],
19	learn	VB	O	learn	xcomp	14	SENT_274	[p15l271t3310r445b3376],
20	how	WRB	O	how	advmod	22	SENT_274	[p15l474t3310r627b3376],
21	to	TO	O	to	aux	22	SENT_274	[p15l653t3327r721b3376],
22	target	VB	O	target	ccomp	19	SENT_274	[p15l751t3327r956b3399],
23	therapeutic	JJ	O	therapeutic	amod	24	SENT_274	[p15l983t3310r1381b3399],
24	strategies	NNS	O	strategy	dobj	22	SENT_274	[p15l1411t3313r1736b3399],
25	to	TO	O	to	_	0	SENT_274	[p15l1766t3327r1834b3376],
26	patients	NNS	O	patient	prep_to	22	SENT_274	[p15l1863t3313r2141b3399],
27	whose	WP$	O	whose	dep	31	SENT_274	[p15l6t3416r228b3482],
28	beneﬁt	NN	O	beneﬁt	nsubj	31	SENT_274	[p15l284t3416r529b3482],
29	would	MD	O	would	aux	31	SENT_274	[p15l580t3416r801b3482],
30	be	VB	O	be	cop	31	SENT_274	[p15l855t3416r936b3482],
31	greatest	JJS	O	greatest	dep	26	SENT_274	[p15l992t3433r1285b3505],
32	,	,	O	,	_	0	SENT_274	[p15l992t3433r1285b3505],
33	thereby	RB	O	thereby	advmod	34	SENT_274	[p15l1344t3416r1612b3505],
34	providing	VBG	O	provide	xcomp	14	SENT_274	[p15l1663t3416r2006b3505],
35	an	DT	O	a	det	36	SENT_274	[p15l2062t3442r2143b3482],
36	opportunity	NN	O	opportunity	dobj	34	SENT_274	[p15l10t3525r432b3611],
37	to	TO	O	to	aux	38	SENT_274	[p15l463t3539r532b3588],
38	limit	VB	O	limit	infmod	36	SENT_274	[p15l567t3522r737b3588],
39	side	NN	O	side	nn	40	SENT_274	[p15l772t3522r906b3588],
40	eﬂects	NNS	O	eﬂects	dobj	38	SENT_274	[p15l943t3522r1157b3588],
41	and	CC	O	and	_	0	SENT_274	[p15l1195t3522r1323b3588],
42	cost	NN	O	cost	dobj	38	SENT_274	[p15l1358t3539r1496b3588],
43	for	IN	O	for	_	0	SENT_274	[p15l1530t3522r1631b3588],
44	large	JJ	O	large	amod	45	SENT_274	[p15l1663t3522r1833b3611],
45	populations	NNS	O	population	prep_for	40	SENT_274	[p15l1867t3522r2139b3611, p15l9t3631r180b3694],
46	of	IN	O	of	_	0	SENT_274	[p15l215t3628r296b3694],
47	patients	NNS	O	patient	prep_of	45	SENT_274	[p15l315t3631r592b3717],
48	with	IN	O	with	_	0	SENT_274	[p15l623t3628r785b3694],
49	CHD	NN	O	chd	prep_with	38	SENT_274	[p15l820t3628r1048b3694],
50	.	.	O	.	_	0	SENT_274	[p15l820t3628r1048b3694],

1	Reprint	JJ	MISC	reprint	amod	2	SENT_275	[p16l11t28r272b107],
2	requests	NNS	O	request	_	0	SENT_275	[p16l298t42r573b107],
3	and	CC	O	and	_	0	SENT_275	[p16l604t26r727b86],
4	correspondence	NN	O	correspondence	conj_and	2	SENT_275	[p16l756t26r1301b107],
5	:	:	O	:	_	0	SENT_275	[p16l756t26r1301b107],
6	Dr.	NNP	O	Dr.	nn	9	SENT_275	[p16l1334t28r1440b86],
7	Glen	NNP	PERSON	Glen	nn	9	SENT_275	[p16l1475t27r1633b86],
8	E.	NNP	PERSON	E.	nn	9	SENT_275	[p16l1665t28r1732b86],
9	Cooke	NNP	PERSON	Cooke	dep	2	SENT_275	[p16l1767t27r1993b99],
10	,	,	O	,	_	0	SENT_275	[p16l1767t27r1993b99],
11	235	CD	NUMBER	235	num	13	SENT_275	[p16l2025t27r2140b87],
12	Davis	NNP	O	Davis	nn	13	SENT_275	[p16l9t126r189b185],
13	HLRI	NNP	O	HLRI	appos	9	SENT_275	[p16l216t126r437b198],
14	,	,	O	,	_	0	SENT_275	[p16l216t126r437b198],
15	The	DT	O	the	det	18	SENT_275	[p16l462t124r595b185],
16	Ohio	NNP	ORGANIZATION	Ohio	nn	18	SENT_275	[p16l623t125r787b185],
17	State	NNP	ORGANIZATION	State	nn	18	SENT_275	[p16l817t125r973b185],
18	University	NNP	ORGANIZATION	University	appos	9	SENT_275	[p16l997t126r1344b205],
19	,	,	O	,	_	0	SENT_275	[p16l997t126r1344b205],
20	473	CD	NUMBER	473	num	21	SENT_275	[p16l1372t127r1486b185],
21	West	NNP	MISC	West	appos	9	SENT_275	[p16l1511t126r1685b185],
22	12th	JJ	ORDINAL	12th	amod	23	SENT_275	[p16l1713t125r1855b186],
23	Avenue	NNP	MISC	Avenue	dep	21	SENT_275	[p16l1877t124r2140b198],
24	,	,	O	,	_	0	SENT_275	[p16l1877t124r2140b198],
25	Columbus	NNP	LOCATION	Columbus	nn	27	SENT_275	[p16l11t223r359b296],
26	,	,	O	,	_	0	SENT_275	[p16l11t223r359b296],
27	Ohio	NNP	LOCATION	Ohio	appos	9	SENT_275	[p16l393t223r557b283],
28	43210-1252	CD	NUMBER	43210-1252	num	27	SENT_275	[p16l587t223r994b283],
29	.	.	O	.	_	0	SENT_275	[p16l587t223r994b283],

1	E	NN	O	e	nn	3	SENT_276	[p16l1029t223r1270b282],
2	—	CD	NUMBER	—	num	3	SENT_276	[p16l1029t223r1270b282],
3	mail	NN	O	mail	_	0	SENT_276	[p16l1029t223r1270b282],
4	:	:	O	:	_	0	SENT_276	[p16l1029t223r1270b282],
5	glen.cooke@osumc.edu	NN	O	glen.cooke@osumc.edu	dep	3	SENT_276	[p16l1302t223r2066b303],
6	.	.	O	.	_	0	SENT_276	[p16l1302t223r2066b303],

1	REFERENCES	NNS	O	reference	_	0	SENT_277	[p16l12t427r522b500],

1	Fitzgerald	NNP	PERSON	Fitzgerald	nn	3	SENT_278	[p16l134t602r422b674],
2	D	NNP	O	D	nn	3	SENT_278	[p16l446t603r541b670],
3	]	NN	O	]	_	0	SENT_278	[p16l446t603r541b670],
4	,	,	O	,	_	0	SENT_278	[p16l446t603r541b670],
5	Roy	NNP	PERSON	Roy	nn	6	SENT_278	[p16l570t603r685b674],
6	L	NNP	PERSON	L	appos	3	SENT_278	[p16l707t603r767b667],
7	,	,	O	,	_	0	SENT_278	[p16l707t603r767b667],
8	Castella	NNP	O	Castella	nn	9	SENT_278	[p16l795t602r1021b655],
9	F	NN	O	f	appos	3	SENT_278	[p16l1045t603r1100b667],
10	,	,	O	,	_	0	SENT_278	[p16l1045t603r1100b667],
11	et	FW	O	et	nn	12	SENT_278	[p16l1128t616r1179b655],
12	al.	FW	O	al.	appos	3	SENT_278	[p16l1204t602r1263b655],
13	.	.	O	.	_	0	SENT_278	[p16l1204t602r1263b655],

1	Platelet	NN	O	platelet	nn	2	SENT_279	[p16l1292t602r1506b655],
2	activation	NN	O	activation	_	0	SENT_279	[p16l1531t604r1805b655],
3	in	IN	O	in	_	0	SENT_279	[p16l1830t604r1884b655],
4	unstable	JJ	O	unstable	amod	6	SENT_279	[p16l1908t602r2142b655],
5	artery	NN	O	artery	nn	6	SENT_279	[p16l135t696r297b754],
6	disease	NN	O	disease	prep_in	2	SENT_279	[p16l322t682r531b735],
7	.	.	O	.	_	0	SENT_279	[p16l322t682r531b735],

1	N	NN	O	n	nn	3	SENT_280	[p16l560t683r613b735],
2	Engl	NNP	O	Engl	nn	3	SENT_280	[p16l642t682r825b754],
3	]	NNP	O	]	nsubj	4	SENT_280	[p16l642t682r825b754],
4	Med	VBD	O	med	_	0	SENT_280	[p16l850t682r987b735],
5	1986	CD	DATE	1986	dobj	4	SENT_280	[p16l1016t682r1488b747],
6	;	:	O	;	_	0	SENT_280	[p16l1016t682r1488b747],
7	315:983	CD	NUMBER	315:983	number	8	SENT_280	[p16l1016t682r1488b747],
8	—	CD	NUMBER	—	dep	5	SENT_280	[p16l1016t682r1488b747],
9	9	CD	NUMBER	9	dep	8	SENT_280	[p16l1016t682r1488b747],
10	.	.	O	.	_	0	SENT_280	[p16l1016t682r1488b747],

1	Fuster	NNP	PERSON	Fuster	nn	2	SENT_281	[p16l134t763r314b815],
2	V	NNP	PERSON	V	_	0	SENT_281	[p16l333t763r396b827],
3	,	,	O	,	_	0	SENT_281	[p16l333t763r396b827],
4	Badimon	NNP	PERSON	Badimon	nn	5	SENT_281	[p16l419t762r680b815],
5	L	NNP	PERSON	L	appos	2	SENT_281	[p16l701t763r760b827],
6	,	,	O	,	_	0	SENT_281	[p16l701t763r760b827],
7	Badimon	NNP	PERSON	Badimon	nn	9	SENT_281	[p16l783t762r1045b815],
8	J	NNP	O	J	nn	9	SENT_281	[p16l1058t763r1125b830],
9	]	NN	O	]	appos	2	SENT_281	[p16l1058t763r1125b830],
10	,	,	O	,	_	0	SENT_281	[p16l1058t763r1125b830],
11	et	FW	O	et	nn	12	SENT_281	[p16l1149t776r1199b815],
12	al.	FW	O	al.	appos	2	SENT_281	[p16l1219t762r1279b815],
13	.	.	O	.	_	0	SENT_281	[p16l1219t762r1279b815],

1	The	DT	O	the	det	2	SENT_282	[p16l1300t761r1418b815],
2	pathogenesis	NN	O	pathogenesis	_	0	SENT_282	[p16l1438t762r1801b834],
3	of	IN	O	of	_	0	SENT_282	[p16l1823t762r1887b815],
4	coronary	JJ	O	coronary	amod	5	SENT_282	[p16l1898t782r2146b834],
5	disease	NN	O	disease	prep_of	2	SENT_282	[p16l135t842r329b895],
6	and	CC	O	and	_	0	SENT_282	[p16l358t842r460b895],
7	the	DT	O	the	det	10	SENT_282	[p16l488t842r577b895],
8	acute	JJ	O	acute	amod	10	SENT_282	[p16l606t856r751b895],
9	coronary	JJ	O	coronary	amod	10	SENT_282	[p16l780t862r1028b914],
10	syndromes	NNS	O	syndrome	conj_and	5	SENT_282	[p16l1054t842r1369b914],
11	.	.	O	.	_	0	SENT_282	[p16l1054t842r1369b914],

1	N	NN	O	n	nn	3	SENT_283	[p16l1401t843r1453b895],
2	Engl	NNP	O	Engl	nn	3	SENT_283	[p16l1484t842r1669b914],
3	]	NNP	O	]	nsubj	4	SENT_283	[p16l1484t842r1669b914],
4	Med	VBD	O	med	_	0	SENT_283	[p16l1696t842r1833b895],
5	1992	CD	DATE	1992	dobj	4	SENT_283	[p16l1864t845r2139b907],
6	;	:	O	;	_	0	SENT_283	[p16l1864t845r2139b907],
7	326	CD	NUMBER	326	num	9	SENT_283	[p16l1864t845r2139b907],
8	:	:	O	:	_	0	SENT_283	[p16l1864t845r2139b907],
9	242-50	CD	NUMBER	242-50	dep	5	SENT_283	[p16l132t922r360b975],
10	.	.	O	.	_	0	SENT_283	[p16l132t922r360b975],

1	.	.	O	.	_	0	SENT_284	[p16l83t1045r92b1054],

1	Peto	JJ	PERSON	peto	amod	2	SENT_285	[p16l134t1002r262b1054],
2	R	NN	O	r	_	0	SENT_285	[p16l297t1002r358b1066],
3	,	,	O	,	_	0	SENT_285	[p16l297t1002r358b1066],
4	Gray	NNP	PERSON	Gray	nn	5	SENT_285	[p16l394t1001r536b1073],
5	R	NNP	PERSON	R	appos	2	SENT_285	[p16l567t1002r628b1066],
6	,	,	O	,	_	0	SENT_285	[p16l567t1002r628b1066],
7	Collins	NNP	ORGANIZATION	Collins	nn	8	SENT_285	[p16l664t1001r866b1054],
8	R	NNP	ORGANIZATION	R	appos	2	SENT_285	[p16l901t1002r962b1066],
9	,	,	O	,	_	0	SENT_285	[p16l901t1002r962b1066],
10	et	FW	O	et	nn	11	SENT_285	[p16l997t1015r1048b1054],
11	al.	FW	O	al.	appos	2	SENT_285	[p16l1080t1001r1139b1054],
12	.	.	O	.	_	0	SENT_285	[p16l1080t1001r1139b1054],

1	Randomised	JJ	O	randomised	amod	2	SENT_286	[p16l1176t1001r1532b1054],
2	trial	NN	O	trial	_	0	SENT_286	[p16l1563t1001r1677b1054],
3	of	IN	O	of	_	0	SENT_286	[p16l1708t1001r1772b1054],
4	prophylactic	NN	O	prophylactic	nn	6	SENT_286	[p16l1794t1001r2143b1073],
5	daily	JJ	SET	daily	amod	6	SENT_286	[p16l135t1080r270b1152],
6	aspirin	NN	O	aspirin	prep_of	2	SENT_286	[p16l313t1082r502b1152],
7	in	IN	O	in	_	0	SENT_286	[p16l547t1082r601b1133],
8	British	JJ	MISC	british	amod	10	SENT_286	[p16l647t1080r840b1133],
9	male	JJ	O	male	amod	10	SENT_286	[p16l886t1080r1018b1133],
10	doctors	NNS	O	doctor	prep_in	6	SENT_286	[p16l1064t1080r1286b1133],
11	.	.	O	.	_	0	SENT_286	[p16l1064t1080r1286b1133],

1	Br	NNP	O	Br	nsubj	2	SENT_287	[p16l1334t1081r1404b1133],
2	Med	VBD	O	med	_	0	SENT_287	[p16l1447t1080r1583b1133],
3	J	NNP	O	J	nn	7	SENT_287	[p16l1621t1081r1649b1148],
4	(	CD	NUMBER	(	num	7	SENT_287	[p16l1696t1079r1843b1145],
5	Clin	NNP	O	Clin	nn	7	SENT_287	[p16l1696t1079r1843b1145],
6	Res	NNP	O	Res	nn	7	SENT_287	[p16l1890t1081r1990b1133],
7	Ed	NNP	O	Ed	dobj	2	SENT_287	[p16l2037t1079r2140b1145],
8	)	CD	NUMBER	)	num	9	SENT_287	[p16l2037t1079r2140b1145],
9	1988	CD	DATE	1988	dep	7	SENT_287	[p16l137t1163r618b1224],
10	;	:	O	;	_	0	SENT_287	[p16l137t1163r618b1224],
11	296:313	CD	NUMBER	296:313	number	12	SENT_287	[p16l137t1163r618b1224],
12	—	CD	NUMBER	—	dep	7	SENT_287	[p16l137t1163r618b1224],
13	6	CD	NUMBER	6	dep	12	SENT_287	[p16l137t1163r618b1224],
14	.	.	O	.	_	0	SENT_287	[p16l137t1163r618b1224],

1	ISIS-2	NN	O	isis-2	_	0	SENT_288	[p16l134t1238r325b1292],
2	(	CD	NUMBER	(	num	1	SENT_288	[p16l354t1237r582b1303],
3	Second	NNP	DURATION	Second	nn	5	SENT_288	[p16l354t1237r582b1303],
4	International	NNP	O	International	nn	5	SENT_288	[p16l606t1238r978b1291],
5	Study	NNP	O	Study	dep	1	SENT_288	[p16l1006t1238r1169b1310],
6	of	IN	O	of	_	0	SENT_288	[p16l1192t1238r1256b1291],
7	Infarct	NNP	O	Infarct	nn	11	SENT_288	[p16l1271t1238r1463b1291],
8	Survival	NNP	O	Survival	nn	11	SENT_288	[p16l1489t1236r1733b1303],
9	)	NNP	O	)	nn	11	SENT_288	[p16l1489t1236r1733b1303],
10	Collaborative	NNP	ORGANIZATION	Collaborative	nn	11	SENT_288	[p16l1763t1238r2142b1291],
11	Group	NNP	ORGANIZATION	Group	prep_of	5	SENT_288	[p16l135t1318r336b1390],
12	.	.	O	.	_	0	SENT_288	[p16l135t1318r336b1390],

1	Randomised	JJ	O	randomised	amod	2	SENT_289	[p16l360t1318r716b1371],
2	trial	NN	O	trial	_	0	SENT_289	[p16l734t1318r847b1371],
3	of	IN	O	of	_	0	SENT_289	[p16l865t1318r929b1371],
4	intravenous	JJ	O	intravenous	amod	5	SENT_289	[p16l938t1320r1264b1371],
5	streptokinase	NNP	O	streptokinase	prep_of	2	SENT_289	[p16l1285t1318r1672b1390],
6	,	,	O	,	_	0	SENT_289	[p16l1285t1318r1672b1390],
7	aspirin	NN	O	aspirin	prep_of	2	SENT_289	[p16l1695t1320r1899b1390],
8	,	,	O	,	_	0	SENT_289	[p16l1695t1320r1899b1390],
9	both	CC	O	both	advmod	7	SENT_289	[p16l1918t1318r2065b1383],
10	,	,	O	,	_	0	SENT_289	[p16l1918t1318r2065b1383],
11	or	CC	O	or	_	0	SENT_289	[p16l2087t1338r2145b1371],
12	neither	DT	O	neither	conj_or	5	SENT_289	[p16l135t1398r336b1451],
13	among	IN	O	among	_	0	SENT_289	[p16l362t1419r555b1470],
14	17,187	CD	NUMBER	17,187	num	15	SENT_289	[p16l583t1399r773b1463],
15	cases	NNS	O	case	prep_among	12	SENT_289	[p16l800t1419r936b1451],
16	of	IN	O	of	_	0	SENT_289	[p16l964t1398r1028b1451],
17	suspected	VBN	O	suspect	amod	20	SENT_289	[p16l1046t1398r1316b1470],
18	acute	JJ	O	acute	amod	20	SENT_289	[p16l1342t1412r1487b1451],
19	myocardial	JJ	O	myocardial	amod	20	SENT_289	[p16l1514t1398r1824b1470],
20	infarction	NN	O	infarction	prep_of	15	SENT_289	[p16l1849t1398r2139b1451],
21	:	:	O	:	_	0	SENT_289	[p16l1849t1398r2139b1451],
22	ISIS	NNP	O	ISIS	dep	2	SENT_289	[p16l133t1478r341b1532],
23	—	CD	NUMBER	—	number	24	SENT_289	[p16l133t1478r341b1532],
24	2	CD	NUMBER	2	dep	22	SENT_289	[p16l133t1478r341b1532],
25	.	.	O	.	_	0	SENT_289	[p16l133t1478r341b1532],

1	Lancet	NNP	O	Lancet	_	0	SENT_290	[p16l372t1479r567b1531],
2	1988	CD	DATE	1988	num	1	SENT_290	[p16l596t1481r1049b1542],
3	;	:	O	;	_	0	SENT_290	[p16l596t1481r1049b1542],
4	2:349	CD	NUMBER	2:349	number	5	SENT_290	[p16l596t1481r1049b1542],
5	—	CD	NUMBER	—	dep	1	SENT_290	[p16l596t1481r1049b1542],
6	60	CD	NUMBER	60	dep	5	SENT_290	[p16l596t1481r1049b1542],
7	.	.	O	.	_	0	SENT_290	[p16l596t1481r1049b1542],

1	.	.	O	.	_	0	SENT_291	[p16l83t1601r92b1610],

1	The	DT	O	the	det	3	SENT_292	[p16l132t1556r250b1610],
2	Steering	NNP	O	Steering	nn	3	SENT_292	[p16l286t1557r520b1629],
3	Committee	NNP	O	Committee	_	0	SENT_292	[p16l553t1557r876b1610],
4	of	IN	O	of	_	0	SENT_292	[p16l910t1557r974b1610],
5	the	DT	O	the	det	11	SENT_292	[p16l997t1557r1085b1610],
6	Physicians	NNP	O	Physicians	nn	11	SENT_292	[p16l1119t1557r1428b1629],
7	’	NNP	O	’	nn	11	SENT_292	[p16l1119t1557r1428b1629],
8	Health	NNP	ORGANIZATION	Health	nn	11	SENT_292	[p16l1462t1557r1659b1610],
9	Study	NNP	ORGANIZATION	Study	nn	11	SENT_292	[p16l1695t1557r1858b1629],
10	Research	NNP	ORGANIZATION	Research	nn	11	SENT_292	[p16l1889t1557r2143b1610],
11	Group	NNP	ORGANIZATION	Group	prep_of	3	SENT_292	[p16l135t1638r336b1710],
12	.	.	O	.	_	0	SENT_292	[p16l135t1638r336b1710],

1	Final	JJ	O	final	amod	2	SENT_293	[p16l389t1638r535b1691],
2	report	NN	O	report	_	0	SENT_293	[p16l584t1652r756b1710],
3	on	IN	O	on	_	0	SENT_293	[p16l804t1659r874b1691],
4	the	DT	O	the	det	6	SENT_293	[p16l923t1638r1011b1691],
5	aspirin	NN	O	aspirin	nn	6	SENT_293	[p16l1062t1640r1251b1710],
6	component	NN	O	component	prep_on	2	SENT_293	[p16l1301t1652r1621b1710],
7	of	IN	O	of	_	0	SENT_293	[p16l1670t1638r1734b1691],
8	the	DT	O	the	det	13	SENT_293	[p16l1773t1638r1861b1691],
9	ongoing	JJ	O	ongoing	amod	13	SENT_293	[p16l1911t1640r2145b1710],
10	Physicians	NNP	O	Physicians	nn	13	SENT_293	[p16l134t1718r443b1790],
11	’	NNP	O	’	nn	13	SENT_293	[p16l134t1718r443b1790],
12	Health	NNP	O	Health	nn	13	SENT_293	[p16l471t1718r668b1771],
13	Study	NNP	O	Study	prep_of	2	SENT_293	[p16l698t1718r872b1790],
14	.	.	O	.	_	0	SENT_293	[p16l698t1718r872b1790],

1	N	NN	O	n	nn	3	SENT_294	[p16l902t1719r955b1771],
2	Engl	NNP	O	Engl	nn	3	SENT_294	[p16l984t1718r1167b1790],
3	]	NNP	O	]	nsubj	4	SENT_294	[p16l984t1718r1167b1790],
4	Med	VBD	O	med	_	0	SENT_294	[p16l1192t1718r1329b1771],
5	1989	CD	DATE	1989	dobj	4	SENT_294	[p16l1358t1718r1874b1783],
6	;	:	O	;	_	0	SENT_294	[p16l1358t1718r1874b1783],
7	321:129	CD	NUMBER	321:129	number	8	SENT_294	[p16l1358t1718r1874b1783],
8	—	CD	NUMBER	—	dep	5	SENT_294	[p16l1358t1718r1874b1783],
9	35	CD	NUMBER	35	dep	8	SENT_294	[p16l1358t1718r1874b1783],
10	.	.	O	.	_	0	SENT_294	[p16l1358t1718r1874b1783],

1	.	.	O	.	_	0	SENT_295	[p16l83t1842r92b1851],

1	The	DT	O	the	det	2	SENT_296	[p16l132t1797r250b1851],
2	RISC	NNP	O	RISC	_	0	SENT_296	[p16l286t1798r448b1851],
3	Group	NNP	O	Group	dep	2	SENT_296	[p16l486t1798r687b1870],
4	.	.	O	.	_	0	SENT_296	[p16l486t1798r687b1870],

1	Risk	NN	O	risk	_	0	SENT_297	[p16l727t1798r854b1851],
2	of	IN	O	of	_	0	SENT_297	[p16l886t1798r950b1851],
3	myocardial	JJ	O	myocardial	amod	4	SENT_297	[p16l976t1798r1286b1870],
4	infarction	NN	O	infarction	prep_of	1	SENT_297	[p16l1319t1798r1595b1851],
5	and	CC	O	and	_	0	SENT_297	[p16l1630t1798r1732b1851],
6	death	NN	O	death	prep_of	1	SENT_297	[p16l1767t1798r1922b1851],
7	during	IN	O	during	_	0	SENT_297	[p16l1957t1798r2145b1870],
8	treatment	NN	O	treatment	prep_during	1	SENT_297	[p16l134t1892r411b1931],
9	with	IN	O	with	_	0	SENT_297	[p16l432t1878r561b1931],
10	low	JJ	O	low	amod	12	SENT_297	[p16l584t1878r688b1931],
11	dose	NN	O	dose	nn	12	SENT_297	[p16l710t1878r834b1931],
12	aspirin	NN	O	aspirin	prep_with	8	SENT_297	[p16l860t1880r1049b1950],
13	and	CC	O	and	_	0	SENT_297	[p16l1075t1878r1177b1931],
14	intravenous	JJ	O	intravenous	amod	15	SENT_297	[p16l1200t1880r1527b1931],
15	heparin	NN	O	heparin	prep_during	1	SENT_297	[p16l1552t1878r1767b1950],
16	in	IN	O	in	_	0	SENT_297	[p16l1791t1880r1845b1931],
17	men	NNS	O	man	prep_in	15	SENT_297	[p16l1870t1899r1992b1931],
18	with	IN	O	with	_	0	SENT_297	[p16l2014t1878r2143b1931],
19	unstable	JJ	O	unstable	amod	22	SENT_297	[p16l133t1958r367b2011],
20	coronary	JJ	O	coronary	amod	22	SENT_297	[p16l395t1978r643b2030],
21	artery	NN	O	artery	nn	22	SENT_297	[p16l667t1972r830b2030],
22	disease	NN	O	disease	prep_with	17	SENT_297	[p16l854t1958r1063b2011],
23	.	.	O	.	_	0	SENT_297	[p16l854t1958r1063b2011],

1	Lancet	NNP	O	Lancet	_	0	SENT_298	[p16l1093t1959r1289b2011],
2	1990	CD	DATE	1990	num	1	SENT_298	[p16l1318t1959r1825b2023],
3	;	:	O	;	_	0	SENT_298	[p16l1318t1959r1825b2023],
4	336:827	CD	NUMBER	336:827	number	5	SENT_298	[p16l1318t1959r1825b2023],
5	—	CD	NUMBER	—	dep	1	SENT_298	[p16l1318t1959r1825b2023],
6	30	CD	NUMBER	30	dep	5	SENT_298	[p16l1318t1959r1825b2023],
7	.	.	O	.	_	0	SENT_298	[p16l1318t1959r1825b2023],

1	Antiplatelet	JJ	O	antiplatelet	amod	2	SENT_299	[p16l132t2037r475b2110],
2	Trialists	NNS	O	trialist	nsubj	3	SENT_299	[p16l506t2037r753b2091],
3	’	VBP	O	’	_	0	SENT_299	[p16l506t2037r753b2091],
4	Collaboration	NN	O	collaboration	dobj	3	SENT_299	[p16l790t2038r1197b2091],
5	.	.	O	.	_	0	SENT_299	[p16l790t2038r1197b2091],

1	Collaborative	JJ	O	collaborative	amod	2	SENT_300	[p16l1237t2038r1617b2091],
2	overview	NN	O	overview	_	0	SENT_300	[p16l1653t2040r1902b2091],
3	of	IN	O	of	_	0	SENT_300	[p16l1935t2038r1999b2091],
4	randomised	JJ	O	randomised	amod	5	SENT_300	[p16l2024t2058r2141b2091, p16l135t2118r374b2171],
5	trials	NNS	O	trial	prep_of	2	SENT_300	[p16l397t2118r533b2171],
6	of	IN	O	of	_	0	SENT_300	[p16l559t2118r624b2171],
7	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_300	[p16l639t2118r956b2190],
8	treatment	NN	O	treatment	prep_of	2	SENT_300	[p16l979t2132r1270b2171],
9	.	.	O	.	_	0	SENT_300	[p16l979t2132r1270b2171],

1	Part	NNP	O	Part	_	0	SENT_301	[p16l1298t2119r1417b2171],
2	1	CD	NUMBER	1	num	1	SENT_301	[p16l1443t2121r1487b2171],
3	:	:	O	:	_	0	SENT_301	[p16l1443t2121r1487b2171],
4	prevention	NN	O	prevention	dep	1	SENT_301	[p16l1514t2120r1818b2190],
5	of	IN	O	of	_	0	SENT_301	[p16l1842t2118r1906b2171],
6	vascular	JJ	O	vascular	amod	7	SENT_301	[p16l1918t2118r2145b2171],
7	death	NN	O	death	prep_of	4	SENT_301	[p16l135t2198r306b2263],
8	,	,	O	,	_	0	SENT_301	[p16l135t2198r306b2263],
9	myocardial	JJ	O	myocardial	amod	10	SENT_301	[p16l350t2198r661b2270],
10	infarction	NN	O	infarction	prep_of	4	SENT_301	[p16l701t2198r992b2263],
11	,	,	O	,	_	0	SENT_301	[p16l701t2198r992b2263],
12	and	CC	O	and	_	0	SENT_301	[p16l1037t2198r1139b2251],
13	stroke	NN	O	stroke	prep_of	4	SENT_301	[p16l1181t2198r1350b2251],
14	by	IN	O	by	_	0	SENT_301	[p16l1390t2198r1459b2270],
15	prolonged	JJ	O	prolonged	amod	17	SENT_301	[p16l1497t2198r1785b2270],
16	antiplatelet	JJ	O	antiplatelet	amod	17	SENT_301	[p16l1827t2198r2144b2270],
17	therapy	NN	O	therapy	prep_by	13	SENT_301	[p16l134t2278r348b2350],
18	in	IN	O	in	_	0	SENT_301	[p16l371t2280r426b2331],
19	different	JJ	O	different	amod	20	SENT_301	[p16l453t2278r690b2331],
20	categories	NNS	O	category	prep_in	17	SENT_301	[p16l716t2280r993b2350],
21	of	IN	O	of	_	0	SENT_301	[p16l1021t2278r1085b2331],
22	patients	NNS	O	patient	prep_of	20	SENT_301	[p16l1101t2280r1338b2350],
23	.	.	O	.	_	0	SENT_301	[p16l1101t2280r1338b2350],

1	BM	NN	O	bm	_	0	SENT_302	[p16l1369t2279r1507b2346],
2	]	CD	NUMBER	]	num	3	SENT_302	[p16l1369t2279r1507b2346],
3	1994	CD	DATE	1994	dep	1	SENT_302	[p16l1536t2281r2044b2343],
4	;	:	O	;	_	0	SENT_302	[p16l1536t2281r2044b2343],
5	308:81	CD	NUMBER	308:81	num	6	SENT_302	[p16l1536t2281r2044b2343],
6	—	NN	O	—	dep	1	SENT_302	[p16l1536t2281r2044b2343],
7	106	CD	NUMBER	106	dep	6	SENT_302	[p16l1536t2281r2044b2343],
8	.	.	O	.	_	0	SENT_302	[p16l1536t2281r2044b2343],

1	.	.	O	.	_	0	SENT_303	[p16l83t2402r92b2411],

1	Herbert	NNP	PERSON	Herbert	nn	2	SENT_304	[p16l135t2358r361b2411],
2	JM	NN	PERSON	jm	_	0	SENT_304	[p16l372t2359r486b2426],
3	,	,	O	,	_	0	SENT_304	[p16l372t2359r486b2426],
4	Frehel	NN	O	frehel	nn	5	SENT_304	[p16l508t2358r690b2411],
5	D	NN	O	d	appos	2	SENT_304	[p16l709t2359r779b2423],
6	,	,	O	,	_	0	SENT_304	[p16l709t2359r779b2423],
7	Vallee	NNP	PERSON	Vallee	nn	8	SENT_304	[p16l801t2358r976b2412],
8	E	NNP	O	E	appos	2	SENT_304	[p16l997t2359r1057b2423],
9	,	,	O	,	_	0	SENT_304	[p16l997t2359r1057b2423],
10	et	FW	O	et	nn	11	SENT_304	[p16l1080t2372r1131b2411],
11	al.	FW	O	al.	appos	2	SENT_304	[p16l1150t2358r1210b2411],
12	.	.	O	.	_	0	SENT_304	[p16l1150t2358r1210b2411],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_305	[p16l1234t2358r1588b2430],
2	,	,	O	,	_	0	SENT_305	[p16l1234t2358r1588b2430],
3	a	DT	O	a	det	8	SENT_305	[p16l1611t2379r1638b2411],
4	novel	JJ	O	novel	amod	8	SENT_305	[p16l1657t2358r1808b2411],
5	antiplatelet	JJ	O	antiplatelet	amod	8	SENT_305	[p16l1827t2358r2144b2430],
6	and	CC	O	and	_	0	SENT_305	[p16l135t2438r237b2491],
7	antithrombotic	JJ	O	antithrombotic	conj_and	5	SENT_305	[p16l264t2438r691b2491],
8	agent	NN	O	agent	appos	1	SENT_305	[p16l718t2452r885b2510],
9	.	.	O	.	_	0	SENT_305	[p16l718t2452r885b2510],

1	Drug	NN	O	drug	nn	2	SENT_306	[p16l915t2439r1067b2510],
2	Rev	NN	O	rev	_	0	SENT_306	[p16l1093t2439r1203b2491],
3	1993	CD	DATE	1993	dep	2	SENT_306	[p16l1229t2441r1710b2503],
4	;	:	O	;	_	0	SENT_306	[p16l1229t2441r1710b2503],
5	11:180	CD	NUMBER	11:180	number	6	SENT_306	[p16l1229t2441r1710b2503],
6	—	CD	NUMBER	—	dep	2	SENT_306	[p16l1229t2441r1710b2503],
7	98	CD	NUMBER	98	dep	6	SENT_306	[p16l1229t2441r1710b2503],
8	.	.	O	.	_	0	SENT_306	[p16l1229t2441r1710b2503],

1	.	.	O	.	_	0	SENT_307	[p16l83t2562r92b2571],

1	Herbert	NNP	PERSON	Herbert	nn	2	SENT_308	[p16l135t2518r361b2571],
2	JM	NN	PERSON	jm	_	0	SENT_308	[p16l382t2519r495b2586],
3	,	,	O	,	_	0	SENT_308	[p16l382t2519r495b2586],
4	Savi	NNP	PERSON	Savi	nn	5	SENT_308	[p16l530t2518r644b2571],
5	P	NN	O	p	appos	2	SENT_308	[p16l673t2519r729b2583],
6	,	,	O	,	_	0	SENT_308	[p16l673t2519r729b2583],
7	Maffrand	NNP	O	Maffrand	nn	8	SENT_308	[p16l759t2518r1026b2571],
8	JP	NNP	O	JP	appos	5	SENT_308	[p16l1047t2519r1134b2586],
9	.	.	O	.	_	0	SENT_308	[p16l1047t2519r1134b2586],

1	Biochemical	JJ	MISC	biochemical	amod	4	SENT_309	[p16l1167t2518r1518b2571],
2	and	CC	O	and	_	0	SENT_309	[p16l1547t2518r1650b2571],
3	pharmacological	JJ	O	pharmacological	conj_and	1	SENT_309	[p16l1677t2518r2144b2590],
4	properties	NNS	O	property	_	0	SENT_309	[p16l133t2600r415b2670],
5	of	IN	O	of	_	0	SENT_309	[p16l438t2598r502b2651],
6	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_309	[p16l513t2598r843b2670],
7	:	:	O	:	_	0	SENT_309	[p16l513t2598r843b2670],
8	a	DT	O	a	det	10	SENT_309	[p16l869t2619r896b2651],
9	new	JJ	O	new	amod	10	SENT_309	[p16l917t2619r1034b2651],
10	ADP	NN	O	adp	dep	4	SENT_309	[p16l1049t2597r1203b2651],
11	receptor	NN	O	receptor	nn	12	SENT_309	[p16l1223t2612r1456b2670],
12	antagonist	NN	O	antagonist	dep	10	SENT_309	[p16l1477t2600r1784b2670],
13	.	.	O	.	_	0	SENT_309	[p16l1477t2600r1784b2670],

1	Eur	NNP	O	Eur	nn	2	SENT_310	[p16l1809t2599r1916b2651],
2	Heart	NNP	O	Heart	_	0	SENT_310	[p16l1936t2599r2143b2666],
3	]	CD	NUMBER	]	num	4	SENT_310	[p16l1936t2599r2143b2666],
4	1999	CD	DATE	1999	dep	2	SENT_310	[p16l137t2681r323b2743],
5	;	:	O	;	_	0	SENT_310	[p16l137t2681r323b2743],
6	1	CD	NUMBER	1	num	8	SENT_310	[p16l137t2681r323b2743],
7	Suppl	NN	O	suppl	nn	8	SENT_310	[p16l356t2678r519b2750],
8	A	NN	O	a	dep	2	SENT_310	[p16l542t2677r866b2731],
9	:	:	O	:	_	0	SENT_310	[p16l542t2677r866b2731],
10	A31-40	NN	O	a31-40	dep	8	SENT_310	[p16l542t2677r866b2731],
11	.	.	O	.	_	0	SENT_310	[p16l542t2677r866b2731],

1	CAPRIE	NNP	O	CAPRIE	nn	3	SENT_311	[p16l135t2757r412b2811],
2	Steering	NNP	O	Steering	nn	3	SENT_311	[p16l464t2758r708b2830],
3	Committee	NNP	O	Committee	_	0	SENT_311	[p16l757t2758r1108b2811],
4	.	.	O	.	_	0	SENT_311	[p16l757t2758r1108b2811],

1	A	DT	O	a	det	4	SENT_312	[p16l1158t2757r1211b2811],
2	randomised	JJ	O	randomised	amod	4	SENT_312	[p16l1258t2758r1603b2811],
3	blinded	JJ	O	blinded	amod	4	SENT_312	[p16l1650t2758r1873b2811],
4	trial	NN	O	trial	nsubj	16	SENT_312	[p16l1921t2758r2040b2811],
5	of	IN	O	of	_	0	SENT_312	[p16l2088t2758r2153b2811],
6	Clopidogrel	NNP	O	Clopidogrel	prep_of	4	SENT_312	[p16l135t2838r489b2910],
7	versus	CC	O	versus	_	0	SENT_312	[p16l511t2859r689b2891],
8	Aspirin	NNP	O	Aspirin	prep_of	4	SENT_312	[p16l713t2837r936b2910],
9	in	IN	O	in	_	0	SENT_312	[p16l962t2840r1017b2891],
10	Patients	NNS	O	patient	prep_in	6	SENT_312	[p16l1043t2839r1280b2891],
11	at	IN	O	at	_	0	SENT_312	[p16l1308t2852r1360b2891],
12	Risk	NN	O	risk	prep_at	10	SENT_312	[p16l1386t2838r1519b2891],
13	of	IN	O	of	_	0	SENT_312	[p16l1541t2838r1607b2891],
14	Ischaemic	JJ	O	ischaemic	amod	15	SENT_312	[p16l1622t2838r1917b2891],
15	Events	NNS	O	event	prep_of	12	SENT_312	[p16l1943t2839r2141b2891],
16	(	VBP	O	(	_	0	SENT_312	[p16l136t2917r478b2982],
17	CAPRIE	JJ	O	caprie	amod	18	SENT_312	[p16l136t2917r478b2982],
18	)	NN	O	)	dobj	16	SENT_312	[p16l136t2917r478b2982],
19	.	.	O	.	_	0	SENT_312	[p16l136t2917r478b2982],

1	Lancet	NNP	O	Lancet	_	0	SENT_313	[p16l512t2919r715b2971],
2	1996	CD	DATE	1996	num	1	SENT_313	[p16l746t2921r1321b2982],
3	;	:	O	;	_	0	SENT_313	[p16l746t2921r1321b2982],
4	348:1329	CD	NUMBER	348:1329	number	5	SENT_313	[p16l746t2921r1321b2982],
5	—	CD	NUMBER	—	dep	1	SENT_313	[p16l746t2921r1321b2982],
6	39	CD	NUMBER	39	dep	5	SENT_313	[p16l746t2921r1321b2982],
7	.	.	O	.	_	0	SENT_313	[p16l746t2921r1321b2982],

1	Herbert	NNP	PERSON	Herbert	nn	2	SENT_314	[p16l135t2997r361b3050],
2	JM	NN	PERSON	jm	_	0	SENT_314	[p16l384t2998r498b3065],
3	,	,	O	,	_	0	SENT_314	[p16l384t2998r498b3065],
4	Bernat	NNP	PERSON	Bernat	nn	5	SENT_314	[p16l532t2998r723b3050],
5	A	NNP	O	A	appos	2	SENT_314	[p16l751t2996r819b3062],
6	,	,	O	,	_	0	SENT_314	[p16l751t2996r819b3062],
7	Samama	NNP	PERSON	Samama	nn	8	SENT_314	[p16l856t2997r1096b3050],
8	M	NNP	O	M	appos	2	SENT_314	[p16l1125t2998r1210b3062],
9	,	,	O	,	_	0	SENT_314	[p16l1125t2998r1210b3062],
10	et	FW	O	et	nn	11	SENT_314	[p16l1244t3011r1295b3050],
11	al.	FW	O	al.	appos	2	SENT_314	[p16l1326t2997r1385b3050],
12	.	.	O	.	_	0	SENT_314	[p16l1326t2997r1385b3050],

1	The	DT	O	the	det	5	SENT_315	[p16l1418t2996r1536b3050],
2	antiaggregating	JJ	O	antiaggregating	amod	5	SENT_315	[p16l1570t2999r2010b3069],
3	and	CC	O	and	_	0	SENT_315	[p16l2042t2997r2143b3050],
4	antithrombotic	JJ	O	antithrombotic	amod	5	SENT_315	[p16l135t3078r562b3131],
5	activity	NN	O	activity	nsubjpass	9	SENT_315	[p16l592t3080r796b3150],
6	of	IN	O	of	_	0	SENT_315	[p16l823t3078r887b3131],
7	ticlopidine	NN	O	ticlopidine	prep_of	5	SENT_315	[p16l906t3078r1208b3150],
8	is	VBZ	O	be	auxpass	9	SENT_315	[p16l1237t3080r1277b3131],
9	potentiated	VBN	O	potentiate	_	0	SENT_315	[p16l1307t3078r1631b3150],
10	by	IN	O	by	_	0	SENT_315	[p16l1657t3078r1726b3150],
11	aspirin	NN	O	aspirin	agent	9	SENT_315	[p16l1753t3080r1942b3150],
12	in	IN	O	in	_	0	SENT_315	[p16l1971t3080r2025b3131],
13	the	DT	O	the	det	14	SENT_315	[p16l2054t3078r2142b3131],
14	rat	NN	O	rat	prep_in	11	SENT_315	[p16l134t3172r223b3211],
15	.	.	O	.	_	0	SENT_315	[p16l134t3172r223b3211],

1	Thromb	NNP	O	Thromb	nn	2	SENT_316	[p16l251t3157r490b3211],
2	Haemost	NNP	O	Haemost	_	0	SENT_316	[p16l519t3159r779b3211],
3	1996	CD	DATE	1996	num	2	SENT_316	[p16l808t3159r1226b3221],
4	;	:	O	;	_	0	SENT_316	[p16l808t3159r1226b3221],
5	76:94	CD	NUMBER	76:94	number	6	SENT_316	[p16l808t3159r1226b3221],
6	—	CD	NUMBER	—	dep	2	SENT_316	[p16l808t3159r1226b3221],
7	8	CD	NUMBER	8	dep	6	SENT_316	[p16l808t3159r1226b3221],
8	.	.	O	.	_	0	SENT_316	[p16l808t3159r1226b3221],

1	JACC	NNP	O	JACC	nn	2	SENT_317	[p16l1408t3253r1542b3310],
2	Vol	NNP	O	Vol	_	0	SENT_317	[p16l1566t3254r1662b3310],
3	.	.	O	.	_	0	SENT_317	[p16l1566t3254r1662b3310],

1	47	CD	NUMBER	47	_	0	SENT_318	[p16l1690t3253r1777b3319],
2	,	,	O	,	_	0	SENT_318	[p16l1690t3253r1777b3319],
3	No.	NN	O	no.	amod	1	SENT_318	[p16l1808t3253r1891b3310],
4	3	CD	NUMBER	3	number	3	SENT_318	[p16l1919t3253r1968b3319],
5	,	,	O	,	_	0	SENT_318	[p16l1919t3253r1968b3319],
6	2006	CD	DATE	2006	appos	1	SENT_318	[p16l1997t3253r2141b3310],
7	February	NNP	DATE	February	tmod	6	SENT_318	[p16l1464t3351r1690b3421],
8	7	CD	DATE	7	num	7	SENT_318	[p16l1714t3351r1761b3417],
9	,	,	O	,	_	0	SENT_318	[p16l1714t3351r1761b3417],
10	2006:541	CD	NUMBER	2006:541	num	7	SENT_318	[p16l1790t3350r2141b3408],
11	—	CD	NUMBER	—	num	12	SENT_318	[p16l1790t3350r2141b3408],
12	6	CD	NUMBER	6	dep	1	SENT_318	[p16l1790t3350r2141b3408],

1	Herbert	NNP	PERSON	Herbert	nn	2	SENT_319	[p17l134t83r360b137],
2	JM	NN	PERSON	jm	_	0	SENT_319	[p17l399t84r513b151],
3	,	,	O	,	_	0	SENT_319	[p17l399t84r513b151],
4	Dol	NN	O	dol	nn	5	SENT_319	[p17l563t84r673b137],
5	F	NN	O	f	appos	2	SENT_319	[p17l719t84r775b148],
6	,	,	O	,	_	0	SENT_319	[p17l719t84r775b148],
7	Bernat	NNP	PERSON	Bernat	nn	8	SENT_319	[p17l825t84r1016b137],
8	A	NNP	O	A	appos	2	SENT_319	[p17l1060t82r1128b149],
9	,	,	O	,	_	0	SENT_319	[p17l1060t82r1128b149],
10	et	FW	O	et	nn	11	SENT_319	[p17l1179t97r1230b137],
11	al.	FW	O	al.	appos	2	SENT_319	[p17l1277t84r1336b137],
12	.	.	O	.	_	0	SENT_319	[p17l1277t84r1336b137],

1	The	DT	O	the	det	5	SENT_320	[p17l1385t82r1503b137],
2	antiaggregating	JJ	O	antiaggregating	amod	5	SENT_320	[p17l1553t86r1993b155],
3	and	CC	O	and	_	0	SENT_320	[p17l2041t83r2143b137],
4	antithrombotic	JJ	O	antithrombotic	amod	5	SENT_320	[p17l134t169r566b222],
5	activity	NN	O	activity	nsubjpass	9	SENT_320	[p17l617t171r824b240],
6	of	IN	O	of	_	0	SENT_320	[p17l872t169r936b222],
7	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_320	[p17l978t169r1298b241],
8	is	VBZ	O	be	auxpass	9	SENT_320	[p17l1347t171r1387b222],
9	potentiated	VBN	O	potentiate	_	0	SENT_320	[p17l1438t169r1766b241],
10	by	IN	O	by	_	0	SENT_320	[p17l1814t169r1884b240],
11	aspirin	NN	O	aspirin	agent	9	SENT_320	[p17l1932t171r2138b241],
12	.	.	O	.	_	0	SENT_320	[p17l1932t171r2138b241],

1	Thromb	NNP	O	Thromb	nn	2	SENT_321	[p17l130t250r370b304],
2	Haemost	NNP	O	Haemost	_	0	SENT_321	[p17l399t253r659b304],
3	1998	CD	DATE	1998	num	2	SENT_321	[p17l687t252r1132b316],
4	;	:	O	;	_	0	SENT_321	[p17l687t252r1132b316],
5	80:512	CD	NUMBER	80:512	number	6	SENT_321	[p17l687t252r1132b316],
6	—	CD	NUMBER	—	dep	2	SENT_321	[p17l687t252r1132b316],
7	8	CD	NUMBER	8	dep	6	SENT_321	[p17l687t252r1132b316],
8	.	.	O	.	_	0	SENT_321	[p17l687t252r1132b316],

1	Harker	NNP	ORGANIZATION	Harker	nn	2	SENT_322	[p17l134t335r337b388],
2	LA	NNP	ORGANIZATION	LA	_	0	SENT_322	[p17l365t334r477b400],
3	,	,	O	,	_	0	SENT_322	[p17l365t334r477b400],
4	Marzek	NNP	O	Marzek	nn	5	SENT_322	[p17l506t335r729b388],
5	UM	NNP	O	UM	appos	2	SENT_322	[p17l753t336r890b400],
6	,	,	O	,	_	0	SENT_322	[p17l753t336r890b400],
7	Kelly	NNP	ORGANIZATION	Kelly	nn	8	SENT_322	[p17l923t335r1070b406],
8	AB	NNP	ORGANIZATION	AB	appos	2	SENT_322	[p17l1093t334r1208b400],
9	,	,	O	,	_	0	SENT_322	[p17l1093t334r1208b400],
10	et	FW	O	et	nn	11	SENT_322	[p17l1239t349r1290b388],
11	al.	FW	O	al.	appos	2	SENT_322	[p17l1318t335r1378b388],
12	.	.	O	.	_	0	SENT_322	[p17l1318t335r1378b388],

1	Clopidogrel	NN	O	clopidogrel	nn	2	SENT_323	[p17l1411t335r1750b407],
2	inhibition	NN	O	inhibition	_	0	SENT_323	[p17l1777t335r2059b388],
3	of	IN	O	of	_	0	SENT_323	[p17l2088t335r2152b388],
4	stent	NN	O	stent	nn	6	SENT_323	[p17l134t433r285b484],
5	,	,	O	,	_	0	SENT_323	[p17l134t433r285b484],
6	graft	NN	O	graft	nn	9	SENT_323	[p17l306t419r439b491],
7	and	CC	O	and	_	0	SENT_323	[p17l458t419r560b472],
8	vascular	JJ	O	vascular	nn	9	SENT_323	[p17l576t419r802b472],
9	thrombogenesis	NN	O	thrombogenesis	prep_of	2	SENT_323	[p17l820t419r1269b491],
10	with	IN	O	with	_	0	SENT_323	[p17l1286t419r1415b472],
11	antithrombotic	JJ	O	antithrombotic	amod	12	SENT_323	[p17l1436t419r1863b472],
12	enhancement	NN	O	enhancement	prep_with	9	SENT_323	[p17l1882t419r2140b472, p17l133t517r280b556],
13	by	IN	O	by	_	0	SENT_323	[p17l299t503r368b575],
14	aspirin	NN	O	aspirin	prep_by	2	SENT_323	[p17l388t506r577b575],
15	in	IN	O	in	_	0	SENT_323	[p17l599t506r653b556],
16	non-human	JJ	O	non-human	amod	17	SENT_323	[p17l676t503r1012b556],
17	primates	NNS	O	primate	prep_in	2	SENT_323	[p17l1033t506r1292b575],
18	.	.	O	.	_	0	SENT_323	[p17l1033t506r1292b575],

1	Circulation	NN	O	circulation	_	0	SENT_324	[p17l1320t503r1641b557],
2	1998	CD	DATE	1998	num	1	SENT_324	[p17l1666t506r2138b568],
3	;	:	O	;	_	0	SENT_324	[p17l1666t506r2138b568],
4	98:2461	CD	NUMBER	98:2461	number	5	SENT_324	[p17l1666t506r2138b568],
5	-9	CD	NUMBER	-9	dep	1	SENT_324	[p17l1666t506r2138b568],
6	.	.	O	.	_	0	SENT_324	[p17l1666t506r2138b568],

1	The	DT	O	the	det	2	SENT_325	[p17l131t586r248b641],
2	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_325	[p17l287t587r626b659],
3	in	IN	O	in	_	0	SENT_325	[p17l661t590r715b640],
4	Unstable	NNP	O	Unstable	nn	5	SENT_325	[p17l750t588r1002b641],
5	Angina	NNP	O	Angina	prep_in	2	SENT_325	[p17l1037t586r1250b659],
6	to	TO	O	to	aux	7	SENT_325	[p17l1285t601r1339b641],
7	Prevent	VB	O	prevent	infmod	2	SENT_325	[p17l1377t588r1595b641],
8	Recurrent	JJ	O	recurrent	amod	9	SENT_325	[p17l1632t588r1914b641],
9	Events	NNS	O	event	dobj	7	SENT_325	[p17l1950t588r2140b641],
10	Trial	NNP	O	Trial	nn	11	SENT_325	[p17l131t670r273b725],
11	Investigators	NNS	O	investigator	tmod	7	SENT_325	[p17l313t672r675b743],
12	(	CD	NUMBER	(	num	14	SENT_325	[p17l720t670r981b736],
13	CURE	NN	O	cure	nn	14	SENT_325	[p17l720t670r981b736],
14	)	NN	O	)	dep	11	SENT_325	[p17l720t670r981b736],
15	.	.	O	.	_	0	SENT_325	[p17l720t670r981b736],

1	Effects	NNS	O	effect	_	0	SENT_326	[p17l1028t672r1217b725],
2	of	IN	O	of	_	0	SENT_326	[p17l1260t672r1324b725],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_326	[p17l1357t672r1673b744],
4	in	IN	O	in	_	0	SENT_326	[p17l1713t674r1768b724],
5	addition	NN	O	addition	_	0	SENT_326	[p17l1810t672r2045b725],
6	to	TO	O	to	_	0	SENT_326	[p17l2087t686r2141b725],
7	aspirin	NN	O	aspirin	prep_in_addition_to	1	SENT_326	[p17l134t759r322b829],
8	in	IN	O	in	_	0	SENT_326	[p17l341t759r396b809],
9	patients	NNS	O	patient	prep_in	1	SENT_326	[p17l414t759r635b829],
10	with	IN	O	with	_	0	SENT_326	[p17l652t757r782b810],
11	acute	JJ	O	acute	amod	13	SENT_326	[p17l801t771r946b810],
12	coronary	JJ	O	coronary	amod	13	SENT_326	[p17l966t777r1213b828],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_326	[p17l1230t757r1529b828],
14	without	IN	O	without	_	0	SENT_326	[p17l1546t757r1771b810],
15	ST	JJ	O	st	amod	18	SENT_326	[p17l1792t756r2144b829],
16	—	NN	O	—	nn	18	SENT_326	[p17l1792t756r2144b829],
17	segment	NN	O	segment	nn	18	SENT_326	[p17l1792t756r2144b829],
18	elevation	NN	O	elevation	prep_without	13	SENT_326	[p17l133t841r400b894],
19	.	.	O	.	_	0	SENT_326	[p17l133t841r400b894],

1	N	NN	O	n	nn	2	SENT_327	[p17l430t842r482b894],
2	EnglJ	NN	O	englj	nsubj	3	SENT_327	[p17l511t841r695b913],
3	Med	VBD	O	med	_	0	SENT_327	[p17l719t841r856b894],
4	2001	CD	DATE	2001	dobj	3	SENT_327	[p17l881t841r1437b906],
5	;	:	O	;	_	0	SENT_327	[p17l881t841r1437b906],
6	345:494	CD	NUMBER	345:494	num	7	SENT_327	[p17l881t841r1437b906],
7	—	NN	O	—	dep	4	SENT_327	[p17l881t841r1437b906],
8	502	CD	NUMBER	502	dep	7	SENT_327	[p17l881t841r1437b906],
9	.	.	O	.	_	0	SENT_327	[p17l881t841r1437b906],

1	Cooke	NNP	ORGANIZATION	Cooke	nn	2	SENT_328	[p17l134t926r319b979],
2	GE	NNP	ORGANIZATION	GE	_	0	SENT_328	[p17l348t926r467b990],
3	,	,	O	,	_	0	SENT_328	[p17l348t926r467b990],
4	Bray	NNP	ORGANIZATION	Bray	nn	5	SENT_328	[p17l496t926r629b997],
5	PF	NNP	ORGANIZATION	PF	appos	2	SENT_328	[p17l652t926r751b990],
6	,	,	O	,	_	0	SENT_328	[p17l652t926r751b990],
7	Hamlington	NNP	PERSON	Hamlington	nn	8	SENT_328	[p17l780t926r1132b997],
8	JD	NNP	O	JD	appos	2	SENT_328	[p17l1151t926r1253b993],
9	,	,	O	,	_	0	SENT_328	[p17l1151t926r1253b993],
10	et	FW	O	et	nn	11	SENT_328	[p17l1282t939r1333b978],
11	al.	FW	O	al.	appos	2	SENT_328	[p17l1359t925r1418b978],
12	.	.	O	.	_	0	SENT_328	[p17l1359t925r1418b978],

1	PIAZ	NN	ORGANIZATION	piaz	nn	2	SENT_329	[p17l1449t916r1573b978],
2	polymorphism	NN	O	polymorphism	_	0	SENT_329	[p17l1599t926r2012b997],
3	and	CC	O	and	_	0	SENT_329	[p17l2041t925r2142b978],
4	eﬂicacy	NN	O	eﬂicacy	conj_and	2	SENT_329	[p17l133t1009r338b1081],
5	of	IN	O	of	_	0	SENT_329	[p17l362t1009r426b1062],
6	aspirin	NN	O	aspirin	prep_of	2	SENT_329	[p17l444t1012r647b1081],
7	.	.	O	.	_	0	SENT_329	[p17l444t1012r647b1081],

1	Lancet	NNP	O	Lancet	_	0	SENT_330	[p17l678t1010r874b1062],
2	1998	CD	DATE	1998	num	1	SENT_330	[p17l902t1009r1338b1074],
3	;	:	O	;	_	0	SENT_330	[p17l902t1009r1338b1074],
4	351:1253	CD	NUMBER	351:1253	dep	1	SENT_330	[p17l902t1009r1338b1074],
5	.	.	O	.	_	0	SENT_330	[p17l902t1009r1338b1074],

1	Goldschmidt	NNP	PERSON	Goldschmidt	_	0	SENT_331	[p17l134t1093r818b1146],
2	.	.	O	.	_	0	SENT_331	[p17l134t1093r818b1146],

1	—	NN	O	—	_	0	SENT_332	[p17l134t1093r818b1146],
2	.	.	O	.	_	0	SENT_332	[p17l134t1093r818b1146],

1	Clermont	NNP	ORGANIZATION	Clermont	nn	2	SENT_333	[p17l134t1093r818b1146],
2	PJ	NNP	ORGANIZATION	PJ	_	0	SENT_333	[p17l854t1094r933b1161],
3	,	,	O	,	_	0	SENT_333	[p17l854t1094r933b1161],
4	Cooke	NNP	ORGANIZATION	Cooke	nn	5	SENT_333	[p17l974t1093r1159b1146],
5	GE	NNP	ORGANIZATION	GE	appos	2	SENT_333	[p17l1198t1093r1317b1158],
6	,	,	O	,	_	0	SENT_333	[p17l1198t1093r1317b1158],
7	Eaton	NNP	ORGANIZATION	Eaton	nn	8	SENT_333	[p17l1357t1094r1529b1146],
8	GM	NNP	ORGANIZATION	GM	appos	2	SENT_333	[p17l1567t1093r1707b1158],
9	,	,	O	,	_	0	SENT_333	[p17l1567t1093r1707b1158],
10	et	FW	O	et	nn	11	SENT_333	[p17l1747t1107r1798b1146],
11	al.	FW	O	al.	appos	2	SENT_333	[p17l1835t1093r1894b1146],
12	.	.	O	.	_	0	SENT_333	[p17l1835t1093r1894b1146],

1	PIA2	NN	O	pia2	_	0	SENT_334	[p17l1934t1083r2075b1158],
2	,	,	O	,	_	0	SENT_334	[p17l1934t1083r2075b1158],
3	a	DT	O	a	det	4	SENT_334	[p17l2116t1114r2143b1146],
4	variant	NN	O	variant	appos	1	SENT_334	[p17l130t1179r327b1230],
5	of	IN	O	of	_	0	SENT_334	[p17l355t1177r419b1230],
6	GPIIIa	NN	O	gpiium	prep_of	4	SENT_334	[p17l440t1177r648b1230],
7	implicated	VBN	O	implicate	partmod	6	SENT_334	[p17l675t1177r973b1249],
8	in	IN	O	in	_	0	SENT_334	[p17l1001t1179r1056b1229],
9	coronary	JJ	O	coronary	amod	11	SENT_334	[p17l1086t1197r1333b1248],
10	thromboembolic	NN	O	thromboembolic	nn	11	SENT_334	[p17l1359t1177r1832b1230],
11	complications	NNS	O	complication	prep_in	7	SENT_334	[p17l1861t1177r2140b1249, p17l133t1262r285b1312],
12	.	.	O	.	_	0	SENT_334	[p17l1861t1177r2140b1249, p17l133t1262r285b1312],

1	J	NNP	O	J	nn	4	SENT_335	[p17l308t1261r336b1327],
2	Am	NNP	O	Am	nn	4	SENT_335	[p17l360t1259r470b1312],
3	Coll	NNP	O	Coll	nn	4	SENT_335	[p17l498t1260r620b1312],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_335	[p17l647t1260r861b1312],
5	2000	CD	DATE	2000	num	4	SENT_335	[p17l885t1263r1299b1324],
6	;	:	O	;	_	0	SENT_335	[p17l885t1263r1299b1324],
7	36:90	CD	NUMBER	36:90	number	8	SENT_335	[p17l885t1263r1299b1324],
8	—	CD	NUMBER	—	dep	4	SENT_335	[p17l885t1263r1299b1324],
9	3	CD	NUMBER	3	dep	8	SENT_335	[p17l885t1263r1299b1324],
10	.	.	O	.	_	0	SENT_335	[p17l885t1263r1299b1324],

1	Bennet	NNP	PERSON	Bennet	nn	2	SENT_336	[p17l133t1344r337b1396],
2	JS	NNP	O	JS	_	0	SENT_336	[p17l372t1343r455b1411],
3	,	,	O	,	_	0	SENT_336	[p17l372t1343r455b1411],
4	Vilaire	NNP	O	Vilaire	nn	5	SENT_336	[p17l500t1343r689b1397],
5	G	NNP	O	G	appos	2	SENT_336	[p17l733t1343r803b1408],
6	,	,	O	,	_	0	SENT_336	[p17l733t1343r803b1408],
7	Burch	NNP	PERSON	Burch	appos	2	SENT_336	[p17l849t1343r1021b1396],
8	*	CD	NUMBER	*	num	7	SENT_336	[p17l1056t1344r1174b1411],
9	A	DT	O	a	det	10	SENT_336	[p17l1218t1342r1272b1395],
10	role	NN	O	role	dep	7	SENT_336	[p17l1313t1343r1418b1396],
11	for	IN	O	for	_	0	SENT_336	[p17l1462t1343r1542b1396],
12	prostaglandins	NNS	O	prostaglandin	prep_for	10	SENT_336	[p17l1583t1343r1995b1415],
13	and	CC	O	and	_	0	SENT_336	[p17l2041t1343r2142b1396],
14	thromboxanes	NNS	O	thromboxane	conj_and	12	SENT_336	[p17l133t1427r534b1480],
15	in	IN	O	in	_	0	SENT_336	[p17l562t1429r616b1480],
16	the	DT	O	the	det	17	SENT_336	[p17l643t1427r731b1480],
17	exposure	NN	O	exposure	prep_in	12	SENT_336	[p17l760t1447r1006b1499],
18	of	IN	O	of	_	0	SENT_336	[p17l1034t1427r1098b1480],
19	platelet	NN	O	platelet	nn	21	SENT_336	[p17l1114t1427r1323b1499],
20	ﬁbrinogen	NN	O	ﬁbrinogen	nn	21	SENT_336	[p17l1349t1427r1640b1499],
21	receptors	NNS	O	receptor	prep_of	17	SENT_336	[p17l1667t1441r1938b1499],
22	.	.	O	.	_	0	SENT_336	[p17l1667t1441r1938b1499],

1	J	NNP	O	J	nn	3	SENT_337	[p17l1961t1428r1990b1495],
2	Clin	NNP	O	Clin	nn	3	SENT_337	[p17l2018t1427r2142b1481],
3	Invest	NNP	O	Invest	_	0	SENT_337	[p17l132t1529r305b1581],
4	1981	CD	DATE	1981	num	3	SENT_337	[p17l334t1529r770b1593],
5	;	:	O	;	_	0	SENT_337	[p17l334t1529r770b1593],
6	68:981	CD	NUMBER	68:981	num	7	SENT_337	[p17l334t1529r770b1593],
7	—	NN	O	—	dep	3	SENT_337	[p17l334t1529r770b1593],
8	7	CD	NUMBER	7	dep	7	SENT_337	[p17l334t1529r770b1593],
9	.	.	O	.	_	0	SENT_337	[p17l334t1529r770b1593],

1	Born	VBN	O	bear	_	0	SENT_338	[p17l133t1612r275b1665],
2	GVR	NN	O	gvr	dobj	1	SENT_338	[p17l301t1611r470b1665],
3	.	.	O	.	_	0	SENT_338	[p17l301t1611r470b1665],

1	Aggregation	NN	O	aggregation	_	0	SENT_339	[p17l496t1610r852b1683],
2	of	IN	O	of	_	0	SENT_339	[p17l878t1611r942b1665],
3	blood	NN	O	blood	nn	4	SENT_339	[p17l956t1612r1117b1665],
4	platelets	NNS	O	platelet	prep_of	1	SENT_339	[p17l1141t1612r1373b1683],
5	by	IN	O	by	_	0	SENT_339	[p17l1398t1612r1466b1683],
6	adenosine	NN	O	adenosine	nn	7	SENT_339	[p17l1489t1612r1769b1665],
7	diphosphate	NN	O	diphosphate	prep_by	1	SENT_339	[p17l1795t1611r2142b1683],
8	and	CC	O	and	_	0	SENT_339	[p17l134t1696r236b1748],
9	its	PRP$	O	its	poss	10	SENT_339	[p17l262t1698r325b1748],
10	reversal	NN	O	reversal	prep_by	1	SENT_339	[p17l353t1696r579b1748],
11	.	.	O	.	_	0	SENT_339	[p17l353t1696r579b1748],

1	Nature	NNP	O	Nature	_	0	SENT_340	[p17l608t1696r805b1748],
2	1962	CD	DATE	1962	num	1	SENT_340	[p17l836t1697r1308b1760],
3	;	:	O	;	_	0	SENT_340	[p17l836t1697r1308b1760],
4	194:927	CD	NUMBER	194:927	number	5	SENT_340	[p17l836t1697r1308b1760],
5	-9	CD	NUMBER	-9	dep	1	SENT_340	[p17l836t1697r1308b1760],
6	.	.	O	.	_	0	SENT_340	[p17l836t1697r1308b1760],

1	.	.	O	.	_	0	SENT_341	[p17l82t1822r91b1831],

1	Jennrich	NNP	O	Jennrich	nn	2	SENT_342	[p17l126t1778r371b1846],
2	RI	NN	O	rus	_	0	SENT_342	[p17l400t1779r488b1843],
3	,	,	O	,	_	0	SENT_342	[p17l400t1779r488b1843],
4	Schluchter	NNP	O	Schluchter	nn	5	SENT_342	[p17l521t1778r822b1831],
5	MD.	NNP	O	MD.	appos	2	SENT_342	[p17l847t1779r989b1831],
6	.	.	O	.	_	0	SENT_342	[p17l847t1779r989b1831],

1	Unbalanced	JJ	O	unbalanced	amod	2	SENT_343	[p17l1018t1778r1358b1831],
2	repeated-measures	NNS	O	repeated-measure	_	0	SENT_343	[p17l1385t1778r1912b1850],
3	models	NNS	O	model	dep	2	SENT_343	[p17l1941t1778r2141b1831],
4	with	IN	O	with	_	0	SENT_343	[p17l130t1862r259b1915],
5	structured	JJ	O	structured	amod	7	SENT_343	[p17l287t1862r571b1914],
6	covariance	NN	O	covariance	nn	7	SENT_343	[p17l598t1864r891b1915],
7	matrices	NNS	O	matrix	prep_with	3	SENT_343	[p17l919t1864r1169b1914],
8	.	.	O	.	_	0	SENT_343	[p17l919t1864r1169b1914],

1	Biometrics	NNS	O	biometric	_	0	SENT_344	[p17l1199t1863r1505b1914],
2	1986	CD	DATE	1986	num	1	SENT_344	[p17l1536t1862r2008b1926],
3	;	:	O	;	_	0	SENT_344	[p17l1536t1862r2008b1926],
4	42:805	CD	NUMBER	42:805	number	5	SENT_344	[p17l1536t1862r2008b1926],
5	—	CD	NUMBER	—	dep	1	SENT_344	[p17l1536t1862r2008b1926],
6	20	CD	NUMBER	20	dep	5	SENT_344	[p17l1536t1862r2008b1926],
7	.	.	O	.	_	0	SENT_344	[p17l1536t1862r2008b1926],

1	Liang	NNP	PERSON	Liang	nn	2	SENT_345	[p17l134t1946r301b2017],
2	KY	NNP	O	KY	_	0	SENT_345	[p17l337t1946r446b2010],
3	,	,	O	,	_	0	SENT_345	[p17l337t1946r446b2010],
4	Zeger	NNP	PERSON	Zeger	nn	5	SENT_345	[p17l485t1945r652b2017],
5	SL	NNP	O	SL	appos	2	SENT_345	[p17l689t1945r784b1998],
6	.	.	O	.	_	0	SENT_345	[p17l689t1945r784b1998],

1	Longitudinal	JJ	O	longitudinal	amod	3	SENT_346	[p17l824t1945r1197b2017],
2	data	NN	O	datum	nn	3	SENT_346	[p17l1232t1945r1350b1998],
3	analysis	NN	O	analysis	nsubj	5	SENT_346	[p17l1386t1945r1599b2017],
4	using	VBG	O	use	partmod	3	SENT_346	[p17l1635t1947r1787b2017],
5	generalized	VBN	O	generalize	_	0	SENT_346	[p17l1820t1945r2142b2017],
6	linear	JJ	O	linear	amod	7	SENT_346	[p17l132t2029r291b2082],
7	models	NNS	O	model	dobj	5	SENT_346	[p17l317t2029r533b2082],
8	.	.	O	.	_	0	SENT_346	[p17l317t2029r533b2082],

1	Biometrics	NNS	O	biometric	_	0	SENT_347	[p17l562t2030r868b2082],
2	1986	CD	DATE	1986	num	1	SENT_347	[p17l899t2030r1336b2094],
3	;	:	O	;	_	0	SENT_347	[p17l899t2030r1336b2094],
4	73:12	CD	NUMBER	73:12	number	5	SENT_347	[p17l899t2030r1336b2094],
5	—	CD	NUMBER	—	dep	1	SENT_347	[p17l899t2030r1336b2094],
6	22	CD	NUMBER	22	dep	5	SENT_347	[p17l899t2030r1336b2094],
7	.	.	O	.	_	0	SENT_347	[p17l899t2030r1336b2094],

1	Madsen	NNP	PERSON	Madsen	nn	2	SENT_348	[p17l132t2112r361b2166],
2	RW	NNP	O	RW	_	0	SENT_348	[p17l403t2113r538b2178],
3	,	,	O	,	_	0	SENT_348	[p17l403t2113r538b2178],
4	Moeschberger	NNP	O	Moeschberger	nn	5	SENT_348	[p17l579t2113r988b2184],
5	ML	NNP	O	ML	appos	2	SENT_348	[p17l1025t2113r1155b2166],
6	.	.	O	.	_	0	SENT_348	[p17l1025t2113r1155b2166],

1	Statistical	JJ	O	statistical	amod	2	SENT_349	[p17l1202t2112r1476b2166],
2	concepts	NNS	O	concept	_	0	SENT_349	[p17l1516t2126r1774b2184],
3	.	.	O	.	_	0	SENT_349	[p17l1516t2126r1774b2184],

1	Englewood	NNP	LOCATION	Englewood	nn	2	SENT_350	[p17l1819t2112r2143b2184],
2	Cliffs	NNPS	O	Cliffs	_	0	SENT_350	[p17l134t2197r300b2261],
3	,	,	O	,	_	0	SENT_350	[p17l134t2197r300b2261],
4	NJ	NNP	O	NJ	appos	2	SENT_350	[p17l327t2197r420b2264],
5	:	:	O	:	_	0	SENT_350	[p17l327t2197r420b2264],
6	Prentice	NNP	PERSON	Prentice	dep	2	SENT_350	[p17l450t2197r856b2261],
7	.	.	O	.	_	0	SENT_350	[p17l450t2197r856b2261],

1	—	NN	O	—	_	0	SENT_351	[p17l450t2197r856b2261],
2	.	.	O	.	_	0	SENT_351	[p17l450t2197r856b2261],

1	Hall	NNP	O	Hall	_	0	SENT_352	[p17l450t2197r856b2261],
2	,	,	O	,	_	0	SENT_352	[p17l450t2197r856b2261],
3	1986	CD	DATE	1986	appos	1	SENT_352	[p17l889t2199r1040b2249],
4	.	.	O	.	_	0	SENT_352	[p17l889t2199r1040b2249],

1	Angiolillo	JJ	O	angiolillo	amod	2	SENT_353	[p17l131t2279r418b2352],
2	DJ	NNP	O	DJ	_	0	SENT_353	[p17l449t2281r543b2348],
3	,	,	O	,	_	0	SENT_353	[p17l449t2281r543b2348],
4	Fernandez	NNP	PERSON	Fernandez	appos	2	SENT_353	[p17l576t2280r1061b2333],
5	.	.	O	.	_	0	SENT_353	[p17l576t2280r1061b2333],

1	—	NN	O	—	_	0	SENT_354	[p17l576t2280r1061b2333],
2	.	.	O	.	_	0	SENT_354	[p17l576t2280r1061b2333],

1	Ortiz	NNP	PERSON	Ortiz	nn	2	SENT_355	[p17l576t2280r1061b2333],
2	A	NNP	O	A	_	0	SENT_355	[p17l1087t2279r1155b2345],
3	,	,	O	,	_	0	SENT_355	[p17l1087t2279r1155b2345],
4	Bernardo	NNP	PERSON	Bernardo	nn	5	SENT_355	[p17l1187t2280r1450b2333],
5	E	NNP	PERSON	E	appos	2	SENT_355	[p17l1482t2281r1543b2345],
6	,	,	O	,	_	0	SENT_355	[p17l1482t2281r1543b2345],
7	et	FW	O	et	nn	8	SENT_355	[p17l1576t2294r1627b2333],
8	al.	FW	O	al.	appos	5	SENT_355	[p17l1656t2280r1716b2333],
9	.	.	O	.	_	0	SENT_355	[p17l1656t2280r1716b2333],

1	PIA	NNP	ORGANIZATION	PIA	nn	2	SENT_356	[p17l1749t2270r1849b2333],
2	polymorphism	NN	O	polymorphism	_	0	SENT_356	[p17l1876t2280r2140b2352, p17l132t2393r306b2465],
3	and	CC	O	and	_	0	SENT_356	[p17l345t2393r447b2446],
4	platelet	NN	O	platelet	nn	5	SENT_356	[p17l482t2393r692b2465],
5	reactivity	NN	O	reactivity	conj_and	2	SENT_356	[p17l727t2395r988b2464],
6	following	VBG	O	follow	_	0	SENT_356	[p17l1021t2393r1290b2464],
7	clopidogrel	NN	O	clopidogrel	prep_following	2	SENT_356	[p17l1326t2393r1642b2465],
8	loading	VBG	O	load	partmod	7	SENT_356	[p17l1677t2393r1890b2465],
9	dose	NN	O	dose	dobj	8	SENT_356	[p17l1926t2393r2050b2446],
10	in	IN	O	in	_	0	SENT_356	[p17l2088t2395r2142b2445],
11	patients	NNS	O	patient	prep_in	8	SENT_356	[p17l132t2508r354b2578],
12	undergoing	VBG	O	undergo	partmod	11	SENT_356	[p17l376t2506r703b2578],
13	coronary	JJ	O	coronary	amod	15	SENT_356	[p17l725t2526r973b2578],
14	stent	NN	O	stent	nn	15	SENT_356	[p17l993t2520r1129b2559],
15	implantation	NN	O	implantation	dobj	12	SENT_356	[p17l1150t2506r1529b2578],
16	.	.	O	.	_	0	SENT_356	[p17l1150t2506r1529b2578],

1	Blood	NNP	O	Blood	nn	3	SENT_357	[p17l1556t2506r1726b2559],
2	Coagul	NNP	O	Coagul	nn	3	SENT_357	[p17l1749t2506r1954b2578],
3	Fibrinolysis	NNP	O	Fibrinolysis	_	0	SENT_357	[p17l1976t2506r2140b2559, p17l134t2591r321b2663],
4	2004	CD	DATE	2004	num	3	SENT_357	[p17l348t2591r797b2656],
5	;	:	O	;	_	0	SENT_357	[p17l348t2591r797b2656],
6	15:89	CD	NUMBER	15:89	number	7	SENT_357	[p17l348t2591r797b2656],
7	-93	CD	NUMBER	-93	dep	3	SENT_357	[p17l348t2591r797b2656],
8	.	.	O	.	_	0	SENT_357	[p17l348t2591r797b2656],

1	Michelson	NNP	PERSON	Michelson	nn	2	SENT_358	[p17l132t2676r434b2728],
2	A	NNP	O	A	_	0	SENT_358	[p17l464t2674r532b2740],
3	,	,	O	,	_	0	SENT_358	[p17l464t2674r532b2740],
4	Furman	NNP	O	Furman	nn	5	SENT_358	[p17l567t2676r793b2728],
5	M	NNP	O	M	appos	2	SENT_358	[p17l824t2676r908b2740],
6	,	,	O	,	_	0	SENT_358	[p17l824t2676r908b2740],
7	Goldschmidt	NNP	PERSON	Goldschmidt	appos	5	SENT_358	[p17l944t2675r1628b2728],
8	.	.	O	.	_	0	SENT_358	[p17l944t2675r1628b2728],

1	—	NN	O	—	_	0	SENT_359	[p17l944t2675r1628b2728],
2	.	.	O	.	_	0	SENT_359	[p17l944t2675r1628b2728],

1	Clermont	NNP	O	Clermont	nn	2	SENT_360	[p17l944t2675r1628b2728],
2	P	NN	O	p	_	0	SENT_360	[p17l1659t2676r1715b2740],
3	,	,	O	,	_	0	SENT_360	[p17l1659t2676r1715b2740],
4	et	FW	O	et	nn	5	SENT_360	[p17l1750t2689r1801b2728],
5	al.	FW	O	al.	appos	2	SENT_360	[p17l1833t2675r1893b2728],
6	.	.	O	.	_	0	SENT_360	[p17l1833t2675r1893b2728],

1	Platelet	NN	O	platelet	nn	5	SENT_361	[p17l1929t2675r2143b2728],
2	GP	NN	O	gp	nn	5	SENT_361	[p17l134t2759r232b2812],
3	IIIa	NN	O	iium	nn	5	SENT_361	[p17l256t2759r364b2812],
4	PIA	NN	O	pium	nn	5	SENT_361	[p17l388t2757r501b2811],
5	polymorphisms	NNS	O	polymorphism	nsubj	6	SENT_361	[p17l523t2759r960b2831],
6	display	VBP	O	display	_	0	SENT_361	[p17l987t2759r1184b2831],
7	diiferent	JJ	O	diiferent	amod	8	SENT_361	[p17l1207t2759r1444b2812],
8	sensitivities	NNS	O	sensitivity	dobj	6	SENT_361	[p17l1468t2761r1790b2812],
9	to	TO	O	to	_	0	SENT_361	[p17l1816t2773r1870b2812],
10	agonists	NNS	O	agonist	prep_to	6	SENT_361	[p17l1897t2761r2138b2830],
11	.	.	O	.	_	0	SENT_361	[p17l1897t2761r2138b2830],

1	Circulation	NN	O	circulation	_	0	SENT_362	[p17l134t2842r456b2895],
2	2000	CD	DATE	2000	num	1	SENT_362	[p17l480t2844r944b2906],
3	;	:	O	;	_	0	SENT_362	[p17l480t2844r944b2906],
4	101:1013	CD	NUMBER	101:1013	number	5	SENT_362	[p17l480t2844r944b2906],
5	—	CD	NUMBER	—	dep	1	SENT_362	[p17l480t2844r944b2906],
6	8	CD	NUMBER	8	dep	5	SENT_362	[p17l956t2845r1002b2895],
7	.	.	O	.	_	0	SENT_362	[p17l956t2845r1002b2895],

1	Undas	NNP	O	Undas	nn	2	SENT_363	[p17l132t2925r313b2978],
2	A	NNP	O	A	_	0	SENT_363	[p17l360t2924r428b2990],
3	,	,	O	,	_	0	SENT_363	[p17l360t2924r428b2990],
4	Sanak	NNP	O	Sanak	nn	5	SENT_363	[p17l481t2925r652b2978],
5	M	NNP	O	M	appos	2	SENT_363	[p17l696t2926r780b2990],
6	,	,	O	,	_	0	SENT_363	[p17l696t2926r780b2990],
7	Musial	NNP	PERSON	Musial	nn	8	SENT_363	[p17l829t2925r1028b2978],
8	J	NNP	PERSON	J	appos	2	SENT_363	[p17l1068t2926r1112b2993],
9	,	,	O	,	_	0	SENT_363	[p17l1068t2926r1112b2993],
10	et	FW	O	et	nn	11	SENT_363	[p17l1163t2939r1214b2978],
11	al.	FW	O	al.	appos	2	SENT_363	[p17l1262t2925r1321b2978],
12	.	.	O	.	_	0	SENT_363	[p17l1262t2925r1321b2978],

1	Platelet	NN	O	platelet	nn	2	SENT_364	[p17l1373t2925r1588b2978],
2	glycoprotein	NN	O	glycoprotein	_	0	SENT_364	[p17l1634t2925r1987b2997],
3	IIIa	NN	O	iium	nn	4	SENT_364	[p17l2034t2926r2143b2978],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_364	[p17l132t3009r561b3081],
5	,	,	O	,	_	0	SENT_364	[p17l132t3009r561b3081],
6	aspirin	NN	O	aspirin	dep	2	SENT_364	[p17l599t3011r803b3081],
7	,	,	O	,	_	0	SENT_364	[p17l599t3011r803b3081],
8	and	CC	O	and	_	0	SENT_364	[p17l840t3009r943b3062],
9	thrombin	NN	O	thrombin	nn	10	SENT_364	[p17l976t3009r1244b3062],
10	generation	NN	O	generation	conj_and	4	SENT_364	[p17l1277t3011r1593b3081],
11	.	.	O	.	_	0	SENT_364	[p17l1277t3011r1593b3081],

1	Lancet	NNP	O	Lancet	_	0	SENT_365	[p17l1631t3010r1827b3062],
2	1999	CD	DATE	1999	num	1	SENT_365	[p17l1862t3009r2138b3074],
3	;	:	O	;	_	0	SENT_365	[p17l1862t3009r2138b3074],
4	353	CD	NUMBER	353	num	6	SENT_365	[p17l1862t3009r2138b3074],
5	:	:	O	:	_	0	SENT_365	[p17l1862t3009r2138b3074],
6	982-3	CD	NUMBER	982-3	dep	1	SENT_365	[p17l134t3096r323b3146],
7	.	.	O	.	_	0	SENT_365	[p17l134t3096r323b3146],

1	Szceklik	NNP	MISC	Szceklik	nn	2	SENT_366	[p18l136t22r371b76],
2	A	NNP	MISC	A	_	0	SENT_366	[p18l386t21r454b88],
3	,	,	O	,	_	0	SENT_366	[p18l386t21r454b88],
4	Undas	NNP	O	Undas	nn	5	SENT_366	[p18l475t23r656b76],
5	A	NNP	O	A	conj_and	2	SENT_366	[p18l676t21r744b88],
6	,	,	O	,	_	0	SENT_366	[p18l676t21r744b88],
7	Sanak	NNP	O	Sanak	nn	8	SENT_366	[p18l769t22r940b76],
8	M	NNP	O	M	conj_and	2	SENT_366	[p18l956t23r1040b88],
9	,	,	O	,	_	0	SENT_366	[p18l956t23r1040b88],
10	Frolow	NNP	O	Frolow	nn	11	SENT_366	[p18l1063t23r1268b76],
11	M	NNP	O	M	conj_and	2	SENT_366	[p18l1284t23r1368b88],
12	,	,	O	,	_	0	SENT_366	[p18l1284t23r1368b88],
13	Wegrzyn	NNP	PERSON	Wegrzyn	nn	15	SENT_366	[p18l1387t23r1651b94],
14	W.	NNP	O	W.	nn	15	SENT_366	[p18l1668t23r1758b76],
15	Relationship	NN	O	relationship	conj_and	2	SENT_366	[p18l1783t22r2141b94],
16	between	IN	O	between	_	0	SENT_366	[p18l131t107r366b160],
17	bleeding	JJ	O	bleeding	amod	18	SENT_366	[p18l400t107r644b178],
18	time	NN	O	time	prep_between	15	SENT_366	[p18l677t109r820b172],
19	,	,	O	,	_	0	SENT_366	[p18l677t109r820b172],
20	aspirin	NN	O	aspirin	conj_and	2	SENT_366	[p18l858t109r1047b179],
21	and	CC	O	and	_	0	SENT_366	[p18l1083t107r1185b160],
22	the	DT	O	the	det	24	SENT_366	[p18l1220t107r1308b160],
23	PLA1/A2	NN	O	pla1/a2	nn	24	SENT_366	[p18l1344t105r1603b161],
24	polymorphism	NN	O	polymorphism	conj_and	2	SENT_366	[p18l1639t107r2052b179],
25	of	IN	O	of	_	0	SENT_366	[p18l2088t107r2152b160],
26	platelet	NN	O	platelet	nn	28	SENT_366	[p18l132t190r341b262],
27	glycoprotein	NN	O	glycoprotein	nn	28	SENT_366	[p18l365t190r718b262],
28	Illa	NN	PERSON	illum	prep_of	24	SENT_366	[p18l744t191r866b243],
29	.	.	O	.	_	0	SENT_366	[p18l744t191r866b243],

1	Br	NN	O	br	_	0	SENT_367	[p18l896t191r1012b258],
2	]	CD	NUMBER	]	num	1	SENT_367	[p18l896t191r1012b258],
3	Haematol	NNP	O	Haematol	dep	1	SENT_367	[p18l1039t190r1322b243],
4	2000	CD	DATE	2000	num	3	SENT_367	[p18l1346t190r1823b255],
5	;	:	O	;	_	0	SENT_367	[p18l1346t190r1823b255],
6	110:965	CD	NUMBER	110:965	num	7	SENT_367	[p18l1346t190r1823b255],
7	—	NN	O	—	dep	1	SENT_367	[p18l1346t190r1823b255],
8	7	CD	NUMBER	7	dep	7	SENT_367	[p18l1346t190r1823b255],
9	.	.	O	.	_	0	SENT_367	[p18l1346t190r1823b255],

1	Macchi	NNP	PERSON	Macchi	nn	2	SENT_368	[p18l132t274r347b326],
2	L	NNP	PERSON	L	_	0	SENT_368	[p18l385t275r444b338],
3	,	,	O	,	_	0	SENT_368	[p18l385t275r444b338],
4	Christiaens	NNP	ORGANIZATION	Christiaens	nn	5	SENT_368	[p18l486t274r806b327],
5	L	NNP	ORGANIZATION	L	appos	2	SENT_368	[p18l846t275r906b338],
6	,	,	O	,	_	0	SENT_368	[p18l846t275r906b338],
7	Brabant	NNP	LOCATION	Brabant	nn	8	SENT_368	[p18l946t274r1173b326],
8	S	NNP	O	S	appos	2	SENT_368	[p18l1212t274r1261b338],
9	,	,	O	,	_	0	SENT_368	[p18l1212t274r1261b338],
10	et	FW	O	et	nn	11	SENT_368	[p18l1303t288r1353b326],
11	al.	FW	O	al.	appos	2	SENT_368	[p18l1391t274r1450b326],
12	.	.	O	.	_	0	SENT_368	[p18l1391t274r1450b326],

1	Resistance	NN	O	resistance	nsubjpass	8	SENT_369	[p18l1494t275r1789b326],
2	in	IN	O	in	_	0	SENT_369	[p18l1827t276r1882b326],
3	Vitro	NNP	O	Vitro	prep_in	1	SENT_369	[p18l1917t276r2048b327],
4	to	TO	O	to	_	0	SENT_369	[p18l2087t288r2141b326],
5	low-dose	JJ	O	low-dose	amod	6	SENT_369	[p18l132t359r389b411],
6	aspirin	NN	O	aspirin	prep_to	3	SENT_369	[p18l423t361r612b430],
7	is	VBZ	O	be	auxpass	8	SENT_369	[p18l644t361r685b411],
8	associated	VBN	O	associate	_	0	SENT_369	[p18l720t358r1002b411],
9	with	IN	O	with	_	0	SENT_369	[p18l1031t358r1160b411],
10	platelet	NN	O	platelet	nn	11	SENT_369	[p18l1192t359r1401b430],
11	PIA1	NN	O	pia1	prep_with	8	SENT_369	[p18l1432t348r1554b411],
12	(	CD	NUMBER	(	num	13	SENT_369	[p18l1592t357r1842b423],
13	GPIlIa	NN	O	gpilium	nn	23	SENT_369	[p18l1592t357r1842b423],
14	)	CD	NUMBER	)	num	15	SENT_369	[p18l1592t357r1842b423],
15	polymorphism	NN	O	polymorphism	dep	13	SENT_369	[p18l1876t359r2140b430, p18l132t443r306b515],
16	but	CC	O	but	_	0	SENT_369	[p18l334t443r428b497],
17	not	RB	O	not	neg	18	SENT_369	[p18l457t457r550b496],
18	with	IN	O	with	nn	23	SENT_369	[p18l574t443r704b497],
19	C807T	NN	O	c807t	nn	22	SENT_369	[p18l733t442r940b497],
20	(	CD	NUMBER	(	num	22	SENT_369	[p18l969t442r1089b508],
21	GP	NN	O	gp	nn	22	SENT_369	[p18l969t442r1089b508],
22	Ia/Ila	NN	O	ia/ila	pobj	18	SENT_369	[p18l1117t442r1301b508],
23	)	NN	O	)	dep	11	SENT_369	[p18l1117t442r1301b508],
24	and	CC	O	and	_	0	SENT_369	[p18l1333t443r1435b497],
25	C-5T	NN	O	c-5t	nn	26	SENT_369	[p18l1465t442r1629b497],
26	Kozak	NN	PERSON	kozak	conj_and	11	SENT_369	[p18l1658t443r1839b496],
27	(	CD	NUMBER	(	num	31	SENT_369	[p18l1867t442r1987b508],
28	GP	NN	O	gp	nn	31	SENT_369	[p18l1867t442r1987b508],
29	Iba	NN	O	iba	nn	31	SENT_369	[p18l2015t442r2139b508],
30	)	CD	NUMBER	)	num	31	SENT_369	[p18l2015t442r2139b508],
31	polymorphisms	NNS	O	polymorphism	dep	26	SENT_369	[p18l132t528r585b599],
32	.	.	O	.	_	0	SENT_369	[p18l132t528r585b599],

1	J	NNP	O	J	nn	4	SENT_370	[p18l608t528r636b595],
2	Am	NNP	O	Am	nn	4	SENT_370	[p18l661t526r770b580],
3	Coll	NNP	O	Coll	nn	4	SENT_370	[p18l798t527r920b581],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_370	[p18l947t527r1161b581],
5	2003	CD	DATE	2003	num	4	SENT_370	[p18l1185t527r1662b593],
6	;	:	O	;	_	0	SENT_370	[p18l1185t527r1662b593],
7	42:1115	CD	NUMBER	42:1115	number	8	SENT_370	[p18l1185t527r1662b593],
8	-9	CD	NUMBER	-9	dep	4	SENT_370	[p18l1185t527r1662b593],
9	.	.	O	.	_	0	SENT_370	[p18l1185t527r1662b593],

1	Moshfegh	NNP	O	Moshfegh	nn	2	SENT_371	[p18l132t612r425b683],
2	K	NNP	O	K	_	0	SENT_371	[p18l467t612r529b677],
3	,	,	O	,	_	0	SENT_371	[p18l467t612r529b677],
4	Redondo	NNP	LOCATION	Redondo	nn	5	SENT_371	[p18l573t612r830b665],
5	M	NNP	O	M	appos	2	SENT_371	[p18l870t612r955b677],
6	,	,	O	,	_	0	SENT_371	[p18l870t612r955b677],
7	Julmy	NNP	O	Julmy	nn	8	SENT_371	[p18l990t612r1164b683],
8	F	NN	O	f	appos	2	SENT_371	[p18l1201t612r1257b677],
9	,	,	O	,	_	0	SENT_371	[p18l1201t612r1257b677],
10	et	FW	O	et	nn	11	SENT_371	[p18l1300t626r1351b665],
11	al.	FW	O	al.	appos	2	SENT_371	[p18l1391t612r1450b665],
12	.	.	O	.	_	0	SENT_371	[p18l1391t612r1450b665],

1	Antiplatelet	JJ	O	antiplatelet	amod	2	SENT_372	[p18l1492t611r1835b684],
2	effects	NNS	O	effect	nsubj	5	SENT_372	[p18l1875t612r2046b665],
3	of	IN	O	of	_	0	SENT_372	[p18l2088t612r2152b665],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_372	[p18l133t697r450b769],
5	compared	VBN	O	compare	_	0	SENT_372	[p18l489t697r767b769],
6	with	IN	O	with	_	0	SENT_372	[p18l803t697r932b750],
7	aspirin	NN	O	aspirin	prep_with	5	SENT_372	[p18l972t699r1161b769],
8	after	IN	O	after	_	0	SENT_372	[p18l1201t697r1328b750],
9	myocardial	JJ	O	myocardial	amod	10	SENT_372	[p18l1367t697r1677b768],
10	infarction	NN	O	infarction	prep_after	5	SENT_372	[p18l1715t697r2005b750],
11	:	:	O	:	_	0	SENT_372	[p18l1715t697r2005b750],
12	enhanced	VBN	O	enhance	amod	14	SENT_372	[p18l2048t718r2139b750, p18l133t781r334b834],
13	inhibitory	JJ	O	inhibitory	amod	14	SENT_372	[p18l361t781r644b853],
14	effects	NNS	O	effect	dep	10	SENT_372	[p18l669t781r840b834],
15	of	IN	O	of	_	0	SENT_372	[p18l870t781r934b834],
16	combination	NN	O	combination	nn	17	SENT_372	[p18l952t781r1309b834],
17	therapy	NN	O	therapy	prep_of	14	SENT_372	[p18l1337t781r1563b853],
18	.	.	O	.	_	0	SENT_372	[p18l1337t781r1563b853],

1	J	NNP	O	J	nn	4	SENT_373	[p18l1586t782r1615b849],
2	Am	NNP	O	Am	nn	4	SENT_373	[p18l1640t780r1749b833],
3	Coll	NNP	O	Coll	nn	4	SENT_373	[p18l1779t781r1901b834],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_373	[p18l1929t781r2143b834],
5	2000	CD	DATE	2000	num	4	SENT_373	[p18l131t865r652b928],
6	;	:	O	;	_	0	SENT_373	[p18l131t865r652b928],
7	36:699	CD	NUMBER	36:699	number	8	SENT_373	[p18l131t865r652b928],
8	-705	CD	NUMBER	-705	dep	4	SENT_373	[p18l131t865r652b928],
9	.	.	O	.	_	0	SENT_373	[p18l131t865r652b928],

